CHEBI ONTOLOGY - ANNOTATIONS |
|
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
| Term: | nematicide |
|
| Accession: | CHEBI:25491
|
browse the term
|
| Definition: | A substance used to destroy pests of the phylum Nematoda (roundworms). |
| Synonyms: | related_synonym: | nematicides; nematocide; nematocides |
| | xref: | wikipedia.en:Nematicide |
|
|
|
|
| G
|
Alb
|
albumin
|
increases expression
|
ISO
|
1,3-dichloro-1-propene results in increased expression of ALB protein
|
CTD |
PMID:2015207 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
multiple interactions
|
EXP
|
GSTT1 protein affects the metabolism of and results in increased activity of 1,3-dichloro-1-propene
|
CTD |
PMID:15790493 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
affects sulfation
|
ISO
|
ABCC1 protein affects the sulfation of 2-naphthol
|
CTD |
PMID:14742140 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO
|
[2-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA
|
CTD |
PMID:27837168 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
EXP
|
2-naphthol inhibits the reaction [Metribolone binds to AR protein]
|
CTD |
PMID:3695475 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Ces1d
|
carboxylesterase 1D
|
affects metabolic processing
|
ISO
|
CES1 protein affects the metabolism of 2-naphthol
|
CTD |
PMID:12837533 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases abundance
|
ISO
|
CYP1A1 protein results in increased abundance of 2-naphthol
|
CTD |
PMID:16243959 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases abundance affects binding decreases activity
|
ISO
|
CYP1A2 protein results in increased abundance of 2-naphthol 2-naphthol binds to CYP1A2 protein 2-naphthol results in decreased activity of CYP1A2 protein
|
CTD |
PMID:15916432 PMID:16243959 PMID:32278787 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
multiple interactions
|
ISO
|
[2-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA
|
CTD |
PMID:27837168 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases abundance
|
ISO
|
CYP2B6 protein results in increased abundance of 2-naphthol
|
CTD |
PMID:16243959 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
increases abundance
|
ISO
|
CYP2E1 protein results in increased abundance of 2-naphthol
|
CTD |
PMID:16243959 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases abundance
|
ISO
|
CYP3A4 protein results in increased abundance of 2-naphthol
|
CTD |
PMID:16243959 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Sult4a1
|
sulfotransferase family 4A, member 1
|
increases metabolic processing
|
ISO
|
SULT4A1 protein results in increased metabolism of 2-naphthol
|
CTD |
PMID:12039030 |
|
NCBI chr 7:117,096,064...117,120,714
Ensembl chr 7:117,096,064...117,120,083
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions
|
ISO
|
2-naphthol binds to and results in decreased activity of THRB protein
|
CTD |
PMID:18584933 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1
|
increases glucuronidation
|
EXP
|
UGT2B1 protein results in increased glucuronidation of 2-naphthol
|
CTD |
PMID:8302279 |
|
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331
|
|
| G
|
Ugt2b15
|
UDP glucuronosyltransferase family 2 member B15
|
increases metabolic processing
|
EXP
|
UGT2B15 protein results in increased metabolism of 2-naphthol
|
CTD |
PMID:7574722 |
|
NCBI chr14:21,122,866...21,138,450
Ensembl chr14:21,122,861...21,138,467
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions increases expression decreases response to substance decreases expression decreases activity
|
ISO EXP
|
abamectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] abamectin results in increased expression of ABCB1A mRNA [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of ABCB1A mRNA]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of ABCB1A mRNA]; Sesame Oil inhibits the reaction [abamectin results in increased expression of ABCB1A mRNA] ABCB1A protein results in decreased susceptibility to abamectin abamectin results in decreased expression of ABCB1A protein abamectin results in decreased activity of ABCB1A protein abamectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride] abamectin results in decreased activity of ABCB1 protein
|
CTD |
PMID:9144452 PMID:17134887 PMID:19879343 PMID:25865432 PMID:31739238 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
multiple interactions decreases activity
|
ISO
|
abamectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] abamectin results in decreased activity of ABCC1 protein
|
CTD |
PMID:25865432 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Actb
|
actin, beta
|
decreases expression
|
ISO
|
abamectin results in decreased expression of ACTB protein
|
CTD |
PMID:19879343 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases expression
|
ISO
|
abamectin results in decreased expression of AKT1 protein
|
CTD |
PMID:30958899 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Ano1
|
anoctamin 1
|
decreases activity
|
ISO
|
abamectin results in decreased activity of ANO1 protein
|
CTD |
PMID:32201246 |
|
NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550
|
|
| G
|
Atf6
|
activating transcription factor 6
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of BAX mRNA]; Hesperidin inhibits the reaction [abamectin results in increased expression of BAX protein] abamectin results in increased expression of BAX mRNA; abamectin results in increased expression of BAX protein
|
CTD |
PMID:34748272 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions decreases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 protein] abamectin results in decreased expression of BCL2 mRNA; abamectin results in decreased expression of BCL2 protein
|
CTD |
PMID:34748272 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Becn1
|
beclin 1
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of BECN1 protein Hesperidin inhibits the reaction [abamectin results in increased expression of BECN1 protein]
|
CTD |
PMID:34748272 |
|
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Casp3
|
caspase 3
|
increases activity increases expression multiple interactions
|
ISO EXP
|
abamectin results in increased activity of CASP3 protein abamectin results in increased expression of CASP3 mRNA; abamectin results in increased expression of CASP3 protein [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [abamectin results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Sesame Oil inhibits the reaction [abamectin results in increased expression of CASP3 protein]
|
CTD |
PMID:30958899 PMID:31739238 PMID:34748272 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cat
|
catalase
|
decreases activity multiple interactions increases activity
|
EXP
|
abamectin results in decreased activity of CAT protein [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased activity of CAT protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased activity of CAT protein]; Hesperidin inhibits the reaction [abamectin results in decreased activity of CAT protein]; Sesame Oil inhibits the reaction [abamectin results in increased activity of CAT protein]
|
CTD |
PMID:31739238 PMID:34748272 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions increases expression
|
EXP
|
[Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]; Sesame Oil inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]
|
CTD |
PMID:31739238 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of EIF2AK3 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of EIF2AK3 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of ERN1 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of ERN1 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in decreased expression of HMOX1 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of HSPA5 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of HSPA5 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of IL1B mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of IL1B mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of IL6 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Jak2
|
Janus kinase 2
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of JAK2 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of JAK2 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
multiple interactions increases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of MAPK14 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of MAPK14 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions decreases expression
|
EXP
|
Hesperidin inhibits the reaction [abamectin results in decreased expression of NFE2L2 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of NFKB1 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of NFKB1 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
ISO
|
abamectin inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; abamectin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
|
CTD |
PMID:25257666 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
| G
|
Sqstm1
|
sequestosome 1
|
decreases expression
|
ISO
|
abamectin results in decreased expression of SQSTM1 protein
|
CTD |
PMID:30958899 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of STAT3 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of STAT3 mRNA]
|
CTD |
PMID:34748272 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tnf
|
tumor necrosis factor
|
increases expression multiple interactions
|
EXP
|
abamectin results in increased expression of TNF mRNA; abamectin results in increased expression of TNF protein [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of TNF protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of TNF protein]; Hesperidin inhibits the reaction [abamectin results in increased expression of TNF mRNA]; Sesame Oil inhibits the reaction [abamectin results in increased expression of TNF protein]
|
CTD |
PMID:31739238 PMID:34748272 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tubb3
|
tubulin, beta 3 class III
|
decreases expression
|
ISO
|
abamectin results in decreased expression of TUBB3 protein
|
CTD |
PMID:19879343 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
EXP ISO
|
Aldicarb results in decreased activity of ACHE protein
|
CTD |
PMID:8134223 PMID:14644616 PMID:16256972 PMID:21251949 PMID:23962483 PMID:27132127 PMID:33844597 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of AGER mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
App
|
amyloid beta precursor protein
|
decreases response to substance
|
ISO
|
APP protein modified form results in decreased susceptibility to Aldicarb
|
CTD |
PMID:34902447 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of BAX protein robinin inhibits the reaction [Aldicarb results in increased expression of BAX protein]
|
CTD |
PMID:39889879 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
EXP
|
Aldicarb results in decreased expression of BCL2 protein robinin inhibits the reaction [Aldicarb results in decreased expression of BCL2 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CASP3 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CASP9 protein]
|
CTD |
PMID:39889879 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity
|
EXP
|
robinin inhibits the reaction [Aldicarb results in decreased activity of CAT protein]
|
CTD |
PMID:39889879 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CCL2 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
multiple interactions
|
EXP
|
Aldicarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
multiple interactions
|
EXP
|
Aldicarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Cst3
|
cystatin C
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CST3 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Aldicarb inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions decreases activity
|
EXP
|
robinin inhibits the reaction [Aldicarb results in decreased activity of GSR protein]
|
CTD |
PMID:39889879 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of HAVCR1 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of HMGB1 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases activity
|
EXP
|
robinin inhibits the reaction [Aldicarb results in decreased activity of HMOX1 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of IL1B mRNA robinin inhibits the reaction [Aldicarb results in increased expression of IL1B mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il2
|
interleukin 2
|
decreases response to substance
|
ISO
|
Aldicarb results in decreased susceptibility to IL2 protein
|
CTD |
PMID:8349949 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il6
|
interleukin 6
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of IL6 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of IL6 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
Aldicarb promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of MYD88 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of MYD88 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
increases phosphorylation
|
ISO
|
Aldicarb results in increased phosphorylation of NEFH protein
|
CTD |
PMID:16256972 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nrxn1
|
neurexin 1
|
multiple interactions
|
ISO
|
NRXN1 protein affects the reaction [NLG-1 results in increased susceptibility to Aldicarb]; NRXN1 protein affects the reaction [NRX-1 results in decreased susceptibility to Aldicarb]
|
CTD |
PMID:23638761 |
|
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
|
|
| G
|
Pax6
|
paired box 6
|
multiple interactions
|
ISO
|
Aldicarb inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of PAX6 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
Aldicarb inhibits the reaction [Progesterone results in increased activity of PGR protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Pon1
|
paraoxonase 1
|
multiple interactions
|
ISO EXP
|
[Calcium results in increased activity of PON1 protein] which results in decreased susceptibility to Aldicarb; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Aldicarb
|
CTD |
PMID:27132127 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of PTGS2 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of RELA mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of TLR4 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of TLR4 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of TNF mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Vpreb1a
|
V-set pre-B cell surrogate light chain 1A
|
decreases expression
|
ISO
|
Aldicarb results in decreased expression of VPREB1 mRNA
|
CTD |
PMID:25424538 |
|
NCBI chr11:97,631,174...97,632,051
Ensembl chr11:97,629,102...97,632,051
|
|
|
|
| G
|
Ercc6
|
ERCC excision repair 6, chromatin remodeling factor
|
affects response to substance
|
ISO
|
ERCC6 protein affects the susceptibility to ascaridole
|
CTD |
PMID:22280988 |
|
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895
|
|
| G
|
Xpc
|
XPC complex subunit, DNA damage recognition and repair factor
|
affects response to substance
|
ISO
|
XPC protein affects the susceptibility to ascaridole
|
CTD |
PMID:22280988 |
|
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
|
|
|
|
| G
|
Abi2
|
abl-interactor 2
|
increases expression
|
EXP
|
carbendazim results in increased expression of ABI2 mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
increases expression
|
ISO
|
carbendazim results in increased expression of ACACA mRNA
|
CTD |
PMID:26071454 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions
|
EXP
|
[carbendazim co-treated with mancozeb] results in increased activity of ACHE protein
|
CTD |
PMID:33217513 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
increases expression
|
ISO
|
carbendazim results in increased expression of AGPAT2 mRNA
|
CTD |
PMID:26071454 |
|
NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:29,814,924...29,826,581
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions affects localization
|
ISO
|
AHR protein affects the reaction [carbendazim results in increased expression of CYP1A1 protein] carbendazim affects the localization of AHR protein
|
CTD |
PMID:27286660 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Alb
|
albumin
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of ALB protein
|
CTD |
PMID:35437878 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Anxa10
|
annexin A10
|
increases expression
|
ISO
|
carbendazim results in increased expression of ANXA10 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
|
|
| G
|
Arg1
|
arginase 1
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of ARG1 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Bag1
|
BAG cochaperone 1
|
increases expression
|
EXP
|
carbendazim results in increased expression of BAG1 mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression
|
EXP
|
carbendazim results in increased expression of BAX mRNA; carbendazim results in increased expression of BAX protein
|
CTD |
PMID:35437878 PMID:35513110 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of BCL2 mRNA
|
CTD |
PMID:35437878 PMID:35513110 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l14
|
Bcl2-like 14
|
increases expression
|
EXP
|
carbendazim results in increased expression of BCL2L14 mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr 4:168,948,919...168,989,450
Ensembl chr 4:168,948,946...168,990,079
|
|
| G
|
Bub1b
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
increases activity
|
ISO
|
carbendazim results in increased activity of BUB1B protein
|
CTD |
PMID:37506866 |
|
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796
|
|
| G
|
Casp3
|
caspase 3
|
increases expression multiple interactions increases activity
|
EXP ISO
|
carbendazim results in increased expression of CASP3 protein Chitosan inhibits the reaction [carbendazim results in increased expression of CASP3 protein] carbendazim results in increased activity of CASP3 protein
|
CTD |
PMID:30851412 PMID:35705592 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cat
|
catalase
|
decreases activity decreases expression multiple interactions
|
EXP
|
carbendazim results in decreased activity of CAT protein carbendazim results in decreased expression of CAT protein [Chlorpyrifos co-treated with carbendazim] results in decreased activity of CAT protein; Chitosan inhibits the reaction [carbendazim results in decreased expression of CAT protein]
|
CTD |
PMID:27268782 PMID:35513110 PMID:35705592 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccnb1
|
cyclin B1
|
increases expression
|
ISO
|
carbendazim results in increased expression of CCNB1 protein
|
CTD |
PMID:37506866 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Clca2
|
chloride channel accessory 2
|
multiple interactions
|
EXP
|
[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of CLCA2 mRNA
|
CTD |
PMID:22382377 |
|
NCBI chr 2:236,655,419...236,682,669
Ensembl chr 2:236,639,545...236,685,129
|
|
| G
|
Cldn11
|
claudin 11
|
multiple interactions
|
EXP
|
[carbendazim co-treated with iprodione] results in decreased expression of CLDN11 protein
|
CTD |
PMID:28576679 |
|
NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539
|
|
| G
|
Clu
|
clusterin
|
decreases expression increases expression
|
EXP
|
carbendazim results in decreased expression of CLU mRNA carbendazim results in increased expression of CLU mRNA
|
CTD |
PMID:22952946 PMID:27466211 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
increases activity increases expression
|
ISO
|
carbendazim results in increased activity of CYP19A1 protein carbendazim results in increased expression of CYP19A1 mRNA
|
CTD |
PMID:14691014 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression multiple interactions
|
ISO EXP
|
carbendazim results in increased expression of CYP1A1 mRNA; carbendazim results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [carbendazim results in increased expression of CYP1A1 protein]; AHR protein affects the reaction [carbendazim results in increased expression of CYP1A1 protein]; salicylamide inhibits the reaction [carbendazim results in increased expression of CYP1A1 protein]
|
CTD |
PMID:10103034 PMID:21784029 PMID:27286660 PMID:32194361 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases expression
|
ISO
|
carbendazim results in increased expression of CYP1A2 mRNA; carbendazim results in increased expression of CYP1A2 protein
|
CTD |
PMID:21784029 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases expression
|
ISO
|
carbendazim results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of CYP2C19 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
decreases activity
|
ISO
|
carbendazim results in decreased activity of CYP2D6 protein
|
CTD |
PMID:20183062 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases expression
|
ISO
|
carbendazim results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of CYP7A1 mRNA; carbendazim results in decreased expression of CYP7A1 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
increases expression
|
ISO
|
carbendazim results in increased expression of DGAT1 mRNA
|
CTD |
PMID:26071454 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
|
|
| G
|
Dgat2
|
diacylglycerol O-acyltransferase 2
|
increases expression
|
ISO
|
carbendazim results in increased expression of DGAT2 mRNA
|
CTD |
PMID:26071454 |
|
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:162,866,237...162,896,566
|
|
| G
|
Dnaaf11
|
dynein axonemal assembly factor 11
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of DNAAF11 mRNA
|
CTD |
PMID:27466211 |
|
NCBI chr 7:100,033,843...100,134,979
Ensembl chr 7:100,034,202...100,135,179
|
|
| G
|
Dpp7
|
dipeptidylpeptidase 7
|
multiple interactions
|
EXP
|
[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of DPP7 mRNA
|
CTD |
PMID:22382377 |
|
NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492
|
|
| G
|
Esr1
|
estrogen receptor 1
|
decreases expression affects localization
|
EXP ISO
|
carbendazim results in decreased expression of ESR1 mRNA carbendazim affects the localization of ESR1 protein
|
CTD |
PMID:28576679 PMID:37506866 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of ESR2 mRNA
|
CTD |
PMID:28576679 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fabp9
|
fatty acid binding protein 9
|
multiple interactions decreases expression
|
EXP
|
Carnitine inhibits the reaction [carbendazim results in decreased expression of FABP9 mRNA]; Carnitine inhibits the reaction [carbendazim results in decreased expression of FABP9 protein] carbendazim results in decreased expression of FABP9 mRNA; carbendazim results in decreased expression of FABP9 protein
|
CTD |
PMID:33965443 |
|
NCBI chr 2:93,499,136...93,503,267
Ensembl chr 2:93,499,134...93,503,260
|
|
| G
|
Fank1
|
fibronectin type III and ankyrin repeat domains 1
|
increases expression
|
EXP
|
carbendazim results in increased expression of FANK1 mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr 1:198,007,496...198,114,790
Ensembl chr 1:198,007,547...198,115,561
|
|
| G
|
Foxa2
|
forkhead box A2
|
increases expression
|
ISO
|
carbendazim results in increased expression of FOXA2 mRNA
|
CTD |
PMID:26071454 |
|
NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:155,923,307...155,928,757
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
decreases expression multiple interactions
|
EXP
|
carbendazim results in decreased expression of FSHB protein Carnitine inhibits the reaction [carbendazim results in decreased expression of FSHB protein]
|
CTD |
PMID:33965443 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of G6PC1 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
increases expression
|
EXP
|
carbendazim results in increased expression of GFAP protein
|
CTD |
PMID:35513110 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
multiple interactions
|
EXP
|
[carbendazim co-treated with iprodione] results in decreased expression of GJA1 protein
|
CTD |
PMID:28576679 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
increases secretion multiple interactions
|
EXP
|
carbendazim results in increased secretion of GOT1 protein Chitosan inhibits the reaction [carbendazim results in increased secretion of GOT1 protein]
|
CTD |
PMID:35705592 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
increases expression increases secretion multiple interactions
|
EXP
|
carbendazim results in increased expression of GPT protein carbendazim results in increased secretion of GPT protein Chitosan inhibits the reaction [carbendazim results in increased secretion of GPT protein]
|
CTD |
PMID:35437878 PMID:35705592 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases expression
|
EXP
|
Chitosan inhibits the reaction [carbendazim results in decreased expression of HMOX1 mRNA]
|
CTD |
PMID:35705592 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Ift81
|
intraflagellar transport 81
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of IFT81 mRNA
|
CTD |
PMID:22952946 PMID:27466211 |
|
NCBI chr12:39,618,559...39,697,971
Ensembl chr12:39,618,651...39,697,962
|
|
| G
|
Il10
|
interleukin 10
|
multiple interactions decreases expression
|
EXP
|
Carnitine inhibits the reaction [carbendazim results in decreased expression of IL10 protein]
|
CTD |
PMID:33965443 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases expression
|
ISO EXP
|
carbendazim results in increased expression of IL1B mRNA; carbendazim results in increased expression of IL1B protein
|
CTD |
PMID:26071454 PMID:35513110 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
increases expression multiple interactions
|
ISO EXP
|
carbendazim results in increased expression of IL6 mRNA; carbendazim results in increased expression of IL6 protein Carnitine inhibits the reaction [carbendazim results in increased expression of IL6 protein]
|
CTD |
PMID:26071454 PMID:33965443 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Itga5
|
integrin subunit alpha 5
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of ITGA5 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
|
|
| G
|
Itgb1
|
integrin subunit beta 1
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of ITGB1 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions increases expression
|
EXP
|
Chitosan inhibits the reaction [carbendazim results in increased expression of KEAP1 mRNA]
|
CTD |
PMID:35705592 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
decreases expression multiple interactions
|
EXP
|
carbendazim results in decreased expression of LHB protein Carnitine inhibits the reaction [carbendazim results in decreased expression of LHB protein]
|
CTD |
PMID:33965443 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Loxl1
|
lysyl oxidase-like 1
|
multiple interactions increases expression
|
EXP
|
2,5-hexanedione promotes the reaction [carbendazim results in increased expression of LOXL1 protein]; [carbendazim co-treated with 2,5-hexanedione] results in decreased expression of LOXL1 mRNA
|
CTD |
PMID:22382377 |
|
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
|
|
| G
|
Lpl
|
lipoprotein lipase
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of LPL protein
|
CTD |
PMID:30496565 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Macrod1
|
mono-ADP ribosylhydrolase 1
|
multiple interactions
|
EXP
|
[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of MACROD1 mRNA
|
CTD |
PMID:22382377 |
|
NCBI chr 1:213,675,413...213,831,571
Ensembl chr 1:213,675,406...213,816,348
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
affects localization
|
ISO
|
carbendazim affects the localization of MAPK1 protein modified form
|
CTD |
PMID:37506866 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
affects localization
|
ISO
|
carbendazim affects the localization of MAPK3 protein modified form
|
CTD |
PMID:37506866 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases expression
|
EXP
|
carbendazim results in increased expression of MAPK8 mRNA
|
CTD |
PMID:35513110 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mfap3l
|
microfibril associated protein 3 like
|
increases expression
|
EXP
|
carbendazim results in increased expression of MFAP3L mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr16:34,422,490...34,465,544
Ensembl chr16:34,426,696...34,441,709
|
|
| G
|
Mir128-1
|
microRNA 128-1
|
increases expression
|
EXP
|
carbendazim results in increased expression of MIR128-1 mRNA
|
CTD |
PMID:32418910 |
|
NCBI chr13:42,251,884...42,251,965
Ensembl chr13:42,251,884...42,251,965
|
|
| G
|
Mir423
|
microRNA 423
|
increases expression
|
EXP
|
carbendazim results in increased expression of MIR423 mRNA
|
CTD |
PMID:32418910 |
|
NCBI chr10:62,412,272...62,412,350
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of MMP2 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of MMP9 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions increases activity
|
EXP
|
[Chlorpyrifos co-treated with carbendazim] results in increased activity of MPO protein carbendazim results in increased activity of MPO protein
|
CTD |
PMID:27268782 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases expression multiple interactions decreases expression
|
ISO EXP
|
carbendazim results in increased expression of NFE2L2 protein Chitosan inhibits the reaction [carbendazim results in decreased expression of NFE2L2 mRNA]
|
CTD |
PMID:30851412 PMID:35705592 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions increases expression
|
EXP
|
Carnitine inhibits the reaction [carbendazim results in increased expression of NOS2 protein]; Chitosan inhibits the reaction [carbendazim results in increased expression of NOS2 protein]
|
CTD |
PMID:33965443 PMID:35705592 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
ISO
|
carbendazim inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
|
CTD |
PMID:25257666 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
| G
|
Ocln
|
occludin
|
decreases expression multiple interactions
|
EXP
|
carbendazim results in decreased expression of OCLN protein Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein]
|
CTD |
PMID:33965443 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
| G
|
Pim1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
increases expression
|
EXP
|
carbendazim results in increased expression of PIM1 mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
decreases expression
|
ISO
|
carbendazim results in decreased expression of PLAU mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Ptgds
|
prostaglandin D2 synthase
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of PTGDS mRNA
|
CTD |
PMID:22952946 |
|
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:28,680,044...28,682,978
|
|
| G
|
Pttg1
|
PTTG1 regulator of sister chromatid separation, securin
|
increases expression
|
ISO
|
carbendazim results in increased expression of PTTG1 protein
|
CTD |
PMID:37506866 |
|
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases expression multiple interactions
|
EXP
|
carbendazim results in increased expression of RELA protein Carnitine inhibits the reaction [carbendazim results in increased expression of RELA protein]
|
CTD |
PMID:33965443 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Serpine2
|
serpin family E member 2
|
increases expression
|
ISO
|
carbendazim results in increased expression of SERPINE2 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
|
|
| G
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3
|
multiple interactions
|
EXP
|
[carbendazim co-treated with 2,5-hexanedione] affects the expression of SHANK3 mRNA
|
CTD |
PMID:22382377 |
|
NCBI chr 7:122,448,323...122,518,623
Ensembl chr 7:122,448,323...122,510,410
|
|
| G
|
Sil1
|
SIL1 nucleotide exchange factor
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of SIL1 mRNA
|
CTD |
PMID:22952946 PMID:27466211 |
|
NCBI chr18:27,146,526...27,378,459
Ensembl chr18:27,146,527...27,307,693
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
increases expression
|
EXP
|
carbendazim results in increased expression of SOD3 mRNA
|
CTD |
PMID:27466211 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
increases expression
|
ISO
|
carbendazim results in increased expression of SREBF1 mRNA
|
CTD |
PMID:26071454 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
decreases expression multiple interactions
|
EXP
|
carbendazim results in decreased expression of STAR mRNA; carbendazim results in decreased expression of STAR protein Carnitine inhibits the reaction [carbendazim results in decreased expression of STAR mRNA]; Carnitine inhibits the reaction [carbendazim results in decreased expression of STAR protein]
|
CTD |
PMID:33965443 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Tbc1d5
|
TBC1 domain family, member 5
|
decreases expression
|
EXP
|
carbendazim results in decreased expression of TBC1D5 mRNA
|
CTD |
PMID:27466211 |
|
NCBI chr 9:3,740,032...4,256,971
Ensembl chr 9:3,750,325...4,253,581
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
ISO
|
carbendazim results in increased expression of TIMP1 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
increases expression
|
ISO
|
carbendazim results in increased expression of TIMP2 mRNA
|
CTD |
PMID:25530041 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP
|
Carnitine inhibits the reaction [carbendazim results in increased expression of TNF protein]
|
CTD |
PMID:33965443 PMID:35437878 PMID:35513110 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnp1
|
transition protein 1
|
increases expression
|
EXP
|
carbendazim results in increased expression of TNP1 mRNA
|
CTD |
PMID:28576679 |
|
NCBI chr 9:82,043,669...82,044,278
Ensembl chr 9:82,043,672...82,044,278
|
|
| G
|
Tnp2
|
transition protein 2
|
increases expression
|
EXP
|
carbendazim results in increased expression of TNP2 mRNA
|
CTD |
PMID:28576679 |
|
NCBI chr10:5,386,735...5,387,463
Ensembl chr10:5,383,885...5,387,467
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression affects activity
|
EXP ISO
|
carbendazim results in increased expression of TP53 mRNA carbendazim affects the activity of TP53 protein
|
CTD |
PMID:35435491 PMID:35513110 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
increases expression
|
EXP
|
carbendazim results in increased expression of TSHB protein
|
CTD |
PMID:33965443 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
|
|
|
|
| G
|
A4galt
|
alpha 1,4-galactosyltransferase
|
affects response to substance
|
ISO
|
A4GALT gene SNP affects the susceptibility to Carbofuran
|
CTD |
PMID:22919386 |
|
NCBI chr 7:116,248,571...116,272,917
Ensembl chr 7:116,247,880...116,273,171
|
|
| G
|
Abhd2
|
abhydrolase domain containing 2, acylglycerol lipase
|
increases expression
|
EXP
|
Carbofuran results in increased expression of ABHD2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO EXP
|
Carbofuran results in decreased activity of ACHE protein
|
CTD |
PMID:7966439 PMID:10918524 PMID:19934164 PMID:22209767 PMID:22807346 PMID:23611293 PMID:23962483 PMID:28725974 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Adam8
|
ADAM metallopeptidase domain 8
|
increases expression
|
EXP
|
Carbofuran results in increased expression of ADAM8 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485
|
|
| G
|
Alb
|
albumin
|
affects binding increases secretion multiple interactions
|
ISO EXP
|
Carbofuran binds to ALB protein Carbofuran results in increased secretion of ALB protein Plant Extracts inhibits the reaction [Carbofuran results in increased secretion of ALB protein]; Silymarin inhibits the reaction [Carbofuran results in increased secretion of ALB protein]
|
CTD |
PMID:27657490 PMID:34264070 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
EXP
|
Carbofuran results in increased expression of BAX protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased expression of BAX protein]
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcat1
|
branched chain amino acid transaminase 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of BCAT1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
| G
|
Bche
|
butyrylcholinesterase
|
decreases activity multiple interactions
|
ISO EXP
|
Carbofuran results in decreased activity of BCHE protein [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
|
CTD |
PMID:17364237 PMID:22209767 PMID:22649187 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of BCL2 protein
|
CTD |
PMID:30471306 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Carbofuran results in decreased expression of CASP3 protein modified form 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased expression of CASP3 protein modified form] Carbofuran results in increased cleavage of and results in increased activity of CASP3 protein
|
CTD |
PMID:22240977 PMID:25564422 PMID:28982980 PMID:30471306 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity
|
EXP
|
Plant Extracts inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]
|
CTD |
PMID:22807346 PMID:24865641 PMID:31334637 PMID:31696704 PMID:34264070 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CCL7 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression multiple interactions
|
EXP
|
Carbofuran results in decreased expression of CCND1 mRNA; Carbofuran results in decreased expression of CCND1 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in decreased expression of CCND1 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CCR1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Cd14
|
CD14 molecule
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CD14 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cdk7
|
cyclin-dependent kinase 7
|
affects response to substance
|
ISO
|
CDK7 gene SNP affects the susceptibility to Carbofuran
|
CTD |
PMID:22102698 |
|
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
EXP
|
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased expression of CDKN1A protein] Carbofuran results in increased expression of CDKN1A mRNA; Carbofuran results in increased expression of CDKN1A protein
|
CTD |
PMID:28982980 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Ch25h
|
cholesterol 25-hydroxylase
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CH25H mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190
|
|
| G
|
Cnp
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of CNP mRNA; Carbofuran results in decreased expression of CNP protein
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063
|
|
| G
|
Crem
|
cAMP responsive element modulator
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CREM mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases hydroxylation
|
ISO
|
CYP1A2 protein results in increased hydroxylation of Carbofuran
|
CTD |
PMID:15560889 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity increases expression
|
ISO
|
Carbofuran results in increased activity of CYP2B6 protein Carbofuran results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
increases hydroxylation
|
ISO
|
CYP2C19 protein results in increased hydroxylation of Carbofuran
|
CTD |
PMID:15560889 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases hydroxylation multiple interactions increases expression increases chemical synthesis increases activity
|
ISO
|
CYP3A4 protein results in increased hydroxylation of Carbofuran [CYP3A4 protein results in increased metabolism of benfuracarb] which results in increased chemical synthesis of Carbofuran; Carbofuran promotes the reaction [CYP3A4 protein affects the metabolism of Testosterone]; Chlorpyrifos inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Carbofuran]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Carbofuran] Carbofuran results in increased expression of CYP3A4 mRNA CYP3A4 protein results in increased chemical synthesis of Carbofuran Carbofuran results in increased activity of CYP3A4 protein
|
CTD |
PMID:15560889 PMID:22310298 PMID:24016712 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Dcx
|
doublecortin
|
decreases expression multiple interactions
|
EXP
|
Carbofuran results in decreased expression of DCX mRNA; Carbofuran results in decreased expression of DCX protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in decreased expression of DCX protein]
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161
|
|
| G
|
Fabp3
|
fatty acid binding protein 3
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FABP3 protein
|
CTD |
PMID:19854236 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
|
|
| G
|
Fcgr2b
|
Fc gamma receptor 2B
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FCGR2B mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517
|
|
| G
|
Fhl1
|
four and a half LIM domains 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FHL1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FOSL1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
decreases expression increases expression
|
EXP
|
Carbofuran results in decreased expression of GFAP protein Carbofuran results in increased expression of GFAP mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases activity
|
EXP
|
Plant Extracts inhibits the reaction [Carbofuran results in increased activity of GPT protein]; Silymarin inhibits the reaction [Carbofuran results in increased activity of GPT protein]
|
CTD |
PMID:19778259 PMID:31334637 PMID:31696704 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of GRIA2 protein
|
CTD |
PMID:28725974 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
increases expression
|
EXP
|
Carbofuran results in increased expression of HAMP mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hspa2
|
heat shock protein family A (Hsp70) member 2
|
increases expression
|
EXP
|
Carbofuran results in increased expression of HSPA2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
|
|
| G
|
Il2
|
interleukin 2
|
decreases response to substance
|
ISO
|
Carbofuran results in decreased susceptibility to IL2 protein
|
CTD |
PMID:8349949 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Klhl40
|
kelch-like family member 40
|
increases expression
|
EXP
|
Carbofuran results in increased expression of KLHL40 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 8:130,318,793...130,324,309
Ensembl chr 8:130,318,794...130,326,299
|
|
| G
|
Klhl41
|
kelch-like family member 41
|
increases expression
|
EXP
|
Carbofuran results in increased expression of KLHL41 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 3:74,842,118...74,855,244
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
affects response to substance
|
ISO
|
LDLR gene SNP affects the susceptibility to Carbofuran
|
CTD |
PMID:22919386 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lmcd1
|
LIM and cysteine-rich domains 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of LMCD1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
|
|
| G
|
Mag
|
myelin-associated glycoprotein
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of MAG mRNA; Carbofuran results in decreased expression of MAG protein
|
CTD |
PMID:30471306 |
|
NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:95,275,635...95,291,060
|
|
| G
|
Mbp
|
myelin basic protein
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of MBP mRNA; Carbofuran results in decreased expression of MBP protein
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mtnr1a
|
melatonin receptor 1A
|
affects binding multiple interactions
|
ISO
|
Carbofuran binds to MTNR1A protein Carbofuran inhibits the reaction [Melatonin binds to MTNR1A protein]
|
CTD |
PMID:28027439 |
|
NCBI chr16:53,876,964...53,896,421
Ensembl chr16:53,876,964...53,896,421
|
|
| G
|
Mtnr1b
|
melatonin receptor 1B
|
affects binding multiple interactions
|
ISO
|
Carbofuran binds to MTNR1B protein Carbofuran inhibits the reaction [Melatonin binds to MTNR1B protein]; Guanosine Triphosphate inhibits the reaction [Carbofuran inhibits the reaction [Melatonin binds to MTNR1B protein]]
|
CTD |
PMID:28027439 |
|
NCBI chr 8:20,919,593...20,934,109
Ensembl chr 8:20,919,593...20,934,109
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression multiple interactions
|
EXP ISO
|
Carbofuran results in increased expression of MYC mRNA Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of MYC gene
|
CTD |
PMID:20211217 PMID:22445671 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myl1
|
myosin, light chain 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of MYL1 protein
|
CTD |
PMID:19854236 |
|
Ensembl chr 9:75,887,227...75,907,971
|
|
| G
|
Myrf
|
myelin regulatory factor
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of MYRF mRNA
|
CTD |
PMID:30471306 |
|
NCBI chr 1:216,279,057...216,311,155
Ensembl chr 1:216,279,057...216,311,178
|
|
| G
|
Nes
|
nestin
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NES mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Neurod1
|
neuronal differentiation 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NEUROD1 mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810
|
|
| G
|
Neurog2
|
neurogenin 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NEUROG2 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr 2:218,767,205...218,769,772
Ensembl chr 2:218,765,949...218,769,784
|
|
| G
|
Nrg1
|
neuregulin 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NRG1 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Olig1
|
oligodendrocyte transcription factor 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of OLIG1 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr11:44,000,450...44,002,592
Ensembl chr11:44,000,281...44,002,592
|
|
| G
|
Olig2
|
oligodendrocyte transcription factor 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of OLIG2 mRNA; Carbofuran results in decreased expression of OLIG2 protein
|
CTD |
PMID:30471306 |
|
NCBI chr11:43,961,585...43,964,961
Ensembl chr11:43,958,940...43,968,634
|
|
| G
|
Pax6
|
paired box 6
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of PAX6 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of PDGFRA mRNA; Carbofuran results in decreased expression of PDGFRA protein
|
CTD |
PMID:30471306 |
|
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
increases expression
|
EXP
|
Carbofuran results in increased expression of PLA2G4A mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
increases expression
|
EXP
|
Carbofuran results in increased expression of PLAU mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plp1
|
proteolipid protein 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of PLP1 mRNA; Carbofuran results in decreased expression of PLP1 protein
|
CTD |
PMID:30471306 |
|
NCBI chr X:104,933,921...104,993,317
Ensembl chr X:104,975,780...104,993,314
|
|
| G
|
Pvr
|
PVR cell adhesion molecule
|
increases expression
|
EXP
|
Carbofuran results in increased expression of PVR mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:88,689,235...88,704,641
Ensembl chr 1:88,688,981...88,704,630
|
|
| G
|
Rbfox3
|
RNA binding fox-1 homolog 3
|
decreases expression multiple interactions
|
EXP
|
Carbofuran results in decreased expression of RBFOX3 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in decreased expression of RBFOX3 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945
|
|
| G
|
Reg3b
|
regenerating family member 3 beta
|
increases expression
|
EXP
|
Carbofuran results in increased expression of REG3B mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014
|
|
| G
|
Rnd1
|
Rho family GTPase 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of RND1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
increases expression
|
EXP
|
Carbofuran results in increased expression of S100B mRNA; Carbofuran results in increased expression of S100B protein
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Serpine1
|
serpin family E member 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of SERPINE1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Smad2
|
SMAD family member 2
|
increases expression multiple interactions increases phosphorylation
|
EXP
|
Carbofuran results in increased expression of SMAD2 mRNA 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Smad3
|
SMAD family member 3
|
increases expression multiple interactions increases phosphorylation
|
EXP
|
Carbofuran results in increased expression of SMAD3 mRNA 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smad7
|
SMAD family member 7
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of SMAD7 mRNA; Carbofuran results in decreased expression of SMAD7 protein
|
CTD |
PMID:28982980 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
|
|
| G
|
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of SMURF2 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr10:92,261,516...92,362,185
Ensembl chr10:92,261,525...92,362,552
|
|
| G
|
Sox2
|
SRY-box transcription factor 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of SOX2 protein
|
CTD |
PMID:22240977 |
|
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of SPP1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases expression
|
EXP
|
Carbofuran results in increased expression of STAT3 mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TGFB1 mRNA; Carbofuran results in increased expression of TGFB1 protein
|
CTD |
PMID:28982980 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TGFB2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tiam1
|
TIAM Rac1 associated GEF 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TIAM1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr11:42,517,527...42,866,280
Ensembl chr11:42,517,528...42,646,075
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TIMP1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TNNI3 protein
|
CTD |
PMID:19854236 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TNNT2 protein
|
CTD |
PMID:19854236 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
ISO
|
Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of TP53 gene
|
CTD |
PMID:22445671 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tubb3
|
tubulin, beta 3 class III
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of TUBB3 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
| G
|
Tubb6
|
tubulin, beta 6 class V
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TUBB6 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303
|
|
| G
|
Uck2
|
uridine-cytidine kinase 2
|
increases expression
|
EXP
|
Carbofuran results in increased expression of UCK2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:81,913,732...81,971,036
Ensembl chr13:81,916,818...81,971,091
|
|
| G
|
Vcan
|
versican
|
increases expression decreases expression
|
EXP
|
Carbofuran results in increased expression of VCAN mRNA Carbofuran results in decreased expression of VCAN mRNA
|
CTD |
PMID:20211217 PMID:30471306 |
|
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
EXP ISO
|
carbosulfan results in decreased activity of ACHE protein carbosulfan metabolite results in decreased activity of ACHE protein; carbosulfan results in decreased activity of ACHE protein
|
CTD |
PMID:3710030 PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity increases metabolic processing increases expression
|
ISO
|
carbosulfan results in increased activity of CYP2B6 protein CYP2B6 protein results in increased metabolism of carbosulfan carbosulfan results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:20307514 PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions decreases activity increases activity increases expression
|
ISO
|
CYP3A4 protein results in increased metabolism of and results in increased activity of carbosulfan; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of carbosulfan] carbosulfan results in decreased activity of CYP3A4 protein carbosulfan results in increased activity of CYP3A4 protein carbosulfan results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:20307514 PMID:22310298 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
increases metabolic processing
|
ISO
|
CYP3A5 protein results in increased metabolism of carbosulfan
|
CTD |
PMID:20307514 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases expression
|
ISO
|
carbosulfan results in increased expression of NR1I3 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
|
|
| G
|
Aars1
|
alanyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of AARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497
|
|
| G
|
Acly
|
ATP citrate lyase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ACLY mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
|
|
| G
|
Acot13
|
acyl-CoA thioesterase 13
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ACOT13 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876
|
|
| G
|
Acp1
|
acid phosphatase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ACP1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959
|
|
| G
|
Actb
|
actin, beta
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ACTB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Actn1
|
actinin, alpha 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of ACTN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Actn4
|
actinin alpha 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ACTN4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320
|
|
| G
|
Actr2
|
actin related protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ACTR2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998
|
|
| G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ADAMTS1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
|
|
| G
|
Adm
|
adrenomedullin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ADM mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adsl
|
adenylosuccinate lyase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ADSL mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872
|
|
| G
|
Ahcy
|
adenosylhomocysteinase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of AHCY mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587
|
|
| G
|
Ahnak2
|
AHNAK nucleoprotein 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of AHNAK2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546
|
|
| G
|
Ahsa1
|
activator of Hsp90 ATPase activity 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AHSA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:112,644,479...112,655,595
|
|
| G
|
Aida
|
axin interactor, dorsalization associated
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AIDA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:97,471,931...97,499,531
Ensembl chr13:97,471,604...97,499,535
|
|
| G
|
Aire
|
autoimmune regulator
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AIRE mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:10,635,775...10,650,709
Ensembl chr20:10,635,775...10,650,709
|
|
| G
|
Akr1c2
|
aldo-keto reductase family 1, member C2
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of AKR1C2 mRNA chloropicrin results in increased expression of AKR1C2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686
|
|
| G
|
Akr1d1
|
aldo-keto reductase family 1, member D1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AKR1D1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540
|
|
| G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ALCAM mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
|
|
| G
|
Aldh1a3
|
aldehyde dehydrogenase 1 family, member A3
|
affects expression
|
ISO
|
chloropicrin affects the expression of ALDH1A3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777
|
|
| G
|
Aldh3a1
|
aldehyde dehydrogenase 3 family, member A1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ALDH3A1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151
|
|
| G
|
Aldh7a1
|
aldehyde dehydrogenase 7 family, member A1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ALDH7A1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of ALDOA mRNA chloropicrin results in decreased expression of ALDOA mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Alpp
|
alkaline phosphatase, placental
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ALPP mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451
|
|
| G
|
Ampd3
|
adenosine monophosphate deaminase 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AMPD3 mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608
|
|
| G
|
Angptl4
|
angiopoietin-like 4
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of ANGPTL4 mRNA chloropicrin results in decreased expression of ANGPTL4 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
|
|
| G
|
Anp32b
|
acidic nuclear phosphoprotein 32 family member B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ANP32B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437
|
|
| G
|
Anxa1
|
annexin A1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ANXA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa2
|
annexin A2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ANXA2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
|
|
| G
|
Anxa3
|
annexin A3
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of ANXA3 mRNA chloropicrin results in decreased expression of ANXA3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Anxa5
|
annexin A5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ANXA5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Anxa8
|
annexin A8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ANXA8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,403,353...9,418,310
|
|
| G
|
Ap2s1
|
adaptor related protein complex 2 subunit sigma 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of AP2S1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:86,545,350...86,557,009
|
|
| G
|
Ap3b1
|
adaptor related protein complex 3 subunit beta 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AP3B1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:27,331,241...27,535,683
Ensembl chr 2:27,334,900...27,537,702
|
|
| G
|
Ap4b1
|
adaptor related protein complex 4 subunit beta 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of AP4B1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:194,006,926...194,018,971
Ensembl chr 2:194,006,919...194,018,968
|
|
| G
|
Apeh
|
acylaminoacyl-peptide hydrolase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of APEH mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711
|
|
| G
|
Apoe
|
apolipoprotein E
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of APOE mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
App
|
amyloid beta precursor protein
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of APP mRNA chloropicrin results in decreased expression of APP mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Arcn1
|
archain 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ARCN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:53,954,401...53,979,005
Ensembl chr 8:53,954,404...53,979,005
|
|
| G
|
Arf4
|
ARF GTPase 4
|
affects expression
|
ISO
|
chloropicrin affects the expression of ARF4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011
|
|
| G
|
Arhgap21
|
Rho GTPase activating protein 21
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ARHGAP21 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:88,256,961...88,380,478
Ensembl chr17:88,256,961...88,380,797
|
|
| G
|
Arhgef2
|
Rho/Rac guanine nucleotide exchange factor 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of ARHGEF2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
|
|
| G
|
Arl16
|
ARF like GTPase 16
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ARL16 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr10:106,235,792...106,237,968
Ensembl chr10:106,235,792...106,237,968
|
|
| G
|
Arl6ip5
|
ARF like GTPase 6 interacting protein 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ARL6IP5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130
|
|
| G
|
Arpc1a
|
actin related protein 2/3 complex, subunit 1A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ARPC1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:14,616,245...14,639,052
Ensembl chr12:14,616,248...14,639,052
|
|
| G
|
Arpc2
|
actin related protein 2/3 complex, subunit 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ARPC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:83,269,932...83,305,409
|
|
| G
|
Arpc5
|
actin related protein 2/3 complex, subunit 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of ARPC5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
affects expression
|
ISO
|
chloropicrin affects the expression of ASNS mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Atf3
|
activating transcription factor 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATF3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atf4
|
activating transcription factor 4
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATF4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atic
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATIC mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756
|
|
| G
|
Atox1
|
antioxidant 1 copper chaperone
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATOX1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP1A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP2A2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp5f1a
|
ATP synthase F1 subunit alpha
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ATP5F1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATP5F1B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Atp5f1c
|
ATP synthase F1 subunit gamma
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP5F1C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073
|
|
| G
|
Atp5f1e
|
ATP synthase F1 subunit epsilon
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATP5F1E mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214
|
|
| G
|
Atp5mf
|
ATP synthase membrane subunit f
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP5MF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709
|
|
| G
|
Atp5mg
|
ATP synthase membrane subunit G
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP5MG mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831
|
|
| G
|
Atp5pb
|
ATP synthase peripheral stalk-membrane subunit b
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ATP5PB mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387
|
|
| G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP5PD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
|
|
| G
|
Atp5po
|
ATP synthase peripheral stalk subunit OSCP
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of ATP5PO mRNA chloropicrin results in decreased expression of ATP5PO mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520
|
|
| G
|
Atp6ap2
|
ATPase H+ transporting accessory protein 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATP6AP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:12,856,708...12,883,670
Ensembl chr X:12,855,859...12,905,875
|
|
| G
|
Atp6v0e1
|
ATPase H+ transporting V0 subunit e1
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATP6V0E1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:16,984,084...17,007,156
Ensembl chr10:16,984,084...17,028,858
|
|
| G
|
Atp6v1b2
|
ATPase H+ transporting V1 subunit B2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP6V1B2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:25,384,254...25,408,388
Ensembl chr16:25,384,257...25,408,839
|
|
| G
|
Atp6v1d
|
ATPase H+ transporting V1 subunit D
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATP6V1D mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346
|
|
| G
|
Atp6v1e1
|
ATPase H+ transporting V1 subunit E1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP6V1E1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:155,694,534...155,716,660
Ensembl chr 4:155,694,534...155,716,678
|
|
| G
|
Atp6v1f
|
ATPase H+ transporting V1 subunit F
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATP6V1F mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:59,033,020...59,035,980
|
|
| G
|
Atp6v1g1
|
ATPase H+ transporting V1 subunit G1
|
affects expression
|
ISO
|
chloropicrin affects the expression of ATP6V1G1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930
|
|
| G
|
Atraid
|
all-trans retinoic acid-induced differentiation factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ATRAID mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:31,035,194...31,039,779
Ensembl chr 6:31,035,194...31,040,946
|
|
| G
|
Avpi1
|
arginine vasopressin-induced 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of AVPI1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:250,879,530...250,885,448
Ensembl chr 1:250,879,530...250,885,704
|
|
| G
|
B2m
|
beta-2 microglobulin
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of B2M mRNA chloropicrin results in decreased expression of B2M mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BAG3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bambi
|
BMP and activin membrane-bound inhibitor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BAMBI mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247
|
|
| G
|
Basp1
|
brain abundant, membrane attached signal protein 1
|
decreases expression increases expression
|
ISO
|
chloropicrin results in decreased expression of BASP1 mRNA chloropicrin results in increased expression of BASP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
|
|
| G
|
Bcar3
|
BCAR3 adaptor protein, NSP family member
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of BCAR3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302
|
|
| G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
affects expression
|
ISO
|
chloropicrin affects the expression of BHLHE40 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BNIP3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bod1
|
biorientation of chromosomes in cell division 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of BOD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:16,497,918...16,504,259
Ensembl chr10:16,497,876...16,504,253
|
|
| G
|
Bola3
|
bolA family member 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BOLA3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:117,410,680...117,420,491
|
|
| G
|
Brd2
|
bromodomain containing 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BRD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
|
|
| G
|
Bsg
|
basigin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BSG mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|
| G
|
Btf3
|
basic transcription factor 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of BTF3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125 Ensembl chr13:31,394,011...31,401,125
|
|
| G
|
Btg1
|
BTG anti-proliferation factor 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of BTG1 mRNA chloropicrin results in decreased expression of BTG1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
|
|
| G
|
Bud31
|
BUD31 homolog
|
increases expression
|
ISO
|
chloropicrin results in increased expression of BUD31 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:14,576,602...14,584,132
Ensembl chr12:14,576,605...14,584,039
|
|
| G
|
C19h19orf53
|
similar to human chromosome 19 open reading frame 53
|
increases expression
|
ISO
|
chloropicrin results in increased expression of C19ORF53 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:40,819,830...40,822,609
|
|
| G
|
C1h19orf33
|
similar to human chromosome 19 open reading frame 33
|
increases expression
|
ISO
|
chloropicrin results in increased expression of C19ORF33 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:93,677,305...93,678,141
Ensembl chr 1:93,677,305...93,678,141
|
|
| G
|
C1qbp
|
complement C1q binding protein
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of C1QBP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235
|
|
| G
|
C9h2orf69
|
similar to human chromosome 2 open reading frame 69
|
increases expression
|
ISO
|
chloropicrin results in increased expression of C2ORF69 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:66,444,084...66,452,720
Ensembl chr 9:66,444,112...66,453,983
|
|
| G
|
Calm2
|
calmodulin 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CALM2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:12,845,170...12,857,830
Ensembl chr15:64,519,554...64,520,657 Ensembl chr 6:64,519,554...64,520,657
|
|
| G
|
Calm3
|
calmodulin 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CALM3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:86,717,321...86,725,960
|
|
| G
|
Calr
|
calreticulin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CALR mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Calu
|
calumenin
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CALU mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:58,914,421...58,941,956
|
|
| G
|
Camlg
|
calcium modulating ligand
|
affects expression
|
ISO
|
chloropicrin affects the expression of CAMLG mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:8,997,868...9,009,140
Ensembl chr17:8,997,272...9,009,012
|
|
| G
|
Camsap2
|
calmodulin regulated spectrin-associated protein family, member 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CAMSAP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:50,274,950...50,354,298
Ensembl chr13:50,274,950...50,354,298
|
|
| G
|
Cap1
|
cyclase associated actin cytoskeleton regulatory protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CAP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:140,427,265...140,507,678
Ensembl chr 5:140,427,269...140,453,470
|
|
| G
|
Cap2
|
cyclase associated actin cytoskeleton regulatory protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CAP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563
|
|
| G
|
Casp3
|
caspase 3
|
increases cleavage
|
ISO
|
chloropicrin results in increased cleavage of CASP3 protein
|
CTD |
PMID:31884112 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cav1
|
caveolin 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of CAV1 mRNA chloropicrin results in decreased expression of CAV1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Cav2
|
caveolin 2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of CAV2 mRNA chloropicrin results in decreased expression of CAV2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425
|
|
| G
|
Cavin1
|
caveolae associated protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CAVIN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:86,384,401...86,398,240
Ensembl chr10:86,384,401...86,396,383
|
|
| G
|
Cbx4
|
chromobox 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CBX4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,835,685...104,841,727
|
|
| G
|
Ccdc59
|
coiled-coil domain containing 59
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CCDC59 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:43,029,272...43,035,655
Ensembl chr 7:43,029,272...43,035,655
|
|
| G
|
Ccdc6
|
coiled-coil domain containing 6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CCDC6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
|
|
| G
|
Ccdc86
|
coiled-coil domain containing 86
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CCDC86 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:217,015,059...217,021,439
Ensembl chr 1:217,014,848...217,021,468
|
|
| G
|
Ccl26
|
C-C motif chemokine ligand 26
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CCL26 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr12:26,745,972...26,750,924
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CCN2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CCND1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CCND2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Ccni
|
cyclin I
|
affects expression
|
ISO
|
chloropicrin affects the expression of CCNI mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:15,164,047...15,186,885
Ensembl chr14:15,164,095...15,186,885
|
|
| G
|
Ccr6
|
C-C motif chemokine receptor 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CCR6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059
|
|
| G
|
Cct2
|
chaperonin containing TCP1 subunit 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CCT2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
|
|
| G
|
Cct8
|
chaperonin containing TCP1 subunit 8
|
affects expression
|
ISO
|
chloropicrin affects the expression of CCT8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328
|
|
| G
|
Cd24
|
CD24 molecule
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CD24 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785
|
|
| G
|
Cd63
|
Cd63 molecule
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CD63 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938
|
|
| G
|
Cd81
|
Cd81 molecule
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CD81 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092
|
|
| G
|
Cdan1
|
codanin 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CDAN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:128,129,664...128,143,520
Ensembl chr 3:128,129,301...128,143,549
|
|
| G
|
Cdc20
|
cell division cycle 20
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CDC20 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
| G
|
Cdc37
|
cell division cycle 37, HSP90 cochaperone
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CDC37 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931
|
|
| G
|
Cdc42ep4
|
CDC42 effector protein 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CDC42EP4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168
|
|
| G
|
Cdh1
|
cadherin 1
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of CDH1 mRNA chloropicrin results in decreased expression of CDH1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh3
|
cadherin 3
|
affects expression
|
ISO
|
chloropicrin affects the expression of CDH3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257
|
|
| G
|
Cdk6
|
cyclin-dependent kinase 6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CDK6 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
|
|
| G
|
Cdk7
|
cyclin-dependent kinase 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CDK7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression affects expression
|
ISO
|
chloropicrin results in increased expression of CDKN1A protein chloropicrin affects the expression of CDKN1A mRNA
|
CTD |
PMID:24548678 PMID:26352163 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CDKN1B protein
|
CTD |
PMID:24548678 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cdkn2aipnl
|
CDKN2A interacting protein N-terminal like
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CDKN2AIPNL mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:36,731,983...36,741,500
Ensembl chr10:36,732,013...36,741,495
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
affects expression
|
ISO
|
chloropicrin affects the expression of CEBPB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cebpd
|
CCAAT/enhancer binding protein delta
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CEBPD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824
|
|
| G
|
Cebpg
|
CCAAT/enhancer binding protein gamma
|
affects expression
|
ISO
|
chloropicrin affects the expression of CEBPG mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283
|
|
| G
|
Cers6
|
ceramide synthase 6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LASS6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544
|
|
| G
|
Cetn2
|
centrin 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CETN2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:155,812,212...155,817,186
Ensembl chr X:155,812,003...155,817,744
|
|
| G
|
Cfl1
|
cofilin 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of CFL1 mRNA chloropicrin results in decreased expression of CFL1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
| G
|
Chic2
|
cysteine-rich hydrophobic domain 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CHIC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:33,511,839...33,546,181
Ensembl chr14:33,511,535...33,548,558
|
|
| G
|
Chmp5
|
charged multivesicular body protein 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CHMP5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:60,877,369...60,894,512
Ensembl chr 5:60,877,341...60,894,511
|
|
| G
|
Chsy1
|
chondroitin sulfate synthase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CHSY1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:129,100,088...129,161,167
Ensembl chr 1:129,100,041...129,161,081
|
|
| G
|
Cib1
|
calcium and integrin binding 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CIB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:143,587,591...143,593,153
Ensembl chr 1:143,587,021...143,593,326
|
|
| G
|
Cisd1
|
CDGSH iron sulfur domain 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CISD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042
|
|
| G
|
Ckap4
|
cytoskeleton-associated protein 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CKAP4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624
|
|
| G
|
Ckb
|
creatine kinase B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CKB mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of CKS2 mRNA chloropicrin results in decreased expression of CKS2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Cldn1
|
claudin 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of CLDN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
| G
|
Clic1
|
chloride intracellular channel 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of CLIC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367
|
|
| G
|
Clk1
|
CDC-like kinase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CLK1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187
|
|
| G
|
Clstn1
|
calsyntenin 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CLSTN1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 5:165,314,128...165,377,627
Ensembl chr 5:165,314,309...165,377,625
|
|
| G
|
Cluap1
|
clusterin associated protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CLUAP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:12,094,346...12,159,440
Ensembl chr10:12,094,346...12,131,693
|
|
| G
|
Cmc2
|
C-x(9)-C motif containing 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CMC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:61,852,126...61,880,768
Ensembl chr19:61,852,126...61,881,019
|
|
| G
|
Cndp2
|
carnosine dipeptidase 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CNDP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900
|
|
| G
|
Cnih1
|
cornichon family member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CNIH1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:22,517,755...22,529,651
Ensembl chr15:22,497,340...22,529,578
|
|
| G
|
Cnih4
|
cornichon family member 4
|
affects expression
|
ISO
|
chloropicrin affects the expression of CNIH4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:95,442,054...95,458,163
Ensembl chr13:95,442,054...95,459,590
|
|
| G
|
Col17a1
|
collagen type XVII alpha 1 chain
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of COL17A1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:256,472,648...256,518,857
Ensembl chr 1:256,472,648...256,518,851
|
|
| G
|
Col7a1
|
collagen type VII alpha 1 chain
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of COL7A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
|
|
| G
|
Commd6
|
COMM domain containing 6
|
affects expression
|
ISO
|
chloropicrin affects the expression of COMMD6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:84,882,069...84,889,124
Ensembl chr15:84,882,548...84,889,194
|
|
| G
|
Copa
|
COPI coat complex subunit alpha
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COPA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:87,078,853...87,119,256
Ensembl chr13:87,078,383...87,119,256
|
|
| G
|
Copb1
|
COPI coat complex subunit beta 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COPB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:177,838,751...177,876,688
Ensembl chr 1:177,838,752...177,872,840
|
|
| G
|
Cox16
|
cytochrome c oxidase assembly factor COX16
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COX16 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:106,745,424...106,912,523
Ensembl chr 6:106,899,494...106,912,484
|
|
| G
|
Cox17
|
cytochrome c oxidase copper chaperone COX17
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COX17 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019
|
|
| G
|
Cox4i1
|
cytochrome c oxidase subunit 4i1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COX4I1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624
|
|
| G
|
Cox5a
|
cytochrome c oxidase subunit 5A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of COX5A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279
|
|
| G
|
Cox5b
|
cytochrome c oxidase subunit 5B
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of COX5B mRNA chloropicrin results in decreased expression of COX5B mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403
|
|
| G
|
Cox6a1
|
cytochrome c oxidase subunit 6A1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COX6A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768
|
|
| G
|
Cox6b1
|
cytochrome c oxidase subunit 6B1
|
affects expression
|
ISO
|
chloropicrin affects the expression of COX6B1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:95,002,513...95,011,516
Ensembl chr 1:95,001,707...95,011,431 Ensembl chr 5:95,001,707...95,011,431
|
|
| G
|
Cox6c
|
cytochrome c oxidase subunit 6C
|
affects expression
|
ISO
|
chloropicrin affects the expression of COX6C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166
|
|
| G
|
Cox7a2
|
cytochrome c oxidase subunit 7A2
|
affects expression
|
ISO
|
chloropicrin affects the expression of COX7A2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512 Ensembl chr 8:55,514,261...55,514,512
|
|
| G
|
Cox7a2l
|
cytochrome c oxidase subunit 7A2 like
|
affects expression
|
ISO
|
chloropicrin affects the expression of COX7A2L mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:16,936,574...16,950,797
Ensembl chr 6:16,936,795...16,950,798
|
|
| G
|
Cox7b
|
cytochrome c oxidase subunit 7B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COX7B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:75,149,036...75,155,285
Ensembl chr X:75,148,996...75,155,284
|
|
| G
|
Cox7c
|
cytochrome c oxidase subunit 7C
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of COX7C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:18,577,149...18,579,170
|
|
| G
|
Cox8a
|
cytochrome c oxidase subunit 8A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of COX8A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623
|
|
| G
|
Cpd
|
carboxypeptidase D
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CPD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CREB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crkl
|
CRK like proto-oncogene, adaptor protein
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CRKL mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:97,033,033...97,067,457
Ensembl chr11:97,024,782...97,067,457
|
|
| G
|
Cryab
|
crystallin, alpha B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CRYAB mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
| G
|
Csrp2
|
cysteine and glycine-rich protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CSRP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238
|
|
| G
|
Cst3
|
cystatin C
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CST3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Cstb
|
cystatin B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CSTB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199
|
|
| G
|
Ctsb
|
cathepsin B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CTSB mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsk
|
cathepsin K
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of CTSK mRNA chloropicrin results in decreased expression of CTSK mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CXCL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CXCL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cyb5b
|
cytochrome b5 type B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of CYB5B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of CYBA mRNA chloropicrin results in decreased expression of CYBA mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cygb
|
cytoglobin
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of CYGB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of CYP1B1 mRNA chloropicrin results in increased expression of CYP1B1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Dad1
|
defender against cell death 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of DAD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287
|
|
| G
|
Dars1
|
aspartyl-tRNA synthetase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Dazap2
|
DAZ associated protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DAZAP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:133,593,503...133,599,044
Ensembl chr 7:133,593,512...133,599,047
|
|
| G
|
Dbi
|
diazepam binding inhibitor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DBI mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
|
|
| G
|
Dcbld2
|
discoidin, CUB and LCCL domain containing 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DCBLD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085
|
|
| G
|
Dctpp1
|
dCTP pyrophosphatase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DCTPP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DDIT3 mRNA; chloropicrin results in increased expression of DDIT3 protein
|
CTD |
PMID:22516760 PMID:26352163 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
affects expression
|
ISO
|
chloropicrin affects the expression of DDIT4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
|
|
| G
|
Ddt
|
D-dopachrome tautomerase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DDT mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:12,883,025...12,886,121
|
|
| G
|
Ddx21
|
DExD-box helicase 21
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DDX21 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238
|
|
| G
|
Ddx5
|
DEAD-box helicase 5
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DDX5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300
|
|
| G
|
Dedd2
|
death effector domain containing 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DEDD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:89,916,906...89,934,663
Ensembl chr 1:89,919,524...89,936,804
|
|
| G
|
Dhrs7
|
dehydrogenase/reductase 7
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DHRS7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744
|
|
| G
|
Dkc1
|
dyskerin pseudouridine synthase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of DKC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:157,751,651...157,757,796
Ensembl chr Y:380,743...385,405 Ensembl chr X:380,743...385,405
|
|
| G
|
Dkk3
|
dickkopf WNT signaling pathway inhibitor 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DKK3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186
|
|
| G
|
Dmc1
|
DNA meiotic recombinase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DMC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:113,005,278...113,047,854
Ensembl chr 7:113,005,281...113,047,854
|
|
| G
|
Dnaja1
|
DnaJ heat shock protein family (Hsp40) member A1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
|
|
| G
|
Dnaja4
|
DnaJ heat shock protein family (Hsp40) member A4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJA4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836
|
|
| G
|
Dnajb1
|
DnaJ heat shock protein family (Hsp40) member B1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
|
|
| G
|
Dnajb4
|
DnaJ heat shock protein family (Hsp40) member B4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJB4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
|
|
| G
|
Dnajb9
|
DnaJ heat shock protein family (Hsp40) member B9
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJB9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
|
|
| G
|
Dnajc28
|
DnaJ heat shock protein family (Hsp40) member C28
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJC28 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482
|
|
| G
|
Dnajc8
|
DnaJ heat shock protein family (Hsp40) member C8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DNAJC8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117
|
|
| G
|
Drap1
|
Dr1 associated protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DRAP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:212,161,107...212,163,833
Ensembl chr 1:212,161,125...212,163,762
|
|
| G
|
Dstn
|
destrin, actin depolymerizing factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DSTN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DUSP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp5
|
dual specificity phosphatase 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of DUSP5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417
|
|
| G
|
Dync1i2
|
dynein cytoplasmic 1 intermediate chain 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of DYNC1I2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 3:76,441,621...76,492,782
Ensembl chr 3:76,424,469...76,492,782
|
|
| G
|
Dynll1
|
dynein light chain LC8-type 1
|
decreases expression increases expression
|
ISO
|
chloropicrin results in decreased expression of DYNLL1 mRNA chloropicrin results in increased expression of DYNLL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
|
|
| G
|
Ebna1bp2
|
EBNA1 binding protein 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EBNA1BP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637
|
|
| G
|
Eef1a1
|
eukaryotic translation elongation factor 1 alpha 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EEF1A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072
|
|
| G
|
Eef1g
|
eukaryotic translation elongation factor 1 gamma
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of EEF1G mRNA chloropicrin results in decreased expression of EEF1G mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479
|
|
| G
|
Eef2
|
eukaryotic translation elongation factor 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EEF2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544
|
|
| G
|
Efnb2
|
ephrin B2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EFNB2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208
|
|
| G
|
Egr1
|
early growth response 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EGR1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Eif1
|
eukaryotic translation initiation factor 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of EIF1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654 Ensembl chr10:25,895,968...25,896,654
|
|
| G
|
Eif1b
|
eukaryotic translation initiation factor 1B
|
affects expression
|
ISO
|
chloropicrin affects the expression of EIF1B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:129,080,497...129,083,772
Ensembl chr 8:129,078,293...129,083,772 Ensembl chr 5:129,078,293...129,083,772
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF2A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif3b
|
eukaryotic translation initiation factor 3, subunit B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EIF3B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:19,310,311...19,334,939
|
|
| G
|
Eif3d
|
eukaryotic translation initiation factor 3, subunit D
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF3D mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:111,420,351...111,432,761
Ensembl chr 7:111,420,351...111,432,740
|
|
| G
|
Eif3e
|
eukaryotic translation initiation factor 3 subunit E
|
affects expression
|
ISO
|
chloropicrin affects the expression of EIF3E mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:76,224,567...76,257,346
Ensembl chr 7:76,224,568...76,257,785
|
|
| G
|
Eif3f
|
eukaryotic translation initiation factor 3, subunit F
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of EIF3F mRNA chloropicrin results in decreased expression of EIF3F mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:172,369,062...172,378,043
Ensembl chr 1:172,369,062...172,378,041
|
|
| G
|
Eif3h
|
eukaryotic translation initiation factor 3, subunit H
|
affects expression
|
ISO
|
chloropicrin affects the expression of EIF3H mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:84,980,891...85,064,284
Ensembl chr 7:84,980,891...85,071,546
|
|
| G
|
Eif3k
|
eukaryotic translation initiation factor 3, subunit K
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF3K mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:93,387,628...93,397,551
Ensembl chr 1:93,387,628...93,397,802
|
|
| G
|
Eif3l
|
eukaryotic translation initiation factor 3, subunit L
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF3L mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:112,522,222...112,544,063
Ensembl chr 7:112,507,831...112,544,062
|
|
| G
|
Eif3m
|
eukaryotic translation initiation factor 3, subunit M
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF3M mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:111,879,589...111,897,193
Ensembl chr 3:111,870,925...111,897,193
|
|
| G
|
Eif4a1
|
eukaryotic translation initiation factor 4A1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EIF4A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602
|
|
| G
|
Eif4a2
|
eukaryotic translation initiation factor 4A2
|
affects expression
|
ISO
|
chloropicrin affects the expression of EIF4A2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323
|
|
| G
|
Eif4a3
|
eukaryotic translation initiation factor 4A3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF4A3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:105,047,567...105,057,561
Ensembl chr10:105,047,568...105,058,207
|
|
| G
|
Eif4b
|
eukaryotic translation initiation factor 4B
|
affects expression
|
ISO
|
chloropicrin affects the expression of EIF4B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064
|
|
| G
|
Eif4h
|
eukaryotic translation initiation factor 4H
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EIF4H mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:27,719,527...27,736,350
Ensembl chr12:27,719,321...27,736,346
|
|
| G
|
Eif6
|
eukaryotic translation initiation factor 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of EIF6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525
|
|
| G
|
Elob
|
elongin B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ELOB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:13,353,413...13,358,484
Ensembl chr10:13,353,417...13,358,563
|
|
| G
|
Eloc
|
elongin C
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ELOC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:7,444,769...7,461,187
Ensembl chr20:25,752,857...25,753,279
|
|
| G
|
Emc7
|
ER membrane protein complex subunit 7
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EMC7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:119,714,617...119,728,748
Ensembl chr 3:119,718,357...119,730,486
|
|
| G
|
Emp3
|
epithelial membrane protein 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EMP3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:105,525,088...105,528,265
|
|
| G
|
Eno1
|
enolase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ENO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
|
|
| G
|
Eny2
|
ENY2, transcription and export complex 2 subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ENY2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:77,465,885...77,489,637
Ensembl chr 7:77,466,119...77,491,057
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of EPAS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Epn1
|
Epsin 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EPN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:77,771,335...77,789,411
Ensembl chr 1:77,771,335...77,789,411
|
|
| G
|
Eprs1
|
glutamyl-prolyl-tRNA synthetase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of EPRS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:99,431,955...99,503,510
Ensembl chr13:99,433,130...99,503,509
|
|
| G
|
Erh
|
ERH, mRNA splicing and mitosis factor
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ERH mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:106,012,255...106,022,521
Ensembl chr 6:106,012,255...106,022,623
|
|
| G
|
Ern1
|
endoplasmic reticulum to nucleus signaling 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ERN1 protein
|
CTD |
PMID:22516760 |
|
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
|
|
| G
|
Errfi1
|
ERBB receptor feedback inhibitor 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of ERRFI1 mRNA chloropicrin results in decreased expression of ERRFI1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
|
|
| G
|
Etfa
|
electron transfer flavoprotein subunit alpha
|
affects expression
|
ISO
|
chloropicrin affects the expression of ETFA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080
|
|
| G
|
Exosc3
|
exosome component 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EXOSC3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:64,369,495...64,374,711
Ensembl chr 5:64,369,495...64,374,902
|
|
| G
|
Ezr
|
ezrin
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of EZR mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
|
|
| G
|
F2r
|
coagulation factor II (thrombin) receptor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of F2R mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of F3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
Fabp5
|
fatty acid binding protein 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FABP5 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
|
|
| G
|
Fam177a1
|
family with sequence similarity 177, member A1
|
affects expression
|
ISO
|
chloropicrin affects the expression of FAM177A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:78,367,780...78,382,703
Ensembl chr 6:78,367,780...78,392,836
|
|
| G
|
Fam83a
|
family with sequence similarity 83, member A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FAM83A mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 7:91,412,366...91,436,819
Ensembl chr 7:91,412,366...91,436,910
|
|
| G
|
Fam98a
|
family with sequence similarity 98, member A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FAM98A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:25,626,108...25,640,767
Ensembl chr 6:25,625,984...25,640,767
|
|
| G
|
Farsb
|
phenylalanyl-tRNA synthetase subunit beta
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FARSB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:87,336,321...87,395,546
Ensembl chr 9:87,336,326...87,395,505
|
|
| G
|
Fasn
|
fatty acid synthase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FASN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fat1
|
FAT atypical cadherin 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FAT1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609
|
|
| G
|
Fau
|
FAU ubiquitin like and ribosomal protein S30 fusion
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FAU mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:212,779,429...212,781,028
Ensembl chr 1:212,779,473...212,781,026 Ensembl chr 1:212,779,473...212,781,026
|
|
| G
|
Fdft1
|
farnesyl diphosphate farnesyl transferase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FDFT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168
|
|
| G
|
Fermt1
|
FERM domain containing kindlin 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FERMT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419
|
|
| G
|
Fermt2
|
FERM domain containing kindlin 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FERMT2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115
|
|
| G
|
Fgfbp1
|
fibroblast growth factor binding protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FGFBP1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr14:71,316,171...71,319,965
Ensembl chr14:71,317,065...71,320,309
|
|
| G
|
Fhl1
|
four and a half LIM domains 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FHL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282
|
|
| G
|
Fhl2
|
four and a half LIM domains 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FHL2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
|
|
| G
|
Fjx1
|
four-jointed box kinase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FJX1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479
|
|
| G
|
Fkbp1a
|
FKBP prolyl isomerase 1A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FKBP1A mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233
|
|
| G
|
Fkbp4
|
FKBP prolyl isomerase 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FKBP4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918
|
|
| G
|
Fktn
|
fukutin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FKTN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:73,134,746...73,191,772
Ensembl chr 5:73,135,361...73,189,181
|
|
| G
|
Flnb
|
filamin B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FLNB mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209
|
|
| G
|
Flot2
|
flotillin 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FLOT2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:63,424,084...63,445,811
Ensembl chr10:63,423,806...63,445,810
|
|
| G
|
Fndc3b
|
fibronectin type III domain containing 3B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FNDC3B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:112,240,108...112,546,113
Ensembl chr 2:112,243,202...112,546,306
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FOS mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fscn1
|
fascin actin-bundling protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of FSCN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
|
|
| G
|
Fst
|
follistatin
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of FST mRNA chloropicrin results in decreased expression of FST mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491
|
|
| G
|
Fstl3
|
follistatin like 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of FSTL3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:10,574,195...10,579,844
Ensembl chr 7:10,574,186...10,590,509
|
|
| G
|
Fth1
|
ferritin heavy chain 1
|
increases expression affects expression
|
ISO
|
chloropicrin results in increased expression of FTH1 mRNA chloropicrin affects the expression of FTH1 mRNA
|
CTD |
PMID:24211530 PMID:26352163 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
| G
|
Ftl1
|
ferritin light chain 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of FTL mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr 1:105,072,858...105,074,705
Ensembl chr X:45,399,355...45,399,915 Ensembl chr 2:45,399,355...45,399,915 Ensembl chr 1:45,399,355...45,399,915
|
|
| G
|
G0s2
|
G0/G1switch 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of G0S2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293
|
|
| G
|
Gabpb2
|
GA binding protein transcription factor subunit beta 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GABPB2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:185,444,309...185,484,200
Ensembl chr 2:185,450,296...185,483,589
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
affects expression
|
ISO
|
chloropicrin affects the expression of GADD45A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GADD45B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GAPDH mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gars1
|
glycyl-tRNA synthetase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of GARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GCLM mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gcn1
|
GCN1 activator of EIF2AK4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GCN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:46,652,273...46,715,119
Ensembl chr12:46,652,273...46,713,488
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GDF15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gdi2
|
GDP dissociation inhibitor 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GDI2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:71,559,460...71,586,147
Ensembl chr17:71,559,461...71,586,147
|
|
| G
|
Gemin4
|
gem (nuclear organelle) associated protein 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GEMIN4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532
|
|
| G
|
Gga1
|
golgi associated, gamma adaptin ear containing, ARF binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GGA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:112,316,530...112,332,249
Ensembl chr 7:112,315,449...112,332,249
|
|
| G
|
Ghitm
|
growth hormone inducible transmembrane protein
|
affects expression
|
ISO
|
chloropicrin affects the expression of GHITM mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:12,907,062...12,918,149
Ensembl chr16:12,905,806...12,918,123
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GJA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of GJB2 mRNA chloropicrin results in decreased expression of GJB2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Gjc1
|
gap junction protein, gamma 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GJC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:88,262,840...88,285,646
Ensembl chr10:88,249,489...88,285,853
|
|
| G
|
Glg1
|
golgi glycoprotein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GLG1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:56,006,459...56,133,528
|
|
| G
|
Glo1
|
glyoxalase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of GLO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191
|
|
| G
|
Glrx
|
glutaredoxin
|
affects expression
|
ISO
|
chloropicrin affects the expression of GLRX mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
|
|
| G
|
Glrx3
|
glutaredoxin 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GLRX3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717
|
|
| G
|
Glrx5
|
glutaredoxin 5
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GLRX5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:129,752,902...129,763,278
Ensembl chr 6:129,752,840...129,763,278
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GNAI2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
| G
|
Gnas
|
GNAS complex locus
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GNAS mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536
|
|
| G
|
Gnb1
|
G protein subunit beta 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GNB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488
|
|
| G
|
Gnpda1
|
glucosamine-6-phosphate deaminase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GNPDA1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr18:30,416,599...30,428,630
Ensembl chr18:30,416,607...30,428,630
|
|
| G
|
Gpn1
|
GPN-loop GTPase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GPN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:30,667,337...30,685,011
Ensembl chr 6:30,666,868...30,685,011
|
|
| G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of GPT2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GPX1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GPX4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gpx8
|
glutathione peroxidase 8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GPX8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:46,409,646...46,413,401
Ensembl chr 2:46,409,139...46,413,406
|
|
| G
|
Grcc10
|
gene rich cluster, C10 gene
|
affects expression
|
ISO
|
chloropicrin affects the expression of C12ORF57 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:159,237,562...159,239,223
|
|
| G
|
Grn
|
granulin precursor
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GRN mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936
|
|
| G
|
Grpel2
|
GrpE-like 2, mitochondrial
|
affects expression
|
ISO
|
chloropicrin affects the expression of GRPEL2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:57,438,168...57,450,408
Ensembl chr18:57,438,168...57,450,717
|
|
| G
|
Gsdme
|
gasdermin E
|
affects expression
|
ISO
|
chloropicrin affects the expression of GSDME mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525
|
|
| G
|
Gspt1
|
G1 to S phase transition 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GSPT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:4,867,687...4,904,186
Ensembl chr10:4,869,465...4,908,040
|
|
| G
|
Gstk1
|
glutathione S-transferase kappa 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GSTK1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
|
|
| G
|
Gsto1
|
glutathione S-transferase omega 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GSTO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of GSTP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gtf2a2
|
general transcription factor 2A subunit 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of GTF2A2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:79,542,682...79,556,484
Ensembl chr 8:79,547,307...79,565,408
|
|
| G
|
Gtf2h5
|
general transcription factor IIH subunit 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of GTF2H5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:49,061,904...49,068,612
Ensembl chr 1:49,061,959...49,070,039
|
|
| G
|
Gtf3a
|
general transcription factor III A
|
affects expression
|
ISO
|
chloropicrin affects the expression of GTF3A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:13,250,643...13,258,587
Ensembl chr12:13,250,644...13,258,587
|
|
| G
|
Guk1
|
guanylate kinase 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of GUK1 mRNA chloropicrin results in decreased expression of GUK1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:44,471,075...44,488,332
Ensembl chr10:44,471,085...44,479,355
|
|
| G
|
H1f2
|
H1.2 linker histone, cluster member
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of H1-2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317
|
|
| G
|
H2ac20
|
H2A clustered histone 20
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of H2AC20 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:186,468,748...186,469,226
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases phosphorylation multiple interactions
|
ISO
|
chloropicrin results in increased phosphorylation of H2AX protein Acetylcysteine inhibits the reaction [chloropicrin results in increased phosphorylation of H2AX protein]
|
CTD |
PMID:31884112 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H2az1
|
H2A.Z variant histone 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of H2AZ1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411
|
|
| G
|
H2bc12
|
H2B clustered histone 12
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of H2BC12 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:47,181,477...47,181,940
Ensembl chr17:47,121,467...47,182,816
|
|
| G
|
H3f3a
|
H3.3 histone A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of H3-3A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:95,065,085...95,076,695
Ensembl chr13:95,065,085...95,076,695
|
|
| G
|
Hars1
|
histidyl-tRNA synthetase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HBEGF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hddc2
|
HD domain containing 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HDDC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:28,100,669...28,133,008
Ensembl chr 1:28,083,521...28,132,977
|
|
| G
|
Hebp2
|
heme binding protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HEBP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:15,014,729...15,021,523
Ensembl chr 1:15,014,729...15,021,523
|
|
| G
|
Herpud1
|
homocysteine inducible ER protein with ubiquitin like domain 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HERPUD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
|
|
| G
|
Hes1
|
hes family bHLH transcription factor 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HES1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
|
|
| G
|
Hes2
|
hes family bHLH transcription factor 2
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of HES2 mRNA chloropicrin results in decreased expression of HES2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:167,947,948...167,964,660
Ensembl chr 5:167,949,918...167,955,601
|
|
| G
|
Higd1a
|
HIG1 hypoxia inducible domain family, member 1A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HIGD1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:130,391,661...130,400,888
|
|
| G
|
Higd2a
|
HIG1 hypoxia inducible domain family, member 2A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HIGD2A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:10,026,961...10,027,885
Ensembl chr17:10,026,961...10,027,874
|
|
| G
|
Hint1
|
histidine triad nucleotide binding protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of HINT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:39,490,225...39,493,970
Ensembl chr 4:93,430,926...93,431,642 Ensembl chr10:93,430,926...93,431,642
|
|
| G
|
Hmgcs1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HMGCS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
|
|
| G
|
Hmgn1
|
high mobility group nucleosome binding domain 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of HMGN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:48,891,813...48,897,732
Ensembl chr11:48,891,814...48,897,771
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression multiple interactions
|
ISO
|
chloropicrin results in increased expression of HMOX1 mRNA; chloropicrin results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [chloropicrin results in increased expression of HMOX1 protein]
|
CTD |
PMID:22516760 PMID:24211530 PMID:26352163 PMID:31884112 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnrnpa0
|
heterogeneous nuclear ribonucleoprotein A0
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of HNRNPA0 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:6,513,129...6,515,786
Ensembl chr17:6,512,629...6,516,127
|
|
| G
|
Hnrnpa2b1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
affects expression
|
ISO
|
chloropicrin affects the expression of HNRNPA2B1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
|
|
| G
|
Hnrnpab
|
heterogeneous nuclear ribonucleoprotein A/B
|
affects expression
|
ISO
|
chloropicrin affects the expression of HNRNPAB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307
|
|
| G
|
Hnrnph1
|
heterogeneous nuclear ribonucleoprotein H1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HNRNPH1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906
|
|
| G
|
Hnrnpm
|
heterogeneous nuclear ribonucleoprotein M
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HNRNPM mRNA; chloropicrin results in increased expression of HNRPM mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871
|
|
| G
|
Hnrnpr
|
heterogeneous nuclear ribonucleoprotein R
|
affects expression
|
ISO
|
chloropicrin affects the expression of HNRNPR mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344
|
|
| G
|
Hps6
|
HPS6, biogenesis of lysosomal organelles complex 2 subunit 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of HPS6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:254,802,250...254,804,859
Ensembl chr 1:254,802,119...254,804,937
|
|
| G
|
Hsd17b7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSD17B7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754
|
|
| G
|
Hsf2bp
|
heat shock transcription factor 2 binding protein
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of HSF2BP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:10,035,263...10,121,262
Ensembl chr20:10,035,263...10,121,826
|
|
| G
|
Hsp90aa1
|
heat shock protein 90 alpha family class A member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSP90AA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499
|
|
| G
|
Hsp90ab1
|
heat shock protein 90 alpha family class B member 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of HSP90AB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
|
|
| G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSP90B1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPA1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPA1B mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa4
|
heat shock protein family A (Hsp70) member 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPA4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPA5 protein
|
CTD |
PMID:22516760 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa6l-ps1
|
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPA6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:85,805,911...85,807,052
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPA8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
affects expression
|
ISO
|
chloropicrin affects the expression of HSPA9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Hspe1
|
heat shock protein family E (Hsp10) member 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of HSPE1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502
|
|
| G
|
Hsph1
|
heat shock protein family H (Hsp110) member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of HSPH1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
|
|
| G
|
Htra1
|
HtrA serine peptidase 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of HTRA1 mRNA chloropicrin results in decreased expression of HTRA1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620
|
|
| G
|
Iars2
|
isoleucyl-tRNA synthetase 2, mitochondrial
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IARS2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:99,363,035...99,397,068
Ensembl chr13:99,362,696...99,397,068
|
|
| G
|
Id1
|
inhibitor of DNA binding 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ID1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
| G
|
Id3
|
inhibitor of DNA binding 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ID3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856
|
|
| G
|
Ier3
|
immediate early response 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IER3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
|
|
| G
|
Ier5
|
immediate early response 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IER5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:69,820,450...69,822,542
Ensembl chr13:69,820,451...69,822,543
|
|
| G
|
Ifi27l2a
|
interferon, alpha-inducible protein 27 like 2A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IFI27L2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:128,363,658...128,365,144
Ensembl chr 6:128,363,658...128,365,146
|
|
| G
|
Ifitm2
|
interferon induced transmembrane protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IFITM2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:205,481,168...205,482,348
|
|
| G
|
Ifitm3
|
interferon induced transmembrane protein 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IFITM3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920
|
|
| G
|
Ifngr2
|
interferon gamma receptor 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IFNGR2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:44,265,703...44,283,975
Ensembl chr11:44,265,703...44,283,975
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IGF1R mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IGF2BP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:92,378,908...92,478,893
Ensembl chr11:92,378,908...92,478,867
|
|
| G
|
Igfbp2
|
insulin-like growth factor binding protein 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IGFBP2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
|
|
| G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IGFBP6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
|
|
| G
|
Igfbp7
|
insulin-like growth factor binding protein 7
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IGFBP7 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620
|
|
| G
|
Il18
|
interleukin 18
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IL18 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
affects expression
|
ISO
|
chloropicrin affects the expression of IL1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IL1B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il20rb
|
interleukin 20 receptor subunit beta
|
affects expression
|
ISO
|
chloropicrin affects the expression of IL20RB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:109,858,108...109,896,066
Ensembl chr 8:109,854,012...109,889,363
|
|
| G
|
Ilf2
|
interleukin enhancer binding factor 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ILF2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:178,256,927...178,268,773
Ensembl chr 2:178,248,585...178,268,920
|
|
| G
|
Imp3
|
IMP U3 small nucleolar ribonucleoprotein 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of IMP3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:66,235,498...66,236,386
|
|
| G
|
Impdh2
|
inosine monophosphate dehydrogenase 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of IMPDH2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873
|
|
| G
|
Inip
|
INTS3 and NABP interacting protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of INIP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:79,443,317...79,457,552
Ensembl chr 5:79,443,317...79,457,552
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
affects expression
|
ISO
|
chloropicrin affects the expression of ITGA3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Itgae
|
integrin subunit alpha E
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ITGAE mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:58,203,331...58,262,606
Ensembl chr10:58,203,364...58,262,606
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ITGAV mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Itgb1
|
integrin subunit beta 1
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of ITGB1 mRNA chloropicrin results in decreased expression of ITGB1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269
|
|
| G
|
Itgb4
|
integrin subunit beta 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ITGB4 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932
|
|
| G
|
Itih5
|
inter-alpha-trypsin inhibitor heavy chain 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ITIH5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496
|
|
| G
|
Itm2b
|
integral membrane protein 2B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of ITM2B mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr15:54,955,549...54,978,455
Ensembl chr15:54,955,552...54,978,455
|
|
| G
|
Jag1
|
jagged canonical Notch ligand 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of JAG1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872
|
|
| G
|
Jtb
|
jumping translocation breakpoint
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of JTB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:177,983,033...177,987,250
Ensembl chr 2:177,982,635...177,987,905
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of JUN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Jund
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of JUND mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148
|
|
| G
|
Kbtbd8
|
kelch repeat and BTB domain containing 8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of KBTBD8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:129,232,781...129,245,608
Ensembl chr 4:129,232,027...129,245,605
|
|
| G
|
Kcnh6
|
potassium voltage-gated channel subfamily H member 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of KCNH6 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:91,449,025...91,471,012
Ensembl chr10:91,449,651...91,470,506
|
|
| G
|
Khdrbs1
|
KH RNA binding domain containing, signal transduction associated 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of KHDRBS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448
|
|
| G
|
Klf6
|
KLF transcription factor 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of KLF6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601
|
|
| G
|
Kpna6
|
karyopherin subunit alpha 6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of KPNA6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:147,272,466...147,307,523
Ensembl chr 5:147,275,918...147,305,851
|
|
| G
|
Krt10
|
keratin 10
|
increases expression
|
ISO
|
chloropicrin results in increased expression of KRT10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:84,834,865...84,839,160
Ensembl chr10:84,834,840...84,839,160
|
|
| G
|
Krt14
|
keratin 14
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of KRT14 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr10:85,638,182...85,642,450
|
|
| G
|
Krt16
|
keratin 16
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of KRT16 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,669,276...85,672,211
|
|
| G
|
Krt19
|
keratin 19
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of KRT19 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952
|
|
| G
|
Krt5
|
keratin 5
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of KRT5 mRNA chloropicrin results in decreased expression of KRT5 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569
|
|
| G
|
Krt6c
|
keratin 6c
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of KRT6C mRNA chloropicrin results in decreased expression of KRT6C mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:134,678,316...134,682,753
Ensembl chr 7:134,678,324...134,682,753
|
|
| G
|
Krt7
|
keratin 7
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of KRT7 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786
|
|
| G
|
Krtcap2
|
keratinocyte associated protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of KRTCAP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:176,952,167...176,956,163
Ensembl chr 2:176,949,809...176,956,163
|
|
| G
|
Kynu
|
kynureninase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of KYNU mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014
|
|
| G
|
Lair1
|
leukocyte-associated immunoglobulin-like receptor 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of LAIR1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:79,140,850...79,261,546
Ensembl chr 1:79,198,311...79,258,037
|
|
| G
|
Lama3
|
laminin subunit alpha 3
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of LAMA3 mRNA chloropicrin results in decreased expression of LAMA3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449
|
|
| G
|
Lama5
|
laminin subunit alpha 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of LAMA5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:187,647,904...187,696,173
|
|
| G
|
Lamb1
|
laminin subunit beta 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LAMB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:53,563,073...53,630,760
|
|
| G
|
Lamb3
|
laminin subunit beta 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LAMB3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081
|
|
| G
|
Lamc1
|
laminin subunit gamma 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LAMC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986
|
|
| G
|
Lamc2
|
laminin subunit gamma 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LAMC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102
|
|
| G
|
Lamp1
|
lysosomal-associated membrane protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of LAMP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159
|
|
| G
|
Lamtor2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LAMTOR2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:176,306,353...176,310,617
Ensembl chr 2:176,306,280...176,310,730
|
|
| G
|
Lamtor5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of LAMTOR5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:197,588,242...197,593,598
Ensembl chr 2:197,588,242...197,593,598
|
|
| G
|
Laptm4b
|
lysosomal protein transmembrane 4 beta
|
affects expression
|
ISO
|
chloropicrin affects the expression of LAPTM4B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:67,319,438...67,362,547
Ensembl chr 7:67,319,542...67,363,258
|
|
| G
|
Lasp1
|
LIM and SH3 protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of LASP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LDHA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldhb
|
lactate dehydrogenase B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of LDHB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408
|
|
| G
|
Lgals1
|
galectin 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of LGALS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800
|
|
| G
|
Lima1
|
LIM domain and actin binding 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of LIMA1 mRNA chloropicrin results in decreased expression of LIMA1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:132,780,556...132,880,343
Ensembl chr 7:132,780,556...132,880,386
|
|
| G
|
Lipa
|
lipase A, lysosomal acid type
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LIPA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
affects expression
|
ISO
|
chloropicrin affects the expression of LITAF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Lmo4
|
LIM domain only 4
|
affects expression
|
ISO
|
chloropicrin affects the expression of LMO4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:235,924,574...235,941,609
Ensembl chr 2:235,924,403...235,941,275
|
|
| G
|
LOC120099557
|
U6 spliceosomal RNA
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of RNU6-15P mRNA chloropicrin results in increased expression of RNU6-15P mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:50,924,780...50,924,886
Ensembl chr X:50,924,780...50,924,886
|
|
| G
|
Lpxn
|
leupaxin
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of LPXN mRNA chloropicrin results in decreased expression of LPXN mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:219,353,319...219,387,743
Ensembl chr 1:219,353,708...219,387,742
|
|
| G
|
Lta4h
|
leukotriene A4 hydrolase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of LTA4H mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641
|
|
| G
|
Ltbp2
|
latent transforming growth factor beta binding protein 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LTBP2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298
|
|
| G
|
Ltbr
|
lymphotoxin beta receptor
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of LTBR mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296
|
|
| G
|
Maged1
|
MAGE family member D1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MAGED1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:63,416,464...63,423,167
Ensembl chr X:63,416,466...63,423,112
|
|
| G
|
Manf
|
mesencephalic astrocyte-derived neurotrophic factor
|
affects expression
|
ISO
|
chloropicrin affects the expression of MANF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910
|
|
| G
|
Maoa
|
monoamine oxidase A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MAOA mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MAP1LC3B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MAP2K1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map7d1
|
MAP7 domain containing 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MAP7D1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:143,812,467...143,837,597
Ensembl chr 5:143,811,924...143,837,021
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation
|
ISO
|
chloropicrin results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:24548678 PMID:31884112 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation
|
ISO
|
chloropicrin results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:24548678 PMID:31884112 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Marcks
|
myristoylated alanine rich protein kinase C substrate
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MARCKS mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882
|
|
| G
|
Mars1
|
methionyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:65,006,456...65,023,880
Ensembl chr 7:64,998,544...65,023,753
|
|
| G
|
Mat2a
|
methionine adenosyltransferase 2A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MAT2A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645
|
|
| G
|
Mcm8
|
minichromosome maintenance 8 homologous recombination repair factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MCM8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:140,539,590...140,569,891
Ensembl chr 3:140,539,647...140,569,891
|
|
| G
|
Mdh1
|
malate dehydrogenase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MDH1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
|
|
| G
|
Mdh2
|
malate dehydrogenase 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MDH2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841
|
|
| G
|
Metap2
|
methionyl aminopeptidase 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of METAP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521
|
|
| G
|
Mettl5
|
methyltransferase 5, N6-adenosine
|
increases expression
|
ISO
|
chloropicrin results in increased expression of METTL5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:75,033,605...75,046,359
Ensembl chr 3:75,026,861...75,045,831
|
|
| G
|
Mfap5
|
microfibril associated protein 5
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MFAP5 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448
|
|
| G
|
Mgst3
|
microsomal glutathione S-transferase 3
|
affects expression
|
ISO
|
chloropicrin affects the expression of MGST3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575
|
|
| G
|
Micos13
|
mitochondrial contact site and cristae organizing system subunit 13
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MICOS13 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:1,526,978...1,528,996
Ensembl chr 9:1,526,673...1,528,928
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MIF mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mir205
|
microRNA 205
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MIR205 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:107,564,535...107,564,642
|
|
| G
|
Mkrn1
|
makorin ring finger protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MKRN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:69,142,710...69,170,211
Ensembl chr 4:69,142,723...69,164,020
|
|
| G
|
Mllt11
|
MLLT11, transcription factor 7 cofactor
|
affects expression
|
ISO
|
chloropicrin affects the expression of MLLT11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:185,484,791...185,493,961
Ensembl chr 2:185,484,793...185,493,961
|
|
| G
|
Mmadhc
|
metabolism of cobalamin associated D
|
affects expression
|
ISO
|
chloropicrin affects the expression of MMADHC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:55,117,832...55,135,735
Ensembl chr 3:55,117,833...55,135,851
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MMP1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp10
|
matrix metallopeptidase 10
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MMP10 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613
|
|
| G
|
Morf4l2
|
mortality factor 4 like 2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of MORF4L2 mRNA chloropicrin results in decreased expression of MORF4L2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855
|
|
| G
|
Mrfap1
|
Morf4 family associated protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of MRFAP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:78,227,225...78,229,002
|
|
| G
|
Mrpl13
|
mitochondrial ribosomal protein L13
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MRPL13 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:88,841,265...88,862,821
Ensembl chr 7:88,841,266...88,862,848
|
|
| G
|
Mrpl18
|
mitochondrial ribosomal protein L18
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MRPL18 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:50,384,951...50,389,769
Ensembl chr 1:50,384,367...50,389,763
|
|
| G
|
Mrpl36
|
mitochondrial ribosomal protein L36
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MRPL36 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:31,794,025...31,797,446
Ensembl chr 1:31,790,887...31,797,808
|
|
| G
|
Mrpl50
|
mitochondrial ribosomal protein L50
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MRPL50 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 5:68,662,933...68,668,087
Ensembl chr 5:68,662,939...68,669,748
|
|
| G
|
Mrpl51
|
mitochondrial ribosomal protein L51
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MRPL51 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:159,677,988...159,681,650
Ensembl chr 4:159,677,827...159,681,641
|
|
| G
|
Mrps15
|
mitochondrial ribosomal protein S15
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MRPS15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:143,606,141...143,616,734
Ensembl chr 5:143,606,148...143,616,339
|
|
| G
|
Mrps21
|
mitochondrial ribosomal protein S21
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of MRPS21 mRNA chloropicrin results in decreased expression of MRPS21 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:186,095,729...186,103,351
Ensembl chr 2:186,095,732...186,103,351
|
|
| G
|
Mrps6
|
mitochondrial ribosomal protein S6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MRPS6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962
|
|
| G
|
Msh3
|
mutS homolog 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MSH3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:25,179,400...25,320,857
Ensembl chr 2:25,179,400...25,321,102
|
|
| G
|
Msn
|
moesin
|
affects expression
|
ISO
|
chloropicrin affects the expression of MSN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:65,005,458...65,075,129
|
|
| G
|
Mt1-ps3
|
metallothionein 1, pseudogene 3
|
affects expression
|
ISO
|
chloropicrin affects the expression of MT1E mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200
|
|
| G
|
Mt1a
|
metallothionein 1A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MT1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mt2
|
metallothionein 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MT2A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mtch1
|
mitochondrial carrier 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MTCH1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:7,391,558...7,415,291
Ensembl chr20:7,391,565...7,415,042
|
|
| G
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MTHFD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350
|
|
| G
|
Mtpn
|
myotrophin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MTPN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:65,126,390...65,153,803
Ensembl chr 4:65,115,980...65,153,924
|
|
| G
|
Mybl1
|
MYB proto-oncogene like 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MYBL1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of MYC mRNA chloropicrin results in decreased expression of MYC mRNA
|
CTD |
PMID:24211530 PMID:26352163 PMID:28476498 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myh10
|
myosin heavy chain 10
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MYH10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,893,166...54,024,036
|
|
| G
|
Myh9
|
myosin, heavy chain 9
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of MYH9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963
|
|
| G
|
Myl12a
|
myosin light chain 12A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MYL12A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:118,338,592...118,346,277
Ensembl chr 9:118,338,604...118,342,634
|
|
| G
|
Myl12b
|
myosin light chain 12B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MRLC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:118,320,479...118,334,810
Ensembl chr 9:118,320,489...118,324,418
|
|
| G
|
Myl6
|
myosin light chain 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MYL6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:1,495,747...1,498,344
|
|
| G
|
Mylip
|
myosin regulatory light chain interacting protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MYLIP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:19,492,826...19,514,490
Ensembl chr17:19,492,826...19,514,471
|
|
| G
|
Myof
|
myoferlin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of MYOF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768
|
|
| G
|
Naca
|
nascent polypeptide associated complex subunit alpha
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NACA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,053,474...1,066,606
Ensembl chr 7:1,054,338...1,066,605
|
|
| G
|
Nars1
|
asparaginyl-tRNA synthetase 1
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of NARS1 mRNA chloropicrin results in increased expression of NARS1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
|
|
| G
|
Nbdy
|
negative regulator of P-body association
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NBDY mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:20,964,915...20,965,121
|
|
| G
|
Ncl
|
nucleolin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NCL mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
|
|
| G
|
Ncoa4
|
nuclear receptor coactivator 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NCOA4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:7,395,502...7,415,846
Ensembl chr16:7,401,802...7,415,840
|
|
| G
|
Ncoa7
|
nuclear receptor coactivator 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NCOA7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:28,674,614...28,835,891
Ensembl chr 1:28,675,426...28,835,886
|
|
| G
|
Ndrg1
|
N-myc downstream regulated 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of NDRG1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913
|
|
| G
|
Ndufa1
|
NADH:ubiquinone oxidoreductase subunit A1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:121,289,904...121,293,555
Ensembl chr X:121,289,925...121,293,555
|
|
| G
|
Ndufa11
|
NADH:ubiquinone oxidoreductase subunit A11
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NDUFA11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:1,637,614...1,641,673
Ensembl chr 9:1,637,595...1,642,727
|
|
| G
|
Ndufa12
|
NADH:ubiquinone oxidoreductase subunit A12
|
affects expression
|
ISO
|
chloropicrin affects the expression of NDUFA12 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:30,658,316...30,685,302
Ensembl chr 7:30,658,322...30,686,300
|
|
| G
|
Ndufa2
|
NADH:ubiquinone oxidoreductase subunit A2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFA2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:28,629,795...28,631,884
Ensembl chr18:28,629,795...28,631,884
|
|
| G
|
Ndufa3
|
NADH:ubiquinone oxidoreductase subunit A3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFA3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:74,512,928...74,515,558
Ensembl chr 1:74,512,928...74,515,558
|
|
| G
|
Ndufa4
|
Ndufa4, mitochondrial complex associated
|
increases expression
|
ISO
|
chloropicrin results in increased expression of COXFA4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,968,391...40,975,559
|
|
| G
|
Ndufa4l2
|
NDUFA4, mitochondrial complex associated like 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of COXFA4L2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 7:65,242,169...65,244,296
Ensembl chr 7:65,242,135...65,244,277
|
|
| G
|
Ndufa8
|
NADH:ubiquinone oxidoreductase subunit A8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFA8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:39,783,479...39,799,507
Ensembl chr 3:39,783,479...39,799,507
|
|
| G
|
Ndufab1
|
NADH:ubiquinone oxidoreductase subunit AB1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFAB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:186,057,113...186,089,373
|
|
| G
|
Ndufaf2
|
NADH:ubiquinone oxidoreductase complex assembly factor 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NDUFAF2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:41,269,141...41,380,895
Ensembl chr 2:41,269,141...41,380,763
|
|
| G
|
Ndufb10
|
NADH:ubiquinone oxidoreductase subunit B10
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFB10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:14,253,805...14,255,966
Ensembl chr10:14,253,805...14,255,966
|
|
| G
|
Ndufb2
|
NADH:ubiquinone oxidoreductase subunit B2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFB2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:69,334,307...69,341,394
Ensembl chr 4:69,334,307...69,340,136 Ensembl chr15:69,334,307...69,340,136
|
|
| G
|
Ndufb5
|
NADH:ubiquinone oxidoreductase subunit B5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFB5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:117,447,035...117,461,590
|
|
| G
|
Ndufb8
|
NADH:ubiquinone oxidoreductase subunit B8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFB8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936
|
|
| G
|
Ndufs3
|
NADH:ubiquinone oxidoreductase core subunit S3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NDUFS3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:97,332,477...97,339,654
Ensembl chr 3:97,332,477...97,345,323
|
|
| G
|
Ndufs4
|
NADH:ubiquinone oxidoreductase subunit S4
|
affects expression
|
ISO
|
chloropicrin affects the expression of NDUFS4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:47,684,420...47,794,914
Ensembl chr 2:47,684,406...47,794,931
|
|
| G
|
Ndufs5
|
NADH:ubiquinone oxidoreductase subunit S5
|
affects expression
|
ISO
|
chloropicrin affects the expression of NDUFS5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:141,258,828...141,264,552
Ensembl chr 2:184,849,197...185,028,909 Ensembl chr 5:184,849,197...185,028,909 Ensembl chr14:184,849,197...185,028,909
|
|
| G
|
Ndufs8
|
NADH:ubiquinone oxidoreductase core subunit S8
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NDUFS8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:210,569,823...210,573,707
Ensembl chr 1:210,569,824...210,572,971
|
|
| G
|
Nedd8
|
NEDD8 ubiquitin like modifier
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NEDD8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:33,123,505...33,135,522
Ensembl chr15:33,123,505...33,135,522
|
|
| G
|
Net1
|
neuroepithelial cell transforming 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NET1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NFE2L2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NFKBIA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nhp2
|
NHP2 ribonucleoprotein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NHP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:36,378,020...36,381,362
Ensembl chr10:36,377,997...36,381,354
|
|
| G
|
Nicol1
|
NELL2 interacting cell ontogeny regulator 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NICOL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:80,992,697...80,994,213
Ensembl chr14:80,992,697...80,994,213
|
|
| G
|
Nme4
|
NME/NM23 nucleoside diphosphate kinase 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NME4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:15,619,106...15,622,961
Ensembl chr10:15,619,106...15,623,098
|
|
| G
|
Nol7
|
nucleolar protein 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NOL7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:21,509,605...21,512,879
Ensembl chr17:21,509,605...21,513,196
|
|
| G
|
Nop10
|
NOP10 ribonucleoprotein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NOP10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:119,521,255...119,522,340
Ensembl chr 3:119,521,255...119,522,340
|
|
| G
|
Nop53
|
NOP53 ribosome biogenesis factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NOP53 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:85,757,271...85,765,089
Ensembl chr 1:85,756,586...85,765,089
|
|
| G
|
Nop58
|
NOP58 ribonucleoprotein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NOP58 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:68,614,992...68,638,911
Ensembl chr 9:68,615,010...68,638,909
|
|
| G
|
Npc1
|
NPC intracellular cholesterol transporter 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NPC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800
|
|
| G
|
Npc2
|
NPC intracellular cholesterol transporter 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NPC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:110,128,325...110,149,245
Ensembl chr 6:110,128,325...110,150,004
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NQO1 mRNA
|
CTD |
PMID:24211530 PMID:26352163 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nsa2
|
NSA2 ribosome biogenesis factor
|
affects expression
|
ISO
|
chloropicrin affects the expression of NSA2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:30,177,753...30,184,004
Ensembl chr 2:30,177,702...30,184,031
|
|
| G
|
Nsun2
|
NOP2/Sun RNA methyltransferase 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NSUN2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:35,490,583...35,514,839
Ensembl chr 1:35,490,583...35,514,306
|
|
| G
|
Nt5e
|
5' nucleotidase, ecto
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of NT5E mRNA chloropicrin results in decreased expression of NT5E mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
|
|
| G
|
Nucks1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NUCKS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:45,897,275...45,926,491
Ensembl chr13:45,897,248...45,923,101
|
|
| G
|
Nudc
|
nuclear distribution C, dynein complex regulator
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NUDC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:151,041,878...151,055,260
Ensembl chr 5:151,041,875...151,055,260
|
|
| G
|
Nupr1
|
nuclear protein 1, transcriptional regulator
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of NUPR1 mRNA chloropicrin results in decreased expression of NUPR1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901
|
|
| G
|
Nxf1
|
nuclear RNA export factor 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of NXF1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:215,084,563...215,097,756
Ensembl chr 1:215,084,099...215,097,756
|
|
| G
|
Nxt1
|
nuclear transport factor 2-like export factor 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of NXT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:156,562,121...156,565,043
Ensembl chr 3:156,560,556...156,565,996
|
|
| G
|
Oat
|
ornithine aminotransferase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of OAT mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754
|
|
| G
|
Oaz1
|
ornithine decarboxylase antizyme 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of OAZ1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:9,533,811...9,536,990
|
|
| G
|
Ociad1
|
OCIA domain containing 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OCIAD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:35,251,891...35,269,440
Ensembl chr14:35,251,333...35,269,283
|
|
| G
|
Ociad2
|
OCIA domain containing 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OCIAD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:35,225,291...35,243,306
Ensembl chr14:35,225,255...35,243,311
|
|
| G
|
Odc1
|
ornithine decarboxylase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ODC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
| G
|
Oga
|
O-GlcNAcase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OGA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:254,547,311...254,582,855
|
|
| G
|
Orc6
|
origin recognition complex, subunit 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ORC6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:37,931,085...37,938,856
Ensembl chr19:37,931,090...37,938,856
|
|
| G
|
Oser1
|
oxidative stress responsive serine-rich 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OSER1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:172,486,417...172,504,607
Ensembl chr 3:172,486,440...172,504,597
|
|
| G
|
Osgin1
|
oxidative stress induced growth inhibitor 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OSGIN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:64,401,173...64,409,162
|
|
| G
|
Ost4
|
oligosaccharyltransferase complex subunit 4, non-catalytic
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OST4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:31,191,198...31,192,422
Ensembl chr 6:31,191,198...31,192,422
|
|
| G
|
Ostc
|
oligosaccharyltransferase complex non-catalytic subunit
|
affects expression
|
ISO
|
chloropicrin affects the expression of OSTC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:221,924,727...221,940,253
Ensembl chr 2:221,874,948...221,940,267
|
|
| G
|
Oxsr1
|
oxidative stress responsive kinase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of OXSR1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:127,850,481...127,941,518
Ensembl chr 8:127,850,484...127,939,750
|
|
| G
|
P4hb
|
prolyl 4-hydroxylase subunit beta
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of P4HB mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
|
|
| G
|
Pa2g4
|
proliferation-associated 2G4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PA2G4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802
|
|
| G
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PABPC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:69,662,513...69,674,806
Ensembl chr 7:69,663,068...69,675,050
|
|
| G
|
Pabpc4
|
poly(A) binding protein, cytoplasmic 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PABPC4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:140,847,835...140,864,089
Ensembl chr 5:140,848,225...140,864,087
|
|
| G
|
Pafah1b1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PAFAH1B1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:60,031,441...60,090,259
Ensembl chr10:60,032,514...60,090,196
|
|
| G
|
Palld
|
palladin, cytoskeletal associated protein
|
affects expression
|
ISO
|
chloropicrin affects the expression of PALLD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232
|
|
| G
|
Pam
|
peptidylglycine alpha-amidating monooxygenase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PAM mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 9:105,445,812...105,719,287
Ensembl chr 9:105,445,929...105,719,285
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage multiple interactions
|
ISO
|
chloropicrin results in increased cleavage of PARP1 protein Acetylcysteine inhibits the reaction [chloropicrin results in increased cleavage of PARP1 protein]
|
CTD |
PMID:31884112 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcbp1
|
poly(rC) binding protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of PCBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:120,530,100...120,532,107
Ensembl chr 4:120,529,172...120,539,111
|
|
| G
|
Pclaf
|
PCNA clamp associated factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PCLAF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106
|
|
| G
|
Pcmt1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PCMT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:3,932,161...3,980,751
Ensembl chr 1:3,932,161...3,964,848
|
|
| G
|
Pcnp
|
PEST proteolytic signal containing nuclear protein
|
affects expression
|
ISO
|
chloropicrin affects the expression of PCNP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:58,061,885...58,076,436
Ensembl chr11:58,061,570...58,076,436
|
|
| G
|
Pdcd7
|
programmed cell death 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PDCD7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:74,757,768...74,772,495
Ensembl chr 8:74,757,768...74,781,634
|
|
| G
|
Pde4c
|
phosphodiesterase 4C
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PDE4C mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr16:18,724,703...18,745,528
Ensembl chr16:18,725,674...18,744,037
|
|
| G
|
Pea15
|
proliferation and apoptosis adaptor protein 15
|
affects expression
|
ISO
|
chloropicrin affects the expression of PEA15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
|
|
| G
|
Pebp1
|
phosphatidylethanolamine binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PEBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780
|
|
| G
|
Perp
|
p53 apoptosis effector related to PMP22
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PERP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687
|
|
| G
|
Pet100
|
PET100 cytochrome c oxidase chaperone
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PET100 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:6,477,703...6,480,435
Ensembl chr12:6,477,777...6,480,431
|
|
| G
|
Pfdn5
|
prefoldin subunit 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of PFDN5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:135,330,364...135,335,102
Ensembl chr 7:135,330,172...135,335,099
|
|
| G
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PFKFB3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052
|
|
| G
|
Pfkfb4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PFKFB4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,522,371...118,565,478
Ensembl chr 8:118,522,365...118,565,468
|
|
| G
|
Pfkp
|
phosphofructokinase, platelet
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PFKP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752
|
|
| G
|
Pfn1
|
profilin 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PFN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,863,881...55,868,611
|
|
| G
|
Pgam1
|
phosphoglycerate mutase 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of PGAM1 mRNA chloropicrin results in decreased expression of PGAM1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:250,673,049...250,690,203
|
|
| G
|
Pgf
|
placental growth factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PGF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Pgk1
|
phosphoglycerate kinase 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of PGK1 mRNA chloropicrin results in decreased expression of PGK1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:75,336,687...75,352,959
|
|
| G
|
Pgm1
|
phosphoglucomutase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PGM1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:119,710,737...119,770,159
|
|
| G
|
Phgdh
|
phosphoglycerate dehydrogenase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PHGDH mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789
|
|
| G
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PHLDA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
|
|
| G
|
Phpt1
|
phosphohistidine phosphatase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PHPT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:28,791,062...28,792,905
|
|
| G
|
Pigy
|
phosphatidylinositol glycan anchor biosynthesis, class Y
|
affects expression
|
ISO
|
chloropicrin affects the expression of PIGY mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:28,965,634...28,967,876
Ensembl chr 8:28,965,617...28,968,508
|
|
| G
|
Pik3r2
|
phosphoinositide-3-kinase regulatory subunit 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PIK3R2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
|
|
| G
|
Pirb
|
paired Ig-like receptor B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of LILRB3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:74,414,556...74,433,015
Ensembl chr 1:74,331,291...74,422,116
|
|
| G
|
Pja2
|
praja ring finger ubiquitin ligase 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PJA2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:111,403,624...111,453,703
Ensembl chr 9:111,403,624...111,453,703
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
affects expression
|
ISO
|
chloropicrin affects the expression of PLAU mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plek2
|
pleckstrin 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PLEK2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 6:103,434,156...103,452,457
Ensembl chr 6:103,434,156...103,452,371
|
|
| G
|
Plin2
|
perilipin 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PLIN2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
|
|
| G
|
Plin3
|
perilipin 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PLIN3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:1,198,336...1,210,212
Ensembl chr 9:1,198,336...1,210,231
|
|
| G
|
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of PLOD2 mRNA chloropicrin results in decreased expression of PLOD2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:101,964,318...102,047,022
|
|
| G
|
Pls3
|
plastin 3
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of PLS3 mRNA chloropicrin results in decreased expression of PLS3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:116,401,247...116,495,898
Ensembl chr X:116,401,293...116,495,893
|
|
| G
|
Pltp
|
phospholipid transfer protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PLTP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505
|
|
| G
|
Pnpt1
|
polyribonucleotide nucleotidyltransferase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PNPT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:107,078,486...107,109,628
Ensembl chr14:107,078,469...107,109,628
|
|
| G
|
Pofut1
|
protein O-fucosyltransferase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of POFUT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:162,168,855...162,195,798
Ensembl chr 3:162,168,606...162,195,018
|
|
| G
|
Polr1d
|
RNA polymerase I and III subunit D
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of POLR1D mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:13,084,505...13,118,069
Ensembl chr12:13,084,512...13,095,627
|
|
| G
|
Polr2f
|
RNA polymerase II, I and III subunit F
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of POLR2F mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:112,593,027...112,604,666
|
|
| G
|
Polr2g
|
RNA polymerase II subunit G
|
increases expression
|
ISO
|
chloropicrin results in increased expression of POLR2G mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:215,118,278...215,125,389
Ensembl chr 1:215,118,262...215,121,805
|
|
| G
|
Pomp
|
proteasome maturation protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of POMP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:12,198,262...12,212,132
Ensembl chr12:12,198,263...12,210,880
|
|
| G
|
Ppa1
|
inorganic pyrophosphatase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of PPA1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:30,132,088...30,160,492
Ensembl chr20:30,133,504...30,160,489
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of PPBP mRNA chloropicrin results in decreased expression of PPBP mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Ppp1r14b
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
affects expression
|
ISO
|
chloropicrin affects the expression of PPP1R14B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:213,594,416...213,596,527
Ensembl chr12:21,088,517...21,101,431 Ensembl chr 1:21,088,517...21,101,431
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PPP1R15A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ppp1r3c
|
protein phosphatase 1, regulatory subunit 3C
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PPP1R3C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:243,871,704...243,878,835
|
|
| G
|
Ppp6c
|
protein phosphatase 6, catalytic subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PPP6C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:43,339,521...43,371,807
Ensembl chr 3:43,341,108...43,371,807
|
|
| G
|
Pprc1
|
PPARG related coactivator 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PPRC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570
|
|
| G
|
Prdx1
|
peroxiredoxin 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PRDX1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
|
|
| G
|
Prdx3
|
peroxiredoxin 3
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of PRDX3 mRNA chloropicrin results in decreased expression of PRDX3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:269,987,685...270,000,300
|
|
| G
|
Prdx5
|
peroxiredoxin 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of PRDX5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020
|
|
| G
|
Prickle4
|
prickle planar cell polarity protein 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PRICKLE4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:20,795,248...20,801,497
Ensembl chr 9:20,794,995...20,803,170
|
|
| G
|
Prnp
|
prion protein
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PRNP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436
|
|
| G
|
Prxl2a
|
peroxiredoxin like 2A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PRXL2A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:16,900,697...16,920,521
Ensembl chr16:16,900,699...16,920,561
|
|
| G
|
Psap
|
prosaposin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSAP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:28,756,951...28,783,422
Ensembl chr20:28,757,181...28,783,421
|
|
| G
|
Psat1
|
phosphoserine aminotransferase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PSAT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693
|
|
| G
|
Psma5
|
proteasome 20S subunit alpha 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMA5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:198,584,502...198,607,867
Ensembl chr 2:198,584,505...198,607,867
|
|
| G
|
Psma6
|
proteasome 20S subunit alpha 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMA6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:78,500,736...78,531,717
|
|
| G
|
Psmb1
|
proteasome 20S subunit beta 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640
|
|
| G
|
Psmb3
|
proteasome 20S subunit beta 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMB3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883
|
|
| G
|
Psmb4
|
proteasome 20S subunit beta 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PSMB4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287
|
|
| G
|
Psmb5
|
proteasome 20S subunit beta 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of PSMB5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379
|
|
| G
|
Psmb6
|
proteasome 20S subunit beta 6
|
affects expression
|
ISO
|
chloropicrin affects the expression of PSMB6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:55,737,852...55,740,218
Ensembl chr10:55,737,888...55,740,218
|
|
| G
|
Psmb7
|
proteasome 20S subunit beta 7
|
affects expression
|
ISO
|
chloropicrin affects the expression of PSMB7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:42,767,500...42,827,470
Ensembl chr 3:42,767,501...42,827,601
|
|
| G
|
Psmc2
|
proteasome 26S subunit, ATPase 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390
|
|
| G
|
Psmd12
|
proteasome 26S subunit, non-ATPase 12
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMD12 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,901,133...92,988,964
|
|
| G
|
Psmd14
|
proteasome 26S subunit, non-ATPase 14
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PSMD14 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:66,662,900...66,755,665
|
|
| G
|
Ptges3
|
prostaglandin E synthase 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PTGES3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,075,230...1,092,363
Ensembl chr 7:1,075,227...1,092,695
|
|
| G
|
Ptgr1
|
prostaglandin reductase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PTGR1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
affects expression increases expression decreases expression
|
ISO
|
chloropicrin affects the expression of PTGS2 mRNA chloropicrin results in increased expression of PTGS2 protein chloropicrin results in decreased expression of PTGS2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 PMID:31884112 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Pthlh
|
parathyroid hormone-like hormone
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of PTHLH mRNA chloropicrin results in decreased expression of PTHLH mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:181,919,400...181,930,454
|
|
| G
|
Ptma
|
prothymosin alpha
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PTMA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:94,624,196...94,628,276
|
|
| G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of PTPN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
| G
|
Ptprf
|
protein tyrosine phosphatase, receptor type, F
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PTPRF mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
|
|
| G
|
Purb
|
purine rich element binding protein B
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PURB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:85,556,296...85,558,779
Ensembl chr14:85,550,417...85,572,205
|
|
| G
|
Pxdn
|
peroxidasin
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of PXDN mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 6:52,308,347...52,385,943
Ensembl chr 6:52,308,364...52,385,942
|
|
| G
|
Pygl
|
glycogen phosphorylase L
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of PYGL mRNA chloropicrin results in decreased expression of PYGL mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:94,426,346...94,476,269
|
|
| G
|
Qars1
|
glutaminyl-tRNA synthetase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of QARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,086,243...118,094,274
Ensembl chr 8:118,086,228...118,094,274
|
|
| G
|
Qrfpr
|
pyroglutamylated RFamide peptide receptor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of QRFPR mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:120,981,235...121,025,020
Ensembl chr 2:120,981,235...121,025,020
|
|
| G
|
Rab27b
|
RAB27B, member RAS oncogene family
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RAB27B mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr18:65,870,230...66,069,597
Ensembl chr18:65,876,342...66,067,700
|
|
| G
|
Rab38
|
RAB38, member RAS oncogene family
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RAB38 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:151,595,153...151,675,492
Ensembl chr 1:151,595,078...151,675,493
|
|
| G
|
Rab5if
|
RAB5 interacting factor
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RAB5IF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:165,818,060...165,828,071
Ensembl chr 3:165,816,588...165,828,067
|
|
| G
|
Rab7a
|
RAB7A, member RAS oncogene family
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RAB7A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:121,983,938...122,064,185
|
|
| G
|
Rabggtb
|
Rab geranylgeranyltransferase subunit beta
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RABGGTB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:245,504,586...245,510,878
Ensembl chr 2:245,504,586...245,510,774
|
|
| G
|
Rac1
|
Rac family small GTPase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RAC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109
|
|
| G
|
Rack1
|
receptor for activated C kinase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of RACK1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,670,270...33,675,948
|
|
| G
|
Rai14
|
retinoic acid induced 14
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RAI14 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:61,273,439...61,411,141
Ensembl chr 2:61,273,439...61,409,791
|
|
| G
|
Rala
|
RAS like proto-oncogene A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RALA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:51,787,682...51,840,738
Ensembl chr17:51,787,699...51,840,733
|
|
| G
|
Ralb
|
RAS like proto-oncogene B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RALB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:33,140,834...33,176,997
Ensembl chr13:33,140,835...33,176,998
|
|
| G
|
Ran
|
RAN, member RAS oncogene family
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RAN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
|
|
| G
|
Ranbp1
|
RAN binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RANBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:96,246,740...96,255,145
|
|
| G
|
Rangap1
|
RAN GTPase activating protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RANGAP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:115,104,823...115,130,564
|
|
| G
|
Rars1
|
arginyl-tRNA synthetase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:20,774,804...20,799,251
Ensembl chr10:20,774,805...20,799,251
|
|
| G
|
Rbis
|
ribosomal biogenesis factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RBIS mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:88,702,599...88,718,587
Ensembl chr 2:88,702,536...88,719,527
|
|
| G
|
Rbm14
|
RNA binding motif protein 14
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RBM14 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:211,523,972...211,535,065
|
|
| G
|
Rbp1
|
retinol binding protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:107,887,417...107,983,847
|
|
| G
|
Rbx1
|
ring-box 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RBX1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191
|
|
| G
|
Rdh11
|
retinol dehydrogenase 11
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RDH11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:103,712,373...103,728,247
Ensembl chr 6:103,712,374...103,729,741
|
|
| G
|
Rexo2
|
RNA exonuclease 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of REXO2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:57,708,420...57,720,142
Ensembl chr 8:57,707,558...57,720,142
|
|
| G
|
Rgs2
|
regulator of G-protein signaling 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RGS2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
| G
|
Rheb
|
Ras homolog, mTORC1 binding
|
affects expression
|
ISO
|
chloropicrin affects the expression of RHEB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:11,012,173...11,053,860
Ensembl chr 4:11,012,643...11,053,931
|
|
| G
|
Rhoa
|
ras homolog family member A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RHOA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Rhob
|
ras homolog family member B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RHOB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772
|
|
| G
|
Rhoc
|
ras homolog family member C
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RHOC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745
|
|
| G
|
Rhod
|
ras homolog family member D
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RHOD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:211,138,126...211,153,953
Ensembl chr 1:211,138,126...211,152,061
|
|
| G
|
Ric8a
|
RIC8 guanine nucleotide exchange factor A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RIC8A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:205,364,796...205,371,102
Ensembl chr 1:205,363,882...205,371,102
|
|
| G
|
Rn7sl1
|
RNA component of signal recognition particle 7SL1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RN7SL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:93,372,872...93,373,170
Ensembl chr 6:93,372,868...93,373,167
|
|
| G
|
Rna5s9
|
RNA, 5S ribosomal 9
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RNA5S9 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr19:68,507,561...68,507,679
Ensembl chr19:68,507,561...68,507,679
|
|
| G
|
Rnd3
|
Rho family GTPase 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RND3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536
|
|
| G
|
Rnf181
|
ring finger protein 181
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RNF181 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:105,972,778...105,979,624
Ensembl chr 4:105,972,797...105,979,500
|
|
| G
|
Rnu6-1
|
RNA, U6 small nuclear 1
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of RNU6-1 mRNA chloropicrin results in increased expression of RNU6-1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:72,489,442...72,489,548
Ensembl chr 8:72,489,442...72,489,548
|
|
| G
|
Rock2
|
Rho-associated coiled-coil containing protein kinase 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of ROCK2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:45,407,965...45,502,771
|
|
| G
|
Romo1
|
reactive oxygen species modulator 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of ROMO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:165,119,794...165,121,394
Ensembl chr 3:165,120,035...165,121,394
|
|
| G
|
Rpf2
|
ribosome production factor 2 homolog
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPF2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:45,184,511...45,205,983
Ensembl chr20:45,184,512...45,206,001
|
|
| G
|
Rpl10a
|
ribosomal protein L10A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL10A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:6,390,533...6,393,091
Ensembl chr20:6,390,179...6,393,091
|
|
| G
|
Rpl11
|
ribosomal protein L11
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:153,557,592...153,561,230
Ensembl chr 5:153,557,597...153,561,127
|
|
| G
|
Rpl12
|
ribosomal protein L12
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL12 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:36,661,940...36,664,314
Ensembl chr 3:36,661,939...36,664,306
|
|
| G
|
Rpl13a
|
ribosomal protein L13A
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL13A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:104,746,223...104,748,914
|
|
| G
|
Rpl14
|
ribosomal protein L14
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of RPL14 mRNA chloropicrin results in increased expression of RPL14 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:129,163,317...129,167,459
|
|
| G
|
Rpl15
|
ribosomal protein L15
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:9,934,663...9,937,946
Ensembl chr15:9,934,679...9,938,308
|
|
| G
|
Rpl17
|
ribosomal protein L17
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL17 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:70,856,275...70,859,388
Ensembl chr 3:111,722,010...111,722,638 Ensembl chr18:111,722,010...111,722,638
|
|
| G
|
Rpl18
|
ribosomal protein L18
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL18 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:105,325,269...105,327,911
Ensembl chr 1:105,325,250...105,327,910
|
|
| G
|
Rpl18a
|
ribosomal protein L18A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL18A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:18,576,467...18,578,653
Ensembl chr 1:70,166,729...70,167,654 Ensembl chr16:70,166,729...70,167,654
|
|
| G
|
Rpl19
|
ribosomal protein L19
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL19 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:83,514,509...83,522,352
Ensembl chr10:83,515,464...83,522,352
|
|
| G
|
Rpl21
|
ribosomal protein L21
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL21 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:13,382,516...13,386,153
Ensembl chr12:13,382,516...13,386,153 Ensembl chr13:13,382,516...13,386,153
|
|
| G
|
Rpl22
|
ribosomal protein L22
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of RPL22 mRNA chloropicrin results in decreased expression of RPL22 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:168,114,432...168,126,114
Ensembl chr 5:168,111,074...168,126,114 Ensembl chr 4:168,111,074...168,126,114 Ensembl chr 7:168,111,074...168,126,114
|
|
| G
|
Rpl23
|
ribosomal protein L23
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL23 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:83,268,223...83,272,184
Ensembl chr10:83,262,592...83,272,214
|
|
| G
|
Rpl23a
|
ribosomal protein L23A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL23A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:63,574,732...63,577,511
Ensembl chr10:63,574,732...63,581,606
|
|
| G
|
Rpl24
|
ribosomal protein L24
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL24 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:58,122,997...58,128,405
Ensembl chr11:58,122,997...58,128,405
|
|
| G
|
Rpl26
|
ribosomal protein L26
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL26 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:54,109,692...54,112,822
Ensembl chr10:54,109,362...54,112,822
|
|
| G
|
Rpl27a
|
ribosomal protein L27A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL27A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:172,971,957...172,977,591
|
|
| G
|
Rpl29
|
ribosomal protein L29
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of RPL29 mRNA chloropicrin results in decreased expression of RPL29 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:115,056,443...115,949,677
Ensembl chr 8:115,947,394...115,950,565
|
|
| G
|
Rpl3
|
ribosomal protein L3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:113,491,943...113,508,115
Ensembl chr 7:113,501,960...113,507,990
|
|
| G
|
Rpl30
|
ribosomal protein L30
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL30 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:67,533,420...67,536,555
Ensembl chr 7:67,465,332...67,536,555
|
|
| G
|
Rpl31
|
ribosomal protein L31
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL31 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:49,143,044...49,147,155
Ensembl chr 9:49,142,955...49,147,155
|
|
| G
|
Rpl32
|
ribosomal protein L32
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL32 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:150,536,650...150,540,214
Ensembl chr 4:150,536,646...150,540,214
|
|
| G
|
Rpl34
|
ribosomal protein L34
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL34 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:221,958,551...221,962,309
Ensembl chr17:79,783,869...79,820,922 Ensembl chr 2:79,783,869...79,820,922
|
|
| G
|
Rpl35
|
ribosomal protein L35
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL35 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:43,162,960...43,166,485
Ensembl chr 3:43,162,764...43,165,947
|
|
| G
|
Rpl35a
|
ribosomal protein L35A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL35A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:81,231,114...81,235,094
Ensembl chr 5:163,826,849...163,827,306 Ensembl chr11:163,826,849...163,827,306
|
|
| G
|
Rpl36
|
ribosomal protein L36
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL36 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:1,529,117...1,534,534
Ensembl chr 1:126,560,003...126,560,369
|
|
| G
|
Rpl36al1
|
ribosomal protein L36A like 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL36AL mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:93,390,864...93,392,258
Ensembl chr 6:93,390,866...93,391,296 Ensembl chr20:93,390,866...93,391,296
|
|
| G
|
Rpl38
|
ribosomal protein L38
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL38 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:100,200,414...100,204,070
Ensembl chr16:10,188,932...10,189,144 Ensembl chr 2:10,188,932...10,189,144 Ensembl chr 3:10,188,932...10,189,144 Ensembl chr14:10,188,932...10,189,144 Ensembl chr10:10,188,932...10,189,144
|
|
| G
|
Rpl39
|
ribosomal protein L39
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL39 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:121,192,901...121,195,896
Ensembl chr 7:31,721,884...31,722,039 Ensembl chr15:31,721,884...31,722,039 Ensembl chr X:31,721,884...31,722,039
|
|
| G
|
Rpl4
|
ribosomal protein L4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:73,566,477...73,571,600
Ensembl chr 8:73,566,466...73,571,788
|
|
| G
|
Rpl41
|
ribosomal protein L41
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPL41 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,562,417...1,563,497
|
|
| G
|
Rpl5
|
ribosomal protein L5
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:1,988,792...1,995,236
Ensembl chr14:1,988,793...1,995,225
|
|
| G
|
Rpl7
|
ribosomal protein L7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:8,000,446...8,003,454
Ensembl chr 5:7,850,630...8,003,451
|
|
| G
|
Rpl7a
|
ribosomal protein L7A
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL7A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:30,637,136...30,639,778
Ensembl chr 3:30,637,059...30,639,791 Ensembl chr18:30,637,059...30,639,791
|
|
| G
|
Rpl7l1
|
ribosomal protein L7-like 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL7L1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:21,695,718...21,703,736
Ensembl chr 9:21,695,707...21,703,735
|
|
| G
|
Rpl8
|
ribosomal protein L8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPL8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103 Ensembl chr 3:110,506,800...110,509,103
|
|
| G
|
Rpl9
|
ribosomal protein L9
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPL9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:43,247,536...43,250,784
Ensembl chr14:43,247,588...43,250,782 Ensembl chr 1:43,247,588...43,250,782
|
|
| G
|
Rplp0
|
ribosomal protein lateral stalk subunit P0
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of RPLP0 mRNA chloropicrin results in decreased expression of RPLP0 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr12:46,715,121...46,718,390
Ensembl chr12:46,715,124...46,718,422
|
|
| G
|
Rplp0l1
|
ribosomal protein lateral stalk subunit P0 like 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPLP0P6 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 2:194,609,881...194,611,022
Ensembl chr 2:194,609,950...194,611,022
|
|
| G
|
Rplp1
|
ribosomal protein lateral stalk subunit P1
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPLP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:71,289,539...71,290,872
Ensembl chr 8:71,289,535...71,290,872
|
|
| G
|
Rplp2
|
ribosomal protein lateral stalk subunit P2
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPLP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:205,975,598...205,978,192
Ensembl chr 1:205,975,894...205,978,191
|
|
| G
|
Rprd1a
|
regulation of nuclear pre-mRNA domain containing 1A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPRD1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:16,066,169...16,114,102
Ensembl chr18:16,066,169...16,114,282
|
|
| G
|
Rps10
|
ribosomal protein S10
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:5,696,135...5,700,863
Ensembl chr20:5,696,135...5,700,150 Ensembl chr 6:5,696,135...5,700,150
|
|
| G
|
Rps11
|
ribosomal protein S11
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:104,742,153...104,744,261
Ensembl chr 1:104,742,155...104,744,337
|
|
| G
|
Rps12
|
ribosomal protein S12
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS12 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:23,499,943...23,502,234
Ensembl chr 1:23,500,073...23,502,235
|
|
| G
|
Rps13
|
ribosomal protein S13
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS13 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:180,007,230...180,009,660
Ensembl chr 1:180,002,471...180,009,660
|
|
| G
|
Rps15
|
ribosomal protein S15
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:10,066,572...10,068,167
Ensembl chr 7:10,066,677...10,068,123
|
|
| G
|
Rps16
|
ribosomal protein S16
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS16 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:92,770,658...92,773,603
Ensembl chr19:56,922,246...56,923,020 Ensembl chr 1:56,922,246...56,923,020
|
|
| G
|
Rps17
|
ribosomal protein S17
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS17 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:144,705,150...144,707,736
Ensembl chr 1:144,705,149...144,707,734 Ensembl chr 8:144,705,149...144,707,734
|
|
| G
|
Rps18
|
ribosomal protein S18
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS18 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:4,933,741...4,937,423
Ensembl chr20:4,917,095...4,937,423
|
|
| G
|
Rps19
|
ribosomal protein S19
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS19 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:89,608,408...89,614,390
Ensembl chr 7:104,324,520...104,325,132 Ensembl chr 1:104,324,520...104,325,132
|
|
| G
|
Rps2
|
ribosomal protein S2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:14,251,841...14,253,697
Ensembl chr10:14,251,380...14,253,695
|
|
| G
|
Rps20
|
ribosomal protein S20
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS20 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:21,616,687...21,618,068
Ensembl chr 3:42,839,965...43,095,621 Ensembl chr 9:42,839,965...43,095,621 Ensembl chr 5:42,839,965...43,095,621
|
|
| G
|
Rps21-ps1
|
ribosomal protein S21, pseudogene 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS21 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:158,670,141...158,670,484
Ensembl chr 5:158,670,116...158,670,490
|
|
| G
|
Rps23
|
ribosomal protein S23
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS23 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:23,814,517...23,816,087
Ensembl chr 2:23,814,497...23,816,088
|
|
| G
|
Rps26l1
|
ribosomal protein S26 like 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS26P11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:64,867,131...64,868,017
|
|
| G
|
Rps27
|
ribosomal protein S27
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS27 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:177,963,499...177,964,708
Ensembl chr 2:177,963,496...177,964,607 Ensembl chr12:177,963,496...177,964,607
|
|
| G
|
Rps27a
|
ribosomal protein S27a
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS27A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:107,486,664...107,488,941
Ensembl chr 5:138,465,088...138,466,080 Ensembl chr14:138,465,088...138,466,080 Ensembl chr 5:138,465,088...138,466,080
|
|
| G
|
Rps27l
|
ribosomal protein S27-like
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RPS27L mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:76,443,658...76,448,593
Ensembl chr12:33,713,661...33,714,130 Ensembl chr 8:33,713,661...33,714,130
|
|
| G
|
Rps28
|
ribosomal protein S28
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS28 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:15,309,964...15,311,333
Ensembl chr16:72,591,164...72,591,373 Ensembl chr 7:72,591,164...72,591,373 Ensembl chr16:72,591,164...72,591,373
|
|
| G
|
Rps3
|
ribosomal protein S3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:163,190,476...163,195,885
Ensembl chr 1:163,189,842...163,195,776
|
|
| G
|
Rps3a
|
ribosomal protein S3a
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS3A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:173,822,673...173,827,042
Ensembl chr 2:173,822,488...173,827,043
|
|
| G
|
Rps4x
|
ribosomal protein S4, X-linked
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS4X mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:71,338,478...71,342,921
Ensembl chr X:71,338,479...71,342,921 Ensembl chr 4:71,338,479...71,342,921
|
|
| G
|
Rps5
|
ribosomal protein S5
|
affects expression
|
ISO
|
chloropicrin affects the expression of RPS5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:82,610,965...82,615,262
Ensembl chr 1:82,610,965...82,615,262
|
|
| G
|
Rps6
|
ribosomal protein S6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:106,417,680...106,420,566
|
|
| G
|
Rps7
|
ribosomal protein S7
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of RPS7 mRNA chloropicrin results in decreased expression of RPS7 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 6:50,994,581...50,999,447
|
|
| G
|
Rps8
|
ribosomal protein S8
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS8 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:135,866,941...135,869,511
Ensembl chr 5:135,866,941...135,869,548
|
|
| G
|
Rps9
|
ribosomal protein S9
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPS9 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:74,427,084...74,430,513
Ensembl chr 1:74,427,087...74,430,105
|
|
| G
|
Rpsa
|
ribosomal protein SA
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RPSA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737
|
|
| G
|
Rraga
|
Ras-related GTP binding A
|
affects expression
|
ISO
|
chloropicrin affects the expression of RRAGA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:106,159,335...106,160,930
Ensembl chr 5:106,158,853...106,160,504
|
|
| G
|
Rrs1
|
ribosome biogenesis regulator 1 homolog
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RRS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:14,516,303...14,517,936
Ensembl chr 5:14,515,254...14,517,943
|
|
| G
|
Rsl24d1
|
ribosomal L24 domain containing 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of RSL24D1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:82,733,627...82,742,632
Ensembl chr 8:82,733,649...82,744,497
|
|
| G
|
Rsrc2
|
arginine and serine rich coiled-coil 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RSRC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:38,500,709...38,520,715
Ensembl chr12:38,500,770...38,520,707
|
|
| G
|
RT1-CE16
|
RT1 class I, locus CE16
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of HLA-A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:3,261,656...3,265,548
|
|
| G
|
Rtn4
|
reticulon 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of RTN4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:107,651,001...107,698,610
Ensembl chr14:107,650,732...107,698,611
|
|
| G
|
Rtraf
|
RNA transcription, translation and transport factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RTRAF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:4,482,699...4,507,115
Ensembl chr15:4,480,966...4,507,115
|
|
| G
|
Rttn
|
rotatin
|
affects expression
|
ISO
|
chloropicrin affects the expression of RTTN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:84,495,813...84,673,079
Ensembl chr18:84,482,601...84,700,463
|
|
| G
|
Rybp
|
RING1 and YY1 binding protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of RYBP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:134,432,663...134,484,732
Ensembl chr 4:134,432,663...134,484,930
|
|
| G
|
S100a10
|
S100 calcium binding protein A10
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of S100A10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103
|
|
| G
|
S100a11
|
S100 calcium binding protein A11
|
increases expression
|
ISO
|
chloropicrin results in increased expression of S100A11 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:181,875,130...181,880,541
|
|
| G
|
S100a16
|
S100 calcium binding protein A16
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of S100A16 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:178,313,986...178,319,696
Ensembl chr 2:178,313,910...178,319,821
|
|
| G
|
S100a2
|
S100 calcium binding protein A2
|
affects expression
|
ISO
|
chloropicrin affects the expression of S100A2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:178,374,659...178,375,903
|
|
| G
|
S100a6
|
S100 calcium binding protein A6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of S100A6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762
|
|
| G
|
S100a8
|
S100 calcium binding protein A8
|
affects expression
|
ISO
|
chloropicrin affects the expression of S100A8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
|
|
| G
|
S100a9
|
S100 calcium binding protein A9
|
increases expression
|
ISO
|
chloropicrin results in increased expression of S100A9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
|
|
| G
|
Sae1
|
SUMO1 activating enzyme subunit 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SAE1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:86,159,114...86,215,089
Ensembl chr 1:86,159,114...86,215,089
|
|
| G
|
Saraf
|
store-operated calcium entry-associated regulatory factor
|
affects expression
|
ISO
|
chloropicrin affects the expression of SARAF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:64,720,404...64,738,653
Ensembl chr16:64,720,418...64,738,653
|
|
| G
|
Sarnp
|
SAP domain containing ribonucleoprotein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SARNP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:1,835,597...1,889,833
Ensembl chr 7:1,835,597...1,897,295
|
|
| G
|
Sars1
|
seryl-tRNA synthetase 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365
|
|
| G
|
Sat1
|
spermidine/spermine N1-acetyl transferase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of SAT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:44,006,781...44,011,374
|
|
| G
|
Scd
|
stearoyl-CoA desaturase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SCD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
|
|
| G
|
Scg5
|
secretogranin V
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SCG5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:120,998,420...121,042,881
Ensembl chr 3:120,998,420...121,042,795
|
|
| G
|
Scoc
|
short coiled-coil protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SCOC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:41,564,166...41,593,932
Ensembl chr19:41,564,112...41,597,912
|
|
| G
|
Sdc1
|
syndecan 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SDC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:37,297,010...37,304,500
|
|
| G
|
Sdf2l1
|
stromal cell-derived factor 2-like 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SDF2L1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:97,376,878...97,379,120
Ensembl chr11:97,376,878...97,379,120
|
|
| G
|
Sdhb
|
succinate dehydrogenase complex iron sulfur subunit B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SDHB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:158,547,775...158,568,589
Ensembl chr 5:158,547,689...158,569,667
|
|
| G
|
Sec11a
|
SEC11 homolog A, signal peptidase complex subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SEC11A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:144,290,680...144,318,658
Ensembl chr 1:144,284,497...144,324,009
|
|
| G
|
Sec61b
|
SEC61 translocon subunit beta
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SEC61B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:66,569,184...66,577,394
Ensembl chr 5:66,569,196...66,580,028
|
|
| G
|
Sec61g
|
Sec61 translocon subunit gamma
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SEC61G mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:95,113,083...95,119,458
Ensembl chr 9:48,798,504...48,798,710 Ensembl chr14:48,798,504...48,798,710
|
|
| G
|
Sel1l3
|
SEL1L family member 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SEL1L3 mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr14:61,988,350...62,095,542
Ensembl chr14:61,988,346...62,095,542
|
|
| G
|
Selenof
|
selenoprotein F
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of SELENOF mRNA chloropicrin results in decreased expression of SELENOF mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 2:236,302,439...236,335,216
Ensembl chr 2:236,302,683...236,335,210
|
|
| G
|
Sem1
|
SEM1 26S proteasome subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SEM1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:35,638,306...35,658,462
Ensembl chr 4:35,638,306...35,658,462
|
|
| G
|
Septin9
|
septin 9
|
affects expression
|
ISO
|
chloropicrin affects the expression of SEPTIN9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:102,908,557...103,077,789
Ensembl chr10:102,908,560...103,077,788
|
|
| G
|
Serf2
|
small EDRK-rich factor 2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SERF2 mRNA chloropicrin results in decreased expression of SERF2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:128,880,681...128,884,457
Ensembl chr 3:128,880,681...128,884,457
|
|
| G
|
Serinc2
|
serine incorporator 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SERINC2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:147,876,477...147,898,797
Ensembl chr 5:147,876,477...147,902,765
|
|
| G
|
Serpinb5
|
serpin family B member 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of SERPINB5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:23,500,203...23,520,401
Ensembl chr13:23,500,198...23,520,400
|
|
| G
|
Serpine1
|
serpin family E member 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SERPINE1 mRNA chloropicrin results in decreased expression of SERPINE1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serpine2
|
serpin family E member 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SERPINE2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
|
|
| G
|
Serpinh1
|
serpin family H member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SERPINH1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:163,055,630...163,062,976
|
|
| G
|
Sertad1
|
SERTA domain containing 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SERTAD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:91,903,297...91,906,565
Ensembl chr 1:91,891,814...91,907,001
|
|
| G
|
Set
|
Set nuclear proto-oncogene
|
affects expression
|
ISO
|
chloropicrin affects the expression of SET mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:33,732,319...33,743,433
|
|
| G
|
Sf3b4
|
splicing factor 3B subunit 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SF3B4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:186,421,667...186,426,419
Ensembl chr 2:186,421,636...186,426,833
|
|
| G
|
Sf3b5
|
splicing factor 3b, subunit 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SF3B5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:9,177,189...9,177,901
Ensembl chr 1:9,177,098...9,177,900
|
|
| G
|
Sf3b6
|
splicing factor 3B, subunit 6
|
affects expression
|
ISO
|
chloropicrin affects the expression of SF3B6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:33,545,495...33,554,537
Ensembl chr 6:33,545,512...33,554,608
|
|
| G
|
Sfn
|
stratifin
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SFN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995
|
|
| G
|
Sfrp1
|
secreted frizzled-related protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SFRP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:75,278,325...75,316,736
Ensembl chr16:75,278,325...75,316,736
|
|
| G
|
Sft2d1
|
SFT2 domain containing 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SFT2D1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:54,957,247...54,973,143
Ensembl chr 1:54,960,692...54,973,143
|
|
| G
|
Sgk1
|
serum/glucocorticoid regulated kinase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SGK1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
|
|
| G
|
Sh3bgrl3
|
SH3 domain binding glutamate-rich protein like 3
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SH3BGRL3 mRNA chloropicrin results in decreased expression of SH3BGRL3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:151,637,897...151,639,270
Ensembl chr 5:151,637,674...151,639,395
|
|
| G
|
Shc1
|
SHC adaptor protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SHC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:177,135,649...177,147,257
Ensembl chr 2:177,135,659...177,147,914
|
|
| G
|
Shcbp1
|
SHC binding and spindle associated 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SHCBP1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr16:91,373,843...91,405,409
Ensembl chr16:91,373,871...91,405,409
|
|
| G
|
Shisa5
|
shisa family member 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SHISA5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,569,975...118,584,880
Ensembl chr 8:118,569,975...118,584,880
|
|
| G
|
Shmt2
|
serine hydroxymethyltransferase 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of SHMT2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:65,244,247...65,249,580
Ensembl chr 7:65,244,247...65,249,567
|
|
| G
|
Slc16a12
|
solute carrier family 16, member 12
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLC16A12 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:241,597,165...241,674,821
Ensembl chr 1:241,599,066...241,674,743
|
|
| G
|
Slc16a3
|
solute carrier family 16 member 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SLC16A3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:106,712,328...106,756,168
Ensembl chr10:106,714,466...106,720,903
|
|
| G
|
Slc1a5
|
solute carrier family 1 member 5
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SLC1A5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:86,584,949...86,599,054
|
|
| G
|
Slc20a1
|
solute carrier family 20 member 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of SLC20A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249
|
|
| G
|
Slc25a5
|
solute carrier family 25 member 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of SLC25A5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:120,897,616...120,900,683
Ensembl chr X:120,897,563...120,900,688
|
|
| G
|
Slc25a5-ps11
|
solute carrier family 25 member 5, pseudogene 11
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SLC25A6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:70,846,358...70,847,597
Ensembl chr18:70,846,358...70,847,597
|
|
| G
|
Slc25a51
|
solute carrier family 25, member 51
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLC25A51 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:64,445,610...64,459,172
Ensembl chr 5:64,443,616...64,459,462
|
|
| G
|
Slc2a1
|
solute carrier family 2 member 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SLC2A1 mRNA chloropicrin results in decreased expression of SLC2A1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
| G
|
Slc30a7
|
solute carrier family 30 member 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLC30A7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:206,544,800...206,607,087
Ensembl chr 2:206,544,800...206,607,043
|
|
| G
|
Slc35b2
|
solute carrier family 35 member B2
|
affects expression
|
ISO
|
chloropicrin affects the expression of SLC35B2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:22,936,031...22,940,114
Ensembl chr 9:22,935,887...22,939,793
|
|
| G
|
Slc38a1
|
solute carrier family 38, member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLC38A1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:129,617,387...129,681,778
|
|
| G
|
Slc38a2
|
solute carrier family 38, member 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of SLC38A2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619
|
|
| G
|
Slc44a4
|
solute carrier family 44, member 4
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLC44A4 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr20:3,907,737...3,923,911
Ensembl chr20:3,907,737...3,923,854
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLC7A11 mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Slc7a5
|
solute carrier family 7 member 5
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SLC7A5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412
|
|
| G
|
Slirp
|
SRA stem-loop interacting RNA binding protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SLIRP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:112,819,684...112,828,715
Ensembl chr 6:112,819,448...112,828,715
|
|
| G
|
Smim30
|
small integral membrane protein 30
|
decreases expression affects expression
|
ISO
|
chloropicrin results in decreased expression of SMIM30 mRNA chloropicrin affects the expression of SMIM30 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:38,251,825...38,252,063
|
|
| G
|
Sms
|
spermine synthase
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SMS mRNA chloropicrin results in decreased expression of SMS mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:41,331,693...41,387,713
Ensembl chr X:41,331,799...41,387,712
|
|
| G
|
Snai2
|
snail family transcriptional repressor 2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SNAI2 mRNA chloropicrin results in decreased expression of SNAI2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
|
|
| G
|
Snd1
|
staphylococcal nuclease and tudor domain containing 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SND1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:58,060,689...58,459,926
Ensembl chr 4:58,060,640...58,459,925
|
|
| G
|
Snrpd2
|
small nuclear ribonucleoprotein D2 polypeptide
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SNRPD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:87,926,030...87,929,259
Ensembl chr 1:87,926,048...87,933,339 Ensembl chr20:87,926,048...87,933,339
|
|
| G
|
Snrpf
|
small nuclear ribonucleoprotein polypeptide F
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SNRPF mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:30,017,460...30,024,162
Ensembl chr 7:30,017,460...30,024,162
|
|
| G
|
Snrpg
|
small nuclear ribonucleoprotein polypeptide G
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SNRPG mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:120,369,676...120,377,263
Ensembl chr 4:120,369,685...120,377,261 Ensembl chr X:120,369,685...120,377,261
|
|
| G
|
Snx3
|
sorting nexin 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SNX3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:47,574,051...47,607,577
Ensembl chr20:47,574,900...47,615,430
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SOD1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sox15
|
SRY-box transcription factor 15
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SOX15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:54,871,793...54,873,497
Ensembl chr10:54,871,788...54,873,497
|
|
| G
|
Spcs1
|
signal peptidase complex subunit 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SPCS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:6,196,653...6,198,221
Ensembl chr16:6,196,654...6,198,468
|
|
| G
|
Spint2
|
serine peptidase inhibitor, Kunitz type, 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SPINT2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:93,685,637...93,708,091
Ensembl chr 1:93,685,641...93,708,091
|
|
| G
|
Spock1
|
sparc/osteonectin, cwcv and kazal like domains proteoglycan 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SPOCK1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr17:6,746,892...7,227,034
Ensembl chr17:6,747,646...7,230,282
|
|
| G
|
Sqle
|
squalene epoxidase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SQLE mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
|
|
| G
|
Sqstm1
|
sequestosome 1
|
increases expression affects expression
|
ISO
|
chloropicrin results in increased expression of SQSTM1 mRNA chloropicrin affects the expression of SQSTM1 mRNA
|
CTD |
PMID:24211530 PMID:26352163 PMID:28476498 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Srgn
|
serglycin
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SRGN mRNA chloropicrin results in decreased expression of SRGN mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,985,508...31,000,327
|
|
| G
|
Srp14
|
signal recognition particle 14
|
affects expression
|
ISO
|
chloropicrin affects the expression of SRP14 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:125,896,128...125,899,819
Ensembl chr 3:125,896,556...125,899,819
|
|
| G
|
Srp19
|
signal recognition particle 19
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SRP19 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr18:26,205,888...26,212,171
Ensembl chr18:26,205,796...26,226,635
|
|
| G
|
Srp9
|
signal recognition particle 9
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SRP9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:96,364,253...96,372,393
Ensembl chr13:96,364,298...96,373,257
|
|
| G
|
Srpx
|
sushi-repeat-containing protein, X-linked
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of SRPX mRNA chloropicrin results in decreased expression of SRPX mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr X:15,349,498...15,420,389
Ensembl chr X:15,349,440...15,420,392
|
|
| G
|
Srrm2
|
serine/arginine repetitive matrix 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of SRRM2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
|
|
| G
|
Srsf2
|
serine and arginine rich splicing factor 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of SRSF2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:102,550,962...102,554,200
Ensembl chr10:102,553,072...102,554,141
|
|
| G
|
Srsf5
|
serine and arginine rich splicing factor 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SRSF5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:106,333,998...106,341,467
Ensembl chr 6:106,336,756...106,341,931
|
|
| G
|
Srsf6
|
serine and arginine rich splicing factor 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SRSF6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:172,009,072...172,014,395
Ensembl chr 3:172,009,061...172,014,392
|
|
| G
|
Srsf9
|
serine and arginine rich splicing factor 9
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of SRSF9 mRNA chloropicrin results in decreased expression of SRSF9 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr12:46,938,948...46,945,213
Ensembl chr12:46,938,950...46,945,283
|
|
| G
|
Ss18l2
|
SS18 like 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SS18L2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:130,252,774...130,255,388
Ensembl chr 8:130,252,782...130,257,367
|
|
| G
|
Ssbp1
|
single stranded DNA binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SSBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:70,232,740...70,242,824
Ensembl chr 4:70,232,794...70,243,700
|
|
| G
|
Ssr4
|
signal sequence receptor subunit 4
|
affects expression
|
ISO
|
chloropicrin affects the expression of SSR4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:156,675,658...156,679,545
Ensembl chr X:156,675,566...156,679,543
|
|
| G
|
Stc1
|
stanniocalcin 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of STC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082
|
|
| G
|
Stc2
|
stanniocalcin 2
|
affects expression
|
ISO
|
chloropicrin affects the expression of STC2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
|
|
| G
|
Stip1
|
stress-induced phosphoprotein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of STIP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:213,638,641...213,657,654
|
|
| G
|
Stk3
|
serine/threonine kinase 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of STK3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:67,938,341...68,208,472
Ensembl chr 7:67,938,378...68,208,508
|
|
| G
|
Stoml2
|
stomatin like 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of STOML2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:62,052,042...62,055,639
Ensembl chr 5:62,052,045...62,055,670
|
|
| G
|
Strap
|
serine/threonine kinase receptor associated protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of STRAP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:172,377,325...172,391,573
Ensembl chr 4:172,377,305...172,392,436
|
|
| G
|
Stt3a
|
STT3 oligosaccharyltransferase complex catalytic subunit A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of STT3A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:44,632,473...44,671,960
Ensembl chr 8:44,632,473...44,672,226
|
|
| G
|
Sugct
|
succinylCoA:glutarate-CoA transferase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SUGCT mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:52,072,012...52,929,852
Ensembl chr17:52,072,052...52,930,281
|
|
| G
|
Sumo2
|
small ubiquitin-like modifier 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SUMO2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr10:101,270,899...101,283,458
Ensembl chr10:101,270,900...101,283,938 Ensembl chr 5:101,270,900...101,283,938
|
|
| G
|
Supt16h
|
SPT16 homolog, facilitates chromatin remodeling subunit
|
increases expression
|
ISO
|
chloropicrin results in increased expression of SUPT16H mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:27,341,196...27,378,314
Ensembl chr15:27,341,196...27,378,314
|
|
| G
|
Surf4
|
surfeit 4
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SURF4 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:30,646,435...30,659,641
Ensembl chr 3:30,638,299...30,661,390
|
|
| G
|
Syncrip
|
synaptotagmin binding, cytoplasmic RNA interacting protein
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SYNCRIP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:98,282,358...98,315,412
Ensembl chr 8:98,282,358...98,315,386
|
|
| G
|
Syne2
|
spectrin repeat containing nuclear envelope protein 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of SYNE2 mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723
|
|
| G
|
Tacstd2
|
tumor-associated calcium signal transducer 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TACSTD2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:98,037,620...98,039,320
Ensembl chr 4:98,033,251...98,039,323
|
|
| G
|
Taf15
|
TATA-box binding protein associated factor 15
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TAF15 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:68,770,408...68,802,458
Ensembl chr10:68,770,430...68,802,458
|
|
| G
|
Tars1
|
threonyl-tRNA synthetase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of TARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:62,095,978...62,114,802
Ensembl chr 2:62,087,763...62,114,802
|
|
| G
|
Tax1bp1
|
Tax1 binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TAX1BP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:83,152,549...83,208,463
Ensembl chr 4:83,110,062...83,209,657
|
|
| G
|
Tax1bp3
|
Tax1 binding protein 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TAX1BP3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:58,294,357...58,298,875
Ensembl chr10:58,294,073...58,298,875
|
|
| G
|
Tbca
|
tubulin folding cofactor A
|
affects expression
|
ISO
|
chloropicrin affects the expression of TBCA mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:27,745,985...27,800,624
Ensembl chr 2:27,746,268...27,800,641
|
|
| G
|
Tbpl1
|
TATA-box binding protein like 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TBPL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:24,597,028...24,622,445
Ensembl chr 1:24,597,074...24,622,439
|
|
| G
|
Tcaf1
|
TRPM8 channel-associated factor 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TCAF1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:72,589,710...72,639,304
Ensembl chr 4:72,589,710...72,639,475
|
|
| G
|
Tceal9
|
transcription elongation factor A like 9
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TCEAL9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:104,037,274...104,039,345
Ensembl chr X:104,032,421...104,041,562
|
|
| G
|
Tent5a
|
terminal nucleotidyltransferase 5A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TENT5A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:95,102,349...95,109,100
Ensembl chr 8:95,105,412...95,109,100
|
|
| G
|
Tfrc
|
transferrin receptor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TFRC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
| G
|
Tgfbi
|
transforming growth factor, beta induced
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TGFBI mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
|
|
| G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TGFBR2 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
| G
|
Thbs1
|
thrombospondin 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of THBS1 mRNA chloropicrin results in decreased expression of THBS1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TIMP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tiparp
|
TCDD-inducible poly(ADP-ribose) polymerase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TIPARP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:152,063,769...152,090,414
Ensembl chr 2:152,063,751...152,090,406
|
|
| G
|
Tkt
|
transketolase
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TKT mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
|
|
| G
|
Tm4sf1
|
transmembrane 4 L six family member 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TM4SF1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:143,606,980...143,616,176
Ensembl chr 2:143,603,271...143,616,176
|
|
| G
|
Tma7
|
translation machinery associated 7 homolog
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TMA7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,604,680...118,609,368
Ensembl chr 8:118,604,680...118,609,368
|
|
| G
|
Tmco1
|
transmembrane and coiled-coil domains 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMCO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr13:81,993,172...82,016,496
Ensembl chr13:81,993,097...82,017,201
|
|
| G
|
Tmed2
|
transmembrane p24 trafficking protein 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TMED2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:37,713,522...37,722,606
Ensembl chr12:37,713,529...37,722,606
|
|
| G
|
Tmed5
|
transmembrane p24 trafficking protein 5
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of TMED5 mRNA chloropicrin results in decreased expression of TMED5 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr14:1,752,857...1,763,990
Ensembl chr14:1,752,745...1,773,389
|
|
| G
|
Tmed9
|
transmembrane p24 trafficking protein 9
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TMED9 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:9,034,797...9,039,311
Ensembl chr17:9,034,823...9,039,319
|
|
| G
|
Tmem123
|
transmembrane protein 123
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TMEM123 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:13,206,907...13,237,069
Ensembl chr 8:13,206,403...13,257,427
|
|
| G
|
Tmem131
|
transmembrane protein 131
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMEM131 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:46,512,328...46,658,624
Ensembl chr 9:46,512,328...46,658,481
|
|
| G
|
Tmem14c
|
transmembrane protein 14C
|
affects expression
|
ISO
|
chloropicrin affects the expression of TMEM14C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr17:23,939,501...23,945,622
Ensembl chr17:23,939,509...23,959,055
|
|
| G
|
Tmem154
|
transmembrane protein 154
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMEM154 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:172,313,290...172,352,939
Ensembl chr 2:172,313,240...172,361,723
|
|
| G
|
Tmem230
|
transmembrane protein 230
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMEM230 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:139,925,878...139,950,517
|
|
| G
|
Tmem256
|
transmembrane protein 256
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMEM256 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:55,056,959...55,058,869
Ensembl chr10:55,056,760...55,058,862
|
|
| G
|
Tmem258
|
transmembrane protein 258
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMEM258 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:216,274,607...216,278,505
|
|
| G
|
Tmem87a
|
transmembrane protein 87A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMEM87A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:127,761,490...127,807,314
Ensembl chr 3:127,761,490...127,807,314
|
|
| G
|
Tmsb10
|
thymosin, beta 10
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMSB10 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:106,568,080...106,569,210
|
|
| G
|
Tmsb4x
|
thymosin beta 4, X-linked
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TMSB4X mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr X:30,761,611...30,763,612
Ensembl chr X:30,761,612...30,763,613
|
|
| G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TNFRSF12A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TNNT2 mRNA
|
CTD |
PMID:24211530 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tomm20
|
translocase of outer mitochondrial membrane 20
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TOMM20 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr19:71,822,429...71,832,420
Ensembl chr19:71,822,411...71,832,510
|
|
| G
|
Tomm40
|
translocase of outer mitochondrial membrane 40
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TOMM40 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:88,486,745...88,498,833
Ensembl chr 1:88,486,758...88,499,671
|
|
| G
|
Tomm5
|
translocase of outer mitochondrial membrane 5
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of TOMM5 mRNA chloropicrin results in decreased expression of TOMM5 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 5:64,158,026...64,160,857
|
|
| G
|
Tomm6
|
translocase of outer mitochondrial membrane 6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TOMM6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:20,801,806...20,803,174
|
|
| G
|
Tomm7
|
translocase of outer mitochondrial membrane 7
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TOMM7 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:12,197,503...12,204,344
Ensembl chr 4:12,197,491...12,204,343
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression increases phosphorylation
|
ISO
|
chloropicrin results in increased expression of TP53 protein chloropicrin results in increased phosphorylation of TP53 protein
|
CTD |
PMID:22516760 PMID:24548678 PMID:31884112 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp63
|
tumor protein p63
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TP63 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr11:88,343,647...88,554,543
Ensembl chr11:88,343,651...88,554,177
|
|
| G
|
Tpi1
|
triosephosphate isomerase 1
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of TPI1 mRNA chloropicrin results in decreased expression of TPI1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:159,301,562...159,305,413
|
|
| G
|
Tpm2
|
tropomyosin 2
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TPM2 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 5:62,566,712...62,576,066
Ensembl chr 5:62,566,652...62,575,726
|
|
| G
|
Tpt1
|
tumor protein, translationally-controlled 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TPT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr15:57,562,217...57,568,968
Ensembl chr15:57,566,067...57,569,554
|
|
| G
|
Tra2b
|
transformer 2 beta
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TRA2B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr11:92,293,403...92,311,651
Ensembl chr11:92,293,410...92,311,781
|
|
| G
|
Tram1
|
translocation associated membrane protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of TRAM1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:10,425,710...10,450,669
Ensembl chr 5:10,425,633...10,470,056
|
|
| G
|
Trib1
|
tribbles pseudokinase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TRIB1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:93,095,973...93,117,480
|
|
| G
|
Trib3
|
tribbles pseudokinase 3
|
affects expression
|
ISO
|
chloropicrin affects the expression of TRIB3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
| G
|
Trip6
|
thyroid hormone receptor interactor 6
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TRIP6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:25,022,959...25,027,366
Ensembl chr12:25,022,909...25,027,363
|
|
| G
|
Trmt112
|
tRNA methyltransferase activator subunit 11-2
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of TRMT112 mRNA chloropicrin results in decreased expression of TRMT112 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 1:213,532,507...213,533,360
Ensembl chr 1:213,532,175...213,533,356
|
|
| G
|
Tsku
|
tsukushi, small leucine rich proteoglycan
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TSKU mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272
|
|
| G
|
Tspo
|
translocator protein
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TSPO mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:116,600,214...116,610,461
Ensembl chr 7:116,600,210...116,610,460
|
|
| G
|
Tspyl1
|
TSPY-like 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of TSPYL1 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr20:39,637,035...39,639,594
Ensembl chr20:39,635,135...39,695,333
|
|
| G
|
Tuba1a
|
tubulin, alpha 1A
|
affects expression
|
ISO
|
chloropicrin affects the expression of TUBA1A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Tuba1b
|
tubulin, alpha 1B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TUBA1B mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Tuba1c
|
tubulin, alpha 1C
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TUBA1C mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
|
|
| G
|
Tuba4a
|
tubulin, alpha 4A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TUBA4A mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584
|
|
| G
|
Tubb3
|
tubulin, beta 3 class III
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TUBB3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
| G
|
Tubb4b
|
tubulin, beta 4B class IVb
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of TUBB4B mRNA chloropicrin results in increased expression of TUBB2C mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
|
|
| G
|
Tubb5
|
tubulin, beta 5 class I
|
affects expression decreases expression
|
ISO
|
chloropicrin affects the expression of TUBB mRNA chloropicrin results in decreased expression of TUBB protein
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,917,539...2,921,726
|
|
| G
|
Tuft1
|
tuftelin 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TUFT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:184,949,437...184,995,321
Ensembl chr 2:184,949,437...184,995,383
|
|
| G
|
Txnip
|
thioredoxin interacting protein
|
affects expression
|
ISO
|
chloropicrin affects the expression of TXNIP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of TXNRD1 mRNA
|
CTD |
PMID:24211530 PMID:26352163 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Uap1
|
UDP-N-acetylglucosamine pyrophosphorylase 1
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of UAP1 mRNA chloropicrin results in decreased expression of UAP1 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr13:84,875,719...84,910,706
Ensembl chr13:84,875,719...84,910,239 Ensembl chr 6:84,875,719...84,910,239
|
|
| G
|
Uba52
|
ubiquitin A-52 residue ribosomal protein fusion product 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of UBA52 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:18,952,583...18,954,780
|
|
| G
|
Uba6
|
ubiquitin-like modifier activating enzyme 6
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of UBA6 mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr14:22,238,832...22,302,650
Ensembl chr14:22,211,601...22,302,650
|
|
| G
|
Ubb
|
ubiquitin B
|
increases expression
|
ISO
|
chloropicrin results in increased expression of UBB mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:47,746,923...47,748,628
Ensembl chr10:47,727,701...47,750,335
|
|
| G
|
Ubc
|
ubiquitin C
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of UBC mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:36,899,673...36,905,275
Ensembl chr12:36,900,127...36,905,275
|
|
| G
|
Ube2f
|
ubiquitin-conjugating enzyme E2F (putative)
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of UBE2F mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 9:99,293,506...99,328,690
Ensembl chr 9:99,293,515...99,330,479
|
|
| G
|
Ube2n
|
ubiquitin-conjugating enzyme E2N
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of UBE2N mRNA
|
CTD |
PMID:28476498 |
|
NCBI chr 7:32,041,190...32,071,252
|
|
| G
|
Ubxn1
|
UBX domain protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of UBXN1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:215,194,418...215,198,343
Ensembl chr 1:215,174,216...215,198,343
|
|
| G
|
Uchl1
|
ubiquitin C-terminal hydrolase L1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of UCHL1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417
|
|
| G
|
Ulbp1
|
UL16 binding protein 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ULBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:3,506,106...3,527,982
|
|
| G
|
Upp1
|
uridine phosphorylase 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of UPP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034
|
|
| G
|
Uqcrh
|
ubiquinol-cytochrome c reductase hinge protein
|
affects expression
|
ISO
|
chloropicrin affects the expression of UQCRH mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:134,782,687...134,790,882
Ensembl chr 5:134,782,255...134,790,926
|
|
| G
|
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII
|
increases expression
|
ISO
|
chloropicrin results in increased expression of UQCRQ mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:38,086,691...38,093,871
Ensembl chr10:38,087,715...38,089,996
|
|
| G
|
Urod
|
uroporphyrinogen decarboxylase
|
increases expression
|
ISO
|
chloropicrin results in increased expression of UROD mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:135,701,294...135,705,380
Ensembl chr 5:135,701,296...135,705,380
|
|
| G
|
Uso1
|
USO1 vesicle transport factor
|
increases expression
|
ISO
|
chloropicrin results in increased expression of USO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:16,150,921...16,216,389
Ensembl chr14:16,150,923...16,216,389
|
|
| G
|
Vamp8
|
vesicle-associated membrane protein 8
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VAMP8 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:106,000,570...106,011,073
|
|
| G
|
Vasn
|
vasorin
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VASN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:11,424,174...11,434,681
Ensembl chr10:11,417,327...11,450,704
|
|
| G
|
Vat1
|
vesicle amine transport 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of VAT1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411
|
|
| G
|
Vcan
|
versican
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VCAN mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
| G
|
Vcp
|
valosin-containing protein
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VCP mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of VDAC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Vdac3
|
voltage-dependent anion channel 3
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VDAC3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr16:76,137,489...76,153,933
Ensembl chr16:76,137,504...76,155,304
|
|
| G
|
Vim
|
vimentin
|
increases expression decreases expression
|
ISO
|
chloropicrin results in increased expression of VIM mRNA chloropicrin results in decreased expression of VIM mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vkorc1
|
vitamin K epoxide reductase complex, subunit 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VKORC1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:191,932,969...191,935,490
|
|
| G
|
Vps26a
|
VPS26 retromer complex component A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VPS26A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr20:30,947,018...30,976,964
Ensembl chr20:30,947,023...30,976,827
|
|
| G
|
Vps29
|
VPS29 retromer complex component
|
increases expression
|
ISO
|
chloropicrin results in increased expression of VPS29 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:39,869,688...39,878,732
Ensembl chr12:39,869,688...39,878,848
|
|
| G
|
Wbp2
|
WW domain binding protein 2
|
increases expression
|
ISO
|
chloropicrin results in increased expression of WBP2 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr10:101,811,308...101,819,766
Ensembl chr10:101,812,321...101,819,770
|
|
| G
|
Wdr1
|
WD repeat domain 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of WDR1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:76,470,238...76,504,086
Ensembl chr14:76,470,176...76,504,080
|
|
| G
|
Wdr6
|
WD repeat domain 6
|
affects expression
|
ISO
|
chloropicrin affects the expression of WDR6 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092
|
|
| G
|
Wfdc21
|
WAP four-disulfide core domain 21
|
decreases expression increases expression
|
ISO
|
chloropicrin results in decreased expression of WFDC21P mRNA chloropicrin results in increased expression of WFDC21P mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr10:69,125,336...69,131,205
Ensembl chr10:69,125,320...69,131,201
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
affects expression
|
ISO
|
chloropicrin affects the expression of XBP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
| G
|
Xpnpep1
|
X-prolyl aminopeptidase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of XPNPEP1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:262,006,761...262,057,479
Ensembl chr 1:262,006,761...262,092,425
|
|
| G
|
Xpnpep3
|
X-prolyl aminopeptidase 3
|
affects expression increases expression
|
ISO
|
chloropicrin affects the expression of XPNPEP3 mRNA chloropicrin results in increased expression of XPNPEP3 mRNA
|
CTD |
PMID:26352163 PMID:28476498 |
|
NCBI chr 7:114,806,398...114,858,934
Ensembl chr 7:114,806,357...114,855,125
|
|
| G
|
Xpo1
|
exportin 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of XPO1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr14:101,434,450...101,476,705
Ensembl chr14:101,434,517...101,476,714
|
|
| G
|
Yars1
|
tyrosyl-tRNA synthetase 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of YARS1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377
|
|
| G
|
Ybx1
|
Y box binding protein 1
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of YBX1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:138,167,444...138,184,188
|
|
| G
|
Ybx3
|
Y box binding protein 3
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of YBX3 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:166,861,181...166,884,691
|
|
| G
|
Ypel5
|
yippee-like 5
|
increases expression
|
ISO
|
chloropicrin results in increased expression of YPEL5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:28,408,079...28,423,536
Ensembl chr 6:28,408,080...28,412,385
|
|
| G
|
Ywhaq
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of YWHAQ mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:46,664,358...46,694,875
Ensembl chr 6:46,664,358...46,694,875
|
|
| G
|
Ywhaz
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
decreases expression
|
ISO
|
chloropicrin results in decreased expression of YWHAZ mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:69,826,404...69,849,007
|
|
| G
|
Zfand2a
|
zinc finger AN1-type containing 2A
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ZFAND2A mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr12:20,275,435...20,286,513
Ensembl chr12:20,275,450...20,286,513
|
|
| G
|
Zfand5
|
zinc finger AN1-type containing 5
|
affects expression
|
ISO
|
chloropicrin affects the expression of ZFAND5 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:228,191,064...228,206,947
Ensembl chr 1:228,192,311...228,206,947
|
|
| G
|
Zfp347
|
zinc finger protein 347
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ZNF14 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 7:8,110,793...8,130,161
Ensembl chr 7:8,111,577...8,130,165
|
|
| G
|
Zfp36
|
zinc finger protein 36
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ZFP36 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
| G
|
Zfp36l1
|
zinc finger protein 36, C3H type-like 1
|
increases expression
|
ISO
|
chloropicrin results in increased expression of ZFP36L1 mRNA
|
CTD |
PMID:26352163 |
|
NCBI chr 6:104,663,396...104,669,815
Ensembl chr 6:104,663,399...104,687,979
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases response to substance multiple interactions
|
ISO
|
ABCB1A protein results in decreased susceptibility to closantel closantel results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]
|
CTD |
PMID:20513441 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Bcl3
|
BCL3, transcription coactivator
|
increases expression
|
EXP
|
closantel results in increased expression of BCL3 mRNA
|
CTD |
PMID:22015988 |
|
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368
|
|
| G
|
Slc25a31
|
solute carrier family 25 member 31
|
decreases activity
|
ISO
|
closantel results in decreased activity of SLC25A31 protein
|
CTD |
PMID:26746582 |
|
NCBI chr 2:125,623,331...125,639,155
Ensembl chr 2:125,623,341...125,654,376
|
|
| G
|
Slc25a4
|
solute carrier family 25 member 4
|
decreases activity
|
ISO
|
closantel results in decreased activity of SLC25A4 protein
|
CTD |
PMID:26746582 |
|
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700
|
|
| G
|
Slc25a5
|
solute carrier family 25 member 5
|
decreases activity
|
ISO
|
closantel results in decreased activity of SLC25A5 protein
|
CTD |
PMID:26746582 |
|
NCBI chr X:120,897,616...120,900,683
Ensembl chr X:120,897,563...120,900,688
|
|
| G
|
Slc25a5-ps11
|
solute carrier family 25 member 5, pseudogene 11
|
decreases activity
|
ISO
|
closantel results in decreased activity of SLC25A6 protein
|
CTD |
PMID:26746582 |
|
NCBI chr18:70,846,358...70,847,597
Ensembl chr18:70,846,358...70,847,597
|
|
| G
|
Thra
|
thyroid hormone receptor alpha
|
increases activity
|
EXP
|
closantel results in increased activity of THRA protein
|
CTD |
PMID:22015988 |
|
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
increases activity
|
EXP
|
closantel results in increased activity of THRB protein
|
CTD |
PMID:22015988 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO
|
Coumaphos metabolite results in decreased activity of ACHE protein; Coumaphos results in decreased activity of ACHE protein
|
CTD |
PMID:30625376 PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO
|
Coumaphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
|
CTD |
PMID:33049310 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Coumaphos binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
Coumaphos binds to and results in increased activity of ESR2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Gpat3
|
glycerol-3-phosphate acyltransferase 3
|
increases expression
|
ISO
|
Coumaphos results in increased expression of GPAT3 mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr14:9,018,762...9,072,552
|
|
| G
|
Lif
|
LIF, interleukin 6 family cytokine
|
increases expression
|
ISO
|
Coumaphos results in increased expression of LIF mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions
|
ISO
|
Coumaphos binds to and results in increased activity of NR1I2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO
|
Coumaphos binds to and results in increased activity of PPARG protein
|
CTD |
PMID:33049310 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Rara
|
retinoic acid receptor, alpha
|
increases activity
|
ISO
|
Coumaphos results in increased activity of RARA protein
|
CTD |
PMID:20143881 |
|
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression
|
ISO
|
Coumaphos results in increased expression of SLC7A11 mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions
|
ISO
|
Coumaphos binds to and results in increased activity of THRB protein
|
CTD |
PMID:33049310 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
Coumaphos metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases activity
|
ISO
|
dazomet results in increased activity of NFE2L2 protein
|
CTD |
PMID:20143881 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
|
|
| G
|
Abca2
|
ATP binding cassette subfamily A member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABCA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,642,660...28,662,689
Ensembl chr 3:28,642,758...28,662,681
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases response to substance increases expression increases activity decreases activity increases export multiple interactions
|
ISO EXP
|
ABCB1 protein results in decreased susceptibility to Diazinon Diazinon results in increased expression of ABCB1 mRNA; Diazinon results in increased expression of ABCB1 protein Diazinon results in increased activity of ABCB1 protein Diazinon results in decreased activity of ABCB1 protein ABCB1 protein results in increased export of Diazinon Cyclosporine inhibits the reaction [ABCB1 protein results in increased export of Diazinon]; Deoxyglucose inhibits the reaction [ABCB1 protein results in increased export of Diazinon]; Diazinon affects the reaction [ABCB1 protein results in increased transport of Digoxin]; Diazinon affects the reaction [ABCB1 protein results in increased transport of Vinblastine]; Diazinon inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Diazinon promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Endosulfan results in decreased activity of ABCB1 protein]; Diazinon promotes the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [phosalone results in decreased activity of ABCB1 protein]; Diazinon promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [propiconazole results in decreased activity of ABCB1 protein]; Diazinon promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Verapamil results in decreased activity of ABCB1 protein]; Sodium Azide inhibits the reaction [ABCB1 protein results in increased export of Diazinon]; valspodar inhibits the reaction [ABCB1 protein results in increased export of Diazinon]
|
CTD |
PMID:16221533 PMID:21127835 PMID:21783720 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb9
|
ATP binding cassette subfamily B member 9
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABCB9 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABCC4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcf3
|
ATP binding cassette subfamily F member 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABCF3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:93,844,863...93,856,595
Ensembl chr11:93,844,363...93,856,595
|
|
| G
|
Abcg1
|
ATP binding cassette subfamily G member 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of ABCG1 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
|
|
| G
|
Abhd14a
|
abhydrolase domain containing 14A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABHD14A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697
|
|
| G
|
Abhd18
|
abhydrolase domain containing 18
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABHD18 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:125,800,488...125,850,167
Ensembl chr 2:125,800,392...125,850,166
|
|
| G
|
Abhd2
|
abhydrolase domain containing 2, acylglycerol lipase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABHD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674
|
|
| G
|
Abhd6
|
abhydrolase domain containing 6, acylglycerol lipase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ABHD6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:19,289,967...19,337,500
Ensembl chr15:19,289,969...19,337,193
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity multiple interactions increases expression
|
ISO EXP
|
Diazinon metabolite results in decreased activity of ACHE protein; Diazinon results in decreased activity of ACHE protein Resveratrol inhibits the reaction [Diazinon results in decreased activity of ACHE protein]; Thioctic Acid inhibits the reaction [Diazinon results in decreased activity of ACHE protein] Diazinon results in increased expression of ACHE mRNA alternative form [[Chlorine co-treated with Diazinon] results in increased abundance of diazoxon] which results in decreased activity of ACHE protein; Obidoxime Chloride inhibits the reaction [Diazinon results in decreased activity of ACHE protein]; Oximes analog inhibits the reaction [Diazinon results in decreased activity of ACHE protein]; PON1 protein polymorphism inhibits the reaction [Diazinon results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Diazinon results in decreased activity of ACHE protein]
|
CTD |
PMID:1855619 PMID:8658539 PMID:17239417 PMID:17366821 PMID:17442507 PMID:19948211 PMID:20338157 PMID:21767560 PMID:21983245 PMID:22209767 PMID:24238291 PMID:25562544 PMID:26721196 PMID:29383019 PMID:30625376 PMID:30978295 PMID:31981688 PMID:32911022 PMID:33844597 PMID:34374289 PMID:35403302 PMID:35934178 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Acly
|
ATP citrate lyase
|
affects expression
|
EXP
|
Diazinon affects the expression of ACLY mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
|
|
| G
|
Acmsd
|
aminocarboxymuconate semialdehyde decarboxylase
|
increases expression
|
EXP
|
Diazinon results in increased expression of ACMSD mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr13:41,752,894...41,798,427
Ensembl chr13:41,752,875...41,798,427
|
|
| G
|
Aco1
|
aconitase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ACO1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
|
|
| G
|
Acsm1
|
acyl-CoA synthetase medium-chain family member 1
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of ACSM1 mRNA
|
CTD |
PMID:17311802 |
|
NCBI chr 1:183,417,052...183,451,897
Ensembl chr 1:183,416,009...183,454,217
|
|
| G
|
Actmap
|
actin maturation protease
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ACTMAP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:91,618,012...91,627,490
Ensembl chr 1:91,617,859...91,627,489
|
|
| G
|
Actn1
|
actinin, alpha 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ACTN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Acvr1c
|
activin A receptor type 1C
|
affects expression
|
EXP
|
Diazinon affects the expression of ACVR1C mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:63,224,322...63,301,252
Ensembl chr 3:63,227,559...63,301,205
|
|
| G
|
Adam17
|
ADAM metallopeptidase domain 17
|
affects expression
|
EXP
|
Diazinon affects the expression of ADAM17 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
| G
|
Adam22
|
ADAM metallopeptidase domain 22
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of ADAM22 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:26,670,984...26,925,843
Ensembl chr 4:26,671,112...26,925,843
|
|
| G
|
Adamtsl4
|
ADAMTS-like 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ADAMTSL4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:185,924,582...185,936,039
Ensembl chr 2:185,924,594...185,935,796
|
|
| G
|
Adcy1
|
adenylate cyclase 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ADCY1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075
|
|
| G
|
Adcy10
|
adenylate cyclase 10
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ADCY10 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr13:80,280,595...80,366,939
Ensembl chr13:80,284,295...80,366,926
|
|
| G
|
Adcy2
|
adenylate cyclase 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ADCY2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
|
|
| G
|
Adcy4
|
adenylate cyclase 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of ADCY4 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026
|
|
| G
|
Adcy8
|
adenylate cyclase 8
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ADCY8 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:98,306,464...98,555,038
|
|
| G
|
Adcy9
|
adenylate cyclase 9
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of ADCY9 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792
|
|
| G
|
Adcyap1
|
adenylate cyclase activating polypeptide 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of ADCYAP1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:120,550,328...120,556,383
|
|
| G
|
Adissp
|
adipose secreted signaling protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ADISSP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:138,817,752...138,832,208
Ensembl chr 3:138,813,179...138,831,847
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ADORA2B gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adra1a
|
adrenoceptor alpha 1A
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ADRA1A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
|
|
| G
|
Adra1b
|
adrenoceptor alpha 1B
|
increases expression
|
EXP
|
Diazinon results in increased expression of ADRA1B mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347
|
|
| G
|
Adra2a
|
adrenoceptor alpha 2A
|
increases expression
|
EXP
|
Diazinon results in increased expression of ADRA2A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of ADRB2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Adrb3
|
adrenoceptor beta 3
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of ADRB3 mRNA Diazinon results in decreased expression of ADRB3 mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420
|
|
| G
|
Adrm1
|
ADRM1 26S proteasome ubiquitin receptor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ADRM1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483
|
|
| G
|
Adsl
|
adenylosuccinate lyase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ADSL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872
|
|
| G
|
Ago2
|
argonaute RISC catalytic component 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AGO2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
|
|
| G
|
Agxt
|
alanine--glyoxylate aminotransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AGXT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:101,122,793...101,132,745
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
affects expression increases activity
|
EXP
|
Diazinon affects the expression of AHR mRNA Diazinon results in increased activity of AHR protein
|
CTD |
PMID:22546817 PMID:28728110 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
affects expression
|
EXP
|
Diazinon affects the expression of AIFM1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Aifm3
|
AIF family member 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AIFM3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:97,009,100...97,030,601
Ensembl chr11:97,008,426...97,023,334
|
|
| G
|
Ak1
|
adenylate kinase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Ak4
|
adenylate kinase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AK4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions affects expression decreases expression
|
ISO EXP
|
[alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of AKT1 protein; [alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in decreased expression of AKT1 protein Diazinon affects the expression of AKT1 mRNA Diazinon results in decreased expression of AKT1 mRNA
|
CTD |
PMID:19883720 PMID:22546817 PMID:35934178 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of AKT2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Aktip
|
AKT interacting protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AKTIP gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:32,039,507...32,059,634
Ensembl chr19:32,039,466...32,067,178
|
|
| G
|
Alb
|
albumin
|
affects binding
|
ISO
|
Diazinon binds to ALB protein
|
CTD |
PMID:29301411 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ALDH1B1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
multiple interactions
|
ISO
|
[Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in decreased expression of ALDH2 mRNA; [Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in decreased expression of and results in decreased activity of ALDH2 protein
|
CTD |
PMID:34830855 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Aldh3b1
|
aldehyde dehydrogenase 3 family, member B1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of ALDH3B1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:210,574,545...210,605,188
Ensembl chr 1:210,573,661...210,610,538
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ALDOA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Aloxe3
|
arachidonate epidermal lipoxygenase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ALOXE3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:54,329,224...54,353,167
Ensembl chr10:54,329,043...54,353,166
|
|
| G
|
Alx4
|
ALX homeobox 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ALX4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:100,067,052...100,103,624
Ensembl chr 3:100,067,052...100,103,624
|
|
| G
|
Amer1
|
APC membrane recruitment protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AMER1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:64,310,492...64,326,377
Ensembl chr X:64,300,953...64,326,332
|
|
| G
|
Amigo2
|
adhesion molecule with Ig like domain 2
|
affects expression
|
EXP
|
Diazinon affects the expression of AMIGO2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218
|
|
| G
|
Amz2
|
archaelysin family metallopeptidase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AMZ2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:94,901,053...94,911,629
Ensembl chr10:94,901,129...94,911,627
|
|
| G
|
Angpt4
|
angiopoietin 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ANGPT4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:160,880,539...160,913,923
Ensembl chr 3:160,880,728...160,913,921
|
|
| G
|
Ankle1
|
ankyrin repeat and LEM domain containing 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of ANKLE1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:18,109,865...18,116,999
Ensembl chr16:18,110,476...18,114,244
|
|
| G
|
Ano3
|
anoctamin 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of ANO3 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 3:117,690,242...118,004,695
Ensembl chr 3:117,692,103...118,004,675
|
|
| G
|
Anp32a
|
acidic nuclear phosphoprotein 32 family member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ANP32A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922
|
|
| G
|
Antkmt
|
adenine nucleotide translocase lysine methyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ANTKMT gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:15,316,797...15,320,950
Ensembl chr10:15,316,772...15,318,656
|
|
| G
|
Anxa1
|
annexin A1
|
affects expression
|
EXP
|
Diazinon affects the expression of ANXA1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa3
|
annexin A3
|
increases expression
|
EXP
|
Diazinon results in increased expression of ANXA3 protein
|
CTD |
PMID:26721910 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Ap1g1
|
adaptor related protein complex 1 subunit gamma 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of AP1G1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr19:54,654,101...54,740,586
Ensembl chr19:54,620,807...54,740,586
|
|
| G
|
Ap1m1
|
adaptor related protein complex 1 subunit mu 1
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of AP1M1 mRNA Diazinon results in increased methylation of AP1M1 gene
|
CTD |
PMID:17452286 PMID:22964155 |
|
NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462
|
|
| G
|
Ap2a2
|
adaptor related protein complex 2 subunit alpha 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AP2A2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:206,081,856...206,155,146
Ensembl chr 1:206,081,878...206,155,150
|
|
| G
|
Ap3b2
|
adaptor related protein complex 3 subunit beta 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AP3B2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:144,821,819...144,854,533
Ensembl chr 1:144,821,819...144,854,432
|
|
| G
|
Ap3d1
|
adaptor related protein complex 3 subunit delta 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AP3D1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342
|
|
| G
|
Ap4m1
|
adaptor related protein complex 4 subunit mu 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AP4M1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:22,163,474...22,171,734
Ensembl chr12:22,163,466...22,171,731
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of APAF1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apbb1
|
amyloid beta precursor protein binding family B member 1
|
affects expression
|
EXP
|
Diazinon affects the expression of APBB1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:169,308,720...169,332,552
|
|
| G
|
Apbb3
|
amyloid beta precursor protein binding family B member 3
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of APBB3 gene Diazinon affects the expression of APBB3 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr18:28,547,205...28,554,383
Ensembl chr18:28,547,205...28,554,383
|
|
| G
|
Apeh
|
acylaminoacyl-peptide hydrolase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of APEH gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711
|
|
| G
|
Apex2
|
apurinic/apyrimidinic endodeoxyribonuclease 2
|
affects expression
|
EXP
|
Diazinon affects the expression of APEX2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr X:22,914,943...22,937,713
Ensembl chr X:22,914,944...22,936,011
|
|
| G
|
Aplp2
|
amyloid beta precursor like protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of APLP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
|
|
| G
|
Apoe
|
apolipoprotein E
|
affects expression
|
EXP
|
Diazinon affects the expression of APOE mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Aqp12a
|
aquaporin 12A
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of AQP12A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:101,001,939...101,007,425
Ensembl chr 9:101,001,939...101,007,425
|
|
| G
|
Aqp6
|
aquaporin 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AQP6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:132,611,069...132,614,004
Ensembl chr 7:132,611,065...132,614,049
|
|
| G
|
Aqp7
|
aquaporin 7
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of AQP7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO
|
Diazinon inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]
|
CTD |
PMID:28728110 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Araf
|
A-Raf proto-oncogene, serine/threonine kinase
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of ARAF mRNA Diazinon results in increased methylation of ARAF gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr X:3,780,932...3,845,919
Ensembl chr X:3,780,932...3,792,611
|
|
| G
|
Arfip1
|
ARF interacting protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARFIP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:172,141,862...172,224,464
Ensembl chr 2:172,141,859...172,221,280
|
|
| G
|
Arg1
|
arginase 1
|
affects expression
|
EXP
|
Diazinon affects the expression of ARG1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Arhgap45
|
Rho GTPase activating protein 45
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARHGAP45 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890
|
|
| G
|
Arhgap5
|
Rho GTPase activating protein 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARHGAP5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636
|
|
| G
|
Arhgef10l
|
Rho guanine nucleotide exchange factor 10 like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARHGEF10L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:158,075,370...158,218,358
Ensembl chr 5:158,075,370...158,180,685
|
|
| G
|
Arhgef16
|
Rho guanine nucleotide exchange factor 16
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARHGEF16 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:170,126,573...170,148,624
Ensembl chr 5:170,126,575...170,148,624
|
|
| G
|
Arhgef17
|
Rho guanine nucleotide exchange factor 17
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARHGEF17 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:164,642,690...164,702,241
Ensembl chr 1:164,642,690...164,702,241
|
|
| G
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor 6
|
affects expression
|
EXP
|
Diazinon affects the expression of ARHGEF6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr X:140,182,734...140,302,812
Ensembl chr X:140,182,734...140,344,458
|
|
| G
|
Arid1a
|
AT-rich interaction domain 1A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARID1A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386
|
|
| G
|
Arpc5
|
actin related protein 2/3 complex, subunit 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARPC5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283
|
|
| G
|
Arpc5l
|
actin related protein 2/3 complex, subunit 5-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARPC5L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240 Ensembl chr 9:43,169,462...43,177,240
|
|
| G
|
Arrb1
|
arrestin, beta 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ARRB1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:163,250,157...163,340,859
|
|
| G
|
Arrdc2
|
arrestin domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARRDC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158
|
|
| G
|
Arrdc3
|
arrestin domain containing 3
|
increases expression
|
ISO
|
Diazinon results in increased expression of ARRDC3 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875
|
|
| G
|
Arsa
|
arylsulfatase A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ARSA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:122,422,971...122,426,971
Ensembl chr 7:122,422,982...122,428,401
|
|
| G
|
Art5
|
ADP-ribosyltransferase 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ART5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:165,885,344...165,895,306
Ensembl chr 1:165,885,280...165,895,306
|
|
| G
|
Asb6
|
ankyrin repeat and SOCS box-containing 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ASB6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:34,508,390...34,513,033
Ensembl chr 3:34,508,140...34,513,033
|
|
| G
|
Asic2
|
acid sensing ion channel subunit 2
|
affects expression
|
EXP
|
Diazinon affects the expression of ASIC2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:66,368,308...67,438,237
Ensembl chr10:66,368,310...66,636,245
|
|
| G
|
Asl
|
argininosuccinate lyase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ASL gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
increases expression
|
ISO
|
Diazinon results in increased expression of ASNS mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Atg101
|
autophagy related 101
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATG101 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:134,277,223...134,286,387
Ensembl chr 7:134,272,847...134,286,379
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of ATM gene Diazinon affects the expression of ATM mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atp11b
|
ATPase phospholipid transporting 11B (putative)
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP11B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:120,513,535...120,619,249
Ensembl chr 2:120,513,552...120,619,249
|
|
| G
|
Atp12a
|
ATPase H+/K+ transporting non-gastric alpha2 subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP12A gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:34,559,209...34,583,866
Ensembl chr15:34,559,209...34,583,866
|
|
| G
|
Atp13a1
|
ATPase 13A1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ATP13A1 mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr16:19,649,065...19,665,126
Ensembl chr16:19,649,066...19,665,120
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP1A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp2a3
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP2A3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278
|
|
| G
|
Atp2b1
|
ATPase plasma membrane Ca2+ transporting 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of ATP2B1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904
|
|
| G
|
Atp2b3
|
ATPase plasma membrane Ca2+ transporting 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP2B3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:156,367,582...156,464,085
Ensembl chr X:156,367,852...156,438,153
|
|
| G
|
Atp4b
|
ATPase H+/K+ transporting subunit beta
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP4B gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:82,846,329...82,855,242
Ensembl chr16:82,846,329...82,855,242
|
|
| G
|
Atp5if1
|
ATP synthase inhibitory factor subunit 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP5IF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677
|
|
| G
|
Atp6v0a2
|
ATPase H+ transporting V0 subunit a2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP6V0A2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:37,608,211...37,640,860
Ensembl chr12:37,472,813...37,640,860
|
|
| G
|
Atp8b2
|
ATPase phospholipid transporting 8B2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ATP8B2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:177,676,205...177,699,575
Ensembl chr 2:177,676,208...177,699,575
|
|
| G
|
Atrx
|
ATRX, chromatin remodeler
|
increases methylation increases expression
|
ISO EXP
|
Diazinon results in increased methylation of ATRX gene Diazinon results in increased expression of ATRX mRNA
|
CTD |
PMID:22964155 PMID:29108742 |
|
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:74,916,548...75,062,880
|
|
| G
|
Aup1
|
AUP1, lipid droplet regulating VLDL assembly factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AUP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:117,118,035...117,121,063
Ensembl chr 4:117,117,999...117,121,061
|
|
| G
|
Aurka
|
aurora kinase A
|
affects expression
|
EXP
|
Diazinon affects the expression of AURKA mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771
|
|
| G
|
Aven
|
apoptosis and caspase activation inhibitor
|
affects expression
|
EXP
|
Diazinon affects the expression of AVEN mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:119,753,395...119,886,009
Ensembl chr 3:119,872,661...119,886,008
|
|
| G
|
Axin1
|
axin 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AXIN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092
|
|
| G
|
Azgp1
|
alpha-2-glycoprotein 1, zinc-binding
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of AZGP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020
|
|
| G
|
B3gat2
|
beta-1,3-glucuronyltransferase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of B3GAT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:33,663,482...33,746,466
Ensembl chr 9:33,663,482...33,746,466
|
|
| G
|
B4galnt3
|
beta-1,4-N-acetyl-galactosaminyl transferase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of B4GALNT3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:155,081,261...155,181,255
Ensembl chr 4:155,081,261...155,181,244
|
|
| G
|
B4galt1
|
beta-1,4-galactosyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of B4GALT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445
|
|
| G
|
B4galt4
|
beta-1,4-galactosyltransferase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of B4GALT4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:75,501,358...75,527,291
Ensembl chr11:75,501,366...75,527,177
|
|
| G
|
Babam2
|
BRISC and BRCA1 A complex member 2
|
affects expression
|
EXP
|
Diazinon affects the expression of BABAM2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:30,089,065...30,467,508
Ensembl chr 6:30,071,611...30,467,341
|
|
| G
|
Bag1
|
BAG cochaperone 1
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of BAG1 mRNA Diazinon affects the expression of BAG1 mRNA
|
CTD |
PMID:17452286 PMID:22546817 |
|
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
affects expression
|
EXP
|
Diazinon affects the expression of BAG3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bag6
|
BAG cochaperone 6
|
affects expression
|
EXP
|
Diazinon affects the expression of BAG6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,680,607...3,693,329
|
|
| G
|
Baiap3
|
BAI1-associated protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BAIAP3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,764,768...14,777,516
Ensembl chr10:14,756,693...14,777,516
|
|
| G
|
Bak1
|
BCL2-antagonist/killer 1
|
affects expression
|
EXP
|
Diazinon affects the expression of BAK1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
| G
|
Banp
|
Btg3 associated nuclear protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BANP gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
decreases expression increases expression multiple interactions affects expression
|
EXP ISO
|
Diazinon results in decreased expression of BAX mRNA Diazinon results in increased expression of BAX mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of BAX mRNA] Diazinon affects the expression of BAX mRNA Diazinon results in increased expression of BAX mRNA; Diazinon results in increased expression of BAX protein crocin inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; crocin inhibits the reaction [Diazinon results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX protein] [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in increased expression of BAX mRNA
|
CTD |
PMID:17452286 PMID:22428454 PMID:22546817 PMID:23523949 PMID:27353299 PMID:27920530 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
affects expression
|
EXP
|
Diazinon affects the expression of BBC3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bcap31
|
B-cell receptor-associated protein 31
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BCAP31 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:156,548,911...156,581,002
Ensembl chr X:156,548,911...156,579,371
|
|
| G
|
Bcar1
|
BCAR1 scaffold protein, Cas family member
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BCAR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:56,588,500...56,623,190
Ensembl chr19:56,588,500...56,623,190
|
|
| G
|
Bche
|
butyrylcholinesterase
|
multiple interactions decreases activity affects binding
|
EXP ISO
|
[Methyl Parathion co-treated with Diazinon] results in decreased activity of BCHE protein; Diazinon inhibits the reaction [Dietary Fats results in increased activity of BCHE protein]; Thioctic Acid inhibits the reaction [Diazinon results in decreased activity of BCHE protein] Diazinon binds to BCHE protein [Chlorpyrifos co-treated with Diazinon] results in decreased activity of BCHE protein; Diazinon analog binds to and results in decreased activity of BCHE protein
|
CTD |
PMID:7893043 PMID:11481665 PMID:20229498 PMID:21767560 PMID:21983245 PMID:22209767 PMID:23123253 PMID:30359674 PMID:32911022 More...
|
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
affects expression multiple interactions decreases expression
|
EXP ISO
|
Diazinon affects the expression of BCL2 mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]
|
CTD |
PMID:22546817 PMID:27920530 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
affects expression
|
EXP
|
Diazinon affects the expression of BCL2L1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bcl2l10
|
Bcl2-like 10
|
affects expression
|
EXP
|
Diazinon affects the expression of BCL2L10 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:84,987,833...84,993,872
|
|
| G
|
Bcl2l12
|
Bcl2 like 12
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BCL2L12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:104,608,753...104,617,472
Ensembl chr 1:104,608,753...104,617,472
|
|
| G
|
Bcl2l13
|
Bcl2-like 13
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of BCL2L13 gene Diazinon affects the expression of BCL2L13 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 4:155,728,284...155,785,058
Ensembl chr 4:155,728,284...155,781,158
|
|
| G
|
Bcl3
|
BCL3, transcription coactivator
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BCL3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368
|
|
| G
|
Bcl6
|
BCL6, transcription repressor
|
affects expression
|
EXP
|
Diazinon affects the expression of BCL6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047
|
|
| G
|
Bcl7a
|
BAF chromatin remodeling complex subunit BCL7A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BCL7A gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:38,872,851...38,904,770
Ensembl chr12:38,872,851...38,904,770
|
|
| G
|
Bcl7c
|
BAF chromatin remodeling complex subunit BCL7C
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BCL7C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:191,703,432...191,754,751
Ensembl chr 1:191,691,089...191,754,641
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
multiple interactions
|
ISO
|
[TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in decreased expression of BDNF mRNA
|
CTD |
PMID:22428454 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Bet1l
|
Bet1 golgi vesicular membrane trafficking protein-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BET1L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:205,361,041...205,364,706
|
|
| G
|
Bex3
|
brain expressed X-linked 3
|
increases expression affects expression
|
EXP
|
Diazinon results in increased expression of BEX3 mRNA Diazinon affects the expression of BEX3 mRNA
|
CTD |
PMID:19130878 PMID:22546817 |
|
NCBI chr X:104,064,896...104,066,425
Ensembl chr X:104,064,515...104,075,906
|
|
| G
|
Bfar
|
bifunctional apoptosis regulator
|
affects expression
|
EXP
|
Diazinon affects the expression of BFAR mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:2,059,189...2,092,207
Ensembl chr10:2,059,058...2,094,183
|
|
| G
|
Bgn
|
biglycan
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BGN gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:156,348,615...156,360,799
|
|
| G
|
Bik
|
BCL2-interacting killer
|
affects expression
|
EXP
|
Diazinon affects the expression of BIK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317
|
|
| G
|
Bin1
|
bridging integrator 1
|
affects expression
|
EXP
|
Diazinon affects the expression of BIN1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458
|
|
| G
|
Bin3
|
bridging integrator 3
|
affects expression
|
EXP
|
Diazinon affects the expression of BIN3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:51,583,474...51,622,329
Ensembl chr15:51,583,481...51,622,329
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
affects expression decreases expression multiple interactions
|
EXP ISO
|
Diazinon affects the expression of BIRC5 mRNA Diazinon results in decreased expression of BIRC5 mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]
|
CTD |
PMID:22546817 PMID:27920530 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Bmf
|
Bcl2 modifying factor
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of BMF mRNA Diazinon affects the expression of BMF mRNA
|
CTD |
PMID:17452286 PMID:22546817 |
|
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
increases expression
|
EXP
|
Diazinon results in increased expression of BMP6 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Bmper
|
BMP-binding endothelial regulator
|
increases expression
|
EXP
|
Diazinon results in increased expression of BMPER mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:30,008,049...30,253,201
Ensembl chr 8:30,008,148...30,434,359
|
|
| G
|
Bms1
|
BMS1 ribosome biogenesis factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BMS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:153,230,471...153,267,437
Ensembl chr 4:153,230,471...153,267,429
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of BNIP3 gene Diazinon affects the expression of BNIP3 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
affects expression
|
EXP
|
Diazinon affects the expression of BNIP3L mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Bok
|
BCL2 family apoptosis regulator BOK
|
affects expression
|
EXP
|
Diazinon affects the expression of BOK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833
|
|
| G
|
Borcs6
|
BLOC-1 related complex subunit 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BORCS6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:54,259,349...54,261,203
Ensembl chr10:54,256,949...54,261,387
|
|
| G
|
Bpi
|
bactericidal/permeability-increasing protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BPI gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:167,329,513...167,356,217
Ensembl chr 3:167,329,530...167,356,396
|
|
| G
|
Bpifb2
|
BPI fold containing family B, member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BPIFB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:162,818,223...162,837,219
Ensembl chr 3:162,818,223...162,837,210
|
|
| G
|
Brd2
|
bromodomain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BRD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
|
|
| G
|
Brf1
|
BRF1 general transcription factor IIIB subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BRF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:137,854,055...137,902,629
Ensembl chr 6:137,855,449...137,902,386
|
|
| G
|
Bri3
|
brain protein I3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BRI3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:15,454,673...15,478,319
Ensembl chr12:15,454,673...15,478,319
|
|
| G
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1
|
affects expression
|
EXP
|
Diazinon affects the expression of BRINP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256
|
|
| G
|
Brinp2
|
BMP/retinoic acid inducible neural specific 2
|
affects expression
|
EXP
|
Diazinon affects the expression of BRINP2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:72,964,498...73,065,312
Ensembl chr13:72,964,502...73,065,294
|
|
| G
|
Bst1
|
bone marrow stromal cell antigen 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of BST1 mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647
|
|
| G
|
Btg1
|
BTG anti-proliferation factor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of BTG1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406
|
|
| G
|
Btg3
|
BTG anti-proliferation factor 3
|
affects expression
|
EXP
|
Diazinon affects the expression of BTG3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082
|
|
| G
|
Bud23
|
BUD23, rRNA methyltransferase and ribosome maturation factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BUD23 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:27,266,093...27,277,300
Ensembl chr12:27,265,521...27,277,297
|
|
| G
|
Bzw1
|
basic leucine zipper and W2 domains 1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of BZW1 gene Diazinon affects the expression of BZW1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684
|
|
| G
|
Bzw2
|
basic leucine zipper and W2 domains 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of BZW2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:58,555,362...58,615,921
Ensembl chr 6:58,554,961...58,615,912
|
|
| G
|
C1h10orf95
|
similar to human chromosome 10 open reading frame 95
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of C10ORF95 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:255,143,264...255,157,901
Ensembl chr 1:255,152,392...255,153,021
|
|
| G
|
C1h19orf33
|
similar to human chromosome 19 open reading frame 33
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of C19ORF33 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:93,677,305...93,678,141
Ensembl chr 1:93,677,305...93,678,141
|
|
| G
|
C2cd2l
|
C2CD2-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of C2CD2L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:53,544,887...53,557,127
Ensembl chr 8:53,544,892...53,555,153
|
|
| G
|
C4h3orf22
|
similar to human chromosome 3 open reading frame 22
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of C3ORF22 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:124,374,885...124,379,380
Ensembl chr 4:124,375,807...124,379,379
|
|
| G
|
C5h1orf159
|
similar to human chromosome 1 open reading frame 159
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of C1ORF159 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:171,983,700...172,001,373
Ensembl chr 5:171,983,936...172,001,373
|
|
| G
|
C5h1orf174
|
similar to human chromosome 1 open reading frame 174
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of C1ORF174 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:169,798,004...169,802,449
Ensembl chr 5:169,797,951...169,802,448
|
|
| G
|
C7
|
complement C7
|
affects expression
|
EXP
|
Diazinon affects the expression of C7 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672
|
|
| G
|
Ca8
|
carbonic anhydrase 8
|
increases expression
|
EXP
|
Diazinon results in increased expression of CAR8 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796
|
|
| G
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CACNA1G gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634
|
|
| G
|
Cacng4
|
calcium voltage-gated channel auxiliary subunit gamma 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CACNG4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:93,183,410...93,245,470
Ensembl chr10:93,183,410...93,245,470
|
|
| G
|
Calm1
|
calmodulin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CALM1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381
|
|
| G
|
Calr
|
calreticulin
|
increases expression
|
ISO
|
Diazinon results in increased expression of CALR mRNA
|
CTD |
PMID:16758764 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Camk2d
|
calcium/calmodulin-dependent protein kinase II delta
|
affects expression
|
EXP
|
Diazinon affects the expression of CAMK2D mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276
|
|
| G
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma
|
affects expression
|
EXP
|
Diazinon affects the expression of CAMK2G mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310
|
|
| G
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CAMK2N2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:93,792,112...93,796,153
Ensembl chr11:93,794,095...93,795,222
|
|
| G
|
Camk4
|
calcium/calmodulin-dependent protein kinase IV
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of CAMK4 mRNA
|
CTD |
PMID:23212306 |
|
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193
|
|
| G
|
Camta2
|
calmodulin binding transcription activator 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CAMTA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,882,071...55,900,575
Ensembl chr10:55,882,071...55,900,179
|
|
| G
|
Cand1
|
cullin-associated and neddylation-dissociated 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CAND1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:56,551,394...56,604,655
|
|
| G
|
Canx
|
calnexin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CANX gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857
|
|
| G
|
Capn10
|
calpain 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CAPN10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912
|
|
| G
|
Capn15
|
calpain 15
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CAPN15 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:15,477,311...15,503,913
Ensembl chr10:15,477,313...15,503,913
|
|
| G
|
Card9
|
caspase recruitment domain family, member 9
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CARD9 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:29,569,907...29,578,402
Ensembl chr 3:29,569,959...29,578,402
|
|
| G
|
Caskin2
|
cask-interacting protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CASKIN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:101,526,131...101,540,362
Ensembl chr10:101,526,195...101,540,349
|
|
| G
|
Casp1
|
caspase 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CASP1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp12
|
caspase 12
|
affects expression
|
EXP
|
Diazinon affects the expression of CASP12 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp2
|
caspase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of CASP2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases cleavage increases expression increases activity
|
EXP ISO
|
crocin inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; crocin inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; crocin inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form] Diazinon results in increased expression of CASP3 mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CASP3 mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP3 mRNA]
|
CTD |
PMID:23523949 PMID:27353299 PMID:27920530 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp4
|
caspase 4
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of CASP4 mRNA Diazinon affects the expression of CASP4 mRNA
|
CTD |
PMID:17452286 PMID:22546817 |
|
NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727
|
|
| G
|
Casp6
|
caspase 6
|
affects expression
|
EXP
|
Diazinon affects the expression of CASP6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp7
|
caspase 7
|
affects expression
|
EXP
|
Diazinon affects the expression of CASP7 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
affects expression increases expression multiple interactions
|
EXP ISO
|
Diazinon affects the expression of CASP8 mRNA Diazinon results in increased expression of CASP8 mRNA Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA]
|
CTD |
PMID:22546817 PMID:27920530 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp8ap2
|
caspase 8 associated protein 2
|
affects expression
|
EXP
|
Diazinon affects the expression of CASP8AP2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632
|
|
| G
|
Casp9
|
caspase 9
|
affects expression multiple interactions increases cleavage increases activity increases expression
|
EXP ISO
|
Diazinon affects the expression of CASP9 mRNA crocin inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] Magnesium Oxide analog inhibits the reaction [Diazinon results in increased activity of CASP9 protein]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]; Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]]
|
CTD |
PMID:17452286 PMID:27353299 PMID:27920530 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
decreases activity multiple interactions increases expression
|
EXP
|
Diazinon results in decreased activity of CAT protein Resveratrol inhibits the reaction [Diazinon results in decreased expression of CAT protein] Diazinon results in increased expression of CAT mRNA
|
CTD |
PMID:29383019 PMID:35403302 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cbln2
|
cerebellin 2 precursor
|
increases expression
|
EXP
|
Diazinon results in increased expression of CBLN2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr18:82,215,210...82,222,648
Ensembl chr18:82,215,220...82,222,648
|
|
| G
|
Cbx3
|
chromobox 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CBX3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:81,876,155...81,889,912
Ensembl chr 4:81,876,649...81,889,911
|
|
| G
|
Ccdc106
|
coiled-coil domain containing 106
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCDC106 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:77,808,723...77,812,816
Ensembl chr 1:77,808,723...77,852,105
|
|
| G
|
Ccdc107
|
coiled-coil domain containing 107
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCDC107 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:62,545,273...62,548,711
Ensembl chr 5:62,544,714...62,548,709
|
|
| G
|
Ccdc142
|
coiled-coil domain containing 142
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCDC142 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:117,164,055...117,172,286
Ensembl chr 4:117,166,135...117,173,935
|
|
| G
|
Ccdc22
|
coiled-coil domain containing 22
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCDC22 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:17,570,184...17,582,130
Ensembl chr X:17,535,659...17,582,130
|
|
| G
|
Ccdc28b
|
coiled coil domain containing 28B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCDC28B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:147,246,627...147,251,629
Ensembl chr 5:147,246,628...147,251,629
|
|
| G
|
Ccdc57
|
coiled-coil domain containing 57
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCDC57 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:106,591,106...106,694,740
Ensembl chr10:106,590,551...106,684,983
|
|
| G
|
Ccl9
|
C-C motif chemokine ligand 9
|
affects expression
|
EXP
|
Diazinon affects the expression of CCL6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877
|
|
| G
|
Ccna1
|
cyclin A1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCNA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300
|
|
| G
|
Ccnd1
|
cyclin D1
|
multiple interactions affects expression
|
ISO EXP
|
[alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in increased expression of CCND1 protein Diazinon affects the expression of CCND1 mRNA
|
CTD |
PMID:19883720 PMID:22546817 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne1
|
cyclin E1
|
affects expression
|
EXP
|
Diazinon affects the expression of CCNE1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccne2
|
cyclin E2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CCNE2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
|
|
| G
|
Ccnf
|
cyclin F
|
affects expression
|
EXP
|
Diazinon affects the expression of CCNF mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837
|
|
| G
|
Ccng1
|
cyclin G1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of CCNG1 gene Diazinon affects the expression of CCNG1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Ccng2
|
cyclin G2
|
increases expression
|
ISO
|
Diazinon results in increased expression of CCNG2 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206
|
|
| G
|
Ccnh
|
cyclin H
|
affects expression
|
EXP
|
Diazinon affects the expression of CCNH mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860
|
|
| G
|
Ccni
|
cyclin I
|
affects expression
|
EXP
|
Diazinon affects the expression of CCNI mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:15,164,047...15,186,885
Ensembl chr14:15,164,095...15,186,885
|
|
| G
|
Ccnt2
|
cyclin T2
|
affects expression
|
EXP
|
Diazinon affects the expression of CCNT2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:41,804,007...41,845,641
Ensembl chr13:41,804,046...41,844,488
|
|
| G
|
Ccpg1
|
cell cycle progression 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CCPG1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:82,600,536...82,660,246
|
|
| G
|
Cct2
|
chaperonin containing TCP1 subunit 2
|
affects expression
|
EXP
|
Diazinon affects the expression of CCT2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977
|
|
| G
|
Cd151
|
CD151 molecule (Raph blood group)
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CD151 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784
|
|
| G
|
Cd2bp2
|
Cd2 (cytoplasmic tail) binding protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CD2BP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:191,239,899...191,244,395
Ensembl chr 1:191,239,901...191,243,398
|
|
| G
|
Cd3g
|
CD3 gamma subunit of T-cell receptor complex
|
affects expression
|
EXP
|
Diazinon affects the expression of CD3G mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918
|
|
| G
|
Cd40
|
CD40 molecule
|
increases expression
|
ISO
|
Diazinon results in increased expression of CD40 protein
|
CTD |
PMID:28119078 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd44
|
CD44 molecule
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CD44 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd5
|
Cd5 molecule
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CD5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:216,790,245...216,811,209
Ensembl chr 1:216,790,245...216,811,209
|
|
| G
|
Cd84
|
CD84 molecule
|
increases expression
|
ISO
|
Diazinon results in increased expression of CD84 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318
|
|
| G
|
Cd86
|
CD86 molecule
|
increases expression
|
ISO
|
Diazinon results in increased expression of CD86 protein
|
CTD |
PMID:28119078 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
| G
|
Cdc20
|
cell division cycle 20
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of CDC20 gene Diazinon affects the expression of CDC20 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
|
|
| G
|
Cdc23
|
cell division cycle 23
|
affects expression
|
EXP
|
Diazinon affects the expression of CDC23 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr18:26,511,019...26,534,872
Ensembl chr18:26,510,355...26,532,646
|
|
| G
|
Cdc25a
|
cell division cycle 25A
|
affects expression
|
EXP
|
Diazinon affects the expression of CDC25A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
|
|
| G
|
Cdc25c
|
cell division cycle 25C
|
affects expression
|
EXP
|
Diazinon affects the expression of CDC25C mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
|
|
| G
|
Cdc34
|
cell division cycle 34, ubiquitin conjugating enzyme
|
affects expression
|
EXP
|
Diazinon affects the expression of CDC34 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526
|
|
| G
|
Cdc37
|
cell division cycle 37, HSP90 cochaperone
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of CDC37 mRNA Diazinon results in increased methylation of CDC37 gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931
|
|
| G
|
Cdc37l1
|
cell division cycle 37-like 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CDC37L1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:236,118,630...236,147,527
Ensembl chr 1:236,118,555...236,207,079
|
|
| G
|
Cdc42ep1
|
CDC42 effector protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDC42EP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,275,759...112,283,665
Ensembl chr 7:112,275,792...112,283,664
|
|
| G
|
Cdc6
|
cell division cycle 6
|
affects expression
|
EXP
|
Diazinon affects the expression of CDC6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
|
|
| G
|
Cdc7
|
cell division cycle 7
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of CDC7 gene Diazinon affects the expression of CDC7 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656
|
|
| G
|
Cdca2
|
cell division cycle associated 2
|
affects expression
|
EXP
|
Diazinon affects the expression of CDCA2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639
|
|
| G
|
Cdca3
|
cell division cycle associated 3
|
affects expression
|
EXP
|
Diazinon affects the expression of CDCA3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
|
|
| G
|
Cdca4
|
cell division cycle associated 4
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of CDCA4 gene Diazinon affects the expression of CDCA4 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580
|
|
| G
|
Cdca5
|
cell division cycle associated 5
|
affects expression
|
EXP
|
Diazinon affects the expression of CDCA5 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309
|
|
| G
|
Cdca8
|
cell division cycle associated 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDCA8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283
|
|
| G
|
Cdcp1
|
CUB domain containing protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDCP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:131,706,140...131,742,799
Ensembl chr 8:131,706,140...131,742,877
|
|
| G
|
Cdh24
|
cadherin 24
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDH24 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:32,061,588...32,071,323
Ensembl chr15:32,061,588...32,071,283
|
|
| G
|
Cdh5
|
cadherin 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDH5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
|
|
| G
|
Cdh7
|
cadherin 7
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of CDH7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:27,186,223...27,336,076
Ensembl chr13:27,187,257...27,336,023
|
|
| G
|
Cdh8
|
cadherin 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDH8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdk11b
|
cyclin-dependent kinase 11B
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK11B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:171,495,042...171,521,143
Ensembl chr 5:171,495,776...171,521,145
|
|
| G
|
Cdk13
|
cyclin-dependent kinase 13
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK13 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr17:51,945,975...52,040,218
Ensembl chr17:51,946,701...52,037,257
|
|
| G
|
Cdk20
|
cyclin-dependent kinase 20
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK20 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr17:706,863...717,828
Ensembl chr17:706,865...713,567
|
|
| G
|
Cdk4
|
cyclin-dependent kinase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDK4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK5 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdk6
|
cyclin-dependent kinase 6
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
|
|
| G
|
Cdk9
|
cyclin-dependent kinase 9
|
affects expression
|
EXP
|
Diazinon affects the expression of CDK9 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:36,394,168...36,399,016
Ensembl chr 3:36,394,169...36,399,528
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CDKN1A gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of CDKN1C mRNA Diazinon results in increased methylation of CDKN1C gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
|
|
| G
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3
|
affects expression
|
EXP
|
Diazinon affects the expression of CDKN3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
|
|
| G
|
Cdt1
|
chromatin licensing and DNA replication factor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CDT1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
multiple interactions increases expression
|
ISO
|
Fulvestrant inhibits the reaction [Diazinon results in increased expression of CEBPA protein]
|
CTD |
PMID:33872936 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
affects expression
|
EXP
|
Diazinon affects the expression of CEBPB mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cebpe
|
CCAAT/enhancer binding protein epsilon
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CEBPE gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:32,139,716...32,141,476
Ensembl chr15:32,139,716...32,141,476
|
|
| G
|
Celf2
|
CUGBP, Elav-like family member 2
|
affects expression
|
EXP
|
Diazinon affects the expression of CELF2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362
|
|
| G
|
Celf6
|
CUGBP, Elav-like family member 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CELF6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:68,870,902...68,901,863
Ensembl chr 8:68,871,093...68,901,863
|
|
| G
|
Cenpf
|
centromere protein F
|
affects expression
|
EXP
|
Diazinon affects the expression of CENPF mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
|
|
| G
|
Cenpx
|
centromere protein X
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CENPX gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:106,489,796...106,492,637
Ensembl chr10:106,489,796...106,492,637
|
|
| G
|
Cep57
|
centrosomal protein 57
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CEP57 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:18,932,808...18,970,890
|
|
| G
|
Cep68
|
centrosomal protein 68
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CEP68 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:98,649,993...98,671,892
Ensembl chr14:98,649,993...98,671,868
|
|
| G
|
Ces2h
|
carboxylesterase 2H
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CES2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752
|
|
| G
|
Cfap298
|
cilia and flagella associated protein 298
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CFAP298 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:43,667,996...43,678,049
Ensembl chr11:43,668,014...43,677,382
|
|
| G
|
Cfdp1
|
craniofacial development protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CFDP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:56,627,596...56,733,099
Ensembl chr19:56,626,963...56,733,098
|
|
| G
|
Cfl1
|
cofilin 1
|
multiple interactions
|
ISO
|
Diazinon results in increased phosphorylation of and results in increased expression of CFL1 protein
|
CTD |
PMID:19647006 |
|
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
multiple interactions increases expression
|
ISO
|
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA]; Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Cgref1
|
cell growth regulator with EF hand domain 1
|
affects expression
|
EXP
|
Diazinon affects the expression of CGREF1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
decreases activity decreases expression
|
EXP
|
Diazinon results in decreased activity of CHAT protein Diazinon results in decreased expression of CHAT mRNA
|
CTD |
PMID:16675431 PMID:17452286 PMID:18812211 PMID:29108742 |
|
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Chd4
|
chromodomain helicase DNA binding protein 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CHD4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:159,584,623...159,617,867
Ensembl chr 4:159,584,654...159,617,866
|
|
| G
|
Chga
|
chromogranin A
|
increases expression
|
EXP
|
Diazinon results in increased expression of CHGA mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237
|
|
| G
|
Chgb
|
chromogranin B
|
increases expression decreases expression
|
EXP
|
Diazinon results in increased expression of CHGB mRNA Diazinon results in decreased expression of CHGB mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054
|
|
| G
|
Chrd
|
chordin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CHRD gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:93,676,400...93,685,584
Ensembl chr11:93,676,400...93,685,278
|
|
| G
|
Chrm1
|
cholinergic receptor, muscarinic 1
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of CHRM1 mRNA Diazinon results in decreased expression of CHRM1 mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602
|
|
| G
|
Chrm2
|
cholinergic receptor, muscarinic 2
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of CHRM2 mRNA Diazinon results in decreased expression of CHRM2 mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,981,006...66,126,464
|
|
| G
|
Chrm4
|
cholinergic receptor, muscarinic 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of CHRM4 mRNA
|
CTD |
PMID:18812211 |
|
NCBI chr 3:98,349,080...98,356,821
Ensembl chr 3:98,348,650...98,358,771
|
|
| G
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
affects expression
|
EXP
|
Diazinon affects the expression of CHRM5 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:119,735,975...119,792,166
|
|
| G
|
Chrna2
|
cholinergic receptor nicotinic alpha 2 subunit
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of CHRNA2 mRNA Diazinon results in increased expression of CHRNA2 mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144
|
|
| G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CHRNA3 mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
affects expression
|
EXP
|
Diazinon affects the expression of CHRNA4 mRNA
|
CTD |
PMID:18812211 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrna5
|
cholinergic receptor nicotinic alpha 5 subunit
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CHRNA5 mRNA
|
CTD |
PMID:18812211 |
|
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:64,265,879...64,294,233
|
|
| G
|
Chrna7
|
cholinergic receptor nicotinic alpha 7 subunit
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of CHRNA7 mRNA Diazinon results in decreased expression of CHRNA7 mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858
|
|
| G
|
Chrnb2
|
cholinergic receptor nicotinic beta 2 subunit
|
affects expression
|
EXP
|
Diazinon affects the expression of CHRNB2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
|
|
| G
|
Chrnb3
|
cholinergic receptor nicotinic beta 3 subunit
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CHRNB3 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:71,417,039...71,454,225
|
|
| G
|
Chrnd
|
cholinergic receptor nicotinic delta subunit
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of CHRND mRNA Diazinon results in increased methylation of CHRND gene
|
CTD |
PMID:17452286 PMID:22964155 |
|
NCBI chr 9:95,310,316...95,318,734
Ensembl chr 9:95,310,298...95,318,745
|
|
| G
|
Chrne
|
cholinergic receptor nicotinic epsilon subunit
|
affects expression
|
EXP
|
Diazinon affects the expression of CHRNE mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr10:55,829,835...55,838,853
Ensembl chr10:55,829,836...55,834,154
|
|
| G
|
Chrng
|
cholinergic receptor nicotinic gamma subunit
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CHRNG mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092
|
|
| G
|
Chst2
|
carbohydrate sulfotransferase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CHST2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301
|
|
| G
|
Chtop
|
chromatin target of PRMT1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CHTOP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:178,278,848...178,291,142
Ensembl chr 2:178,278,848...178,290,348
|
|
| G
|
Cidea
|
cell death-inducing DFFA-like effector a
|
affects expression
|
EXP
|
Diazinon affects the expression of CIDEA mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382
|
|
| G
|
Cinp
|
cyclin-dependent kinase 2-interacting protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CINP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:135,698,477...135,720,798
Ensembl chr 6:135,706,793...135,720,689
|
|
| G
|
Cirbp
|
cold inducible RNA binding protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CIRBP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,184,515...10,189,623
|
|
| G
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CITED4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361
|
|
| G
|
Ckb
|
creatine kinase B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CKB gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
multiple interactions increases activity
|
EXP
|
crocin inhibits the reaction [Diazinon results in increased activity of CKM protein]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CKM protein]
|
CTD |
PMID:23523949 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Cks2
|
CDC28 protein kinase regulatory subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CKS2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
|
|
| G
|
Clcn6
|
chloride voltage-gated channel 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CLCN6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:163,715,593...163,748,301
Ensembl chr 5:163,717,439...163,748,198
|
|
| G
|
Cldn6
|
claudin 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CLDN6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:13,213,837...13,218,578
Ensembl chr10:13,213,956...13,218,581
|
|
| G
|
Clip2
|
CAP-GLY domain containing linker protein 2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of CLIP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:27,798,289...27,863,486
Ensembl chr12:27,799,524...27,863,484
|
|
| G
|
Cltrn
|
collectrin, amino acid transport regulator
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CLTRN mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr X:33,993,825...34,027,124
Ensembl chr X:33,993,825...34,027,181
|
|
| G
|
Cmtr1
|
cap methyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CMTR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:7,724,286...7,784,787
Ensembl chr20:7,683,946...7,784,263
|
|
| G
|
Cndp2
|
carnosine dipeptidase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CNDP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900
|
|
| G
|
Cnfn
|
cornifelin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CNFN gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:90,079,409...90,081,556
Ensembl chr 1:90,078,552...90,081,556
|
|
| G
|
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of CNKSR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:40,722,843...40,971,730
Ensembl chr X:40,722,996...40,965,604
|
|
| G
|
Cnn2
|
calponin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CNN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312
|
|
| G
|
Cnnm2
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CNNM2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:255,585,063...255,709,455
Ensembl chr 1:255,585,095...255,704,849
|
|
| G
|
Cnnm3
|
cyclin and CBS domain divalent metal cation transport mediator 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CNNM3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:46,251,252...46,266,613
Ensembl chr 9:46,251,265...46,266,613
|
|
| G
|
Cnp
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CNP gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063
|
|
| G
|
Coa8
|
cytochrome c oxidase assembly factor 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of COA8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:136,593,399...136,618,237
Ensembl chr 6:136,592,787...136,619,602
|
|
| G
|
Coch
|
cochlin
|
increases expression
|
EXP
|
Diazinon results in increased expression of COCH mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502
|
|
| G
|
Col1a2
|
collagen type I alpha 2 chain
|
increases expression
|
EXP
|
Diazinon results in increased expression of COL1A2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
| G
|
Col23a1
|
collagen type XXIII alpha 1 chain
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of COL23A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:36,050,327...36,337,279
Ensembl chr10:36,050,259...36,337,897
|
|
| G
|
Col4a3
|
collagen type IV alpha 3 chain
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of COL4A3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:91,323,990...91,453,077
|
|
| G
|
Col8a1
|
collagen type VIII alpha 1 chain
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of COL8A1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229
|
|
| G
|
Col8a2
|
collagen type VIII alpha 2 chain
|
increases expression
|
EXP
|
Diazinon results in increased expression of COL8A2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884
|
|
| G
|
Colec12
|
collectin sub-family member 12
|
increases expression
|
EXP
|
Diazinon results in increased expression of COLEC12 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297
|
|
| G
|
Comt
|
catechol-O-methyltransferase
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of COMT mRNA; Diazinon results in decreased expression of COMT protein
|
CTD |
PMID:18812211 PMID:26721910 |
|
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
|
|
| G
|
Copb2
|
COPI coat complex subunit beta 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of COPB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:108,040,687...108,062,810
Ensembl chr 8:108,040,693...108,064,550
|
|
| G
|
Cox14
|
cytochrome c oxidase assembly factor COX14
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of COX14 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:132,731,069...132,733,159
Ensembl chr 7:132,731,069...132,733,159
|
|
| G
|
Cox8a
|
cytochrome c oxidase subunit 8A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of COX8A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623
|
|
| G
|
Cp
|
ceruloplasmin
|
increases expression
|
EXP
|
Diazinon results in increased expression of CP mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CPEB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263
|
|
| G
|
Cplx2
|
complexin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CPLX2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,228,449...10,297,467
|
|
| G
|
Cplx3
|
complexin 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of CPLX3 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:66,899,438...66,906,200
Ensembl chr 8:66,899,438...66,906,200
|
|
| G
|
Cpne2
|
copine 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CPNE2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:10,440,245...10,477,783
Ensembl chr19:10,434,647...10,477,783
|
|
| G
|
Cpne7
|
copine 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CPNE7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197
|
|
| G
|
Cpne8
|
copine 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CPNE8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060
|
|
| G
|
Crabp1
|
cellular retinoic acid binding protein 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CRABP1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470
|
|
| G
|
Crat
|
carnitine O-acetyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CRAT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
decreases expression
|
EXP ISO
|
Diazinon results in decreased expression of CREB1 mRNA
|
CTD |
PMID:17452286 PMID:23212306 PMID:35934178 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crh
|
corticotropin releasing hormone
|
increases expression
|
EXP
|
Diazinon results in increased expression of CRH mRNA
|
CTD |
PMID:20682304 |
|
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386
|
|
| G
|
Crhr1
|
corticotropin releasing hormone receptor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CRHR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466
|
|
| G
|
Crim1
|
cysteine rich transmembrane BMP regulator 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of CRIM1 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416
|
|
| G
|
Crip2
|
cysteine-rich protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CRIP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:138,042,175...138,047,121
Ensembl chr 6:138,041,906...138,047,120
|
|
| G
|
Crispld2
|
cysteine-rich secretory protein LCCL domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CRISPLD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349
|
|
| G
|
Crk
|
CRK proto-oncogene, adaptor protein
|
affects expression
|
EXP
|
Diazinon affects the expression of CRK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:61,028,736...61,054,971
Ensembl chr10:61,028,757...61,082,988
|
|
| G
|
Crlf1
|
cytokine receptor-like factor 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CRLF1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr16:18,958,695...18,970,026
Ensembl chr16:18,957,956...18,969,970
|
|
| G
|
Cryba2
|
crystallin, beta A2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CRYBA2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 9:83,895,921...83,906,651
Ensembl chr 9:83,895,922...83,899,131
|
|
| G
|
Csnk1d
|
casein kinase 1, delta
|
affects expression
|
EXP
|
Diazinon affects the expression of CSNK1D mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953
|
|
| G
|
Csnk2a2
|
casein kinase 2 alpha 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CSNK2A2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136
|
|
| G
|
Cstb
|
cystatin B
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of CSTB mRNA Diazinon results in increased methylation of CSTB gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199
|
|
| G
|
Ctcf
|
CCCTC-binding factor
|
affects expression
|
EXP
|
Diazinon affects the expression of CTCF mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:50,431,478...50,481,013
Ensembl chr19:50,431,689...50,481,012
|
|
| G
|
Ctdsp1
|
CTD small phosphatase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CTDSP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412
|
|
| G
|
Ctns
|
cystinosin, lysosomal cystine transporter
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CTNS gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:58,300,069...58,315,725
Ensembl chr10:58,299,967...58,321,661
|
|
| G
|
Ctsz
|
cathepsin Z
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CTSZ gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:183,643,077...183,653,847
Ensembl chr 3:183,643,077...183,657,012
|
|
| G
|
Cul3
|
cullin 3
|
affects expression
|
EXP
|
Diazinon affects the expression of CUL3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427
|
|
| G
|
Cux2
|
cut-like homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CUX2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528
|
|
| G
|
Cwf19l2
|
CWF19 like cell cycle control factor 2
|
affects expression
|
EXP
|
Diazinon affects the expression of CWF19L2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:6,036,158...6,102,686
Ensembl chr 6:6,026,861...6,102,635
|
|
| G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of CX3CR1 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
|
|
| G
|
Cyb561
|
cytochrome b-561
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CYB561 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:91,377,866...91,388,548
Ensembl chr10:91,377,866...91,385,097
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CYBA gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
multiple interactions increases expression affects localization
|
EXP ISO
|
crocin inhibits the reaction [Diazinon affects the localization of CYCS protein]; Vitamin E inhibits the reaction [Diazinon affects the localization of CYCS protein] Diazinon results in increased expression of CYCS mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CYCS mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CYCS mRNA]
|
CTD |
PMID:23523949 PMID:27920530 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of CYP1A1 mRNA; Diazinon results in increased expression of CYP1A1 protein
|
CTD |
PMID:21784029 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions affects metabolic processing increases expression
|
ISO EXP
|
CYP1A2 protein results in decreased sulfation of and results in increased activity of Diazinon; CYP1A2 protein results in increased metabolism of and results in increased activity of Diazinon CYP1A2 protein affects the metabolism of Diazinon [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon Diazinon results in increased expression of CYP1A2 mRNA; Diazinon results in increased expression of CYP1A2 protein
|
CTD |
PMID:11708902 PMID:15557345 PMID:15764407 PMID:17442507 PMID:21784029 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of CYP1B1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
multiple interactions affects metabolic processing
|
ISO
|
CYP2B6 protein results in decreased sulfation of and results in increased activity of Diazinon CYP2B6 protein affects the metabolism of Diazinon
|
CTD |
PMID:15557345 PMID:15764407 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
multiple interactions affects metabolic processing increases expression
|
ISO
|
CYP2C19 protein results in decreased sulfation of and results in increased activity of Diazinon; CYP2C19 protein results in increased metabolism of and results in increased activity of Diazinon CYP2C19 protein affects the metabolism of Diazinon Diazinon results in increased expression of CYP2C19 mRNA
|
CTD |
PMID:11708902 PMID:15764407 PMID:16757081 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
increases expression
|
ISO
|
Diazinon results in increased expression of CYP2D6 mRNA
|
CTD |
PMID:16757081 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
| G
|
Cyp2s1
|
cytochrome P450, family 2, subfamily s, polypeptide 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CYP2S1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:90,437,741...90,453,073
Ensembl chr 1:90,438,224...90,453,073
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions increases methylation affects metabolic processing increases expression
|
ISO
|
CYP3A4 protein results in decreased sulfation of and results in increased activity of Diazinon; CYP3A4 protein results in increased metabolism of and results in increased activity of Diazinon Diazinon results in increased methylation of CYP3A4 promoter CYP3A4 protein affects the metabolism of Diazinon Diazinon results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:11708902 PMID:15764407 PMID:16757081 PMID:35331105 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
increases expression
|
ISO
|
Diazinon results in increased expression of CYP3A5 mRNA
|
CTD |
PMID:16757081 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cyp4f40
|
cytochrome P450, family 4, subfamily f, polypeptide 40
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CYP4F11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:12,342,121...12,357,974
Ensembl chr 7:12,342,590...12,356,733
|
|
| G
|
Cyp4x1
|
cytochrome P450, family 4, subfamily x, polypeptide 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of CYP4X1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:133,888,439...133,923,254
Ensembl chr 5:133,888,439...133,919,642
|
|
| G
|
Cystm1
|
cysteine-rich transmembrane module containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of CYSTM1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:28,219,861...28,287,574
Ensembl chr18:28,220,004...28,287,574
|
|
| G
|
Dad1
|
defender against cell death 1
|
affects expression
|
EXP
|
Diazinon affects the expression of DAD1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287
|
|
| G
|
Dalrd3
|
DALR anticodon binding domain containing 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DALRD3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,142,009...118,147,082
Ensembl chr 8:118,144,197...118,147,822
|
|
| G
|
Dap
|
death-associated protein
|
affects expression
|
EXP
|
Diazinon affects the expression of DAP mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:83,910,060...83,962,673
|
|
| G
|
Dapk3
|
death-associated protein kinase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of DAPK3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:9,174,904...9,183,272
|
|
| G
|
Daxx
|
death-domain associated protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DAXX gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720
|
|
| G
|
Dbh
|
dopamine beta-hydroxylase
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of DBH mRNA Diazinon results in increased expression of DBH mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316
|
|
| G
|
Dbn1
|
drebrin 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DBN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122
|
|
| G
|
Dcxr
|
dicarbonyl and L-xylulose reductase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DCXR gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:106,504,730...106,506,619
|
|
| G
|
Dda1
|
DET1 and DDB1 associated 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DDA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:18,190,280...18,197,914
Ensembl chr16:18,190,306...18,197,913
|
|
| G
|
Ddb1
|
damage-specific DNA binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DDB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596
|
|
| G
|
Ddc
|
dopa decarboxylase
|
affects binding
|
ISO
|
Diazinon binds to [DDC protein binds to Pyridoxal Phosphate]; Diazinon binds to DDC protein
|
CTD |
PMID:35151785 |
|
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
|
|
| G
|
Ddias
|
DNA damage-induced apoptosis suppressor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DDIAS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:156,318,563...156,342,869
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
affects expression
|
EXP
|
Diazinon affects the expression of DDIT3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Ddit4
|
DNA-damage-inducible transcript 4
|
affects expression
|
EXP
|
Diazinon affects the expression of DDIT4 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
|
|
| G
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DDR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276
|
|
| G
|
Ddt
|
D-dopachrome tautomerase
|
increases expression
|
EXP
|
Diazinon results in increased expression of DDT protein
|
CTD |
PMID:26721910 |
|
NCBI chr20:12,883,025...12,886,121
|
|
| G
|
Ddx17
|
DEAD-box helicase 17
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DDX17 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747
|
|
| G
|
Ddx19a
|
DEAD-box helicase 19A
|
affects expression
|
EXP
|
Diazinon affects the expression of DDX19A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:55,851,854...55,872,209
Ensembl chr19:55,851,854...55,872,209
|
|
| G
|
Ddx39a
|
DExD-box helicase 39A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DDX39A gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306
|
|
| G
|
Dedd2
|
death effector domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DEDD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:89,916,906...89,934,663
Ensembl chr 1:89,919,524...89,936,804
|
|
| G
|
Depp1
|
DEPP autophagy regulator 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DEPP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
|
|
| G
|
Dexi
|
Dexi homolog
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DEXI gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:5,632,400...5,645,653
Ensembl chr10:5,632,961...5,645,648
|
|
| G
|
Dgat1
|
diacylglycerol O-acyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DGAT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
|
|
| G
|
Dgcr8
|
DGCR8 microprocessor complex subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DGCR8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:96,208,959...96,241,560
Ensembl chr11:96,209,038...96,241,551
|
|
| G
|
Dgke
|
diacylglycerol kinase epsilon
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DGKE gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:74,348,931...74,374,509
Ensembl chr10:74,350,246...74,374,478
|
|
| G
|
Dhh
|
desert hedgehog signaling molecule
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DHH gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352
|
|
| G
|
Dhrs1
|
dehydrogenase/reductase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DHRS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734
|
|
| G
|
Dhx40
|
DEAH-box helicase 40
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DHX40 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:72,081,867...72,118,792
Ensembl chr10:72,081,867...72,118,958
|
|
| G
|
Diablo
|
diablo, IAP-binding mitochondrial protein
|
affects expression
|
EXP
|
Diazinon affects the expression of DIABLO mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
|
|
| G
|
Dido1
|
death inducer-obliterator 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DIDO1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823
|
|
| G
|
Dipk1b
|
divergent protein kinase domain 1B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DIPK1B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:29,853,973...29,862,255
|
|
| G
|
Dkk1
|
dickkopf WNT signaling pathway inhibitor 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of DKK1 mRNA
|
CTD |
PMID:18502319 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650
|
|
| G
|
Dkk3
|
dickkopf WNT signaling pathway inhibitor 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of DKK3 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186
|
|
| G
|
Dlg1
|
discs large MAGUK scaffold protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of DLG1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797
|
|
| G
|
Dlg5
|
discs large MAGUK scaffold protein 5
|
affects expression
|
EXP
|
Diazinon affects the expression of DLG5 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:125,287...237,334
Ensembl chr15:125,290...237,332
|
|
| G
|
Dlgap5
|
DLG associated protein 5
|
affects expression
|
EXP
|
Diazinon affects the expression of DLGAP5 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176
|
|
| G
|
Dmtn
|
dematin actin binding protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DMTN gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:52,087,667...52,111,956
Ensembl chr15:52,087,667...52,112,128
|
|
| G
|
Dnaaf2
|
dynein, axonemal, assembly factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DNAAF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:93,397,157...93,406,323
Ensembl chr 6:93,397,164...93,406,323
|
|
| G
|
Dnaja2
|
DnaJ heat shock protein family (Hsp40) member A2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DNAJA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120
|
|
| G
|
Dnajb1
|
DnaJ heat shock protein family (Hsp40) member B1
|
increases expression increases methylation
|
ISO
|
Diazinon results in increased expression of DNAJB1 mRNA Diazinon results in increased methylation of DNAJB1 gene
|
CTD |
PMID:22964155 PMID:24356939 |
|
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
|
|
| G
|
Dnajb13
|
DnaJ heat shock protein family (Hsp40) member B13
|
affects expression
|
EXP
|
Diazinon affects the expression of DNAJB13 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:164,260,716...164,275,172
Ensembl chr 1:164,260,724...164,275,093
|
|
| G
|
Dnajb2
|
DnaJ heat shock protein family (Hsp40) member B2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DNAJB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:84,179,695...84,187,942
|
|
| G
|
Dnajb4
|
DnaJ heat shock protein family (Hsp40) member B4
|
increases expression
|
ISO
|
Diazinon results in increased expression of DNAJB4 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
|
|
| G
|
Dnase2
|
deoxyribonuclease 2, lysosomal
|
affects expression
|
EXP
|
Diazinon affects the expression of DNASE2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:40,149,505...40,152,225
|
|
| G
|
Dnm2
|
dynamin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DNM2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:28,254,529...28,336,295
|
|
| G
|
Dock4
|
dedicator of cytokinesis 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DOCK4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:63,240,136...63,629,772
|
|
| G
|
Dohh
|
deoxyhypusine hydroxylase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DOHH gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:8,972,202...8,977,025
Ensembl chr 7:8,972,202...8,977,025
|
|
| G
|
Dok1
|
docking protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DOK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:117,095,171...117,098,251
Ensembl chr 4:117,095,175...117,097,825
|
|
| G
|
Dok4
|
docking protein 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DOK4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:10,152,511...10,163,182
Ensembl chr19:10,152,458...10,164,190
|
|
| G
|
Dolpp1
|
dolichyldiphosphatase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DOLPP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:34,063,825...34,072,133
Ensembl chr 3:34,063,825...34,072,132
|
|
| G
|
Dpf2
|
double PHD fingers 2
|
affects expression
|
EXP
|
Diazinon affects the expression of DPF2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:212,612,986...212,628,376
Ensembl chr 1:212,612,986...212,628,289
|
|
| G
|
Dph2
|
diphthamide biosynthesis 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DPH2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:136,713,868...136,716,828
|
|
| G
|
Dpp7
|
dipeptidylpeptidase 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DPP7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492
|
|
| G
|
Dpys
|
dihydropyrimidinase
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of DPYS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:72,707,566...72,814,183
Ensembl chr 7:72,721,048...72,814,142
|
|
| G
|
Drd2
|
dopamine receptor D2
|
affects expression
|
EXP
|
Diazinon affects the expression of DRD2 mRNA
|
CTD |
PMID:18812211 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
|
|
| G
|
Drd4
|
dopamine receptor D4
|
affects expression
|
EXP
|
Diazinon affects the expression of DRD4 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458
|
|
| G
|
Dsn1
|
DSN1 component of MIS12 kinetochore complex
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DSN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:166,072,775...166,089,029
Ensembl chr 3:166,074,033...166,085,890
|
|
| G
|
Dtymk
|
deoxythymidylate kinase
|
affects expression
|
EXP
|
Diazinon affects the expression of DTYMK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504
|
|
| G
|
Duoxa1
|
dual oxidase maturation factor 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of DUOXA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:129,703,416...129,714,110
Ensembl chr 3:129,703,416...129,706,829
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of DUSP1 gene Diazinon affects the expression of DUSP1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp18
|
dual specificity phosphatase 18
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DUSP18 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:83,013,850...83,035,168
Ensembl chr14:83,011,014...83,056,929
|
|
| G
|
Dusp3
|
dual specificity phosphatase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DUSP3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063
|
|
| G
|
Dusp7
|
dual specificity phosphatase 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DUSP7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:115,887,892...115,895,126
|
|
| G
|
Dvl1
|
dishevelled segment polarity protein 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of DVL1 mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966
|
|
| G
|
Dvl2
|
dishevelled segment polarity protein 2
|
affects expression
|
EXP
|
Diazinon affects the expression of DVL2 mRNA
|
CTD |
PMID:18502319 |
|
NCBI chr10:55,222,245...55,231,506
Ensembl chr10:55,222,056...55,231,506
|
|
| G
|
Dvl3
|
dishevelled segment polarity protein 3
|
affects expression
|
EXP
|
Diazinon affects the expression of DVL3 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr11:93,869,834...93,887,013
Ensembl chr11:93,869,834...93,886,903
|
|
| G
|
Dyrk2
|
dual specificity tyrosine phosphorylation regulated kinase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of DYRK2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942
|
|
| G
|
E2f4
|
E2F transcription factor 4
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of E2F4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:50,084,335...50,091,731
Ensembl chr19:50,084,335...50,091,834
|
|
| G
|
Ech1
|
enoyl-CoA hydratase 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of ECH1 protein
|
CTD |
PMID:26721910 |
|
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
|
|
| G
|
Edc4
|
enhancer of mRNA decapping 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EDC4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:50,683,924...50,695,916
Ensembl chr19:50,683,897...50,697,620
|
|
| G
|
Edf1
|
endothelial differentiation-related factor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EDF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,764,906...28,779,499
|
|
| G
|
Edn3
|
endothelin 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EDN3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329
|
|
| G
|
Eef2k
|
eukaryotic elongation factor-2 kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EEF2K gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:184,824,420...184,888,048
Ensembl chr 1:184,824,420...184,888,048
|
|
| G
|
Efhd2
|
EF-hand domain family, member D2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EFHD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:159,443,960...159,460,369
|
|
| G
|
Efna1
|
ephrin A1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EFNA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
|
|
| G
|
Efna2
|
ephrin A2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EFNA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,167,091...10,177,719
Ensembl chr 7:10,167,091...10,177,719
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
affects expression
|
EXP
|
Diazinon affects the expression of EGFR mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of EGLN3 mRNA Diazinon results in increased methylation of EGLN3 gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
|
|
| G
|
Egr1
|
early growth response 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EGR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Ehd1
|
EH-domain containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EHD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:213,008,049...213,031,485
|
|
| G
|
Ehd2
|
EH-domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EHD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943
|
|
| G
|
Eif2ak2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EIF2AK2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116
|
|
| G
|
Eif3a
|
eukaryotic translation initiation factor 3, subunit A
|
increases expression
|
EXP
|
Diazinon results in increased expression of EIF3A mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
|
|
| G
|
Eif3k
|
eukaryotic translation initiation factor 3, subunit K
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EIF3K gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:93,387,628...93,397,551
Ensembl chr 1:93,387,628...93,397,802
|
|
| G
|
Eif5a
|
eukaryotic translation initiation factor 5A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EIF5A gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330
|
|
| G
|
Elk3
|
ETS transcription factor ELK3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ELK3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:29,655,676...29,718,163
Ensembl chr 7:29,655,693...29,691,661
|
|
| G
|
Ell
|
elongation factor for RNA polymerase II
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ELL gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:18,877,751...18,925,449
Ensembl chr16:18,877,751...18,925,076
|
|
| G
|
Elovl1
|
ELOVL fatty acid elongase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ELOVL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352
|
|
| G
|
Emsy
|
EMSY transcriptional repressor, BRCA2 interacting
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EMSY gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:162,295,167...162,364,742
Ensembl chr 1:162,295,169...162,364,707
|
|
| G
|
Eno1
|
enolase 1
|
increases expression increases methylation
|
ISO
|
Diazinon results in increased expression of ENO1 protein Diazinon results in increased methylation of ENO1 gene
|
CTD |
PMID:19647006 PMID:22964155 |
|
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
|
|
| G
|
Eno3
|
enolase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ENO3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540
|
|
| G
|
Entrep3
|
endosomal transmembrane epsin interactor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ENTREP3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:176,887,135...176,893,047
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EPAS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Epha10
|
EPH receptor A10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EPHA10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:142,424,260...142,460,305
Ensembl chr 5:142,424,296...142,460,305
|
|
| G
|
Ephx1
|
epoxide hydrolase 1
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of EPHX1 mRNA
|
CTD |
PMID:17311802 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
|
|
| G
|
Erbb3
|
erb-b2 receptor tyrosine kinase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of ERBB3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
|
|
| G
|
Ercc5
|
ERCC excision repair 5, endonuclease
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of ERCC5 mRNA
|
CTD |
PMID:16539210 |
|
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084
|
|
| G
|
Ergic3
|
ERGIC and golgi 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ERGIC3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:164,985,108...164,994,897
Ensembl chr 3:164,984,853...164,994,897
|
|
| G
|
Eri1
|
exoribonuclease 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ERI1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:63,427,412...63,447,521
Ensembl chr16:63,427,403...63,447,896
|
|
| G
|
Erlin2
|
ER lipid raft associated 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ERLIN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:71,720,486...71,736,999
Ensembl chr16:71,721,364...71,736,503
|
|
| G
|
Erp29
|
endoplasmic reticulum protein 29
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ERP29 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010
|
|
| G
|
Espl1
|
extra spindle pole bodies like 1, separase
|
affects expression
|
EXP
|
Diazinon affects the expression of ESPL1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570
|
|
| G
|
Esr1
|
estrogen receptor 1
|
decreases activity affects binding increases activity
|
ISO
|
Diazinon results in decreased activity of ESR1 protein Diazinon binds to ESR1 protein Diazinon results in increased activity of ESR1 protein
|
CTD |
PMID:22562034 PMID:28728110 PMID:33872936 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esrra
|
estrogen related receptor, alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ESRRA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811
|
|
| G
|
Esyt1
|
extended synaptotagmin 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ESYT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:1,513,381...1,530,836
Ensembl chr 7:1,513,381...1,530,732
|
|
| G
|
Ets1
|
ETS proto-oncogene 1, transcription factor
|
affects expression
|
EXP
|
Diazinon affects the expression of ETS1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
|
|
| G
|
Ets2
|
ETS proto-oncogene 2, transcription factor
|
affects expression
|
EXP
|
Diazinon affects the expression of ETS2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842
|
|
| G
|
Etv1
|
ETS variant transcription factor 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of ETV1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 6:61,316,836...61,408,985
Ensembl chr 6:61,317,429...61,408,959
|
|
| G
|
Exosc4
|
exosome component 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of EXOSC4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:109,928,491...109,931,233
Ensembl chr 7:109,928,498...109,931,820
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of F3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
F5
|
coagulation factor V
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of F5 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
Faah
|
fatty acid amide hydrolase
|
decreases activity
|
ISO
|
Diazinon results in decreased activity of FAAH protein
|
CTD |
PMID:11350214 |
|
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:134,716,545...134,735,396
|
|
| G
|
Faap20
|
FA core complex associated protein 20
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FAAP20 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:171,083,328...171,097,599
Ensembl chr 5:171,087,847...171,097,599
|
|
| G
|
Fadd
|
Fas associated via death domain
|
decreases expression multiple interactions
|
ISO
|
Diazinon results in decreased expression of FADD mRNA [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FADD mRNA]; Magnesium Oxide promotes the reaction [Diazinon results in decreased expression of FADD mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of FADD mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Faf1
|
Fas associated factor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of FAF1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:129,654,677...130,018,604
Ensembl chr 5:129,654,445...130,020,516
|
|
| G
|
Faim
|
Fas apoptotic inhibitory molecule
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FAIM gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:108,423,259...108,445,365
Ensembl chr 8:108,423,221...108,440,151
|
|
| G
|
Fam118a
|
family with sequence similarity 118, member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FAM118A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:118,032,313...118,058,888
Ensembl chr 7:118,032,444...118,058,887
|
|
| G
|
Fam124a
|
family with sequence similarity 124 member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FAM124A gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:40,975,789...41,031,069
Ensembl chr15:40,975,877...41,029,628
|
|
| G
|
Fam167a
|
family with sequence similarity 167, member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FAM167A gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:41,861,271...41,891,427
Ensembl chr15:41,861,227...41,891,418
|
|
| G
|
Fam83a
|
family with sequence similarity 83, member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FAM83A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:91,412,366...91,436,819
Ensembl chr 7:91,412,366...91,436,910
|
|
| G
|
Fance
|
FA complementation group E
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FANCE gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:6,371,153...6,388,366
Ensembl chr20:6,377,234...6,388,365
|
|
| G
|
Farp2
|
FERM, ARH/RhoGEF and pleckstrin domain protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FARP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:101,501,061...101,609,092
Ensembl chr 9:101,501,102...101,609,086
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
increases expression multiple interactions affects expression
|
ISO EXP
|
Diazinon results in increased expression of FAS mRNA Fulvestrant inhibits the reaction [Diazinon results in increased expression of FAS mRNA] Diazinon affects the expression of FAS mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of FAS mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of FAS mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of FAS mRNA]
|
CTD |
PMID:22546817 PMID:27920530 PMID:33872936 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
decreases expression multiple interactions
|
ISO
|
Diazinon results in decreased expression of FASLG mRNA [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fasn
|
fatty acid synthase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FASN gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fastk
|
Fas-activated serine/threonine kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FASTK gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:11,624,689...11,629,867
|
|
| G
|
Fat2
|
FAT atypical cadherin 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of FAT2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr10:39,864,765...39,957,027
Ensembl chr10:39,864,766...39,956,902
|
|
| G
|
Fbxl14
|
F-box and leucine-rich repeat protein 14
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FBXL14 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:154,334,820...154,338,638
Ensembl chr 4:154,334,092...154,377,959
|
|
| G
|
Fbxo2
|
F-box protein 2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of FBXO2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:163,875,757...163,881,508
|
|
| G
|
Fbxo3
|
F-box protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FBXO3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:110,872,185...110,904,479
Ensembl chr 3:110,872,220...110,904,479
|
|
| G
|
Fbxo30
|
F-box protein 30
|
increases expression
|
ISO
|
Diazinon results in increased expression of FBXO30 mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:7,475,575...7,493,199
|
|
| G
|
Fbxo32
|
F-box protein 32
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FBXO32 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491
|
|
| G
|
Fbxo5
|
F-box protein 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FBXO5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781
|
|
| G
|
Fbxw5
|
F-box and WD repeat domain containing 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FBXW5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:28,720,778...28,725,235
|
|
| G
|
Fchsd2
|
FCH and double SH3 domains 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FCHSD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:164,775,916...165,097,391
Ensembl chr 1:164,775,926...165,097,391
|
|
| G
|
Fech
|
ferrochelatase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FECH gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546
|
|
| G
|
Fen1
|
flap structure-specific endonuclease 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FEN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016
|
|
| G
|
Fermt2
|
FERM domain containing kindlin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FERMT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
decreases expression increases methylation affects expression
|
EXP ISO
|
Diazinon results in decreased expression of FGF1 mRNA Diazinon results in increased methylation of FGF1 gene Diazinon affects the expression of FGF1 mRNA
|
CTD |
PMID:19130878 PMID:22546817 PMID:22964155 |
|
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Fgf12
|
fibroblast growth factor 12
|
affects expression
|
EXP
|
Diazinon affects the expression of FGF12 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543
|
|
| G
|
Fgf14
|
fibroblast growth factor 14
|
affects expression
|
EXP
|
Diazinon affects the expression of FGF14 mRNA
|
CTD |
PMID:17589599 |
|
NCBI chr15:107,442,800...108,086,486
Ensembl chr15:107,451,634...108,085,808
|
|
| G
|
Fgf16
|
fibroblast growth factor 16
|
affects expression
|
EXP
|
Diazinon affects the expression of FGF16 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr X:74,882,863...74,893,598
Ensembl chr X:74,882,995...74,944,246
|
|
| G
|
Fgf17
|
fibroblast growth factor 17
|
decreases expression increases methylation
|
EXP ISO
|
Diazinon results in decreased expression of FGF17 mRNA Diazinon results in increased methylation of FGF17 gene
|
CTD |
PMID:19130878 PMID:22964155 |
|
NCBI chr15:52,118,141...52,132,083
Ensembl chr15:52,121,191...52,132,016
|
|
| G
|
Fgf19
|
fibroblast growth factor 19
|
affects expression
|
EXP
|
Diazinon affects the expression of FGF15 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
decreases expression affects expression
|
EXP ISO
|
Diazinon results in decreased expression of FGF2 mRNA Diazinon affects the expression of FGF2 mRNA
|
CTD |
PMID:17589599 PMID:19130878 PMID:22546817 PMID:35934178 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgf20
|
fibroblast growth factor 20
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of FGF20 mRNA
|
CTD |
PMID:17589599 |
|
NCBI chr16:58,734,003...58,741,650
Ensembl chr16:58,734,003...58,741,627
|
|
| G
|
Fgf21
|
fibroblast growth factor 21
|
affects expression
|
EXP
|
Diazinon affects the expression of FGF21 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
|
|
| G
|
Fgf22
|
fibroblast growth factor 22
|
decreases expression increases methylation
|
EXP ISO
|
Diazinon results in decreased expression of FGF22 mRNA Diazinon results in increased methylation of FGF22 gene
|
CTD |
PMID:17589599 PMID:22964155 |
|
NCBI chr 7:10,598,254...10,600,945
Ensembl chr 7:10,597,538...10,600,945
|
|
| G
|
Fgf23
|
fibroblast growth factor 23
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of FGF23 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 4:161,600,439...161,609,991
Ensembl chr 4:161,600,383...161,609,991
|
|
| G
|
Fgf9
|
fibroblast growth factor 9
|
affects expression
|
EXP
|
Diazinon affects the expression of FGF9 mRNA
|
CTD |
PMID:19130878 PMID:22546817 |
|
NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of FGFR1 mRNA Diazinon results in increased expression of FGFR1 mRNA
|
CTD |
PMID:17589599 PMID:19130878 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fgfr3
|
fibroblast growth factor receptor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FGFR3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209
|
|
| G
|
Fgfr4
|
fibroblast growth factor receptor 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of FGFR4 mRNA
|
CTD |
PMID:17589599 PMID:19130878 |
|
NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,466,692...9,481,389
|
|
| G
|
Fhl3
|
four and a half LIM domains 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FHL3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:142,238,634...142,246,011
Ensembl chr 5:142,235,109...142,246,034
|
|
| G
|
Fibcd1
|
fibrinogen C domain containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FIBCD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:35,490,459...35,524,142
Ensembl chr 3:35,490,459...35,524,142
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
affects expression
|
EXP
|
Diazinon affects the expression of FIS1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Flii
|
FLII, actin remodeling protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FLII gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:45,893,566...45,907,547
Ensembl chr10:45,893,572...45,907,491
|
|
| G
|
Flot2
|
flotillin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FLOT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:63,424,084...63,445,811
Ensembl chr10:63,423,806...63,445,810
|
|
| G
|
Flt3lg
|
Fms related receptor tyrosine kinase 3 ligand
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FLT3LG gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:104,751,518...104,756,925
Ensembl chr 1:104,749,983...104,757,038
|
|
| G
|
Fn1
|
fibronectin 1
|
decreases expression multiple interactions
|
EXP
|
Diazinon results in decreased expression of FN1 protein Thioctic Acid inhibits the reaction [Diazinon results in decreased expression of FN1 protein]
|
CTD |
PMID:32911022 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fndc11
|
fibronectin type III domain containing 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FNDC11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,708,045...188,710,670
Ensembl chr 3:188,707,334...188,714,164
|
|
| G
|
Fnta
|
farnesyltransferase, CAAX box, subunit alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FNTA gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:72,767,864...72,786,193
Ensembl chr16:72,767,627...72,788,229
|
|
| G
|
Folr1
|
folate receptor alpha
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of FOLR1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669
|
|
| G
|
Foxi1
|
forkhead box I1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FOXI1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:19,310,466...19,314,405
Ensembl chr10:19,310,482...19,314,405
|
|
| G
|
Foxm1
|
forkhead box M1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FOXM1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172
|
|
| G
|
Foxo1
|
forkhead box O1
|
multiple interactions increases expression
|
EXP
|
[Dietary Fats co-treated with Diazinon] results in increased expression of FOXO1 mRNA; Resveratrol inhibits the reaction [Diazinon results in increased expression of FOXO1 mRNA]
|
CTD |
PMID:30359674 PMID:35403302 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Foxo3
|
forkhead box O3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FOXO3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Foxp2
|
forkhead box P2
|
increases expression
|
EXP
|
Diazinon results in increased expression of FOXP2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 4:44,099,848...44,677,700
Ensembl chr 4:44,099,959...44,677,696
|
|
| G
|
Foxp3
|
forkhead box P3
|
multiple interactions decreases expression
|
ISO
|
chrysin inhibits the reaction [Diazinon results in decreased expression of FOXP3 mRNA]
|
CTD |
PMID:36114367 |
|
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:17,580,380...17,595,894
|
|
| G
|
Fscn1
|
fascin actin-bundling protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FSCN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
|
|
| G
|
Fuom
|
fucose mutarotase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FUOM gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:204,318,180...204,322,690
Ensembl chr 1:204,316,354...204,322,690
|
|
| G
|
Fus
|
Fus RNA binding protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of FUS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
|
|
| G
|
Fv1
|
Friend virus susceptibility 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of C19ORF48P gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:103,867,358...103,873,336
Ensembl chr 1:103,867,373...103,873,342
|
|
| G
|
Fyn
|
FYN proto-oncogene, Src family tyrosine kinase
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of FYN mRNA Diazinon results in increased methylation of FYN gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479
|
|
| G
|
Fzd1
|
frizzled class receptor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of FZD1 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176
|
|
| G
|
Fzd3
|
frizzled class receptor 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of FZD3 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr15:43,596,962...43,664,047
Ensembl chr15:43,596,965...43,663,960
|
|
| G
|
Fzd4
|
frizzled class receptor 4
|
affects expression
|
EXP
|
Diazinon affects the expression of FZD4 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 1:152,692,507...152,701,372
Ensembl chr 1:152,692,507...152,701,372
|
|
| G
|
Fzd5
|
frizzled class receptor 5
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of FZD5 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612
|
|
| G
|
Fzd6
|
frizzled class receptor 6
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of FZD6 mRNA Diazinon affects the expression of FZD6 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 7:71,939,916...71,971,685
Ensembl chr 7:71,939,973...71,971,680
|
|
| G
|
Fzd7
|
frizzled class receptor 7
|
affects expression
|
EXP
|
Diazinon affects the expression of FZD7 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585
|
|
| G
|
Fzd9
|
frizzled class receptor 9
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of FZD9 mRNA Diazinon results in decreased expression of FZD9 mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr12:27,063,640...27,065,954
Ensembl chr12:27,063,415...27,074,485
|
|
| G
|
Fzr1
|
fizzy and cell division cycle 20 related 1
|
decreases methylation decreases expression affects expression
|
ISO EXP
|
Diazinon results in decreased methylation of FZR1 gene Diazinon results in decreased expression of FZR1 mRNA Diazinon affects the expression of FZR1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 PMID:29108742 |
|
NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,989,769...8,995,199
|
|
| G
|
G3bp1
|
G3BP stress granule assembly factor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of G3BP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
affects expression
|
EXP
|
Diazinon affects the expression of G6PD mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gabbr2
|
gamma-aminobutyric acid type B receptor subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GABBR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
affects binding
|
ISO
|
Diazinon binds to [GAD1 protein binds to Pyridoxal Phosphate]; Diazinon binds to GAD1 protein
|
CTD |
PMID:35151785 |
|
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gad2
|
glutamate decarboxylase 2
|
affects binding
|
ISO
|
Diazinon binds to [GAD2 protein binds to Pyridoxal Phosphate]; Diazinon binds to GAD2 protein
|
CTD |
PMID:35151785 |
|
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
affects expression
|
EXP
|
Diazinon affects the expression of GADD45A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma
|
affects expression
|
EXP
|
Diazinon affects the expression of GADD45G mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369
|
|
| G
|
Gak
|
cyclin G associated kinase
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GAK mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr14:1,234,272...1,308,492
Ensembl chr14:1,234,266...1,323,974
|
|
| G
|
Galk1
|
galactokinase 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of GALK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258
|
|
| G
|
Galns
|
galactosamine (N-acetyl)-6-sulfatase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GALNS gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:67,537,175...67,570,900
Ensembl chr19:67,534,737...67,571,191
|
|
| G
|
Galnt18
|
polypeptide N-acetylgalactosaminyltransferase 18
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GALNT18 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:175,027,832...175,338,883
Ensembl chr 1:175,027,839...175,338,883
|
|
| G
|
Galt
|
galactose-1-phosphate uridylyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GALT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:61,722,871...61,726,128
Ensembl chr 5:61,722,466...61,726,125
|
|
| G
|
Gap43
|
growth associated protein 43
|
increases expression
|
EXP
|
Diazinon results in increased expression of GAP43 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
affects expression
|
EXP
|
Diazinon affects the expression of GAPDH mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Garnl3
|
GTPase activating Rap/RanGAP domain-like 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of GARNL3 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 3:36,686,388...36,830,011
Ensembl chr 3:36,686,389...36,830,020
|
|
| G
|
Gas2l1
|
growth arrest-specific 2 like 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GAS2L1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:84,169,398...84,175,514
Ensembl chr14:84,169,398...84,175,514
|
|
| G
|
Gas6
|
growth arrest specific 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GAS6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088
|
|
| G
|
Gata3
|
GATA binding protein 3
|
multiple interactions increases expression
|
ISO
|
chrysin inhibits the reaction [Diazinon results in increased expression of GATA3 mRNA]
|
CTD |
PMID:36114367 |
|
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
|
|
| G
|
Gata5
|
GATA binding protein 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GATA5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:187,796,140...187,804,327
Ensembl chr 3:187,796,142...187,804,327
|
|
| G
|
Gata6
|
GATA binding protein 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GATA6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322
|
|
| G
|
Gatd1
|
glutamine amidotransferase class 1 domain containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GATD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:205,936,189...205,942,121
Ensembl chr 1:205,936,687...205,942,779
|
|
| G
|
Gba2
|
glucosylceramidase beta 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GBA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:62,618,176...62,630,160
Ensembl chr 5:62,618,177...62,630,308
|
|
| G
|
Gcat
|
glycine C-acetyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GCAT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664
|
|
| G
|
Gcfc2
|
GC-rich sequence DNA-binding factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GCFC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:116,039,432...116,076,330
Ensembl chr 4:116,039,433...116,077,152
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of GCH1 gene Diazinon affects the expression of GCH1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
increases expression
|
ISO
|
Diazinon results in increased expression of GCLC mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
increases expression
|
ISO
|
Diazinon results in increased expression of GCLM mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gcnt2
|
glucosaminyl (N-acetyl) transferase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GCNT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:24,002,592...24,107,339
Ensembl chr17:24,002,597...24,106,989
|
|
| G
|
Gcnt3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
increases expression
|
ISO
|
Diazinon results in increased expression of GCNT3 mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595
|
|
| G
|
Gdf5
|
growth differentiation factor 5
|
affects expression
|
EXP
|
Diazinon affects the expression of GDF5 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:164,914,401...164,918,593
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
affects expression
|
EXP
|
Diazinon affects the expression of GFAP mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gfod2
|
Gfo/Idh/MocA-like oxidoreductase domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GFOD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:50,508,626...50,556,945
Ensembl chr19:50,513,709...50,557,132
|
|
| G
|
Gfra2
|
GDNF family receptor alpha 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of GFRA2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr15:52,351,499...52,443,369
Ensembl chr15:52,351,514...52,477,782
|
|
| G
|
Gfus
|
GDP-L-fucose synthase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GFUS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:109,492,808...109,497,719
Ensembl chr 7:109,492,809...109,497,662
|
|
| G
|
Git1
|
GIT ArfGAP 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GIT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:62,840,165...62,854,508
Ensembl chr10:62,840,394...62,854,508
|
|
| G
|
Gjb4
|
gap junction protein, beta 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GJB4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:144,948,231...144,964,014
Ensembl chr 5:144,951,184...144,964,097
|
|
| G
|
Gli4
|
GLI family zinc finger 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GLI4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:109,205,812...109,211,650
Ensembl chr 7:109,205,953...109,211,648
|
|
| G
|
Glrx3
|
glutaredoxin 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GLRX3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717
|
|
| G
|
Gls
|
glutaminase
|
increases expression
|
EXP
|
Diazinon results in increased expression of GLS mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861
|
|
| G
|
Glyr1
|
glyoxylate reductase 1 homolog
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GLYR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:11,038,577...11,074,093
Ensembl chr10:11,038,568...11,074,090
|
|
| G
|
Gmds
|
GDP-mannose 4, 6-dehydratase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GMDS gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:32,304,029...32,830,708
Ensembl chr17:32,304,056...32,830,706
|
|
| G
|
Gmfb
|
glia maturation factor, beta
|
affects expression
|
EXP
|
Diazinon affects the expression of GMFB mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr15:22,549,705...22,560,125
Ensembl chr15:22,547,034...22,560,308
|
|
| G
|
Gmip
|
Gem-interacting protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GMIP gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:19,634,630...19,648,916
Ensembl chr16:19,634,630...19,647,933
|
|
| G
|
Gmppb
|
GDP-mannose pyrophosphorylase B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GMPPB gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,616,029...117,622,866
|
|
| G
|
Gna11
|
G protein subunit alpha 11
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GNA11 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558
|
|
| G
|
Gna12
|
G protein subunit alpha 12
|
affects expression
|
EXP
|
Diazinon affects the expression of GNA12 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185
|
|
| G
|
Gna13
|
G protein subunit alpha 13
|
affects expression
|
EXP
|
Diazinon affects the expression of GNA13 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr10:94,837,271...94,870,290
Ensembl chr10:94,836,444...94,874,968
|
|
| G
|
Gna14
|
G protein subunit alpha 14
|
affects expression
|
EXP
|
Diazinon affects the expression of GNA14 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
affects expression
|
EXP
|
Diazinon affects the expression of GNAI2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
| G
|
Gnai3
|
G protein subunit alpha i3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GNAI3 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:198,430,920...198,468,874
|
|
| G
|
Gnao1
|
G protein subunit alpha o1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GNAO1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,040,788...11,198,437
|
|
| G
|
Gnaq
|
G protein subunit alpha q
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of GNAQ mRNA Diazinon affects the expression of GNAQ mRNA
|
CTD |
PMID:17452286 PMID:22546817 |
|
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742
|
|
| G
|
Gnat1
|
G protein subunit alpha transducin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of GNAT1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:117,229,575...117,234,311
Ensembl chr 8:117,229,575...117,234,311
|
|
| G
|
Gnaz
|
G protein subunit alpha z
|
affects expression
|
EXP
|
Diazinon affects the expression of GNAZ mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr20:13,642,853...13,693,616
Ensembl chr20:13,644,020...13,669,287
|
|
| G
|
Gnb1
|
G protein subunit beta 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GNB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488
|
|
| G
|
Gnb5
|
G protein subunit beta 5
|
affects expression
|
EXP
|
Diazinon affects the expression of GNB5 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:84,956,629...84,985,576
Ensembl chr 8:84,953,815...84,986,888
|
|
| G
|
Gng12
|
G protein subunit gamma 12
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GNG12 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
|
|
| G
|
Gnl3l
|
G protein nucleolar 3 like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GNL3L gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:23,404,324...23,437,501
Ensembl chr X:23,404,324...23,439,315
|
|
| G
|
Gnpnat1
|
glucosamine-phosphate N-acetyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GNPNAT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:21,076,129...21,088,526
Ensembl chr15:21,076,130...21,088,423
|
|
| G
|
Gpat3
|
glycerol-3-phosphate acyltransferase 3
|
increases expression
|
ISO
|
Diazinon results in increased expression of GPAT3 mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr14:9,018,762...9,072,552
|
|
| G
|
Gpc1
|
glypican 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GPC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933
|
|
| G
|
Gpi
|
glucose-6-phosphate isomerase
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of GPI gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
|
|
| G
|
Gpr17
|
G protein-coupled receptor 17
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of GPR17 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702
|
|
| G
|
Gpr35
|
G protein-coupled receptor 35
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GPR35 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:100,974,580...100,995,330
Ensembl chr 9:100,962,538...100,986,985
|
|
| G
|
Gprc5b
|
G protein-coupled receptor, class C, group 5, member B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GPRC5B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757
|
|
| G
|
Gpsm1
|
G-protein signaling modulator 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of GPSM1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:29,526,802...29,565,920
|
|
| G
|
Gpsm3
|
G-protein signaling modulator 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GPSM3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,161,730...4,189,072
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases expression
|
EXP
|
Resveratrol inhibits the reaction [Diazinon results in increased expression of GPT protein]
|
CTD |
PMID:35403302 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpt2
|
glutamic--pyruvic transaminase 2
|
increases expression increases methylation
|
ISO
|
Diazinon results in increased expression of GPT2 mRNA Diazinon results in increased methylation of GPT2 gene
|
CTD |
PMID:22964155 PMID:24356939 |
|
NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
increases expression affects expression decreases expression
|
EXP
|
Diazinon results in increased expression of GPX1 mRNA Diazinon affects the expression of GPX1 mRNA Diazinon results in decreased expression of GPX1 mRNA
|
CTD |
PMID:19440498 PMID:22546817 PMID:29383019 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx2
|
glutathione peroxidase 2
|
affects expression increases expression
|
EXP
|
Diazinon affects the expression of GPX2 mRNA Diazinon results in increased expression of GPX2 mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of GPX3 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
affects expression
|
EXP
|
Diazinon affects the expression of GPX4 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gpx6
|
glutathione peroxidase 6
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GPX6 mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr17:48,104,197...48,111,816
Ensembl chr17:48,104,197...48,111,007
|
|
| G
|
Gpx7
|
glutathione peroxidase 7
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GPX7 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725
|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of GRIA1 mRNA Diazinon results in increased expression of GRIA1 mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GRIA2 mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Gria4
|
glutamate ionotropic receptor AMPA type subunit 4
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GRIA4 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:9,847,052...10,319,881
|
|
| G
|
Grik2
|
glutamate ionotropic receptor kainate type subunit 2
|
affects expression
|
EXP
|
Diazinon affects the expression of GRIK2 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202
|
|
| G
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GRIK3 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873
|
|
| G
|
Grik4
|
glutamate ionotropic receptor kainate type subunit 4
|
affects expression
|
EXP
|
Diazinon affects the expression of GRIK4 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 8:51,802,045...52,228,751
Ensembl chr 8:51,802,058...52,102,063
|
|
| G
|
Grik5
|
glutamate ionotropic receptor kainate type subunit 5
|
affects expression
|
EXP
|
Diazinon affects the expression of GRIK5 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 1:89,733,736...89,795,769
Ensembl chr 1:89,733,741...89,794,962
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of GRIN1 mRNA
|
CTD |
PMID:23212306 |
|
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
affects expression increases expression
|
EXP
|
Diazinon affects the expression of GRIN2A mRNA Diazinon results in increased expression of GRIN2A mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
decreases expression
|
ISO EXP
|
Diazinon results in decreased expression of GRIN2B mRNA
|
CTD |
PMID:19440498 PMID:23212306 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Grin2c
|
glutamate ionotropic receptor NMDA type subunit 2C
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRIN2C mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr10:100,987,410...101,006,064
Ensembl chr10:100,987,513...101,005,409
|
|
| G
|
Grin2d
|
glutamate ionotropic receptor NMDA type subunit 2D
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GRIN2D mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 1:105,443,317...105,483,400
Ensembl chr 1:105,444,813...105,481,236
|
|
| G
|
Grina
|
glutamate ionotropic receptor NMDA type subunit associated protein 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRINA mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042
|
|
| G
|
Grk1
|
G protein-coupled receptor kinase 1
|
affects expression
|
EXP
|
Diazinon affects the expression of GRK1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr16:82,821,184...82,837,971
Ensembl chr16:82,826,022...82,837,971
|
|
| G
|
Grk3
|
G protein-coupled receptor kinase 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRK3 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr12:49,285,228...49,395,803
Ensembl chr12:49,285,263...49,395,802
|
|
| G
|
Grm1
|
glutamate metabotropic receptor 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRM1 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443
|
|
| G
|
Grm2
|
glutamate metabotropic receptor 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRM2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:116,158,810...116,171,857
|
|
| G
|
Grm3
|
glutamate metabotropic receptor 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GRM3 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:25,319,942...25,564,764
|
|
| G
|
Grm4
|
glutamate metabotropic receptor 4
|
affects expression
|
EXP
|
Diazinon affects the expression of GRM4 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr20:5,486,024...5,574,668
Ensembl chr20:5,482,977...5,574,668
|
|
| G
|
Grm6
|
glutamate metabotropic receptor 6
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRM6 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr10:35,669,003...35,683,729
Ensembl chr10:35,669,003...35,683,729
|
|
| G
|
Grm7
|
glutamate metabotropic receptor 7
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRM7 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:145,286,714...146,169,099
Ensembl chr 4:145,286,924...146,169,201
|
|
| G
|
Grm8
|
glutamate metabotropic receptor 8
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GRM8 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:56,770,771...57,687,639
|
|
| G
|
Grp
|
gastrin releasing peptide
|
increases expression
|
EXP
|
Diazinon results in increased expression of GRP mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037
|
|
| G
|
Gse1
|
Gse1 coiled-coil protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GSE1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:65,182,678...65,538,183
Ensembl chr19:65,446,263...65,538,176
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
multiple interactions affects expression
|
ISO EXP
|
[alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] affects the phosphorylation of GSK3B protein Diazinon affects the expression of GSK3B mRNA
|
CTD |
PMID:19883720 PMID:22546817 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
affects expression
|
EXP
|
Diazinon affects the expression of GSR mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gsta2
|
glutathione S-transferase alpha 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GSTA2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
| G
|
Gsta3
|
glutathione S-transferase alpha 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GSTA3 protein
|
CTD |
PMID:26721910 |
|
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654
|
|
| G
|
Gsta4
|
glutathione S-transferase alpha 4
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of GSTA4 mRNA Diazinon results in increased expression of GSTA4 mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488
|
|
| G
|
Gsta5
|
glutathione S-transferase alpha 5
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of GSTA5 mRNA Diazinon results in increased expression of GSTA5 mRNA
|
CTD |
PMID:17452286 PMID:19440498 |
|
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765
|
|
| G
|
Gstk1
|
glutathione S-transferase kappa 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GSTK1 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of GSTM1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstm2
|
glutathione S-transferase mu 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of GSTM2 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
| G
|
Gstm4
|
glutathione S-transferase mu 4
|
increases expression increases methylation
|
EXP ISO
|
Diazinon results in increased expression of GSTM4 mRNA Diazinon results in increased methylation of GSTM4 gene
|
CTD |
PMID:17452286 PMID:19440498 PMID:22964155 |
|
NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:198,358,744...198,373,638
|
|
| G
|
Gstm5
|
glutathione S-transferase, mu 5
|
increases methylation decreases expression
|
ISO EXP
|
Diazinon results in increased methylation of GSTM3 gene Diazinon results in decreased expression of GSTM3 mRNA
|
CTD |
PMID:17452286 PMID:19440498 PMID:22964155 |
|
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731
|
|
| G
|
Gstm5l
|
glutathione S-transferase, mu 5-like
|
increases expression
|
EXP
|
Diazinon results in increased expression of GSTM5 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:198,231,285...198,238,122
Ensembl chr 2:198,232,596...198,238,252
|
|
| G
|
Gsto1
|
glutathione S-transferase omega 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of GSTO1 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
|
|
| G
|
Gsto2
|
glutathione S-transferase omega 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GSTO2 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 1:256,673,376...256,695,154
Ensembl chr 1:256,673,274...256,695,146
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
affects expression
|
EXP
|
Diazinon affects the expression of GSTP2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of GSTT1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gstt2
|
glutathione S-transferase theta 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of GSTT2 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr20:12,819,053...12,822,724
Ensembl chr20:12,818,540...12,822,718
|
|
| G
|
Gstt3
|
glutathione S-transferase, theta 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of GSTT3 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr20:12,873,618...12,881,974
Ensembl chr20:12,874,374...12,881,973
|
|
| G
|
Gtf2f1
|
general transcription factor IIF subunit 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GTF2F1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:1,931,033...1,940,197
Ensembl chr 9:1,930,055...1,940,197
|
|
| G
|
Gtf3c1
|
general transcription factor IIIC subunit 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of GTF3C1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:189,634,645...189,700,995
|
|
| G
|
H2ac18
|
H2A clustered histone 18
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of H2AC18 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:186,497,271...186,497,865
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
[Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in increased expression of H2AX protein
|
CTD |
PMID:34830855 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
H3c1
|
H3 clustered histone 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of H3C1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:41,796,236...41,796,759
Ensembl chr17:41,795,396...41,797,281 Ensembl chr17:41,795,396...41,797,281
|
|
| G
|
Hacd1
|
3-hydroxyacyl-CoA dehydratase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HACD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:81,992,284...82,014,676
Ensembl chr17:81,992,292...82,014,592
|
|
| G
|
Hagh
|
hydroxyacyl glutathione hydrolase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HAGH gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043
|
|
| G
|
Haus1
|
HAUS augmin-like complex, subunit 1
|
affects expression
|
EXP
|
Diazinon affects the expression of HAUS1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr18:73,550,549...73,561,757
Ensembl chr18:73,548,669...73,565,761
|
|
| G
|
Hcfc2
|
host cell factor C2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HCFC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:22,875,440...22,907,391
Ensembl chr 7:22,864,278...22,907,322
|
|
| G
|
Hcn4
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 4
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of HCN4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:68,118,062...68,155,482
Ensembl chr 8:68,118,062...68,155,495
|
|
| G
|
Hdac3
|
histone deacetylase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HDAC3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025
|
|
| G
|
Hdc
|
histidine decarboxylase
|
affects binding
|
ISO
|
Diazinon binds to [HDC protein binds to Pyridoxal Phosphate]; Diazinon binds to HDC protein
|
CTD |
PMID:35151785 |
|
NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711
|
|
| G
|
Hddc3
|
HD domain containing 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HDDC3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:143,708,703...143,711,010
Ensembl chr 1:143,705,320...143,711,010
|
|
| G
|
Helz
|
helicase with zinc finger
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HELZ gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:92,979,039...93,144,868
Ensembl chr10:92,999,733...93,138,075
|
|
| G
|
Hemk1
|
HemK methyltransferase family member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HEMK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:116,878,317...116,889,342
Ensembl chr 8:116,878,318...116,888,873
|
|
| G
|
Henmt1
|
HEN methyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HENMT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:199,258,107...199,291,739
Ensembl chr 2:199,274,480...199,287,822
|
|
| G
|
Hes6
|
hes family bHLH transcription factor 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HES6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
|
|
| G
|
Heyl
|
hes-related family bHLH transcription factor with YRPW motif-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HEYL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:140,793,271...140,810,262
Ensembl chr 5:140,793,271...140,810,262
|
|
| G
|
Hhatl
|
hedgehog acyltransferase-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HHATL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:130,324,510...130,331,580
Ensembl chr 8:130,324,510...130,331,509
|
|
| G
|
Hhex
|
hematopoietically expressed homeobox
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HHEX gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:244,602,945...244,608,532
Ensembl chr 1:244,602,825...244,608,604
|
|
| G
|
Hip1r
|
huntingtin interacting protein 1 related
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of HIP1R mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654
|
|
| G
|
Hmbs
|
hydroxymethylbilane synthase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HMBS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802
|
|
| G
|
Hmgn2
|
high mobility group nucleosomal binding domain 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HMGN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
affects expression increases expression
|
EXP ISO
|
Diazinon affects the expression of HMOX1 mRNA Diazinon results in increased expression of HMOX1 mRNA
|
CTD |
PMID:22546817 PMID:28119078 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnf1b
|
HNF1 homeobox B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HNF1B gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361
|
|
| G
|
Hnrnpa2b1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
increases expression
|
EXP
|
Diazinon results in increased expression of HNRNPA2B1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
|
|
| G
|
Hnrnph1
|
heterogeneous nuclear ribonucleoprotein H1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HNRNPH1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906
|
|
| G
|
Hnrnpl
|
heterogeneous nuclear ribonucleoprotein L
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HNRNPL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:93,235,729...93,239,061
|
|
| G
|
Homer1
|
homer scaffold protein 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of HOMER1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657
|
|
| G
|
Hoxa13
|
homeo box A13
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HOXA13 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:82,689,566...82,691,701
Ensembl chr 4:82,689,566...82,691,701
|
|
| G
|
Hrk
|
harakiri, BCL2 interacting protein
|
affects expression
|
EXP
|
Diazinon affects the expression of HRK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561
|
|
| G
|
Hs3st2
|
heparan sulfate-glucosamine 3-sulfotransferase 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of HS3ST2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:185,387,445...185,508,700
Ensembl chr 1:185,386,761...185,508,700
|
|
| G
|
Hs3st3b1
|
heparan sulfate-glucosamine 3-sulfotransferase 3B1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HS3ST3B1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:49,060,693...49,093,185
Ensembl chr10:49,060,693...49,093,185
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases activity
|
ISO
|
Diazinon results in increased activity of HSF1 protein
|
CTD |
PMID:34170685 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
affects expression
|
EXP
|
Diazinon affects the expression of HSPA1A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
increases expression
|
ISO
|
Diazinon results in increased expression of HSPA1B mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression decreases expression
|
ISO
|
Diazinon results in increased expression of HSPA5 protein Diazinon results in decreased expression of HSPA5 mRNA
|
CTD |
PMID:19647006 PMID:24356939 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa6l-ps1
|
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of HSPA6 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr13:85,805,911...85,807,052
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HSPB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Htr1a
|
5-hydroxytryptamine receptor 1A
|
multiple interactions increases expression
|
EXP
|
Diazinon promotes the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein] Diazinon results in increased expression of HTR1A protein
|
CTD |
PMID:17035140 |
|
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760
|
|
| G
|
Htr1b
|
5-hydroxytryptamine receptor 1B
|
increases expression
|
EXP
|
Diazinon results in increased expression of HTR1B mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
|
|
| G
|
Htr1d
|
5-hydroxytryptamine receptor 1D
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of HTR1D mRNA
|
CTD |
PMID:18835401 |
|
NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012
|
|
| G
|
Htr1f
|
5-hydroxytryptamine receptor 1F
|
affects expression
|
EXP
|
Diazinon affects the expression of HTR1F mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr11:16,089,266...16,090,665
Ensembl chr11:16,081,053...16,274,580
|
|
| G
|
Htr2a
|
5-hydroxytryptamine receptor 2A
|
increases expression multiple interactions
|
EXP
|
Diazinon results in increased expression of HTR2A mRNA; Diazinon results in increased expression of HTR2A protein Diazinon promotes the reaction [Ketanserin binds to HTR2A protein]
|
CTD |
PMID:17035140 PMID:17452286 |
|
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
|
|
| G
|
Htr2b
|
5-hydroxytryptamine receptor 2B
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of HTR2B mRNA
|
CTD |
PMID:18835401 |
|
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087
|
|
| G
|
Htr2c
|
5-hydroxytryptamine receptor 2C
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of HTR2C mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324
|
|
| G
|
Htr3a
|
5-hydroxytryptamine receptor 3A
|
increases expression
|
EXP
|
Diazinon results in increased expression of HTR3A mRNA
|
CTD |
PMID:18835401 |
|
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:58,138,226...58,150,884
|
|
| G
|
Htr3b
|
5-hydroxytryptamine receptor 3B
|
affects expression
|
EXP
|
Diazinon affects the expression of HTR3B mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:58,175,785...58,204,939
Ensembl chr 8:58,175,101...58,204,939
|
|
| G
|
Htr5a
|
5-hydroxytryptamine receptor 5A
|
affects expression
|
EXP
|
Diazinon affects the expression of HTR5A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:8,178,802...8,188,485
Ensembl chr 4:8,178,802...8,200,482
|
|
| G
|
Htr5b
|
5-hydroxytryptamine (serotonin) receptor 5B
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of HTR5B mRNA Diazinon affects the expression of HTR5B mRNA
|
CTD |
PMID:17452286 PMID:29108742 |
|
NCBI chr13:35,239,662...35,252,586
Ensembl chr13:35,239,662...35,252,586
|
|
| G
|
Htr6
|
5-hydroxytryptamine receptor 6
|
affects expression
|
EXP
|
Diazinon affects the expression of HTR6 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:156,579,901...156,595,147
|
|
| G
|
Htr7
|
5-hydroxytryptamine receptor 7
|
affects expression
|
EXP
|
Diazinon affects the expression of HTR7 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:243,049,081...243,173,230
|
|
| G
|
Hyou1
|
hypoxia up-regulated 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of HYOU1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997
|
|
| G
|
Icam2
|
intercellular adhesion molecule 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ICAM2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:91,808,449...91,819,319
Ensembl chr10:91,808,316...91,815,072
|
|
| G
|
Icam5
|
intercellular adhesion molecule 5
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of ICAM5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:27,843,563...27,851,767
Ensembl chr 8:27,844,780...27,857,104
|
|
| G
|
Id2
|
inhibitor of DNA binding 2
|
affects expression
|
EXP
|
Diazinon affects the expression of ID2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
|
|
| G
|
Idh3b
|
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta
|
affects expression
|
EXP
|
Diazinon affects the expression of IDH3B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:137,934,971...137,940,275
Ensembl chr 3:137,934,697...137,940,107
|
|
| G
|
Idh3g
|
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IDH3G gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:156,666,573...156,675,482
Ensembl chr X:156,666,577...156,675,799
|
|
| G
|
Ifitm1
|
interferon induced transmembrane protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of IFITM1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
|
|
| G
|
Ifng
|
interferon gamma
|
affects expression multiple interactions decreases expression
|
ISO
|
Diazinon affects the expression of IFNG protein chrysin inhibits the reaction [Diazinon results in decreased expression of IFNG mRNA]; chrysin inhibits the reaction [Diazinon results in decreased expression of IFNG protein] Diazinon results in decreased expression of IFNG mRNA; Diazinon results in decreased expression of IFNG protein
|
CTD |
PMID:17499902 PMID:19589100 PMID:36114367 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifrd2
|
interferon-related developmental regulator 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IFRD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836
|
|
| G
|
Ift27
|
intraflagellar transport 27
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IFT27 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:111,619,145...111,635,129
Ensembl chr 7:111,619,077...111,634,936
|
|
| G
|
Ift57
|
intraflagellar transport 57
|
affects expression
|
EXP
|
Diazinon affects the expression of IFT57 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:64,528,349...64,593,545
Ensembl chr11:64,528,349...64,593,545
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of IGF1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
affects expression
|
EXP
|
Diazinon affects the expression of IGF2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IGF2BP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:81,405,021...81,447,814
Ensembl chr10:81,404,797...81,447,846
|
|
| G
|
Igfbp6
|
insulin-like growth factor binding protein 6
|
increases expression
|
EXP
|
Diazinon results in increased expression of IGFBP6 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
|
|
| G
|
Ighg1
|
immunoglobulin heavy constant gamma 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IGHG1 gene
|
CTD |
PMID:22964155 |
|
|
|
| G
|
Igsf9
|
immunoglobulin superfamily, member 9
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IGSF9 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:87,480,979...87,497,974
Ensembl chr13:87,481,279...87,497,974
|
|
| G
|
Ikbip
|
IKBKB interacting protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IKBIP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:27,467,097...27,485,776
Ensembl chr 7:27,467,055...27,491,460
|
|
| G
|
Il10
|
interleukin 10
|
affects expression multiple interactions increases expression decreases expression
|
ISO
|
Diazinon affects the expression of IL10 protein chrysin inhibits the reaction [Diazinon results in increased expression of IL10 mRNA] Diazinon results in increased expression of IL10 mRNA; Diazinon results in increased expression of IL10 protein Diazinon results in decreased expression of IL10 mRNA
|
CTD |
PMID:17499902 PMID:36114367 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12a
|
interleukin 12A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IL12A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
|
|
| G
|
Il12b
|
interleukin 12B
|
affects expression decreases expression
|
ISO
|
Diazinon affects the expression of IL12B protein Diazinon results in decreased expression of IL12B mRNA
|
CTD |
PMID:17499902 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il17a
|
interleukin 17A
|
multiple interactions increases expression
|
ISO
|
chrysin inhibits the reaction [Diazinon results in increased expression of IL17A mRNA] Diazinon results in increased expression of IL17A mRNA; Diazinon results in increased expression of IL17A protein
|
CTD |
PMID:36114367 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases expression
|
ISO
|
Diazinon results in increased expression of IL1B mRNA
|
CTD |
PMID:30978295 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il2
|
interleukin 2
|
affects expression decreases expression
|
ISO
|
Diazinon affects the expression of IL2 protein Diazinon results in decreased expression of IL2 mRNA
|
CTD |
PMID:17499902 PMID:35934178 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il4
|
interleukin 4
|
affects expression increases expression multiple interactions decreases expression
|
ISO
|
Diazinon affects the expression of IL4 protein Diazinon results in increased expression of IL4 mRNA; Diazinon results in increased expression of IL4 protein chrysin inhibits the reaction [Diazinon results in increased expression of IL4 mRNA] Diazinon results in decreased expression of IL4 mRNA
|
CTD |
PMID:17499902 PMID:19589100 PMID:35934178 PMID:36114367 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
increases secretion increases expression multiple interactions
|
ISO
|
Diazinon results in increased secretion of IL6 protein Diazinon results in increased expression of IL6 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Diazinon results in increased expression of IL6 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Diazinon results in increased expression of IL6 mRNA]
|
CTD |
PMID:28119078 PMID:35934178 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Ilf3
|
interleukin enhancer binding factor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ILF3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:28,198,543...28,236,612
|
|
| G
|
Inf2
|
inverted formin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of INF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:137,470,259...137,497,039
Ensembl chr 6:137,470,286...137,497,039
|
|
| G
|
Inka1
|
inka box actin regulator 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of INKA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,552,875...117,554,565
Ensembl chr 8:117,552,875...117,554,565
|
|
| G
|
Inpp5b
|
inositol polyphosphate-5-phosphatase B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of INPP5B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:142,281,454...142,345,993
Ensembl chr 5:142,281,418...142,345,991
|
|
| G
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D
|
increases expression
|
EXP
|
Diazinon results in increased expression of INPP5D mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
|
|
| G
|
Inpp5e
|
inositol polyphosphate-5-phosphatase E
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of INPP5E gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:29,614,868...29,627,542
Ensembl chr 3:29,614,868...29,627,542
|
|
| G
|
Ins1
|
insulin 1
|
multiple interactions decreases expression increases expression
|
EXP
|
Diazinon inhibits the reaction [Dietary Fats results in increased expression of INS1 protein]; Resveratrol inhibits the reaction [Diazinon results in increased expression of INS1 protein] Diazinon results in decreased expression of INS1 protein
|
CTD |
PMID:24238291 PMID:30359674 PMID:35403302 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
|
|
| G
|
Ins2
|
insulin 2
|
increases methylation decreases secretion multiple interactions
|
ISO
|
Diazinon results in increased methylation of INS gene Diazinon results in decreased secretion of INS protein; Diazinon results in decreased secretion of INS protein alternative form [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein]; Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased secretion of INS protein]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein]
|
CTD |
PMID:22964155 PMID:27920530 |
|
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
|
|
| G
|
Insrr
|
insulin receptor-related receptor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of INSRR gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:175,553,244...175,572,676
Ensembl chr 2:175,553,293...175,572,676
|
|
| G
|
Ints11
|
integrator complex subunit 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of INTS11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:171,761,370...171,779,883
Ensembl chr 5:171,761,371...171,779,883
|
|
| G
|
Ipcef1
|
interaction protein for cytohesin exchange factors 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of IPCEF1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:45,654,252...45,857,045
Ensembl chr 1:45,662,818...45,856,993
|
|
| G
|
Iqgap2
|
IQ motif containing GTPase activating protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IQGAP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649
|
|
| G
|
Iqsec1
|
IQ motif and Sec7 domain ArfGEF 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IQSEC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:124,725,917...125,045,351
Ensembl chr 4:124,725,917...125,045,550
|
|
| G
|
Irs2
|
insulin receptor substrate 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of IRS2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
|
|
| G
|
Isca1
|
iron-sulfur cluster assembly 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ISCA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,910,795...4,923,476
|
|
| G
|
Iscu
|
iron-sulfur cluster assembly enzyme
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ISCU gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:48,512,852...48,518,696
Ensembl chr12:48,512,852...48,518,696
|
|
| G
|
Isg15
|
ISG15 ubiquitin-like modifier
|
affects expression
|
EXP
|
Diazinon affects the expression of ISG15 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656
|
|
| G
|
Itga11
|
integrin subunit alpha 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ITGA11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:72,041,432...72,150,137
Ensembl chr 8:72,016,652...72,150,137
|
|
| G
|
Itgb2
|
integrin subunit beta 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ITGB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
|
|
| G
|
Itpka
|
inositol-trisphosphate 3-kinase A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ITPKA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:127,179,841...127,188,405
Ensembl chr 3:127,179,808...127,188,414
|
|
| G
|
Itpr2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ITPR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763
|
|
| G
|
Jakmip3
|
janus kinase and microtubule interacting protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of JAKMIP3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:203,182,764...203,310,714
Ensembl chr 1:203,241,125...203,310,713
|
|
| G
|
Jmjd6
|
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
|
affects expression
|
EXP
|
Diazinon affects the expression of JMJD6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986
|
|
| G
|
Jpt2
|
Jupiter microtubule associated homolog 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of JPT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,467,652...14,487,769
Ensembl chr10:14,467,661...14,535,664
|
|
| G
|
Jtb
|
jumping translocation breakpoint
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of JTB gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:177,983,033...177,987,250
Ensembl chr 2:177,982,635...177,987,905
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
affects expression
|
EXP
|
Diazinon affects the expression of JUN mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of JUNB gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Jund
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of JUND gene Diazinon affects the expression of JUND mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148
|
|
| G
|
Katna1
|
katanin catalytic subunit A1
|
affects expression
|
EXP
|
Diazinon affects the expression of KATNA1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:4,022,886...4,064,513
Ensembl chr 1:4,022,876...4,064,512
|
|
| G
|
Kcna1
|
potassium voltage-gated channel subfamily A member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KCNA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:161,150,378...161,160,051
Ensembl chr 4:161,147,418...161,160,044
|
|
| G
|
Kcna2
|
potassium voltage-gated channel subfamily A member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KCNA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:197,392,746...197,406,606
Ensembl chr 2:197,392,698...197,407,519
|
|
| G
|
Kcne2
|
potassium voltage-gated channel subfamily E regulatory subunit 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of KCNE2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr11:45,003,468...45,015,942
Ensembl chr11:45,014,406...45,016,168
|
|
| G
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of KCNJ15 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:48,046,953...48,091,285
Ensembl chr11:48,035,655...48,092,457
|
|
| G
|
Kcnk1
|
potassium two pore domain channel subfamily K member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KCNK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:70,856,985...70,895,053
Ensembl chr19:70,856,985...70,895,051
|
|
| G
|
Kcnk5
|
potassium two pore domain channel subfamily K member 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KCNK5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:4,171,625...4,213,896
Ensembl chr15:4,171,610...4,213,897
|
|
| G
|
Kctd15
|
potassium channel tetramerization domain containing 15
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KCTD15 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:96,395,794...96,411,502
Ensembl chr 1:96,395,794...96,410,631
|
|
| G
|
Kctd8
|
potassium channel tetramerization domain containing 8
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of KCTD8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:39,127,210...39,372,118
Ensembl chr14:39,127,379...39,372,078
|
|
| G
|
Kdelr1
|
KDEL endoplasmic reticulum protein retention receptor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KDELR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:105,483,598...105,494,587
Ensembl chr 1:105,480,967...105,494,600
|
|
| G
|
Kdelr3
|
KDEL endoplasmic reticulum protein retention receptor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KDELR3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,959,632...112,969,858
Ensembl chr 7:112,959,718...112,969,858
|
|
| G
|
Kdm3a
|
lysine demethylase 3A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KDM3A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:105,189,208...105,233,370
|
|
| G
|
Kdm4b
|
lysine demethylase 4B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KDM4B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:1,245,885...1,324,384
Ensembl chr 9:1,245,899...1,324,384
|
|
| G
|
Khsrp
|
KH-type splicing regulatory protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KHSRP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:1,949,557...1,959,400
Ensembl chr 9:1,949,557...1,959,497
|
|
| G
|
Kiaa1191
|
KIAA1191 homolog
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KIAA1191 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:10,054,249...10,066,922
Ensembl chr17:10,054,265...10,067,095
|
|
| G
|
Kif12
|
kinesin family member 12
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of KIF12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:81,611,730...81,620,977
Ensembl chr 5:81,611,734...81,618,369
|
|
| G
|
Kif1c
|
kinesin family member 1C
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KIF1C gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,913,010...55,942,220
Ensembl chr10:55,913,093...55,942,220
|
|
| G
|
Kif20b
|
kinesin family member 20B
|
affects expression
|
EXP
|
Diazinon affects the expression of KIF20B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451
|
|
| G
|
Kiss1
|
KiSS-1 metastasis-suppressor
|
increases methylation multiple interactions
|
ISO
|
Diazinon results in increased methylation of KISS1 gene [[[Environmental Pollutants results in increased abundance of Insecticides] which results in increased abundance of Diazinon] which results in increased abundance of 2-isopropyl-6-methyl-4-pyrimidinol] which results in decreased methylation of KISS1 gene
|
CTD |
PMID:22964155 PMID:36657687 |
|
NCBI chr13:47,327,159...47,332,759
Ensembl chr13:47,327,004...47,332,906
|
|
| G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KIT gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
| G
|
Kitlg
|
KIT ligand
|
increases expression
|
EXP
|
Diazinon results in increased expression of KITLG mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
| G
|
Klc2
|
kinesin light chain 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KLC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:211,843,927...211,854,160
Ensembl chr 1:211,843,929...211,854,160
|
|
| G
|
Klf10
|
KLF transcription factor 10
|
affects expression
|
EXP
|
Diazinon affects the expression of KLF10 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948
|
|
| G
|
Klf15
|
KLF transcription factor 15
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KLF15 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
|
|
| G
|
Klf16
|
KLF transcription factor 16
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KLF16 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:9,789,185...9,799,004
Ensembl chr 7:9,775,042...9,798,999
|
|
| G
|
Klhl22
|
kelch-like family member 22
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of KLHL22 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr11:96,695,168...96,736,079
Ensembl chr11:96,695,171...96,738,065
|
|
| G
|
Klhl24
|
kelch-like family member 24
|
increases expression
|
ISO
|
Diazinon results in increased expression of KLHL24 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050
|
|
| G
|
Klhl4
|
kelch-like family member 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of KLHL4 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr X:83,626,047...83,916,328
Ensembl chr X:83,819,076...83,916,328
|
|
| G
|
Klk15
|
kallikrein-related peptidase 15
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of KLK15 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:103,834,215...103,843,321
Ensembl chr 1:103,834,215...103,843,321
|
|
| G
|
Klk5
|
kallikrein related-peptidase 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KLK5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:103,432,743...103,442,011
Ensembl chr 1:103,433,065...103,441,305
|
|
| G
|
Klk8
|
kallikrein related-peptidase 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KLK8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:103,388,352...103,395,195
Ensembl chr 1:103,388,352...103,395,195
|
|
| G
|
Kmt2a
|
lysine methyltransferase 2A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KMT2A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317
|
|
| G
|
Kndc1
|
kinase non-catalytic C-lobe domain containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KNDC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:204,119,597...204,167,967
Ensembl chr 1:204,119,659...204,167,965
|
|
| G
|
Kri1
|
KRI1 homolog
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KRI1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:28,093,175...28,107,576
Ensembl chr 8:28,093,175...28,107,557
|
|
| G
|
Krt14
|
keratin 14
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KRT14 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:85,638,182...85,642,450
|
|
| G
|
Krt17
|
keratin 17
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KRT17 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:85,679,068...85,683,792
Ensembl chr10:85,679,070...85,683,787
|
|
| G
|
Krt18
|
keratin 18
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of KRT18 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Krt78
|
keratin 78
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of KRT78 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:134,952,877...134,960,727
Ensembl chr 7:134,953,043...134,960,220
|
|
| G
|
Lamp3
|
lysosomal-associated membrane protein 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of LAMP3 mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr11:94,657,817...94,726,451
Ensembl chr11:94,661,399...94,726,195
|
|
| G
|
Lancl1
|
LanC like glutathione S-transferase 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of LANCL1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 9:75,968,284...75,998,397
Ensembl chr 9:75,968,286...76,003,475
|
|
| G
|
Lancl3
|
LanC like family member 3
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of LANCL3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:16,150,991...16,282,425
Ensembl chr X:16,150,991...16,282,425
|
|
| G
|
Lats2
|
large tumor suppressor kinase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of LATS2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:35,940,632...35,992,225
Ensembl chr15:35,940,632...35,980,842
|
|
| G
|
Lcmt2
|
leucine carboxyl methyltransferase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LCMT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:128,553,707...128,555,831
Ensembl chr 3:128,553,052...128,590,969
|
|
| G
|
Ldb2
|
LIM domain binding 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of LDB2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr14:70,489,243...70,810,573
Ensembl chr14:70,489,620...70,810,574
|
|
| G
|
Ldb3
|
LIM domain binding 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LDB3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:9,862,161...9,926,338
Ensembl chr16:9,862,161...9,926,985
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
multiple interactions decreases expression
|
EXP
|
crocin inhibits the reaction [Diazinon results in decreased expression of LDLR mRNA]
|
CTD |
PMID:24132704 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lgals1
|
galectin 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of LGALS1 protein
|
CTD |
PMID:19647006 |
|
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800
|
|
| G
|
Lgals4
|
galectin 4
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of LGALS4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:93,248,463...93,260,002
Ensembl chr 1:93,252,283...93,259,998
|
|
| G
|
Lgi1
|
leucine-rich, glioma inactivated 1
|
affects expression
|
EXP
|
Diazinon affects the expression of LGI1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:245,455,691...245,497,036
Ensembl chr 1:245,455,599...245,499,095
|
|
| G
|
Lhx5
|
LIM homeobox 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LHX5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:41,786,746...41,795,183
Ensembl chr12:41,786,746...41,795,183
|
|
| G
|
Lif
|
LIF, interleukin 6 family cytokine
|
increases expression
|
ISO
|
Diazinon results in increased expression of LIF mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
| G
|
Lig1
|
DNA ligase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LIG1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
|
|
| G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
affects expression
|
EXP
|
Diazinon affects the expression of LITAF mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
|
|
| G
|
Lmna
|
lamin A/C
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LMNA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
|
|
| G
|
Loxl1
|
lysyl oxidase-like 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of LOXL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:67,587,636...67,612,224
Ensembl chr 8:67,587,636...67,612,224
|
|
| G
|
Loxl2
|
lysyl oxidase-like 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LOXL2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:51,091,547...51,182,843
Ensembl chr15:51,069,997...51,182,842
|
|
| G
|
Lpin2
|
lipin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LPIN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:118,529,988...118,604,796
Ensembl chr 9:118,529,943...118,604,796
|
|
| G
|
Lpl
|
lipoprotein lipase
|
multiple interactions increases expression
|
ISO
|
Fulvestrant inhibits the reaction [Diazinon results in increased expression of LPL mRNA]
|
CTD |
PMID:33872936 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lrr1
|
leucine rich repeat protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LRR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:93,379,159...93,387,950
Ensembl chr 6:93,379,169...93,387,950
|
|
| G
|
Lrrc8d
|
leucine rich repeat containing 8 VRAC subunit D
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LRRC8D gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:4,335,114...4,411,549
Ensembl chr14:4,332,130...4,445,639
|
|
| G
|
Lsm4
|
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LSM4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886
|
|
| G
|
Lsm7
|
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LSM7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:9,507,373...9,509,787
Ensembl chr 7:9,507,367...9,514,115
|
|
| G
|
Lsp1
|
lymphocyte-specific protein 1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of LSP1 gene Diazinon affects the expression of LSP1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893
|
|
| G
|
Lss
|
lanosterol synthase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LSS gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253
|
|
| G
|
Ltf
|
lactotransferrin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LTF gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:119,878,344...119,901,189
|
|
| G
|
Ltk
|
leukocyte receptor tyrosine kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LTK gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:127,188,479...127,195,356
Ensembl chr 3:127,188,480...127,197,402
|
|
| G
|
Lum
|
lumican
|
increases expression
|
EXP
|
Diazinon results in increased expression of LUM mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
|
|
| G
|
Ly6d
|
lymphocyte antigen 6 family member D
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LY6D gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:108,532,207...108,533,943
Ensembl chr 7:108,532,215...108,533,716
|
|
| G
|
Ly86
|
lymphocyte antigen 86
|
affects expression
|
EXP
|
Diazinon affects the expression of LY86 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr17:27,621,313...27,705,336
Ensembl chr17:27,621,313...27,692,743
|
|
| G
|
Lyn
|
LYN proto-oncogene, Src family tyrosine kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of LYN gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:21,437,084...21,554,461
|
|
| G
|
Lypd2
|
Ly6/Plaur domain containing 2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of LYPD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:108,506,545...108,508,582
Ensembl chr 7:108,506,545...108,508,582
|
|
| G
|
Madd
|
MAP-kinase activating death domain
|
affects expression
|
EXP
|
Diazinon affects the expression of MADD mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:97,570,787...97,613,509
|
|
| G
|
Maff
|
MAF bZIP transcription factor F
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MAFF gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
|
|
| G
|
Mafk
|
MAF bZIP transcription factor K
|
affects expression
|
EXP
|
Diazinon affects the expression of MAFK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192
|
|
| G
|
Mageh1
|
MAGE family member H1
|
affects expression
|
EXP
|
Diazinon affects the expression of MAGEH1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr X:21,725,709...21,726,965
Ensembl chr X:21,718,669...21,727,219
|
|
| G
|
Man1b1
|
mannosidase, alpha, class 1B, member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MAN1B1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,539,778...28,563,155
Ensembl chr 3:28,541,347...28,563,154
|
|
| G
|
Maob
|
monoamine oxidase B
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MAOB mRNA
|
CTD |
PMID:18812211 PMID:18835401 |
|
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
|
|
| G
|
Map1b
|
microtubule-associated protein 1B
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of MAP1B protein
|
CTD |
PMID:17239417 |
|
NCBI chr 2:32,551,423...32,644,471
Ensembl chr 2:32,551,423...32,657,094
|
|
| G
|
Map2k7
|
mitogen activated protein kinase kinase 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MAP2K7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:7,389,155...7,398,377
|
|
| G
|
Map3k10
|
mitogen activated protein kinase kinase kinase 10
|
affects expression
|
EXP
|
Diazinon affects the expression of MAP3K10 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:92,083,376...92,101,676
Ensembl chr 1:92,083,376...92,101,676
|
|
| G
|
Map3k11
|
mitogen-activated protein kinase kinase kinase 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MAP3K11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:212,404,685...212,417,986
Ensembl chr 1:212,403,680...212,417,983
|
|
| G
|
Map3k6
|
mitogen-activated protein kinase kinase kinase 6
|
affects expression
|
EXP
|
Diazinon affects the expression of MAP3K6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
decreases expression increases phosphorylation decreases phosphorylation multiple interactions
|
ISO EXP
|
Diazinon results in decreased expression of MAPK1 protein modified form Diazinon results in increased phosphorylation of MAPK1 protein Diazinon results in decreased phosphorylation of MAPK1 protein crocin inhibits the reaction [Diazinon results in decreased phosphorylation of MAPK1 protein]
|
CTD |
PMID:20338157 PMID:24132704 PMID:28119078 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk11
|
mitogen-activated protein kinase 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MAPK11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
|
|
| G
|
Mapk12
|
mitogen-activated protein kinase 12
|
affects expression
|
EXP
|
Diazinon affects the expression of MAPK12 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:122,085,647...122,096,307
Ensembl chr 7:122,085,913...122,096,307
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
affects expression decreases expression increases phosphorylation multiple interactions decreases phosphorylation
|
EXP ISO
|
Diazinon affects the expression of MAPK3 mRNA Diazinon results in decreased expression of MAPK3 mRNA Diazinon results in increased phosphorylation of MAPK3 protein crocin inhibits the reaction [Diazinon results in decreased phosphorylation of MAPK3 protein]
|
CTD |
PMID:22546817 PMID:24132704 PMID:28119078 PMID:35934178 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases expression
|
EXP
|
Diazinon results in increased expression of MAPK8 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk8ip1
|
mitogen-activated protein kinase 8 interacting protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of MAPK8IP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:98,810,540...98,829,302
Ensembl chr 3:98,810,541...98,828,368
|
|
| G
|
Mapkapk3
|
MAPK activated protein kinase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MAPKAPK3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:116,808,429...116,842,228
|
|
| G
|
Mcf2l
|
MCF.2 cell line derived transforming sequence-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MCF2L gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:83,209,277...83,355,683
Ensembl chr16:83,209,280...83,354,956
|
|
| G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
affects expression
|
EXP
|
Diazinon affects the expression of MCL1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
|
|
| G
|
Mcm6
|
minichromosome maintenance complex component 6
|
affects expression
|
EXP
|
Diazinon affects the expression of MCM6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
|
|
| G
|
Mcrs1
|
microspherule protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of MCRS1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:132,262,719...132,271,533
Ensembl chr 7:132,262,722...132,271,533
|
|
| G
|
Mdc1
|
mediator of DNA damage checkpoint 1
|
affects expression
|
EXP
|
Diazinon affects the expression of MDC1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960
|
|
| G
|
Mdh1
|
malate dehydrogenase 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MDH1 protein
|
CTD |
PMID:26721910 |
|
NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232
|
|
| G
|
Mdk
|
midkine
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MDK gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
affects expression
|
EXP
|
Diazinon affects the expression of MDM2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Mdm4
|
MDM4 regulator of p53
|
affects expression
|
EXP
|
Diazinon affects the expression of MDM4 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:46,922,236...47,068,241
Ensembl chr13:46,958,298...47,026,372
|
|
| G
|
Med26
|
mediator complex subunit 26
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MED26 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:17,333,770...17,384,797
Ensembl chr16:17,327,734...17,383,603
|
|
| G
|
Med27
|
mediator complex subunit 27
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MED27 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:33,027,240...33,201,240
Ensembl chr 3:33,027,525...33,201,240
|
|
| G
|
Medag
|
mesenteric estrogen-dependent adipogenesis
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MEDAG gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:10,649,526...10,670,913
Ensembl chr12:10,649,526...10,692,756
|
|
| G
|
Megf8
|
multiple EGF-like-domains 8
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of MEGF8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:90,030,057...90,079,423
Ensembl chr 1:90,030,388...90,079,422
|
|
| G
|
Mepce
|
methylphosphate capping enzyme
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MEPCE gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:24,548,596...24,553,315
Ensembl chr12:24,548,596...24,553,877
|
|
| G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
affects expression
|
EXP
|
Diazinon affects the expression of MET mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
| G
|
Mex3b
|
mex-3 RNA binding family member B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MEX3B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:146,264,319...146,268,554
Ensembl chr 1:146,264,318...146,268,543
|
|
| G
|
Mfrp
|
membrane frizzled-related protein
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MFRP mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:53,342,483...53,347,696
Ensembl chr 8:53,342,534...53,347,861
|
|
| G
|
Mfsd8
|
major facilitator superfamily domain containing 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MFSD8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:125,749,994...125,784,689
Ensembl chr 2:125,749,994...125,785,919
|
|
| G
|
Mgat5b
|
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MGAT5B gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:102,619,559...102,689,023
Ensembl chr10:102,619,559...102,689,017
|
|
| G
|
Mgmt
|
O-6-methylguanine-DNA methyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MGMT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:201,140,661...201,367,482
|
|
| G
|
Mgst1
|
microsomal glutathione S-transferase 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of MGST1 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
|
|
| G
|
Mgst2
|
microsomal glutathione S-transferase 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MGST2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661
|
|
| G
|
Mgst3
|
microsomal glutathione S-transferase 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MGST3 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575
|
|
| G
|
Mideas
|
mitotic deacetylase associated SANT domain protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MIDEAS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:109,519,011...109,585,631
Ensembl chr 6:109,519,011...109,560,312
|
|
| G
|
Mief2
|
mitochondrial elongation factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MIEF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:45,907,576...45,913,658
Ensembl chr10:45,908,706...45,913,658
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
increases expression increases methylation
|
ISO
|
Diazinon results in increased expression of MIF protein Diazinon results in increased methylation of MIF gene
|
CTD |
PMID:19647006 PMID:22964155 |
|
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
affects expression
|
EXP
|
Diazinon affects the expression of MKI67 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mlec
|
malectin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MLEC gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:47,118,918...47,133,598
Ensembl chr12:47,118,855...47,130,064
|
|
| G
|
Mlf2
|
myeloid leukemia factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MLF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:159,425,542...159,430,584
Ensembl chr 4:159,411,732...159,430,571
|
|
| G
|
Mmp15
|
matrix metallopeptidase 15
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MMP15 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,669,506...9,691,000
|
|
| G
|
Mn1
|
MN1 proto-oncogene, transcriptional regulator
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:50,841,632...50,880,795
Ensembl chr12:50,841,632...50,880,795
|
|
| G
|
Moap1
|
modulator of apoptosis 1
|
affects expression
|
EXP
|
Diazinon affects the expression of MOAP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:127,647,389...127,649,324
Ensembl chr 6:127,613,488...127,669,324
|
|
| G
|
Mob3b
|
MOB kinase activator 3B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MOB3B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678
|
|
| G
|
Mon1b
|
MON1 homolog B, secretory trafficking associated
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MON1B gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:58,526,503...58,534,478
Ensembl chr19:58,526,326...58,533,950
|
|
| G
|
Moxd1
|
monooxygenase, DBH-like 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MOXD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:22,894,543...22,984,599
Ensembl chr 1:22,894,543...22,984,223
|
|
| G
|
Mpp2
|
MAGUK p55 scaffold protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MPP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,511,638...87,544,029
|
|
| G
|
Mpst
|
mercaptopyruvate sulfurtransferase
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MPST protein
|
CTD |
PMID:26721910 |
|
NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650
|
|
| G
|
Mpz
|
myelin protein zero
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of MPZ mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr13:86,103,290...86,109,156
Ensembl chr13:86,103,290...86,109,155
|
|
| G
|
Mrap2
|
melanocortin 2 receptor accessory protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MRAP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:96,968,239...97,024,581
Ensembl chr 8:96,988,079...97,024,579
|
|
| G
|
Mrpl20
|
mitochondrial ribosomal protein L20
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MRPL20 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:171,690,664...171,695,728
Ensembl chr 5:171,691,198...171,695,728
|
|
| G
|
Mrpl23
|
mitochondrial ribosomal protein L23
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MRPL23 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:207,116,930...207,124,702
Ensembl chr 1:207,116,462...207,124,699
|
|
| G
|
Mrps30
|
mitochondrial ribosomal protein S30
|
affects expression
|
EXP
|
Diazinon affects the expression of MRPS30 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:52,189,049...52,196,136
Ensembl chr 2:52,189,058...52,195,904
|
|
| G
|
Mrps34
|
mitochondrial ribosomal protein S34
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MRPS34 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,420,543...14,421,674
Ensembl chr10:14,408,136...14,421,771
|
|
| G
|
Mrtfa
|
myocardin related transcription factor A
|
affects expression
|
EXP
|
Diazinon affects the expression of MRTFA mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:114,424,481...114,594,594
Ensembl chr 7:114,424,481...114,594,594
|
|
| G
|
Msh2
|
mutS homolog 2
|
affects expression
|
EXP
|
Diazinon affects the expression of MSH2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503
|
|
| G
|
Mt-co3
|
mitochondrially encoded cytochrome c oxidase III
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of COX3 mRNA
|
CTD |
PMID:18214912 |
|
NCBI chr MT:8,599...9,382
Ensembl chr MT:8,584...9,367
|
|
| G
|
Mtarc1
|
mitochondrial amidoxime reducing component 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MTARC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:98,854,235...98,894,208
Ensembl chr13:98,871,289...98,894,252
|
|
| G
|
Mtch1
|
mitochondrial carrier 1
|
affects expression
|
EXP
|
Diazinon affects the expression of MTCH1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:7,391,558...7,415,291
Ensembl chr20:7,391,565...7,415,042
|
|
| G
|
Mterf3
|
mitochondrial transcription termination factor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MTERF3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:65,711,654...65,729,926
Ensembl chr 7:65,711,662...65,729,895
|
|
| G
|
Mus81
|
MUS81 structure-specific endonuclease subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MUS81 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:212,219,793...212,225,214
Ensembl chr 1:212,219,795...212,225,068
|
|
| G
|
Mvd
|
mevalonate diphosphate decarboxylase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MVD gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366
|
|
| G
|
Mx2
|
MX dynamin like GTPase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MX2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:50,375,101...50,399,373
Ensembl chr11:50,375,191...50,402,478
|
|
| G
|
Mxd1
|
max dimerization protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MXD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129
|
|
| G
|
Mxd3
|
Max dimerization protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MXD3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278
|
|
| G
|
Mxd4
|
Max dimerization protein 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MXD4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:80,786,768...80,800,790
Ensembl chr14:80,786,342...80,800,788
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
multiple interactions affects expression
|
ISO EXP
|
[alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in increased expression of MYC protein Diazinon affects the expression of MYC mRNA
|
CTD |
PMID:19883720 PMID:22546817 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Mycn
|
MYCN proto-oncogene, bHLH transcription factor
|
affects expression
|
EXP
|
Diazinon affects the expression of MYCN mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:41,446,684...41,452,508
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MYD88 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Myef2
|
myelin expression factor 2
|
affects expression
|
EXP
|
Diazinon affects the expression of MYEF2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 3:132,791,694...132,827,572
Ensembl chr 3:132,791,694...132,827,523
|
|
| G
|
Myh10
|
myosin heavy chain 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MYH10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,893,166...54,024,036
|
|
| G
|
Mylk3
|
myosin light chain kinase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MYLK3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:37,858,298...37,916,805
Ensembl chr19:37,865,141...37,915,827
|
|
| G
|
Myo9a
|
myosin IXA
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of MYO9A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:69,044,853...69,248,094
Ensembl chr 8:69,044,885...69,245,231
|
|
| G
|
Mysm1
|
myb-like, SWIRM and MPN domains 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of MYSM1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 5:114,877,112...114,981,463
Ensembl chr 5:114,889,269...114,942,385
|
|
| G
|
Naa80
|
N(alpha)-acetyltransferase 80, NatH catalytic subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NAA80 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,132,957...117,136,207
Ensembl chr 8:117,133,494...117,136,207
|
|
| G
|
Nacc2
|
NACC family member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NACC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:29,278,077...29,345,098
Ensembl chr 3:29,281,190...29,344,840
|
|
| G
|
Nagpa
|
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NAGPA gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:10,886,723...10,895,066
Ensembl chr10:10,886,733...10,895,074
|
|
| G
|
Napa
|
NSF attachment protein alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NAPA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:85,915,088...85,934,054
Ensembl chr 1:85,915,119...85,934,053
|
|
| G
|
Nars2
|
asparaginyl-tRNA synthetase 2, mitochondrial
|
increases expression
|
EXP
|
Diazinon results in increased expression of NARS2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:160,711,680...160,823,311
Ensembl chr 1:160,711,696...160,827,606
|
|
| G
|
Nat10
|
N-acetyltransferase 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NAT10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:110,566,582...110,604,829
Ensembl chr 3:110,566,582...110,604,836
|
|
| G
|
Nbl1
|
NBL1, DAN family BMP antagonist
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NBL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186
|
|
| G
|
Nckipsd
|
NCK interacting protein with SH3 domain
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NCKIPSD gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,390,121...118,401,121
Ensembl chr 8:118,390,159...118,401,118
|
|
| G
|
Ndc80
|
NDC80 kinetochore complex component
|
affects expression
|
EXP
|
Diazinon affects the expression of NDC80 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568
|
|
| G
|
Ndn
|
necdin, MAGE family member
|
affects expression
|
EXP
|
Diazinon affects the expression of NDN mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:125,261,059...125,262,658
Ensembl chr 1:125,260,997...125,262,785
|
|
| G
|
Ndrg2
|
NDRG family member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NDRG2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125
|
|
| G
|
Ndufaf3
|
NADH:ubiquinone oxidoreductase complex assembly factor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NDUFAF3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,139,891...118,141,723
Ensembl chr 8:118,139,892...118,141,723
|
|
| G
|
Ndufb10
|
NADH:ubiquinone oxidoreductase subunit B10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NDUFB10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,253,805...14,255,966
Ensembl chr10:14,253,805...14,255,966
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
affects expression decreases expression
|
EXP ISO
|
Diazinon affects the expression of NEFH mRNA Diazinon results in decreased expression of NEFH protein
|
CTD |
PMID:17239417 PMID:17452286 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nefm
|
neurofilament medium chain
|
increases expression
|
EXP
|
Diazinon results in increased expression of NEFM mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163
|
|
| G
|
Nek2
|
NIMA-related kinase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of NEK2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
|
|
| G
|
Nek3
|
NIMA-related kinase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of NEK3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr16:76,569,465...76,594,921
Ensembl chr16:76,569,496...76,594,921
|
|
| G
|
Net1
|
neuroepithelial cell transforming 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of NET1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270
|
|
| G
|
Neurod1
|
neuronal differentiation 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of NEUROD1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810
|
|
| G
|
Neurog3
|
neurogenin 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NEUROG3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:30,622,533...30,624,015
Ensembl chr20:30,622,533...30,624,015
|
|
| G
|
Nf2
|
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
|
affects expression
|
EXP
|
Diazinon affects the expression of NF2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:83,850,894...83,934,263
Ensembl chr14:83,850,894...83,934,151
|
|
| G
|
Nfatc3
|
nuclear factor of activated T-cells 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NFATC3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992
|
|
| G
|
Nfkb2
|
nuclear factor kappa B subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NFKB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
|
|
| G
|
Nfya
|
nuclear transcription factor Y subunit alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NFYA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:20,085,067...20,111,521
Ensembl chr 9:20,085,073...20,111,504
|
|
| G
|
Nfyc
|
nuclear transcription factor Y subunit gamma
|
affects expression
|
EXP
|
Diazinon affects the expression of NFYC mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:139,622,020...139,690,545
Ensembl chr 5:139,622,020...139,679,884
|
|
| G
|
Ngf
|
nerve growth factor
|
affects expression decreases expression multiple interactions
|
EXP ISO
|
Diazinon affects the expression of NGF mRNA Diazinon results in decreased expression of NGF mRNA [Diazinon co-treated with NGF protein] results in decreased expression of SLC17A8 mRNA; [Diazinon co-treated with NGF protein] results in increased expression of SLC1A4 mRNA; [Diazinon co-treated with NGF protein] results in increased expression of SLC1A5 mRNA; [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in decreased expression of NGF mRNA
|
CTD |
PMID:19130878 PMID:20600679 PMID:22428454 PMID:23212306 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
affects expression
|
EXP
|
Diazinon affects the expression of NGFR mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nifk
|
nucleolar protein interacting with the FHA domain of MKI67
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NIFK gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:31,946,119...31,955,950
Ensembl chr13:31,946,108...31,959,561
|
|
| G
|
Ninj1
|
ninjurin 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NINJ1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:15,659,208...15,668,115
Ensembl chr17:15,659,200...15,668,063
|
|
| G
|
Nipa2
|
NIPA magnesium transporter 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NIPA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:115,935,759...115,960,034
Ensembl chr 1:115,936,063...115,959,913
|
|
| G
|
Nisch
|
nischarin
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of NISCH mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr16:6,370,809...6,407,104
Ensembl chr16:6,370,809...6,407,387
|
|
| G
|
Nit1
|
nitrilase 1
|
increases methylation decreases expression
|
ISO EXP
|
Diazinon results in increased methylation of NIT1 gene Diazinon results in decreased expression of NIT1 protein
|
CTD |
PMID:22964155 PMID:26721910 |
|
NCBI chr13:86,302,334...86,305,770
Ensembl chr13:86,298,387...86,305,770
|
|
| G
|
Nkg7
|
natural killer cell granule protein 7
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of NKG7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:102,981,497...102,982,564
Ensembl chr 1:102,981,450...102,982,562
|
|
| G
|
Nkx2-2
|
NK2 homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NKX2-2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:155,072,621...155,083,699
Ensembl chr 3:155,073,250...155,083,249
|
|
| G
|
Nlrp1a
|
NLR family, pyrin domain containing 1A
|
affects expression
|
EXP
|
Diazinon affects the expression of NLRP1A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:56,277,134...56,332,229
Ensembl chr10:56,277,134...56,323,880
|
|
| G
|
Nme3
|
NME/NM23 nucleoside diphosphate kinase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of NME3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:14,421,922...14,422,878
Ensembl chr10:14,421,702...14,422,907
|
|
| G
|
Nnat
|
neuronatin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NNAT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:166,646,384...166,649,086
|
|
| G
|
Noa1
|
nitric oxide associated 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NOA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:31,189,570...31,205,600
Ensembl chr14:31,188,978...31,205,599
|
|
| G
|
Noc4l
|
nucleolar complex associated 4 homolog
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NOC4L gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:51,675,852...51,680,392
Ensembl chr12:51,675,838...51,680,390
|
|
| G
|
Nol3
|
nucleolar protein 3
|
affects expression
|
EXP
|
Diazinon affects the expression of NOL3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722
|
|
| G
|
Nop2
|
NOP2 nucleolar protein
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of NOP2 mRNA Diazinon results in increased methylation of NOP2 gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 4:159,618,894...159,630,697
Ensembl chr 4:159,618,966...159,630,697
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
increases expression
|
ISO
|
Diazinon results in increased expression of NOS2 mRNA
|
CTD |
PMID:28119078 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Npas1
|
neuronal PAS domain protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NPAS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:86,295,509...86,316,018
Ensembl chr 1:86,295,515...86,314,893
|
|
| G
|
Npm1
|
nucleophosmin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of NPM1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
|
|
| G
|
Npr2
|
natriuretic peptide receptor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NPR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:62,678,197...62,697,360
Ensembl chr 5:62,678,367...62,697,343
|
|
| G
|
Npy
|
neuropeptide Y
|
increases expression
|
EXP
|
Diazinon results in increased expression of NPY mRNA
|
CTD |
PMID:20682304 |
|
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
decreases expression increases expression
|
ISO
|
Diazinon results in decreased expression of NQO1 mRNA Diazinon results in increased expression of NQO1 mRNA
|
CTD |
PMID:17311802 PMID:24356939 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases activity
|
ISO
|
Diazinon results in increased activity of NR1I2 protein
|
CTD |
PMID:28728110 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases activity
|
ISO
|
Diazinon results in increased activity of NR1I3 protein
|
CTD |
PMID:28927721 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Nr2c2
|
nuclear receptor subfamily 2, group C, member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NR2C2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:126,167,350...126,223,942
Ensembl chr 4:126,168,085...126,223,942
|
|
| G
|
Nr5a1
|
nuclear receptor subfamily 5, group A, member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NR5A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:42,874,505...42,896,109
Ensembl chr 3:42,875,221...42,896,046
|
|
| G
|
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NR6A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:42,904,832...43,094,622
Ensembl chr 3:42,904,832...43,092,951
|
|
| G
|
Nradd
|
neurotrophin receptor associated death domain
|
affects expression
|
EXP
|
Diazinon affects the expression of NRADD mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:119,478,055...119,481,336
Ensembl chr 8:119,477,240...119,481,214
|
|
| G
|
Nrxn2
|
neurexin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NRXN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,155,673...213,271,526
Ensembl chr 1:213,155,673...213,271,526
|
|
| G
|
Nsun5
|
NOP2/Sun RNA methyltransferase 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NSUN5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:26,930,204...26,935,887
Ensembl chr12:26,930,863...26,936,130
|
|
| G
|
Ntf4
|
neurotrophin 4
|
affects expression
|
EXP
|
Diazinon affects the expression of NTF5 mRNA
|
CTD |
PMID:18502319 |
|
NCBI chr 1:105,030,035...105,032,866
Ensembl chr 1:105,029,764...105,034,038
|
|
| G
|
Ntn1
|
netrin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of NTN1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:53,398,852...53,597,595
Ensembl chr10:53,398,852...53,584,060
|
|
| G
|
Ntng2
|
netrin G2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NTNG2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:32,889,856...32,949,032
Ensembl chr 3:32,890,575...32,943,821
|
|
| G
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of NTRK1 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of NTRK2 mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Ntrk3
|
neurotrophic receptor tyrosine kinase 3
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of NTRK3 mRNA Diazinon results in decreased expression of NTRK3 mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:141,542,569...141,913,004
|
|
| G
|
Nts
|
neurotensin
|
increases expression decreases expression
|
EXP
|
Diazinon results in increased expression of NTS mRNA Diazinon results in decreased expression of NTS mRNA
|
CTD |
PMID:20682304 PMID:29108742 |
|
NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961
|
|
| G
|
Ntsr1
|
neurotensin receptor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NTSR1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:187,983,778...188,033,934
Ensembl chr 3:187,983,778...188,033,934
|
|
| G
|
Nuak2
|
NUAK family kinase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of NUAK2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:46,305,744...46,322,755
Ensembl chr13:46,305,975...46,322,748
|
|
| G
|
Nudc
|
nuclear distribution C, dynein complex regulator
|
affects expression
|
EXP
|
Diazinon affects the expression of NUDC mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:151,041,878...151,055,260
Ensembl chr 5:151,041,875...151,055,260
|
|
| G
|
Nudt14
|
nudix hydrolase 14
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NUDT14 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:137,831,382...137,838,370
Ensembl chr 6:137,831,373...137,838,370
|
|
| G
|
Nudt22
|
nudix hydrolase 22
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NUDT22 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,612,008...213,615,626
Ensembl chr 1:213,612,009...213,615,713
|
|
| G
|
Nuf2
|
NUF2 component of NDC80 kinetochore complex
|
affects expression
|
EXP
|
Diazinon affects the expression of NUF2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598
|
|
| G
|
Nup188
|
nucleoporin 188
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of NUP188 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:33,957,778...34,014,122
Ensembl chr 3:33,957,791...34,014,122
|
|
| G
|
Nutf2
|
nuclear transport factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of NUTF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:50,662,168...50,683,457
Ensembl chr19:50,662,394...50,683,454
|
|
| G
|
Nxph3
|
neurexophilin 3
|
increases methylation increases expression
|
ISO EXP
|
Diazinon results in increased methylation of NXPH3 gene Diazinon results in increased expression of NXPH3 mRNA
|
CTD |
PMID:22964155 PMID:29108742 |
|
NCBI chr10:80,953,080...80,956,746
Ensembl chr10:80,952,227...80,956,668
|
|
| G
|
Ogn
|
osteoglycin
|
increases expression
|
EXP
|
Diazinon results in increased expression of OGN mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,238,500...15,259,252
|
|
| G
|
Opn4
|
opsin 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of OPN4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:9,926,638...9,935,810
Ensembl chr16:9,926,902...9,949,928
|
|
| G
|
Orai3
|
ORAI calcium release-activated calcium modulator 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ORAI3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:191,811,671...191,816,530
Ensembl chr 1:191,811,424...191,816,530
|
|
| G
|
Otc
|
ornithine transcarbamylase
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of OTC protein
|
CTD |
PMID:26721910 |
|
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
|
|
| G
|
Otof
|
otoferlin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of OTOF gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:31,647,869...31,744,476
Ensembl chr 6:31,647,914...31,744,476
|
|
| G
|
Otop2
|
otopetrin 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of OTOP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:101,063,701...101,073,271
Ensembl chr10:101,063,701...101,073,271
|
|
| G
|
Otx2
|
orthodenticle homeobox 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of OTX2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr15:24,422,876...24,432,709
Ensembl chr15:24,422,876...24,432,472
|
|
| G
|
Ovca2
|
OVCA2 serine hydrolase domain containing
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of OVCA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:60,524,385...60,527,547
Ensembl chr10:60,522,026...60,527,536
|
|
| G
|
Oxct2b
|
3-oxoacid CoA transferase 2B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of OXCT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:140,681,746...140,683,500
Ensembl chr 5:140,671,211...140,696,448
|
|
| G
|
P4ha3
|
prolyl 4-hydroxylase subunit alpha 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of P4HA3 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:164,040,852...164,075,922
Ensembl chr 1:164,040,864...164,076,435
|
|
| G
|
Pabpc6
|
poly(A) binding protein, cytoplasmic 6
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PABPC3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:53,592,902...53,595,978
Ensembl chr 1:53,592,884...53,595,973
|
|
| G
|
Pacsin2
|
protein kinase C and casein kinase substrate in neurons 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PACSIN2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:116,385,571...116,478,609
Ensembl chr 7:116,384,190...116,478,537
|
|
| G
|
Padi1
|
peptidyl arginine deiminase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PADI1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:158,402,614...158,435,077
Ensembl chr 5:158,402,614...158,435,077
|
|
| G
|
Paep
|
progestagen associated endometrial protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAEP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,929,252...28,932,592
|
|
| G
|
Paf1
|
PAF1 homolog, Paf1/RNA polymerase II complex component
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:92,811,197...92,816,775
Ensembl chr 1:92,798,237...92,816,779
|
|
| G
|
Pafah1b3
|
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAFAH1B3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:90,009,085...90,011,611
Ensembl chr 1:90,009,085...90,011,611
|
|
| G
|
Paics
|
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAICS gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,553,357...31,587,027
|
|
| G
|
Pan3
|
poly(A) specific ribonuclease subunit PAN3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAN3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:12,512,835...12,637,066
Ensembl chr12:12,512,835...12,631,492
|
|
| G
|
Paox
|
polyamine oxidase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAOX gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:204,349,326...204,358,140
Ensembl chr 1:204,348,987...204,358,481
|
|
| G
|
Papola
|
poly (A) polymerase alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAPOLA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:130,446,236...130,499,371
Ensembl chr 6:130,446,797...130,499,336
|
|
| G
|
Papolg
|
poly(A) polymerase gamma
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PAPOLG gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:102,028,842...102,062,155
Ensembl chr14:102,028,842...102,062,155
|
|
| G
|
Pard6a
|
par-6 family cell polarity regulator alpha
|
affects expression
|
EXP
|
Diazinon affects the expression of PARD6A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:50,499,420...50,502,301
Ensembl chr19:50,499,442...50,502,674
|
|
| G
|
Park7
|
Parkinsonism associated deglycase
|
decreases expression decreases activity
|
EXP ISO
|
Diazinon results in decreased expression of PARK7 mRNA Diazinon results in decreased activity of PARK7 protein
|
CTD |
PMID:21968025 PMID:36842454 |
|
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
|
|
| G
|
Parm1
|
prostate androgen-regulated mucin-like protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PARM1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:16,752,541...16,861,570
Ensembl chr14:16,752,541...16,881,138
|
|
| G
|
Parp16
|
poly (ADP-ribose) polymerase family, member 16
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PARP16 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:74,626,399...74,644,610
Ensembl chr 8:74,622,878...74,644,612
|
|
| G
|
Pax6
|
paired box 6
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PAX6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pbx2
|
PBX homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PBX2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,156,107...4,161,503
Ensembl chr20:4,156,107...4,161,827
|
|
| G
|
Pcbp4
|
poly(rC) binding protein 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCBP4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:115,971,751...115,981,987
Ensembl chr 8:115,971,326...115,981,982
|
|
| G
|
Pcdh1
|
protocadherin 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCDH1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:30,258,154...30,290,828
Ensembl chr18:30,258,154...30,290,436
|
|
| G
|
Pcdh12
|
protocadherin 12
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCDH12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:30,354,910...30,370,485
Ensembl chr18:30,354,910...30,370,485
|
|
| G
|
Pcdh7
|
protocadherin 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCDH7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:56,684,817...57,114,976
Ensembl chr14:56,687,725...57,112,665
|
|
| G
|
Pcm1
|
pericentriolar material 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PCM1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr16:57,711,833...57,808,842
Ensembl chr16:57,711,833...57,808,599
|
|
| G
|
Pcmt1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCMT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:3,932,161...3,980,751
Ensembl chr 1:3,932,161...3,964,848
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCNA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pcsk4
|
proprotein convertase subtilisin/kexin type 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCSK4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,032,040...10,040,263
Ensembl chr 7:10,031,988...10,040,255
|
|
| G
|
Pcsk5
|
proprotein convertase subtilisin/kexin type 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PCSK5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347
|
|
| G
|
Pdcd1
|
programmed cell death 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PDCD1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:101,866,124...101,879,278
Ensembl chr 9:101,866,126...101,879,270
|
|
| G
|
Pdcd2
|
programmed cell death 2
|
affects expression
|
EXP
|
Diazinon affects the expression of PDCD2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:65,158,034...65,163,524
Ensembl chr 1:65,158,034...65,163,524
|
|
| G
|
Pdcd4
|
programmed cell death 4
|
increases expression
|
ISO
|
Diazinon results in increased expression of PDCD4 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189
|
|
| G
|
Pdcd5
|
programmed cell death 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PDCD5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:97,442,755...97,448,084
Ensembl chr 1:97,442,755...97,449,844
|
|
| G
|
Pdcd6
|
programmed cell death 6
|
affects expression
|
EXP
|
Diazinon affects the expression of PDCD6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:30,795,105...30,810,771
Ensembl chr 1:30,795,040...30,810,773
|
|
| G
|
Pde10a
|
phosphodiesterase 10A
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PDE10A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:54,313,343...54,765,668
Ensembl chr 1:54,317,732...54,764,051
|
|
| G
|
Pde11a
|
phosphodiesterase 11A
|
increases expression
|
EXP
|
Diazinon results in increased expression of PDE11A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 3:81,320,822...81,704,397
Ensembl chr 3:81,320,822...81,680,612
|
|
| G
|
Pde1a
|
phosphodiesterase 1A
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PDE1A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212
|
|
| G
|
Pde1c
|
phosphodiesterase 1C
|
affects expression
|
EXP
|
Diazinon affects the expression of PDE1C mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:86,629,074...87,108,147
Ensembl chr 4:86,626,282...87,193,259
|
|
| G
|
Pde3a
|
phosphodiesterase 3A
|
affects expression
|
EXP
|
Diazinon affects the expression of PDE3A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270
|
|
| G
|
Pde5a
|
phosphodiesterase 5A
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PDE5A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298
|
|
| G
|
Pde8a
|
phosphodiesterase 8A
|
increases expression
|
EXP
|
Diazinon results in increased expression of PDE8A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:144,575,428...144,698,215
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
increases expression
|
ISO
|
Diazinon results in increased expression of PDGFA mRNA
|
CTD |
PMID:30978295 |
|
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdia5
|
protein disulfide isomerase family A, member 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PDIA5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:78,777,436...78,892,370
Ensembl chr11:78,777,419...78,864,329
|
|
| G
|
Pdlim7
|
PDZ and LIM domain 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PDLIM7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956
|
|
| G
|
Pdp2
|
pyruvate dehydrogenase phosphatase catalytic subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PDP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:392,858...400,529
Ensembl chr19:392,183...400,902
|
|
| G
|
Pea15
|
proliferation and apoptosis adaptor protein 15
|
affects expression
|
EXP
|
Diazinon affects the expression of PEA15 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
|
|
| G
|
Pebp1
|
phosphatidylethanolamine binding protein 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PEBP1 protein
|
CTD |
PMID:26721910 |
|
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780
|
|
| G
|
Peds1
|
plasmanylethanolamine desaturase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PEDS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:176,769,111...176,788,278
|
|
| G
|
Peg10
|
paternally expressed 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PEG10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:33,817,190...33,819,166 Ensembl chr 4:33,817,190...33,819,166
|
|
| G
|
Peli2
|
pellino E3 ubiquitin protein ligase family member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PELI2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:23,872,984...24,017,448
Ensembl chr15:23,872,984...24,014,817
|
|
| G
|
Perp
|
p53 apoptosis effector related to PMP22
|
affects expression
|
EXP
|
Diazinon affects the expression of PERP mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:15,361,778...15,374,687
|
|
| G
|
Pfkp
|
phosphofructokinase, platelet
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PFKP gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752
|
|
| G
|
Pgf
|
placental growth factor
|
affects expression
|
EXP
|
Diazinon affects the expression of PGF mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Pglyrp2
|
peptidoglycan recognition protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PGLYRP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:12,069,414...12,082,437
Ensembl chr 7:12,069,414...12,078,369
|
|
| G
|
Phactr3
|
phosphatase and actin regulator 3
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PHACTR3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:185,582,134...185,801,404
Ensembl chr 3:185,582,796...185,801,822
|
|
| G
|
Pheta1
|
PH domain containing endocytic trafficking adaptor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PHETA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:40,372,553...40,378,321
Ensembl chr12:40,367,001...40,377,854
|
|
| G
|
Phka2
|
phosphorylase kinase regulatory subunit alpha 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PHKA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:37,979,629...38,102,656
Ensembl chr X:37,979,629...38,102,144
|
|
| G
|
Phlda1
|
pleckstrin homology-like domain, family A, member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PHLDA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542
|
|
| G
|
Phlda2
|
pleckstrin homology-like domain, family A, member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PHLDA2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920
|
|
| G
|
Phospho1
|
phosphoethanolamine/phosphocholine phosphatase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PHOSPHO1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:81,258,810...81,266,345
Ensembl chr10:81,257,427...81,268,481
|
|
| G
|
Phpt1
|
phosphohistidine phosphatase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PHPT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,791,062...28,792,905
|
|
| G
|
Pias3
|
protein inhibitor of activated STAT, 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PIAS3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:186,921,384...186,930,292
Ensembl chr 2:186,921,428...186,936,714
|
|
| G
|
Pick1
|
protein interacting with PRKCA 1
|
increases expression increases methylation
|
EXP ISO
|
Diazinon results in increased expression of PICK1 mRNA Diazinon results in increased methylation of PICK1 gene
|
CTD |
PMID:17452286 PMID:22964155 |
|
NCBI chr 7:112,676,890...112,697,275
Ensembl chr 7:112,677,322...112,697,257
|
|
| G
|
Pid1
|
phosphotyrosine interaction domain containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PID1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070
|
|
| G
|
Pidd1
|
p53-induced death domain protein 1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of PIDD1 gene Diazinon affects the expression of PIDD1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 1:205,966,392...205,972,359
Ensembl chr 1:205,966,392...205,971,600
|
|
| G
|
Pigq
|
phosphatidylinositol glycan anchor biosynthesis, class Q
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PIGQ gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:15,447,080...15,463,088
Ensembl chr10:15,447,081...15,463,088
|
|
| G
|
Pik3r2
|
phosphoinositide-3-kinase regulatory subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PIK3R2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
|
|
| G
|
Pilra
|
paired immunoglobin-like type 2 receptor alpha
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PILRA gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:23,452,626...23,464,772
|
|
| G
|
Pim2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PIM2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:17,289,509...17,294,778
Ensembl chr X:17,289,509...17,294,778
|
|
| G
|
Pin1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PIN1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:27,465,538...27,477,016
|
|
| G
|
Pink1
|
PTEN induced kinase 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PINK1 mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
| G
|
Pisd
|
phosphatidylserine decarboxylase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PISD gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:82,166,401...82,215,479
Ensembl chr14:82,166,412...82,215,913
|
|
| G
|
Pitx3
|
paired-like homeodomain 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PITX3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:254,942,550...254,955,325
Ensembl chr 1:254,942,608...254,955,336
|
|
| G
|
Pkd1
|
polycystin 1, transient receptor potential channel interacting
|
affects expression
|
EXP
|
Diazinon affects the expression of PKD1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681
|
|
| G
|
Pkib
|
cAMP-dependent protein kinase inhibitor beta
|
increases expression
|
EXP
|
Diazinon results in increased expression of PKIB mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr20:37,511,564...37,608,607
Ensembl chr20:37,512,822...37,608,401
|
|
| G
|
Pla2g6
|
phospholipase A2 group VI
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PLA2G6 mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr 7:112,731,803...112,771,978
Ensembl chr 7:112,731,803...112,771,609
|
|
| G
|
Plcb1
|
phospholipase C beta 1
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of PLCB1 mRNA Diazinon results in increased methylation of PLCB1 gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646
|
|
| G
|
Pld4
|
phospholipase D family, member 4
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PLD4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:137,639,948...137,647,462
Ensembl chr 6:137,639,945...137,649,024
|
|
| G
|
Plekhf1
|
pleckstrin homology and FYVE domain containing 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PLEKHF1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:100,045,340...100,046,817
Ensembl chr 1:100,027,056...100,053,452
|
|
| G
|
Plekhg2
|
pleckstrin homology and RhoGEF domain containing G2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PLEKHG2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:92,779,449...92,792,610
Ensembl chr 1:92,779,449...92,792,610
|
|
| G
|
Plekhj1
|
pleckstrin homology domain containing J1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PLEKHJ1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:9,566,200...9,570,993
|
|
| G
|
Plin1
|
perilipin 1
|
increases expression multiple interactions
|
ISO
|
Diazinon results in increased expression of PLIN1 protein Fulvestrant inhibits the reaction [Diazinon results in increased expression of PLIN1 protein]
|
CTD |
PMID:33872936 |
|
NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206
|
|
| G
|
Plk1
|
polo-like kinase 1
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of PLK1 gene Diazinon affects the expression of PLK1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637
|
|
| G
|
Plk2
|
polo-like kinase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of PLK2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
|
|
| G
|
Plk4
|
polo-like kinase 4
|
affects expression
|
EXP
|
Diazinon affects the expression of PLK4 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892
|
|
| G
|
Plp2
|
proteolipid protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PLP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:17,506,153...17,509,552
Ensembl chr X:17,506,059...17,509,550
|
|
| G
|
Plppr2
|
phospholipid phosphatase related 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PLPPR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:28,742,787...28,755,555
Ensembl chr 8:28,745,639...28,755,555
|
|
| G
|
Plxdc1
|
plexin domain containing 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PLXDC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:83,418,837...83,478,451
Ensembl chr10:83,418,837...83,478,755
|
|
| G
|
Pmp22
|
peripheral myelin protein 22
|
affects expression
|
EXP
|
Diazinon affects the expression of PMP22 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:48,294,932...48,324,941
Ensembl chr10:48,297,437...48,324,940
|
|
| G
|
Pnisr
|
PNN interacting serine and arginine rich protein
|
increases expression
|
EXP
|
Diazinon results in increased expression of PNISR mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 5:40,190,214...40,219,619
Ensembl chr 5:40,192,735...40,219,611
|
|
| G
|
Pnpla7
|
patatin-like phospholipase domain containing 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PNPLA7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,180,670...28,259,673
Ensembl chr 3:28,180,751...28,259,672
|
|
| G
|
Poglut2
|
protein O-glucosyltransferase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POGLUT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:53,748,484...53,801,453
Ensembl chr 9:53,740,998...53,760,588
|
|
| G
|
Polb
|
DNA polymerase beta
|
affects expression
|
EXP
|
Diazinon affects the expression of POLB mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr16:76,081,903...76,105,174
Ensembl chr16:76,081,864...76,108,180
|
|
| G
|
Pold4
|
DNA polymerase delta 4, accessory subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POLD4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:210,956,110...210,957,863
Ensembl chr 1:210,956,099...210,957,860
|
|
| G
|
Pole
|
DNA polymerase epsilon, catalytic subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POLE gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662
|
|
| G
|
Polg
|
DNA polymerase gamma, catalytic subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POLG gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:142,792,119...142,808,933
Ensembl chr 1:142,792,119...142,808,838
|
|
| G
|
Polr2f
|
RNA polymerase II, I and III subunit F
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POLR2F gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:112,593,027...112,604,666
|
|
| G
|
Polr2l
|
RNA polymerase II, I and III subunit L
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POLR2L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:205,999,607...206,001,615
Ensembl chr19:8,341,868...8,342,071
|
|
| G
|
Pon1
|
paraoxonase 1
|
affects response to substance multiple interactions decreases expression increases response to substance increases hydrolysis affects metabolic processing
|
ISO EXP
|
PON1 gene polymorphism affects the susceptibility to Diazinon; PON1 protein affects the susceptibility to Diazinon; PON1 protein polymorphism affects the susceptibility to Diazinon PON1 protein polymorphism inhibits the reaction [Diazinon results in decreased activity of ACHE protein] Diazinon results in decreased expression of PON1 mRNA PON1 gene mutant form results in increased susceptibility to Diazinon PON1 protein results in increased hydrolysis of Diazinon PON1 protein affects the metabolism of Diazinon
|
CTD |
PMID:11022865 PMID:11888590 PMID:15864126 PMID:16002382 PMID:16027737 PMID:16331452 PMID:19907334 PMID:29383019 PMID:31981688 More...
|
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pou2f2
|
POU class 2 homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POU2F2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:89,810,153...89,897,560
Ensembl chr 1:89,812,093...89,897,564
|
|
| G
|
Pou3f1
|
POU class 3 homeobox 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POU3F1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:142,195,090...142,198,070
Ensembl chr 5:142,194,066...142,202,704
|
|
| G
|
Pou4f2
|
POU class 4 homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of POU4F2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:46,390,958...46,394,599
Ensembl chr19:46,390,958...46,394,599
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPARA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases activity multiple interactions increases expression
|
ISO
|
Diazinon results in increased activity of PPARG protein Fulvestrant inhibits the reaction [Diazinon results in increased expression of PPARG protein]
|
CTD |
PMID:28728110 PMID:33872936 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppfia3
|
PTPRF interacting protein alpha 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPFIA3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:104,953,598...104,982,373
Ensembl chr 1:104,953,598...104,982,278
|
|
| G
|
Ppm1d
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
affects expression
|
EXP
|
Diazinon affects the expression of PPM1D mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256
|
|
| G
|
Ppm1f
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PPM1F gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:97,568,627...97,598,613
Ensembl chr11:97,568,625...97,598,545
|
|
| G
|
Ppm1j
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPM1J gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:194,966,854...194,972,228
Ensembl chr 2:194,966,950...194,972,227
|
|
| G
|
Ppp1r13b
|
protein phosphatase 1, regulatory subunit 13B
|
affects expression
|
EXP
|
Diazinon affects the expression of PPP1R13B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:136,711,834...136,785,068
Ensembl chr 6:136,711,834...136,785,113
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP1R15A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ppp2ca
|
protein phosphatase 2 catalytic subunit alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP2CA gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:36,856,534...36,878,789
|
|
| G
|
Ppp2cb
|
protein phosphatase 2 catalytic subunit beta
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP2CB gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:65,261,181...65,282,634
|
|
| G
|
Ppp2r5b
|
protein phosphatase 2, regulatory subunit B', beta
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP2R5B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:212,956,533...212,964,706
Ensembl chr 1:212,956,533...212,964,662
|
|
| G
|
Ppp2r5d
|
protein phosphatase 2, regulatory subunit B', delta
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP2R5D gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:21,767,963...21,797,997
Ensembl chr 9:21,767,688...21,797,996
|
|
| G
|
Ppp4c
|
protein phosphatase 4, catalytic subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP4C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168
|
|
| G
|
Ppp4r2
|
protein phosphatase 4, regulatory subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP4R2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:135,010,919...135,051,844
Ensembl chr 4:135,010,919...135,051,844
|
|
| G
|
Ppp5c
|
protein phosphatase 5, catalytic subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PPP5C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:86,818,297...86,842,505
Ensembl chr 1:86,818,297...86,842,950
|
|
| G
|
Pqbp1
|
polyglutamine binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PQBP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:17,275,445...17,280,018
Ensembl chr X:17,275,759...17,280,016
|
|
| G
|
Prdm10
|
PR/SET domain 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PRDM10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:37,982,210...38,085,907
Ensembl chr 8:37,982,403...38,085,907
|
|
| G
|
Prdx2
|
peroxiredoxin 2
|
affects expression
|
EXP
|
Diazinon affects the expression of PRDX2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRDX6 protein
|
CTD |
PMID:26721910 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Prkaa1
|
protein kinase AMP-activated catalytic subunit alpha 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of PRKAA1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
|
|
| G
|
Prkab2
|
protein kinase AMP-activated non-catalytic subunit beta 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of PRKAB2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:187,946,008...187,961,615
Ensembl chr 2:187,945,982...187,961,608
|
|
| G
|
Prkag2
|
protein kinase AMP-activated non-catalytic subunit gamma 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRKAG2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,744,588...10,985,939
|
|
| G
|
Prkar2a
|
protein kinase cAMP-dependent type II regulatory subunit alpha
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRKAR2A mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 8:118,271,608...118,337,332
Ensembl chr 8:118,274,167...118,337,330
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
affects expression
|
EXP
|
Diazinon affects the expression of PRKCD mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prkch
|
protein kinase C, eta
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRKCH mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477
|
|
| G
|
Prkci
|
protein kinase C, iota
|
affects expression
|
EXP
|
Diazinon affects the expression of PRKCI mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784
|
|
| G
|
Prkcq
|
protein kinase C, theta
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRKCQ mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr17:72,156,215...72,288,508
Ensembl chr17:72,156,215...72,288,508
|
|
| G
|
Prkcz
|
protein kinase C, zeta
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PRKCZ gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
|
|
| G
|
Prkd2
|
protein kinase D2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PRKD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675
|
|
| G
|
Prkd3
|
protein kinase D3
|
affects expression
|
EXP
|
Diazinon affects the expression of PRKD3 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 6:21,784,665...21,860,600
Ensembl chr 6:21,784,673...21,860,600
|
|
| G
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRKN mRNA
|
CTD |
PMID:21968025 |
|
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304
|
|
| G
|
Prlr
|
prolactin receptor
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of PRLR mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882
|
|
| G
|
Prmt1
|
protein arginine methyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PRMT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:104,595,335...104,604,827
|
|
| G
|
Prok1
|
prokineticin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PROK1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:197,538,747...197,547,550
Ensembl chr 2:197,537,068...197,547,550
|
|
| G
|
Prokr2
|
prokineticin receptor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PROKR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:140,077,629...140,092,327
Ensembl chr 3:140,077,630...140,092,093
|
|
| G
|
Prr22
|
proline rich 22
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PRR22 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:1,686,295...1,688,129
Ensembl chr 9:1,686,295...1,688,129
|
|
| G
|
Prr3
|
proline rich 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PRR3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:2,797,677...2,804,674
Ensembl chr20:2,797,105...2,798,617
|
|
| G
|
Prss27
|
serine protease 27
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PRSS27 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:13,574,526...13,581,887
Ensembl chr10:13,574,526...13,581,887
|
|
| G
|
Prss38
|
serine protease 38
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of PRSS38 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:44,658,888...44,665,089
Ensembl chr10:44,658,894...44,667,364
|
|
| G
|
Prxl2b
|
peroxiredoxin like 2B
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of PRXL2B mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 5:170,744,953...170,747,556
Ensembl chr 5:170,744,953...170,747,556
|
|
| G
|
Psd
|
pleckstrin and Sec7 domain containing
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PSD gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:255,114,703...255,130,151
Ensembl chr 1:255,114,703...255,129,553
|
|
| G
|
Psen1
|
presenilin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PSEN1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:109,054,160...109,106,191
Ensembl chr 6:109,060,352...109,106,189
|
|
| G
|
Psmb2
|
proteasome 20S subunit beta 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PSMB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:144,255,058...144,287,200
Ensembl chr 5:144,255,026...144,287,608
|
|
| G
|
Psmc4
|
proteasome 26S subunit, ATPase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PSMC4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060
|
|
| G
|
Psmd1
|
proteasome 26S subunit, non-ATPase 1
|
affects expression
|
EXP
|
Diazinon affects the expression of PSMD1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:94,157,971...94,233,218
Ensembl chr 9:94,157,971...94,233,218
|
|
| G
|
Psmd3
|
proteasome 26S subunit, non-ATPase 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PSMD3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:84,139,249...84,151,879
Ensembl chr10:84,139,677...84,151,878
|
|
| G
|
Psmd8
|
proteasome 26S subunit, non-ATPase 8
|
affects expression
|
EXP
|
Diazinon affects the expression of PSMD8 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:93,601,857...93,608,689
Ensembl chr 1:93,601,853...93,608,689
|
|
| G
|
Psme1
|
proteasome activator subunit 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of PSME1 protein
|
CTD |
PMID:26721910 |
|
NCBI chr15:33,038,962...33,041,849
Ensembl chr15:33,038,597...33,041,848
|
|
| G
|
Ptbp1
|
polypyrimidine tract binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PTBP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,493,199...10,502,957
Ensembl chr 7:10,493,200...10,502,957
|
|
| G
|
Ptch1
|
patched 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PTCH1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,548,449...1,613,461
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
increases methylation increases expression multiple interactions affects expression decreases expression
|
ISO EXP
|
Diazinon results in increased methylation of PTEN gene Diazinon results in increased expression of PTEN mRNA Dietary Fats promotes the reaction [Diazinon results in increased expression of PTEN mRNA] Diazinon affects the expression of PTEN mRNA Diazinon results in decreased expression of PTEN mRNA
|
CTD |
PMID:22546817 PMID:22964155 PMID:30359674 PMID:35403302 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression
|
ISO
|
Diazinon results in increased expression of PTGS2 mRNA
|
CTD |
PMID:28119078 PMID:35934178 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptk2b
|
protein tyrosine kinase 2 beta
|
multiple interactions
|
ISO
|
[alachlor co-treated with Captan co-treated with Diazinon co-treated with Endosulfan co-treated with mancozeb co-treated with Maneb] results in decreased expression of PTK2B protein modified form
|
CTD |
PMID:19883720 |
|
NCBI chr15:44,536,275...44,656,754
Ensembl chr15:44,531,249...44,656,806
|
|
| G
|
Ptma
|
prothymosin alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PTMA gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:94,624,196...94,628,276
|
|
| G
|
Ptn
|
pleiotrophin
|
affects expression
|
EXP
|
Diazinon affects the expression of PTN mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
|
|
| G
|
Ptprd
|
protein tyrosine phosphatase, receptor type, D
|
increases expression
|
EXP
|
Diazinon results in increased expression of PTPRD mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:95,095,858...96,178,903
|
|
| G
|
Pttg1
|
PTTG1 regulator of sister chromatid separation, securin
|
affects expression
|
EXP
|
Diazinon affects the expression of PTTG1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
|
|
| G
|
Pus1
|
pseudouridine synthase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PUS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:51,539,659...51,548,975
Ensembl chr12:51,540,212...51,548,973
|
|
| G
|
Pxylp1
|
2-phosphoxylose phosphatase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PXYLP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:106,299,303...106,364,603
Ensembl chr 8:106,299,304...106,364,603
|
|
| G
|
Pycard
|
PYD and CARD domain containing
|
affects expression
|
EXP
|
Diazinon affects the expression of PYCARD mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419
|
|
| G
|
Pygb
|
glycogen phosphorylase B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PYGB gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:160,072,115...160,123,961
|
|
| G
|
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of PYROXD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:251,472,609...251,498,316
Ensembl chr 1:251,471,849...251,498,008
|
|
| G
|
Qpctl
|
glutaminyl-peptide cyclotransferase-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of QPCTL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:87,916,771...87,925,843
Ensembl chr 1:87,916,772...87,925,843
|
|
| G
|
Qrich1
|
glutamine-rich 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of QRICH1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,095,435...118,135,001
Ensembl chr 8:118,095,429...118,134,999
|
|
| G
|
Rab1a
|
RAB1A, member RAS oncogene family
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAB1A gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:98,623,582...98,648,766
Ensembl chr14:98,623,635...98,661,582
|
|
| G
|
Rab3il1
|
RAB3A interacting protein-like 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAB3IL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:216,071,043...216,107,609
Ensembl chr 1:216,071,084...216,107,609
|
|
| G
|
Rab5a
|
RAB5A, member RAS oncogene family
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAB5A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,721,122...6,749,447
|
|
| G
|
Rabep1
|
rabaptin, RAB GTPase binding effector protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of RABEP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:56,064,742...56,168,778
Ensembl chr10:56,064,753...56,166,177
|
|
| G
|
Rac2
|
Rac family small GTPase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:111,996,742...112,009,267
|
|
| G
|
Rack1
|
receptor for activated C kinase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RACK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,670,270...33,675,948
|
|
| G
|
Rad9a
|
RAD9 checkpoint clamp component A
|
affects expression
|
EXP
|
Diazinon affects the expression of RAD9A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:210,917,970...210,983,038
Ensembl chr 1:210,917,970...210,925,161
|
|
| G
|
Rala
|
RAS like proto-oncogene A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RALA gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:51,787,682...51,840,738
Ensembl chr17:51,787,699...51,840,733
|
|
| G
|
Ralgdsl2
|
ral guanine nucleotide dissociation stimulator like 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RGL2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,950,379...4,958,315
Ensembl chr20:4,950,381...4,958,135
|
|
| G
|
Ranbp1
|
RAN binding protein 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of RANBP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:96,246,740...96,255,145
|
|
| G
|
Rap1gap
|
Rap1 GTPase-activating protein
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of RAP1GAP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:155,157,558...155,222,622
|
|
| G
|
Rap2a
|
RAP2A, member of RAS oncogene family
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAP2A gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:104,003,744...104,004,234
|
|
| G
|
Rap2b
|
RAP2B, member of RAS oncogene family
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAP2B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:147,749,387...147,749,938
Ensembl chr 2:147,748,791...147,755,549
|
|
| G
|
Rara
|
retinoic acid receptor, alpha
|
affects expression
|
EXP
|
Diazinon affects the expression of RARA mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160
|
|
| G
|
Rasl12
|
RAS-like, family 12
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of RASL12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:74,813,000...74,827,041
Ensembl chr 8:74,813,000...74,827,897
|
|
| G
|
Rassf1
|
Ras association domain family member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RASSF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:117,103,362...117,114,805
|
|
| G
|
Rassf5
|
Ras association domain family member 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RASSF5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:45,189,768...45,255,277
Ensembl chr13:45,189,804...45,255,277
|
|
| G
|
Rax
|
retina and anterior neural fold homeobox
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RAX gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:61,733,322...61,737,444
Ensembl chr18:61,733,322...61,737,444
|
|
| G
|
Rb1
|
RB transcriptional corepressor 1
|
affects expression
|
EXP
|
Diazinon affects the expression of RB1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
| G
|
Rbck1
|
RANBP2-type and C3HC4-type zinc finger containing 1
|
affects expression
|
EXP
|
Diazinon affects the expression of RBCK1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:161,249,389...161,266,321
Ensembl chr 3:161,249,390...161,266,032
|
|
| G
|
Rbl2
|
RB transcriptional corepressor like 2
|
affects expression
|
EXP
|
Diazinon affects the expression of RBL2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:32,049,690...32,096,467
Ensembl chr19:32,049,691...32,096,411
|
|
| G
|
Rbm15b
|
RNA binding motif protein 15B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RBM15B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:116,422,309...116,425,374
Ensembl chr 8:116,421,540...116,425,940
|
|
| G
|
Rbm34
|
RNA binding motif protein 34
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of RBM34 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:71,832,189...71,854,038
Ensembl chr19:71,833,763...71,853,946
|
|
| G
|
Rbm38
|
RNA binding motif protein 38
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RBM38 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:182,219,898...182,232,723
Ensembl chr 3:182,219,899...182,232,714
|
|
| G
|
Rbm47
|
RNA binding motif protein 47
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of RBM47 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr14:42,407,226...42,545,304
Ensembl chr14:42,466,335...42,543,163
|
|
| G
|
Rcor2
|
REST corepressor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RCOR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,882,585...213,890,022
Ensembl chr 1:213,878,519...213,890,022
|
|
| G
|
Recql4
|
RecQ like helicase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RECQL4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:110,304,094...110,311,258
|
|
| G
|
Reep5
|
receptor accessory protein 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of REEP5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:26,219,528...26,257,505
Ensembl chr18:26,219,530...26,250,660
|
|
| G
|
Ret
|
ret proto-oncogene
|
affects expression
|
EXP
|
Diazinon affects the expression of RET mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556
|
|
| G
|
Rev3l
|
REV3 like, DNA directed polymerase zeta catalytic subunit
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of REV3L gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:44,686,482...44,844,668
Ensembl chr20:44,686,940...44,844,668
|
|
| G
|
Rfk
|
riboflavin kinase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RFK gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:224,226,632...224,234,185
Ensembl chr 1:224,226,628...224,235,698 Ensembl chr X:224,226,628...224,235,698
|
|
| G
|
Rfx3
|
regulatory factor X3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RFX3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:234,863,462...235,122,989
Ensembl chr 1:234,863,462...235,122,536
|
|
| G
|
Rgs10
|
regulator of G-protein signaling 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RGS10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:192,376,772...192,422,640
Ensembl chr 1:192,376,774...192,418,904
|
|
| G
|
Rgs17
|
regulator of G-protein signaling 17
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of RGS17 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:44,627,583...44,729,957
Ensembl chr 1:44,632,964...44,729,945
|
|
| G
|
Rgs19
|
regulator of G-protein signaling 19
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RGS19 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:189,182,041...189,190,494
Ensembl chr 3:189,182,383...189,190,736
|
|
| G
|
Rgs2
|
regulator of G-protein signaling 2
|
affects expression
|
EXP
|
Diazinon affects the expression of RGS2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
|
|
| G
|
Rgs3
|
regulator of G-protein signaling 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RGS3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:81,037,588...81,177,446
Ensembl chr 5:81,056,068...81,177,445
|
|
| G
|
Rgs4
|
regulator of G-protein signaling 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of RGS4 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884
|
|
| G
|
Rhoq
|
ras homolog family member Q
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RHOQ gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:13,368,499...13,403,929
Ensembl chr 1:115,757,909...115,759,467
|
|
| G
|
Rilp
|
Rab interacting lysosomal protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RILP gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:60,853,316...60,857,096
Ensembl chr10:60,853,547...60,857,092
|
|
| G
|
Ring1
|
ring finger protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RING1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,832,013...4,835,516
Ensembl chr20:4,831,993...4,835,513
|
|
| G
|
Rnd3
|
Rho family GTPase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of RND3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536
|
|
| G
|
Rnf139
|
ring finger protein 139
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RNF139 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:92,329,201...92,340,386
Ensembl chr 7:92,329,157...92,341,721
|
|
| G
|
Rnf181
|
ring finger protein 181
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RNF181 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:105,972,778...105,979,624
Ensembl chr 4:105,972,797...105,979,500
|
|
| G
|
Rnf207
|
ring finger protein 207
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RNF207 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:168,098,074...168,112,585
Ensembl chr 5:168,097,456...168,111,094
|
|
| G
|
Rnf34
|
ring finger protein 34
|
affects expression
|
EXP
|
Diazinon affects the expression of RNF34 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr12:39,364,461...39,385,391
Ensembl chr12:39,355,578...39,385,340
|
|
| G
|
Rnf4
|
ring finger protein 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RNF4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:80,625,864...80,647,138
Ensembl chr14:80,625,866...80,647,148
|
|
| G
|
Rnf44
|
ring finger protein 44
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RNF44 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:9,925,100...9,939,496
Ensembl chr17:9,930,375...9,939,478
|
|
| G
|
Rnpc3
|
RNA-binding region (RNP1, RRM) containing 3
|
increases expression
|
EXP
|
Diazinon results in increased expression of RNPC3 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 2:204,121,191...204,145,128
Ensembl chr 2:204,121,193...204,145,128
|
|
| G
|
Rorc
|
RAR-related orphan receptor C
|
multiple interactions increases expression
|
ISO
|
chrysin inhibits the reaction [Diazinon results in increased expression of RORC mRNA]
|
CTD |
PMID:36114367 |
|
NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:184,698,818...184,724,566
|
|
| G
|
Rpl12
|
ribosomal protein L12
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RPL12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:36,661,940...36,664,314
Ensembl chr 3:36,661,939...36,664,306
|
|
| G
|
Rpl8
|
ribosomal protein L8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RPL8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:110,506,815...110,509,106
Ensembl chr 7:110,506,800...110,509,103 Ensembl chr 3:110,506,800...110,509,103
|
|
| G
|
Rpp25
|
ribonuclease P and MRP subunit p25
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RPP25 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:66,803,262...66,804,642
Ensembl chr 8:66,803,212...66,810,550
|
|
| G
|
Rprm
|
reprimo, TP53 dependent G2 arrest mediator homolog
|
increases expression
|
EXP
|
Diazinon results in increased expression of RPRM mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 3:58,948,618...58,950,035
Ensembl chr 3:58,799,866...58,950,542
|
|
| G
|
Rps16
|
ribosomal protein S16
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RPS16 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:92,770,658...92,773,603
Ensembl chr19:56,922,246...56,923,020 Ensembl chr 1:56,922,246...56,923,020
|
|
| G
|
Rps2
|
ribosomal protein S2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RPS2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,251,841...14,253,697
Ensembl chr10:14,251,380...14,253,695
|
|
| G
|
Rps5
|
ribosomal protein S5
|
increases methylation decreases expression
|
ISO
|
Diazinon results in increased methylation of RPS5 gene Diazinon results in decreased expression of RPS5 mRNA
|
CTD |
PMID:18214912 PMID:22964155 |
|
NCBI chr 1:82,610,965...82,615,262
Ensembl chr 1:82,610,965...82,615,262
|
|
| G
|
Rras2
|
RAS related 2
|
increases expression
|
ISO
|
Diazinon results in increased expression of RRAS2 mRNA
|
CTD |
PMID:26198647 |
|
NCBI chr 1:177,668,143...177,737,551
Ensembl chr 1:177,668,144...177,737,551
|
|
| G
|
Rrbp1
|
ribosome binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RRBP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:151,768,386...151,830,255
Ensembl chr 3:151,768,386...151,830,255
|
|
| G
|
Rrm1
|
ribonucleotide reductase catalytic subunit M1
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of RRM1 mRNA
|
CTD |
PMID:16539210 |
|
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:166,235,900...166,260,944
|
|
| G
|
Rspo1
|
R-spondin 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RSPO1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:142,536,162...142,557,611
Ensembl chr 5:142,536,344...142,557,776
|
|
| G
|
Rtel1
|
regulator of telomere elongation helicase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RTEL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,778,329...188,842,877
Ensembl chr 3:188,807,951...188,843,709
|
|
| G
|
Rtn4
|
reticulon 4
|
affects expression
|
EXP
|
Diazinon affects the expression of RTN4 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:107,651,001...107,698,610
Ensembl chr14:107,650,732...107,698,611
|
|
| G
|
Rtn4rl2
|
reticulon 4 receptor-like 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RTN4RL2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:90,361,234...90,377,775
Ensembl chr 3:90,361,839...90,377,974
|
|
| G
|
Runx3
|
RUNX family transcription factor 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RUNX3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:152,644,270...152,702,835
Ensembl chr 5:152,644,270...152,702,835
|
|
| G
|
Rxrb
|
retinoid X receptor beta
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of RXRB gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:4,818,707...4,824,968
Ensembl chr20:4,818,709...4,825,359
|
|
| G
|
S100a6
|
S100 calcium binding protein A6
|
affects expression
|
EXP
|
Diazinon affects the expression of S100A6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:178,398,481...178,399,762
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
affects expression
|
EXP
|
Diazinon affects the expression of S100B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
S1pr2
|
sphingosine-1-phosphate receptor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of S1PR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:27,779,452...27,790,344
Ensembl chr 8:27,774,566...27,790,577
|
|
| G
|
Sacm1l
|
SAC1 like phosphatidylinositide phosphatase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SACM1L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:132,053,465...132,109,857
Ensembl chr 8:132,053,049...132,109,857
|
|
| G
|
Samd12
|
sterile alpha motif domain containing 12
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SAMD12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:86,658,709...86,953,879
Ensembl chr 7:86,658,072...87,207,686
|
|
| G
|
Samd14
|
sterile alpha motif domain containing 14
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SAMD14 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:80,453,952...80,469,182
Ensembl chr10:80,454,641...80,469,179
|
|
| G
|
Samd4a
|
sterile alpha motif domain containing 4A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SAMD4A gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:22,616,200...22,831,872
Ensembl chr15:22,614,287...22,831,872
|
|
| G
|
Samhd1
|
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SAMHD1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:166,179,742...166,214,448
Ensembl chr 3:166,181,588...166,214,410
|
|
| G
|
Sart1
|
spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP
|
affects expression
|
EXP
|
Diazinon affects the expression of SART1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:212,119,824...212,128,517
Ensembl chr 1:212,104,557...212,128,486
|
|
| G
|
Sass6
|
SAS-6 centriolar assembly protein
|
increases expression
|
EXP
|
Diazinon results in increased expression of SASS6 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 2:207,231,896...207,263,840
Ensembl chr 2:207,231,333...207,263,851
|
|
| G
|
Sbno2
|
strawberry notch homolog 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SBNO2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:10,256,221...10,300,175
Ensembl chr 7:10,253,248...10,300,176
|
|
| G
|
Scamp1
|
secretory carrier membrane protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SCAMP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:27,168,863...27,251,637
Ensembl chr 2:27,168,864...27,251,742
|
|
| G
|
Scarb1
|
scavenger receptor class B, member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SCARB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
| G
|
Scgb1c1
|
secretoglobin, family 1C, member 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SCGB1C1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:205,352,216...205,354,656
Ensembl chr 1:205,353,437...205,354,656
|
|
| G
|
Scn2a
|
sodium voltage-gated channel alpha subunit 2
|
affects expression
|
EXP
|
Diazinon affects the expression of SCN2A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:70,710,862...70,845,569
Ensembl chr 3:70,710,954...70,845,279
|
|
| G
|
Scube3
|
signal peptide, CUB domain and EGF like domain containing 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SCUBE3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:6,200,891...6,232,848
Ensembl chr20:6,200,178...6,233,051
|
|
| G
|
Sec14l3
|
SEC14-like lipid binding 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SEC14L3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:83,168,154...83,181,240
Ensembl chr14:83,168,208...83,179,654
|
|
| G
|
Sema3b
|
semaphorin 3B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SEMA3B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:117,150,307...117,161,570
Ensembl chr 8:117,150,589...117,157,658
|
|
| G
|
Sema3g
|
semaphorin 3G
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of SEMA3G gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:6,420,025...6,431,655
Ensembl chr16:6,420,012...6,432,553
|
|
| G
|
Sema4c
|
semaphorin 4C
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SEMA4C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:46,287,540...46,298,041
Ensembl chr 9:46,287,542...46,297,998
|
|
| G
|
Sema6a
|
semaphorin 6A
|
increases expression
|
EXP
|
Diazinon results in increased expression of SEMA6A mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr18:42,237,227...42,358,540
Ensembl chr18:42,237,228...42,358,540
|
|
| G
|
Sema7a
|
semaphorin 7A (John Milton Hagen blood group)
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SEMA7A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058
|
|
| G
|
Senp17
|
Sumo1/sentrin/SMT3 specific peptidase 17
|
affects expression
|
EXP
|
Diazinon affects the expression of SENP17 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:162,813,023...162,814,450
Ensembl chr 4:162,810,737...162,814,647
|
|
| G
|
Serpina1
|
serpin family A member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SERPINA1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
|
|
| G
|
Serpina12
|
serpin family A member 12
|
multiple interactions increases expression
|
EXP
|
Diazinon inhibits the reaction [Dietary Fats results in increased expression of SERPINA12 protein] Diazinon results in increased expression of SERPINA12 protein
|
CTD |
PMID:30359674 |
|
NCBI chr 6:128,717,334...128,732,049
Ensembl chr 6:128,717,334...128,732,049
|
|
| G
|
Setd3
|
SET domain containing 3, actin N3(tau)-histidine methyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SETD3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:132,787,478...132,854,421
Ensembl chr 6:132,787,495...132,854,421
|
|
| G
|
Sf3a1
|
splicing factor 3A subunit 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SF3A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:83,254,971...83,275,720
Ensembl chr14:83,254,971...83,275,720
|
|
| G
|
Sfxn5
|
sideroflexin 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SFXN5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:119,307,692...119,427,531
Ensembl chr 4:119,308,386...119,427,259
|
|
| G
|
Sgms1
|
sphingomyelin synthase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SGMS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:239,409,991...239,681,195
Ensembl chr 1:239,409,991...239,505,774
|
|
| G
|
Sgpl1
|
sphingosine-1-phosphate lyase 1
|
affects expression
|
EXP
|
Diazinon affects the expression of SGPL1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:29,590,652...29,637,064
Ensembl chr20:29,592,721...29,667,753
|
|
| G
|
Sgpp1
|
sphingosine-1-phosphate phosphatase 1
|
affects expression
|
EXP
|
Diazinon affects the expression of SGPP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 6:100,161,024...100,182,214
Ensembl chr 6:100,161,024...100,182,259
|
|
| G
|
Sgsm3
|
small G protein signaling modulator 3
|
affects expression
|
EXP
|
Diazinon affects the expression of SGSM3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:114,394,724...114,424,285
Ensembl chr 7:114,394,813...114,424,489
|
|
| G
|
Sh2b3
|
SH2B adaptor protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SH2B3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:40,392,633...40,414,335
|
|
| G
|
Sh3bp1
|
SH3-domain binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SH3BP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:112,338,087...112,350,659
Ensembl chr 7:112,338,107...112,350,659
|
|
| G
|
Sh3gl1
|
SH3 domain containing GRB2 like 1, endophilin A2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SH3GL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:929,459...956,922
Ensembl chr 9:928,563...956,890
|
|
| G
|
Sh3glb1
|
SH3 domain -containing GRB2-like endophilin B1
|
affects expression
|
EXP
|
Diazinon affects the expression of SH3GLB1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:236,410,436...236,445,140
|
|
| G
|
Sh3kbp1
|
SH3 domain-containing kinase-binding protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of SH3KBP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr X:38,686,530...39,031,658
Ensembl chr X:38,686,530...39,031,393
|
|
| G
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SHANK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:103,944,416...103,993,887
Ensembl chr 1:103,944,813...103,992,356
|
|
| G
|
Shb
|
SH2 domain containing adaptor protein B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SHB gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:64,473,694...64,581,072
Ensembl chr 5:64,473,694...64,581,072
|
|
| G
|
Shisa5
|
shisa family member 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SHISA5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,569,975...118,584,880
Ensembl chr 8:118,569,975...118,584,880
|
|
| G
|
Siah2
|
siah E3 ubiquitin protein ligase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of SIAH2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:145,063,847...145,081,675
Ensembl chr 2:145,063,857...145,081,873
|
|
| G
|
Siglec10
|
sialic acid binding Ig-like lectin 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SIGLEC10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:102,953,894...102,962,964
Ensembl chr 1:102,953,918...102,962,964
|
|
| G
|
Sin3a
|
SIN3 transcription regulator family member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SIN3A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:66,377,471...66,432,150
Ensembl chr 8:66,381,657...66,434,542
|
|
| G
|
Sirt1
|
sirtuin 1
|
decreases expression multiple interactions
|
EXP
|
Diazinon results in decreased expression of SIRT1 mRNA Resveratrol inhibits the reaction [Diazinon results in decreased expression of SIRT1 mRNA]
|
CTD |
PMID:35403302 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Sirt2
|
sirtuin 2
|
affects expression
|
EXP
|
Diazinon affects the expression of SIRT2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:93,181,224...93,204,499
|
|
| G
|
Sirt3
|
sirtuin 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SIRT3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:205,371,710...205,394,076
|
|
| G
|
Skil
|
SKI-like proto-oncogene
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SKIL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:114,175,534...114,203,663
Ensembl chr 2:114,175,534...114,201,974
|
|
| G
|
Slc10a3
|
solute carrier family 10, member 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC10A3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:157,306,043...157,309,849
Ensembl chr X:157,303,915...157,309,793
|
|
| G
|
Slc12a4
|
solute carrier family 12 member 4
|
affects expression
|
EXP
|
Diazinon affects the expression of SLC12A4 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:50,748,268...50,770,217
Ensembl chr19:50,748,279...50,770,259
|
|
| G
|
Slc12a7
|
solute carrier family 12 member 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC12A7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:31,301,243...31,382,825
Ensembl chr 1:31,301,243...31,382,957
|
|
| G
|
Slc13a4
|
solute carrier family 13 member 4
|
affects expression
|
EXP
|
Diazinon affects the expression of SLC13A4 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 4:64,910,505...64,955,986
Ensembl chr 4:64,910,507...64,955,986
|
|
| G
|
Slc16a13
|
solute carrier family 16, member 13
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC16A13 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,424,633...55,436,555
|
|
| G
|
Slc17a8
|
solute carrier family 17 member 8
|
multiple interactions
|
ISO
|
[Diazinon co-treated with NGF protein] results in decreased expression of SLC17A8 mRNA
|
CTD |
PMID:20600679 |
|
NCBI chr 7:25,881,557...25,936,837
Ensembl chr 7:25,881,557...25,935,410
|
|
| G
|
Slc18a1
|
solute carrier family 18 member A1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SLC18A1 mRNA
|
CTD |
PMID:18812211 PMID:18835401 |
|
NCBI chr16:25,408,485...25,453,786
Ensembl chr16:25,420,243...25,453,786
|
|
| G
|
Slc18a2
|
solute carrier family 18 member A2
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of SLC18A2 mRNA Diazinon results in decreased expression of SLC18A2 mRNA
|
CTD |
PMID:17452286 PMID:18812211 PMID:18835401 |
|
NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:268,400,016...268,435,231
|
|
| G
|
Slc18a3
|
solute carrier family 18 member A3
|
increases expression
|
EXP
|
Diazinon results in increased expression of SLC18A3 mRNA
|
CTD |
PMID:18812211 |
|
NCBI chr16:7,719,953...7,722,814
|
|
| G
|
Slc19a1
|
solute carrier family 19 member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC19A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:11,583,928...11,601,959
Ensembl chr20:11,583,929...11,601,488
|
|
| G
|
Slc1a2
|
solute carrier family 1 member 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SLC1A2 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
|
|
| G
|
Slc1a3
|
solute carrier family 1 member 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SLC1A3 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 2:59,482,707...59,557,808
Ensembl chr 2:59,482,709...59,557,808
|
|
| G
|
Slc1a4
|
solute carrier family 1 member 4
|
multiple interactions
|
ISO
|
[Diazinon co-treated with NGF protein] results in increased expression of SLC1A4 mRNA
|
CTD |
PMID:20600679 |
|
NCBI chr14:98,718,646...98,761,672
Ensembl chr14:98,730,450...98,761,790
|
|
| G
|
Slc1a5
|
solute carrier family 1 member 5
|
multiple interactions
|
ISO
|
[Diazinon co-treated with NGF protein] results in increased expression of SLC1A5 mRNA
|
CTD |
PMID:20600679 |
|
NCBI chr 1:86,584,949...86,599,052
Ensembl chr 1:86,584,949...86,599,054
|
|
| G
|
Slc22a18
|
solute carrier family 22, member 18
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC67A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:208,100,032...208,124,382
Ensembl chr 1:208,101,136...208,124,380
|
|
| G
|
Slc22a8
|
solute carrier family 22 member 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC22A8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
|
|
| G
|
Slc25a29
|
solute carrier family 25 member 29
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC25A29 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:133,506,403...133,517,322
Ensembl chr 6:133,506,331...133,517,827
|
|
| G
|
Slc25a47
|
solute carrier family 25, member 47
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC25A47 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:133,531,741...133,537,375
Ensembl chr 6:133,531,728...133,537,877
|
|
| G
|
Slc27a3
|
solute carrier family 27 member 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC27A3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:178,150,835...178,155,503
Ensembl chr 2:178,150,835...178,155,503
|
|
| G
|
Slc29a4
|
solute carrier family 29 member 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC29A4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:16,967,047...16,998,276
Ensembl chr12:16,967,047...16,988,338
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of SLC2A4 mRNA
|
CTD |
PMID:24238291 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Slc2a4rg
|
SLC2A4 regulator
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC2A4RG gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,871,509...188,874,652
|
|
| G
|
Slc31a1
|
solute carrier family 31 member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC31A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:80,830,574...80,859,810
Ensembl chr 5:80,830,389...80,859,809
|
|
| G
|
Slc35e4
|
solute carrier family 35, member E4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC35E4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:83,026,914...83,033,778
Ensembl chr14:83,026,915...83,033,778
|
|
| G
|
Slc38a1
|
solute carrier family 38, member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC38A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:129,612,414...129,681,727
Ensembl chr 7:129,617,387...129,681,778
|
|
| G
|
Slc38a6
|
solute carrier family 38, member 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC38A6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:97,723,526...97,814,394
Ensembl chr 6:97,723,471...97,785,791
|
|
| G
|
Slc40a1
|
solute carrier family 40 member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC40A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:55,525,532...55,543,460
|
|
| G
|
Slc46a2
|
solute carrier family 46, member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC46A2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:79,594,003...79,603,074
Ensembl chr 5:79,595,150...79,603,114
|
|
| G
|
Slc4a2
|
solute carrier family 4 member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC4A2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:11,628,860...11,646,961
Ensembl chr 4:11,628,862...11,645,402
|
|
| G
|
Slc5a7
|
solute carrier family 5 member 7
|
affects expression
|
EXP
|
Diazinon affects the expression of SLC5A7 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr 9:7,922,693...7,953,509
Ensembl chr 9:7,922,697...7,953,509
|
|
| G
|
Slc6a20a
|
solute carrier family 6 member 20a
|
increases expression
|
EXP
|
Diazinon results in increased expression of SLC6A20 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:132,159,768...132,200,016
Ensembl chr 8:132,158,915...132,200,008
|
|
| G
|
Slc6a3
|
solute carrier family 6 member 3
|
affects expression increases expression
|
EXP
|
Diazinon affects the expression of SLC6A3 mRNA Diazinon results in increased expression of SLC6A3 mRNA
|
CTD |
PMID:18812211 PMID:29108742 |
|
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:31,537,990...31,578,962
|
|
| G
|
Slc6a4
|
solute carrier family 6 member 4
|
decreases expression increases expression
|
EXP
|
Diazinon results in decreased expression of SLC6A4 mRNA; Diazinon results in decreased expression of SLC6A4 protein Diazinon results in increased expression of SLC6A4 protein
|
CTD |
PMID:17035140 PMID:18835401 PMID:26297601 |
|
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:62,324,254...62,357,056
|
|
| G
|
Slc6a8
|
solute carrier family 6 member 8
|
increases expression
|
EXP
|
Diazinon results in increased expression of SLC6A8 mRNA
|
CTD |
PMID:18812211 |
|
NCBI chr X:156,536,017...156,545,321
Ensembl chr X:156,536,017...156,545,321
|
|
| G
|
Slc6a9
|
solute carrier family 6 member 9
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLC6A9 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172
|
|
| G
|
Slc7a11
|
solute carrier family 7 member 11
|
increases expression
|
ISO
|
Diazinon results in increased expression of SLC7A11 mRNA
|
CTD |
PMID:24356939 PMID:26198647 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
|
|
| G
|
Slco1a5
|
solute carrier organic anion transporter family, member 1A5
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SLCO1A5 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 4:176,903,387...176,985,589
Ensembl chr 4:176,903,330...176,985,563
|
|
| G
|
Slco2a1
|
solute carrier organic anion transporter family, member 2a1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLCO2A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:112,467,739...112,551,923
Ensembl chr 8:112,467,160...112,551,921
|
|
| G
|
Slco4a1
|
solute carrier organic anion transporter family, member 4a1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SLCO4A1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:187,936,735...187,955,873
Ensembl chr 3:187,936,820...187,955,871
|
|
| G
|
Slfnl1
|
schlafen-like 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of SLFNL1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:139,402,861...139,407,332
Ensembl chr 5:139,403,672...139,407,332
|
|
| G
|
Sltm
|
SAFB-like, transcription modulator
|
increases expression
|
EXP
|
Diazinon results in increased expression of SLTM mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:80,096,555...80,142,668
Ensembl chr 8:80,097,652...80,142,671
|
|
| G
|
Smarce1
|
SWI/SNF related BAF chromatin remodeling complex subunit E1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SMARCE1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:84,655,468...84,678,259
Ensembl chr10:84,655,468...84,676,185
|
|
| G
|
Smc3
|
structural maintenance of chromosomes 3
|
affects expression
|
EXP
|
Diazinon affects the expression of SMC3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:262,606,731...262,649,832
Ensembl chr 1:262,607,080...262,649,825
|
|
| G
|
Smg7
|
SMG7 nonsense mediated mRNA decay factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SMG7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:67,536,016...67,600,624
Ensembl chr13:67,536,044...67,600,437
|
|
| G
|
Smpd3
|
sphingomyelin phosphodiesterase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of SMPD3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:51,072,209...51,155,639
Ensembl chr19:51,072,209...51,085,936
|
|
| G
|
Smpd4
|
sphingomyelin phosphodiesterase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SMPD4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:96,866,805...96,890,520
Ensembl chr11:96,866,805...96,890,520
|
|
| G
|
Snai1
|
snail family transcriptional repressor 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SNAI1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:176,667,476...176,671,965
|
|
| G
|
Snapc2
|
small nuclear RNA activating complex, polypeptide 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SNAPC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:7,403,650...7,406,840
Ensembl chr12:7,403,469...7,406,840
|
|
| G
|
Sncb
|
synuclein, beta
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of SNCB gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:9,851,825...9,860,143
Ensembl chr17:9,840,019...9,860,142
|
|
| G
|
Sncg
|
synuclein, gamma
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SNCG gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,706,753...9,712,076
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of SOD1 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of SOD2 mRNA
|
CTD |
PMID:19440498 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SOD3 mRNA
|
CTD |
PMID:17452286 |
|
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Son
|
SON DNA and RNA binding protein
|
affects expression
|
EXP
|
Diazinon affects the expression of SON mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:44,336,818...44,409,127
Ensembl chr11:44,377,976...44,409,127
|
|
| G
|
Sord
|
sorbitol dehydrogenase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SORD gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100
|
|
| G
|
Sostdc1
|
sclerostin domain containing 1
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of SOSTDC1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 6:58,778,623...58,782,797
Ensembl chr 6:58,778,623...58,782,866
|
|
| G
|
Sox12
|
SRY-box transcription factor 12
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SOX12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:161,319,800...161,320,819
Ensembl chr 3:161,298,764...161,326,428
|
|
| G
|
Sp1
|
Sp1 transcription factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
|
|
| G
|
Sp4
|
Sp4 transcription factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SP4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:145,330,416...145,395,750
Ensembl chr 6:145,330,416...145,395,146
|
|
| G
|
Spag5
|
sperm associated antigen 5
|
affects expression
|
EXP
|
Diazinon affects the expression of SPAG5 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,696,466...63,714,811
|
|
| G
|
Spag7
|
sperm associated antigen 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SPAG7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,875,868...55,882,025
Ensembl chr10:55,875,868...55,882,025
|
|
| G
|
Spata2L
|
spermatogenesis associated 2-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SPATA2L gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:68,177,599...68,182,122
Ensembl chr19:68,176,615...68,182,069
|
|
| G
|
Spata3
|
spermatogenesis associated 3
|
affects expression
|
EXP
|
Diazinon affects the expression of SPATA3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:94,107,832...94,120,280
Ensembl chr 9:94,107,807...94,119,172
|
|
| G
|
Spatc1l
|
spermatogenesis and centriole associated 1-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SPATC1L gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:12,073,542...12,082,866
Ensembl chr20:12,073,543...12,118,253
|
|
| G
|
Sphk1
|
sphingosine kinase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SPHK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:102,257,413...102,263,086
Ensembl chr10:102,258,975...102,263,082
|
|
| G
|
Spsb2
|
splA/ryanodine receptor domain and SOCS box containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SPSB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:159,298,362...159,301,568
Ensembl chr 4:159,299,159...159,309,021
|
|
| G
|
Sptbn4
|
spectrin, beta, non-erythrocytic 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SPTBN4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:91,778,379...91,865,970
Ensembl chr 1:91,778,380...91,865,049
|
|
| G
|
Sqstm1
|
sequestosome 1
|
increases methylation increases expression affects expression
|
ISO EXP
|
Diazinon results in increased methylation of SQSTM1 gene Diazinon results in increased expression of SQSTM1 mRNA Diazinon affects the expression of SQSTM1 mRNA
|
CTD |
PMID:22546817 PMID:22964155 PMID:26198647 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Srf
|
serum response factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SRF gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:21,924,050...21,933,338
Ensembl chr 9:21,924,076...21,933,337
|
|
| G
|
Srms
|
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SRMS gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,696,070...188,702,474
Ensembl chr 3:188,696,071...188,702,474
|
|
| G
|
Srrm1
|
serine and arginine repetitive matrix 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SRRM1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:152,843,167...152,875,554
Ensembl chr 5:152,843,169...152,875,436
|
|
| G
|
Srrm2
|
serine/arginine repetitive matrix 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SRRM2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
|
|
| G
|
Srrt
|
serrate, RNA effector molecule
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SRRT gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:25,027,883...25,042,847
Ensembl chr12:25,029,334...25,042,845
|
|
| G
|
Srxn1
|
sulfiredoxin 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of SRXN1 mRNA
|
CTD |
PMID:24356939 PMID:26198647 |
|
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
|
|
| G
|
Ssbp3
|
single stranded DNA binding protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SSBP3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:126,920,145...127,057,968
Ensembl chr 5:126,919,120...127,056,799
|
|
| G
|
Ssr2
|
signal sequence receptor subunit 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SSR2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:176,346,117...176,354,868
Ensembl chr 2:176,346,404...176,355,781
|
|
| G
|
Sstr1
|
somatostatin receptor 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of SSTR1 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 6:81,567,237...81,571,759
Ensembl chr 6:81,566,850...81,571,992
|
|
| G
|
Sstr4
|
somatostatin receptor 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SSTR4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:156,307,992...156,309,855
Ensembl chr 3:156,307,093...156,550,348
|
|
| G
|
St3gal2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ST3GAL2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:55,798,112...55,849,226
Ensembl chr19:55,799,471...55,849,225
|
|
| G
|
St3gal4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ST3GAL4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:41,673,510...41,723,158
Ensembl chr 8:41,673,510...41,712,551
|
|
| G
|
Stag1
|
STAG1 cohesin complex component
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of STAG1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:110,057,981...110,443,666
Ensembl chr 8:110,058,056...110,443,665
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions
|
EXP
|
Diazinon inhibits the reaction [PMSG-HCG results in increased expression of STAR mRNA]
|
CTD |
PMID:29881411 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Steap3
|
STEAP3 metalloreductase
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of STEAP3 gene Diazinon affects the expression of STEAP3 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr13:33,904,710...33,950,100
Ensembl chr13:33,904,710...33,950,080
|
|
| G
|
Stip1
|
stress-induced phosphoprotein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of STIP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:213,638,641...213,657,654
|
|
| G
|
Stk17b
|
serine/threonine kinase 17b
|
affects expression
|
EXP
|
Diazinon affects the expression of STK17B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:62,801,912...62,832,511
Ensembl chr 9:62,803,005...62,832,511
|
|
| G
|
Strbp
|
spermatid perinuclear RNA binding protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of STRBP gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:41,738,096...41,879,054
Ensembl chr 3:41,712,311...41,824,707
|
|
| G
|
Stub1
|
STIP1 homology and U-box containing protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of STUB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:15,355,278...15,357,559
Ensembl chr10:15,355,279...15,357,559
|
|
| G
|
Stx1a
|
syntaxin 1A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of STX1A gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:27,278,517...27,306,547
Ensembl chr12:27,278,517...27,306,471
|
|
| G
|
Suox
|
sulfite oxidase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SUOX gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:1,687,666...1,691,759
Ensembl chr 7:1,687,666...1,690,235
|
|
| G
|
Suv39h1
|
SUV39H1 histone lysine methyltransferase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SUV39H1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942
|
|
| G
|
Suv39h1-ps1
|
SUV39H1 histone lysine methyltransferase, pseudogene 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SUV39H1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:146,828,818...146,831,485
|
|
| G
|
Sync
|
syncoilin, intermediate filament protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SYNC gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:146,915,715...146,940,547
Ensembl chr 5:146,916,361...146,943,191
|
|
| G
|
Syndig1
|
synapse differentiation inducing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SYNDIG1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:158,491,474...158,695,174
Ensembl chr 3:158,491,996...158,658,652
|
|
| G
|
Syt8
|
synaptotagmin 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of SYT8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:207,017,602...207,023,076
Ensembl chr 1:207,017,461...207,023,076
|
|
| G
|
Syvn1
|
synoviolin 1
|
affects expression
|
EXP
|
Diazinon affects the expression of SYVN1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:212,766,736...212,775,426
Ensembl chr 1:212,768,907...212,776,457
|
|
| G
|
Tab1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TAB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:113,556,157...113,587,351
Ensembl chr 7:113,555,819...113,587,351
|
|
| G
|
Tac1
|
tachykinin, precursor 1
|
increases expression
|
EXP
|
Diazinon results in increased expression of TAC1 mRNA
|
CTD |
PMID:20682304 |
|
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
|
|
| G
|
Tac4
|
tachykinin precursor 4
|
increases expression
|
EXP
|
Diazinon results in increased expression of TAC4 mRNA
|
CTD |
PMID:20682304 |
|
NCBI chr10:80,704,640...80,712,972
Ensembl chr10:80,701,987...80,712,972
|
|
| G
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3
|
affects expression
|
EXP
|
Diazinon affects the expression of TACC3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:81,275,755...81,289,894
Ensembl chr14:81,275,755...81,289,698
|
|
| G
|
Taf6
|
TATA-box binding protein associated factor 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TAF6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:22,169,570...22,178,031
Ensembl chr12:22,168,718...22,177,938
|
|
| G
|
Tax1bp1
|
Tax1 binding protein 1
|
affects expression
|
EXP
|
Diazinon affects the expression of TAX1BP1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 4:83,152,549...83,208,463
Ensembl chr 4:83,110,062...83,209,657
|
|
| G
|
Tax1bp3
|
Tax1 binding protein 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TAX1BP3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:58,294,357...58,298,875
Ensembl chr10:58,294,073...58,298,875
|
|
| G
|
Tbc1d10b
|
TBC1 domain family, member 10b
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TBC1D10B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:191,245,472...191,257,128
Ensembl chr 1:191,239,615...191,257,128
|
|
| G
|
Tbc1d14
|
TBC1 domain family, member 14
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TBC1D14 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:78,397,345...78,496,863
Ensembl chr14:78,397,355...78,496,865
|
|
| G
|
Tbx21
|
T-box transcription factor 21
|
decreases expression multiple interactions
|
ISO
|
Diazinon results in decreased expression of TBX21 mRNA chrysin inhibits the reaction [Diazinon results in decreased expression of TBX21 mRNA]
|
CTD |
PMID:36114367 |
|
NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,578,751...82,595,253
|
|
| G
|
Tcf7
|
transcription factor 7
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of TCF7 gene Diazinon affects the expression of TCF7 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr10:36,924,363...36,954,279
Ensembl chr10:36,924,363...36,954,279
|
|
| G
|
Tcfl5
|
transcription factor like 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TCFL5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,112,037...188,131,883
Ensembl chr 3:188,112,037...188,131,883
|
|
| G
|
Tcirg1
|
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TCIRG1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:210,556,270...210,568,021
Ensembl chr 1:210,556,270...210,568,033
|
|
| G
|
Tdp1
|
tyrosyl-DNA phosphodiesterase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TDP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:124,892,821...124,960,646
Ensembl chr 6:124,881,574...124,960,642
|
|
| G
|
Tead2
|
TEA domain transcription factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TEAD2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:104,838,795...104,855,635
Ensembl chr 1:104,838,623...104,855,630
|
|
| G
|
Tecr
|
trans-2,3-enoyl-CoA reductase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TECR gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:41,431,422...41,472,880
Ensembl chr19:41,446,071...41,474,432
|
|
| G
|
Tedc1
|
tubulin epsilon and delta complex 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TEDC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:138,056,029...138,068,899
Ensembl chr 6:138,056,027...138,067,274
|
|
| G
|
Tent5c
|
terminal nucleotidyltransferase 5C
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TENT5C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:190,541,668...190,563,902
Ensembl chr 2:190,540,650...190,565,995
|
|
| G
|
Tesk1
|
testis associated actin remodelling kinase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TESK1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:62,487,763...62,493,492
Ensembl chr 5:62,487,763...62,493,492
|
|
| G
|
Tex13b
|
testis expressed 13B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TEX13B gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:109,278,123...109,299,718
Ensembl chr X:109,279,874...109,282,878
|
|
| G
|
Tfdp2
|
transcription factor Dp-2
|
affects expression
|
EXP
|
Diazinon affects the expression of TFDP2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:105,640,018...105,781,026
Ensembl chr 8:105,640,033...105,781,001
|
|
| G
|
Tfip11
|
tuftelin interacting protein 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TFIP11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:49,960,025...49,972,257
Ensembl chr12:49,960,026...49,972,257
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
affects expression increases expression multiple interactions
|
EXP ISO
|
Diazinon affects the expression of TGFB1 mRNA Diazinon results in increased expression of TGFB1 mRNA; Diazinon results in increased expression of TGFB1 protein chrysin inhibits the reaction [Diazinon results in increased expression of TGFB1 mRNA]
|
CTD |
PMID:22546817 PMID:30978295 PMID:36114367 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb3
|
transforming growth factor, beta 3
|
increases expression affects expression
|
ISO EXP
|
Diazinon results in increased expression of TGFB3 mRNA Diazinon affects the expression of TGFB3 mRNA
|
CTD |
PMID:16758764 PMID:22546817 |
|
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
|
|
| G
|
Tgif2
|
TGFB-induced factor homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TGIF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:165,791,101...165,808,669
Ensembl chr 3:165,793,480...165,808,666
|
|
| G
|
Tgm2
|
transglutaminase 2
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of TGM2 gene Diazinon affects the expression of TGM2 mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
|
|
| G
|
Th
|
tyrosine hydroxylase
|
increases expression
|
EXP
|
Diazinon results in increased expression of TH mRNA
|
CTD |
PMID:17452286 PMID:18812211 |
|
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Thra
|
thyroid hormone receptor alpha
|
affects expression
|
EXP
|
Diazinon affects the expression of THRA mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
|
|
| G
|
Timm8b
|
translocase of inner mitochondrial membrane 8 homolog B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TIMM8B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:59,850,737...59,852,117
Ensembl chr 8:59,850,728...59,852,962
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TIMP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Tinf2
|
TERF1 interacting nuclear factor 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TINF2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:33,140,611...33,146,930
Ensembl chr15:33,140,714...33,146,930
|
|
| G
|
Tkt
|
transketolase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TKT gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,729,991...5,756,431
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
increases response to substance multiple interactions
|
ISO
|
TLR4 protein mutant form results in increased susceptibility to Diazinon [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in decreased expression of BDNF mRNA; [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in decreased expression of NGF mRNA; [TLR4 protein mutant form results in increased susceptibility to Diazinon] which results in increased expression of BAX mRNA
|
CTD |
PMID:22428454 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tlr8
|
toll-like receptor 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TLR8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:30,708,714...30,733,104
Ensembl chr X:30,708,033...30,737,079
|
|
| G
|
Tm2d3
|
TM2 domain containing 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TM2D3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:128,677,680...128,687,580
Ensembl chr 1:128,677,629...128,687,580
|
|
| G
|
Tm6sf1
|
transmembrane 6 superfamily member 1
|
increases expression
|
ISO
|
Diazinon results in increased expression of TM6SF1 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 1:145,209,052...145,237,725
Ensembl chr 1:145,209,585...145,237,715
|
|
| G
|
Tm9sf1
|
transmembrane 9 superfamily member 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TM9SF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:33,097,541...33,108,106
Ensembl chr15:33,097,552...33,105,290
|
|
| G
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6
|
affects expression
|
EXP
|
Diazinon affects the expression of TMBIM6 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:132,405,217...132,422,492
Ensembl chr 7:132,386,134...132,422,492
|
|
| G
|
Tmc2
|
transmembrane channel-like 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:137,849,513...137,917,462
Ensembl chr 3:137,849,513...137,917,462
|
|
| G
|
Tmcc2
|
transmembrane and coiled-coil domain family 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMCC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:46,346,177...46,383,862
Ensembl chr13:46,346,177...46,383,862
|
|
| G
|
Tmem141
|
transmembrane protein 141
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM141 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:28,837,665...28,839,623
Ensembl chr 3:28,836,576...28,839,623
|
|
| G
|
Tmem147
|
transmembrane protein 147
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM147 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:95,104,448...95,106,268
Ensembl chr 1:95,104,452...95,106,283
|
|
| G
|
Tmem176b
|
transmembrane protein 176B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM176B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:79,097,808...79,105,263
Ensembl chr 4:79,097,808...79,105,263
|
|
| G
|
Tmem256
|
transmembrane protein 256
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM256 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:55,056,959...55,058,869
Ensembl chr10:55,056,760...55,058,862
|
|
| G
|
Tmem268
|
transmembrane protein 268
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM268 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:81,990,314...82,016,970
Ensembl chr 5:81,991,367...82,016,968
|
|
| G
|
Tmem38a
|
transmembrane protein 38a
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM38A gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:17,292,215...17,307,704
Ensembl chr16:17,292,215...17,333,132
|
|
| G
|
Tmem38b
|
transmembrane protein 38B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM38B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:73,255,662...73,291,383
Ensembl chr 5:73,255,632...73,292,384
|
|
| G
|
Tmem61
|
transmembrane protein 61
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM61 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:126,495,615...126,505,242
Ensembl chr 5:126,495,615...126,505,242
|
|
| G
|
Tmem80
|
transmembrane protein 80
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM80 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:205,865,564...205,873,933
Ensembl chr 1:205,864,852...205,873,933
|
|
| G
|
Tmem98
|
transmembrane protein 98
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMEM98 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:66,293,895...66,304,806
Ensembl chr10:66,293,867...66,304,803
|
|
| G
|
Tmsb10
|
thymosin, beta 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TMSB10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:106,568,080...106,569,210
|
|
| G
|
Tnf
|
tumor necrosis factor
|
increases expression multiple interactions affects expression increases secretion
|
EXP ISO
|
Diazinon results in increased expression of TNF protein Diazinon results in increased expression of TNF mRNA; Diazinon results in increased expression of TNF protein Diazinon promotes the reaction [Dietary Fats results in increased expression of TNF protein] [TNF protein co-treated with Diazinon] results in decreased expression of CXCL8 mRNA; TNF protein affects the reaction [Diazinon affects the expression of TNF mRNA] Diazinon results in increased secretion of TNF protein
|
CTD |
PMID:19589100 PMID:24238291 PMID:28119078 PMID:30359674 PMID:30978295 PMID:35934178 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfaip1
|
TNF alpha induced protein 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TNFAIP1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:63,915,824...63,930,514
Ensembl chr10:63,915,825...63,930,514
|
|
| G
|
Tnfaip2
|
TNF alpha induced protein 2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of TNFAIP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:136,297,388...136,311,106
Ensembl chr 6:136,298,082...136,311,106
|
|
| G
|
Tnfrsf10b
|
TNF receptor superfamily member 10b
|
decreases expression multiple interactions
|
ISO
|
Diazinon results in decreased expression of TNFRSF10A mRNA Magnesium Oxide analog promotes the reaction [Diazinon results in decreased expression of TNFRSF10A mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of TNFRSF10A mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
|
|
| G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TNFRSF12A gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
multiple interactions increases expression
|
ISO
|
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of TNFRSF1A mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfrsf22
|
tumor necrosis factor receptor superfamily, member 22
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of TNFRSF10C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:208,269,844...208,285,823
Ensembl chr 1:208,258,836...208,289,832
|
|
| G
|
Tnfrsf25
|
TNF receptor superfamily member 25
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TNFRSF25 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:167,904,377...167,909,052
Ensembl chr 5:167,904,786...167,909,052
|
|
| G
|
Tnfsf12
|
TNF superfamily member 12
|
affects expression
|
EXP
|
Diazinon affects the expression of TNFSF12 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr10:54,902,616...54,912,628
Ensembl chr10:54,902,616...54,911,913
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TNNT2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tnrc6b
|
trinucleotide repeat containing adaptor 6B
|
affects expression
|
EXP
|
Diazinon affects the expression of TNRC6B mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 7:114,132,574...114,350,010
Ensembl chr 7:114,132,573...114,342,973
|
|
| G
|
Tomm40
|
translocase of outer mitochondrial membrane 40
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TOMM40 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:88,486,745...88,498,833
Ensembl chr 1:88,486,758...88,499,671
|
|
| G
|
Tor3a
|
torsin family 3, member A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TOR3A gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:71,324,073...71,348,625
Ensembl chr13:71,324,076...71,348,624
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression multiple interactions affects expression
|
EXP ISO
|
Diazinon results in increased expression of TP53 mRNA [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of TP53 mRNA]; Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of TP53 mRNA] Diazinon affects the expression of TP53 mRNA
|
CTD |
PMID:17452286 PMID:22546817 PMID:27920530 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tp53bp2
|
tumor protein p53 binding protein, 2
|
affects expression
|
EXP
|
Diazinon affects the expression of TP53BP2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr13:96,620,429...96,677,090
Ensembl chr13:96,620,428...96,677,616
|
|
| G
|
Tp53i11
|
tumor protein p53 inducible protein 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TP53I11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432
|
|
| G
|
Tp73
|
tumor protein p73
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TP73 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:169,903,801...169,963,552
|
|
| G
|
Tph1
|
tryptophan hydroxylase 1
|
affects expression increases expression
|
EXP
|
Diazinon affects the expression of TPH1 mRNA Diazinon results in increased expression of TPH1 mRNA
|
CTD |
PMID:17452286 PMID:18835401 |
|
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:106,085,953...106,312,484
|
|
| G
|
Tprg1l
|
tumor protein p63 regulated 1-like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TPRG1L gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:170,004,577...170,007,784
Ensembl chr 5:170,004,577...170,007,983
|
|
| G
|
Tpsab1
|
tryptase alpha/beta 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TPSAB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,864,887...14,867,302
Ensembl chr10:14,864,887...14,867,302
|
|
| G
|
Tra2a
|
transformer 2 alpha
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRA2A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:79,551,542...79,570,619
|
|
| G
|
Tradd
|
TNFRSF1A-associated via death domain
|
affects expression
|
EXP
|
Diazinon affects the expression of TRADD mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:50,046,061...50,052,550
|
|
| G
|
Traf2
|
Tnf receptor-associated factor 2
|
increases expression multiple interactions
|
ISO
|
Diazinon results in increased expression of TRAF2 mRNA Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of TRAF2 mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of TRAF2 mRNA]
|
CTD |
PMID:27920530 |
|
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691
|
|
| G
|
Traf7
|
TNF receptor associated factor 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRAF7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:14,038,117...14,056,832
Ensembl chr10:14,038,117...14,056,694
|
|
| G
|
Trappc3
|
trafficking protein particle complex subunit 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRAPPC3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:143,843,612...143,857,347
Ensembl chr 5:143,836,912...143,857,345
|
|
| G
|
Trex1
|
three prime repair exonuclease 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TREX1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:118,585,081...118,586,083
|
|
| G
|
Trib3
|
tribbles pseudokinase 3
|
affects expression
|
EXP
|
Diazinon affects the expression of TRIB3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
|
|
| G
|
Trim28
|
tripartite motif-containing 28
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRIM28 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:82,724,842...82,731,566
Ensembl chr 1:82,724,838...82,731,572
|
|
| G
|
Trim3
|
tripartite motif-containing 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRIM3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:169,362,751...169,385,430
Ensembl chr 1:169,356,738...169,385,430
|
|
| G
|
Trim59
|
tripartite motif-containing 59
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRIM59 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:155,579,183...155,593,450
Ensembl chr 2:155,567,115...155,598,645
|
|
| G
|
Trip11
|
thyroid hormone receptor interactor 11
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRIP11 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:126,760,263...126,832,619
Ensembl chr 6:126,760,265...126,832,570
|
|
| G
|
Trip13
|
thyroid hormone receptor interactor 13
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRIP13 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:31,185,700...31,230,638
Ensembl chr 1:31,185,594...31,230,634
|
|
| G
|
Trir
|
telomerase RNA component interacting RNase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRIR gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:40,029,952...40,033,368
Ensembl chr19:40,029,952...40,033,368
|
|
| G
|
Trmt1
|
tRNA methyltransferase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRMT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:40,361,583...40,374,971
Ensembl chr19:40,361,583...40,374,622
|
|
| G
|
Trmt112
|
tRNA methyltransferase activator subunit 11-2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRMT112 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:213,532,507...213,533,360
Ensembl chr 1:213,532,175...213,533,356
|
|
| G
|
Trmt2b
|
tRNA methyltransferase 2 homolog B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRMT2B gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:101,716,656...101,777,105
|
|
| G
|
Trpm4
|
transient receptor potential cation channel, subfamily M, member 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRPM4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:104,918,462...104,949,453
Ensembl chr 1:104,918,462...104,948,653
|
|
| G
|
Trpm5
|
transient receptor potential cation channel, subfamily M, member 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRPM5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:207,684,811...207,707,380
Ensembl chr 1:207,685,157...207,707,088
|
|
| G
|
Trpv3
|
transient receptor potential cation channel, subfamily V, member 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRPV3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:58,382,054...58,413,657
Ensembl chr10:58,382,054...58,411,800
|
|
| G
|
Trrap
|
transformation/transcription domain-associated protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TRRAP gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:14,851,758...14,941,444
Ensembl chr12:14,851,758...14,941,407
|
|
| G
|
Tsc22d2
|
TSC22 domain family, member 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TSC22D2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:144,796,760...144,847,930
Ensembl chr 2:144,796,841...144,843,559
|
|
| G
|
Tsnare1
|
t-SNARE domain containing 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TSNARE1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:108,115,051...108,296,299
|
|
| G
|
Tspear
|
thrombospondin-type laminin G domain and EAR repeats
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TSPEAR gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:10,771,365...10,944,285
Ensembl chr20:10,771,371...10,943,708
|
|
| G
|
Tssc4
|
tumor suppressing subtransferable candidate 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TSSC4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:207,681,420...207,684,244
Ensembl chr 1:207,682,322...207,685,485
|
|
| G
|
Ttc16
|
tetratricopeptide repeat domain 16
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TTC16 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:36,450,271...36,462,590
Ensembl chr 3:36,446,272...36,462,368
|
|
| G
|
Ttc19
|
tetratricopeptide repeat domain 19
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TTC19 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:47,469,043...47,496,923
Ensembl chr10:47,469,043...47,517,286
|
|
| G
|
Ttk
|
Ttk protein kinase
|
affects expression
|
EXP
|
Diazinon affects the expression of TTK mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664
|
|
| G
|
Ttl
|
tubulin tyrosine ligase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TTL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:136,752,025...136,781,758
Ensembl chr 3:136,752,000...136,781,758
|
|
| G
|
Ttll12
|
tubulin tyrosine ligase like 12
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TTLL12 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:116,612,609...116,631,244
Ensembl chr 7:116,612,609...116,631,577
|
|
| G
|
Ttpal
|
alpha tocopherol transfer protein like
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TTPAL gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:172,697,683...172,715,973
Ensembl chr 3:172,697,729...172,715,983
|
|
| G
|
Ttr
|
transthyretin
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of TTR mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969
|
|
| G
|
Tub
|
TUB bipartite transcription factor
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TUB gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:172,386,772...172,465,791
Ensembl chr 1:172,382,197...172,465,790
|
|
| G
|
Tuba4a
|
tubulin, alpha 4A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TUBA4A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:84,158,280...84,162,584
|
|
| G
|
Tubb4a
|
tubulin, beta 4A class IVa
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of TUBB4A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:2,004,840...2,012,286
|
|
| G
|
Tubb4b
|
tubulin, beta 4B class IVb
|
increases expression
|
EXP
|
Diazinon results in increased expression of TUBB4B mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:28,435,148...28,439,719
|
|
| G
|
Tube1
|
tubulin, epsilon 1
|
affects expression
|
EXP
|
Diazinon affects the expression of TUBE1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr20:44,105,405...44,124,947
Ensembl chr20:44,107,022...44,125,271
|
|
| G
|
Tut1
|
terminal uridylyl transferase 1, U6 snRNA-specific
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TUT1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:215,277,802...215,288,869
|
|
| G
|
Txndc17
|
thioredoxin domain containing 17
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of TXNDC17 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:57,331,312...57,334,284
Ensembl chr10:57,331,312...57,334,284
|
|
| G
|
Txnl1
|
thioredoxin-like 1
|
affects expression
|
EXP
|
Diazinon affects the expression of TXNL1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr18:59,397,275...59,428,072
Ensembl chr18:59,398,535...59,435,518
|
|
| G
|
U2af1l4
|
U2 small nuclear RNA auxiliary factor 1-like 4
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of U2AF1L4 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:94,943,684...94,945,906
Ensembl chr 1:94,942,544...94,946,391
|
|
| G
|
Uba6
|
ubiquitin-like modifier activating enzyme 6
|
increases expression
|
EXP
|
Diazinon results in increased expression of UBA6 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr14:22,238,832...22,302,650
Ensembl chr14:22,211,601...22,302,650
|
|
| G
|
Ube2b
|
ubiquitin-conjugating enzyme E2B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UBE2B gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:36,749,365...36,764,335
Ensembl chr10:36,749,369...36,765,587
|
|
| G
|
Ube2c
|
ubiquitin-conjugating enzyme E2C
|
affects expression
|
EXP
|
Diazinon affects the expression of UBE2C mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
|
|
| G
|
Ube2d2
|
ubiquitin-conjugating enzyme E2D 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UBE2D2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:27,638,399...27,680,386
Ensembl chr18:27,638,527...27,683,074
|
|
| G
|
Ube2l3
|
ubiquitin-conjugating enzyme E2L 3
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of UBE2L3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:97,300,584...97,343,084
Ensembl chr11:97,301,945...97,343,084
|
|
| G
|
Ube2q1
|
ubiquitin conjugating enzyme E2 Q1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UBE2Q1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:177,496,480...177,505,631
Ensembl chr 2:177,496,560...177,505,629
|
|
| G
|
Ube2s
|
ubiquitin-conjugating enzyme E2S
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UBE2S gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:78,057,659...78,061,719
Ensembl chr 1:78,057,598...78,081,628
|
|
| G
|
Ube2z
|
ubiquitin-conjugating enzyme E2Z
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UBE2Z gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:81,494,522...81,513,641
Ensembl chr10:81,494,523...81,513,641
|
|
| G
|
Ube3a
|
ubiquitin protein ligase E3A
|
increases expression
|
EXP
|
Diazinon results in increased expression of UBE3A mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:119,206,148...119,297,097
|
|
| G
|
Ubl4a
|
ubiquitin-like 4A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UBL4A gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:157,302,528...157,305,380
Ensembl chr X:157,304,254...157,305,380
|
|
| G
|
Uchl1
|
ubiquitin C-terminal hydrolase L1
|
affects expression
|
EXP
|
Diazinon affects the expression of UCHL1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417
|
|
| G
|
Uchl5
|
ubiquitin C-terminal hydrolase L5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UCHL5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr13:58,070,947...58,106,825
Ensembl chr13:58,042,029...58,107,441
|
|
| G
|
Unc13c
|
unc-13 homolog C
|
increases expression
|
EXP
|
Diazinon results in increased expression of UNC13C mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 8:83,127,650...83,553,822
Ensembl chr 8:83,128,523...83,553,822
|
|
| G
|
Unc45a
|
unc-45 myosin chaperone A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UNC45A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:143,691,183...143,705,944
Ensembl chr 1:143,691,186...143,707,312
|
|
| G
|
Unc5a
|
unc-5 netrin receptor A
|
affects expression
|
EXP
|
Diazinon affects the expression of UNC5A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr17:9,620,005...9,675,794
Ensembl chr17:9,620,005...9,676,140
|
|
| G
|
Unc5c
|
unc-5 netrin receptor C
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UNC5C gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:232,854,352...233,208,482
Ensembl chr 2:232,846,262...233,208,482
|
|
| G
|
Ung
|
uracil-DNA glycosylase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UNG gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
|
|
| G
|
Upf1
|
UPF1, RNA helicase and ATPase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UPF1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:19,110,531...19,131,327
Ensembl chr16:19,110,538...19,131,327
|
|
| G
|
Uroc1
|
urocanate hydratase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UROC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 4:124,402,119...124,433,787
Ensembl chr 4:124,402,156...124,434,212
|
|
| G
|
Urod
|
uroporphyrinogen decarboxylase
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UROD gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:135,701,294...135,705,380
Ensembl chr 5:135,701,296...135,705,380
|
|
| G
|
Usb1
|
U6 snRNA biogenesis phosphodiesterase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of USB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:9,695,370...9,708,329
Ensembl chr19:9,694,267...9,708,329
|
|
| G
|
Usp16
|
ubiquitin specific peptidase 16
|
affects expression
|
EXP
|
Diazinon affects the expression of USP16 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr11:40,166,651...40,196,792
Ensembl chr11:40,167,692...40,196,823
|
|
| G
|
Usp33
|
ubiquitin specific peptidase 33
|
increases expression
|
EXP
|
Diazinon results in increased expression of USP33 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 2:243,938,958...243,988,424
Ensembl chr 2:243,943,175...243,988,424
|
|
| G
|
Utp14a
|
UTP14A small subunit processome component
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of UTP14A gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:132,317,163...132,342,524
Ensembl chr X:132,317,159...132,342,523
|
|
| G
|
Utp18
|
UTP18 small subunit processome component
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UTP18 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:79,308,785...79,336,241
Ensembl chr10:79,308,787...79,336,197
|
|
| G
|
Uvrag
|
UV radiation resistance associated
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of UVRAG gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:162,596,514...162,854,348
Ensembl chr 1:162,596,515...162,854,348
|
|
| G
|
Vamp2
|
vesicle-associated membrane protein 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VAMP2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:54,292,423...54,296,657
Ensembl chr10:54,292,806...54,296,654
|
|
| G
|
Vars1
|
valyl-tRNA synthetase 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VARS1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr20:3,810,427...3,825,193
Ensembl chr20:3,810,429...3,824,951
|
|
| G
|
Vash1
|
vasohibin 1
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of VASH1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:112,060,086...112,076,689
Ensembl chr 6:112,060,086...112,076,689
|
|
| G
|
Vasn
|
vasorin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VASN gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:11,424,174...11,434,681
Ensembl chr10:11,417,327...11,450,704
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
affects expression
|
EXP
|
Diazinon affects the expression of VEGFA mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vegfb
|
vascular endothelial growth factor B
|
affects expression
|
EXP
|
Diazinon affects the expression of VEGFB mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:213,600,966...213,607,152
|
|
| G
|
Vegfc
|
vascular endothelial growth factor C
|
affects expression
|
EXP
|
Diazinon affects the expression of VEGFC mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887
|
|
| G
|
Vhl
|
von Hippel-Lindau tumor suppressor
|
increases methylation affects expression
|
ISO EXP
|
Diazinon results in increased methylation of VHL gene Diazinon affects the expression of VHL mRNA
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 4:148,328,099...148,334,992
Ensembl chr 4:148,328,079...148,334,991
|
|
| G
|
Vim
|
vimentin
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VIM gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vldlr
|
very low density lipoprotein receptor
|
increases expression
|
ISO
|
Diazinon results in increased expression of VLDLR mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154
|
|
| G
|
Vpreb1a
|
V-set pre-B cell surrogate light chain 1A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VPREB1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr11:97,631,174...97,632,051
Ensembl chr11:97,629,102...97,632,051
|
|
| G
|
Vps18
|
VPS18 core subunit of CORVET and HOPS complexes
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VPS18 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:126,733,276...126,744,130
Ensembl chr 3:126,733,232...126,744,129
|
|
| G
|
Vps26b
|
VPS26 retromer complex component B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VPS26B gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:33,675,025...33,696,132
Ensembl chr 8:33,675,025...33,696,132
|
|
| G
|
Vps35
|
VPS35 retromer complex component
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VPS35 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:37,938,989...37,974,887
Ensembl chr19:37,938,720...37,974,886
|
|
| G
|
Vsx2
|
visual system homeobox 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VSX2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 6:109,932,943...109,972,005
Ensembl chr 6:109,948,313...109,971,100
|
|
| G
|
Vwa5a
|
von Willebrand factor A domain containing 5A
|
affects expression
|
EXP
|
Diazinon affects the expression of VWA5A mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 8:47,712,352...47,745,847
Ensembl chr 8:47,712,369...47,736,307
|
|
| G
|
Vwc2
|
von Willebrand factor C domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of VWC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr14:89,897,543...90,038,732
Ensembl chr14:89,897,887...90,032,188
|
|
| G
|
Wdfy2
|
WD repeat and FYVE domain containing 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDFY2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:41,259,840...41,385,549
Ensembl chr15:41,259,884...41,385,549
|
|
| G
|
Wdr3
|
WD repeat domain 3
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDR3 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:190,194,474...190,217,087
Ensembl chr 2:190,194,474...190,217,087
|
|
| G
|
Wdr45b
|
WD repeat domain 45B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDR45B gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:107,097,655...107,127,839
Ensembl chr10:107,097,755...107,127,831
|
|
| G
|
Wdr6
|
WD repeat domain 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDR6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092
|
|
| G
|
Wdr7
|
WD repeat domain 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDR7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr18:59,435,733...59,718,800
Ensembl chr18:59,435,768...59,718,800
|
|
| G
|
Wdr83
|
WD repeat domain 83
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDR83 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:39,981,890...39,987,443
Ensembl chr19:39,981,262...39,987,442
|
|
| G
|
Wdr83os
|
WD repeat domain 83 opposite strand
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDR83OS gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:39,980,247...39,981,619
Ensembl chr19:39,980,247...39,982,737
|
|
| G
|
Wdtc1
|
WD and tetratricopeptide repeats 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WDTC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:150,775,358...150,843,558
Ensembl chr 5:150,775,358...150,824,307
|
|
| G
|
Wee1
|
WEE1 G2 checkpoint kinase
|
affects expression increases methylation
|
EXP ISO
|
Diazinon affects the expression of WEE1 mRNA Diazinon results in increased methylation of WEE1 gene
|
CTD |
PMID:22546817 PMID:22964155 |
|
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
|
|
| G
|
Wfdc1
|
WAP four-disulfide core domain 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WFDC1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:64,628,689...64,647,739
Ensembl chr19:64,607,794...64,648,028
|
|
| G
|
Wfdc2
|
WAP four-disulfide core domain 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WFDC2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161
|
|
| G
|
Wipi2
|
WD repeat domain, phosphoinositide interacting 2
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WIPI2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:17,024,876...17,053,306
Ensembl chr12:17,024,878...17,071,406
|
|
| G
|
Wnt10a
|
Wnt family member 10A
|
affects expression increases methylation decreases expression
|
EXP ISO
|
Diazinon affects the expression of WNT10A mRNA Diazinon results in increased methylation of WNT10A gene Diazinon results in decreased expression of WNT10A mRNA
|
CTD |
PMID:18502319 PMID:19130878 PMID:22964155 |
|
NCBI chr 9:83,798,594...83,811,060
Ensembl chr 9:83,798,594...83,811,067
|
|
| G
|
Wnt2
|
Wnt family member 2
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of WNT2 mRNA
|
CTD |
PMID:18502319 |
|
NCBI chr 4:47,294,300...47,340,284
Ensembl chr 4:47,294,300...47,421,976
|
|
| G
|
Wnt2b
|
Wnt family member 2B
|
increases expression affects expression
|
EXP
|
Diazinon results in increased expression of WNT2B mRNA Diazinon affects the expression of WNT2B mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr 2:195,142,573...195,156,945
Ensembl chr 2:195,135,176...195,157,144
|
|
| G
|
Wnt3a
|
Wnt family member 3A
|
affects expression
|
EXP
|
Diazinon affects the expression of WNT3A mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,533,734...44,577,919
|
|
| G
|
Wnt4
|
Wnt family member 4
|
affects expression
|
EXP
|
Diazinon affects the expression of WNT4 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:154,797,311...154,817,128
|
|
| G
|
Wnt5a
|
Wnt family member 5A
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of WNT5A mRNA Diazinon results in decreased expression of WNT5A mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860
|
|
| G
|
Wnt6
|
Wnt family member 6
|
increases expression
|
EXP
|
Diazinon results in increased expression of WNT6 mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 9:83,778,552...83,792,186
Ensembl chr 9:83,778,552...83,792,186
|
|
| G
|
Wnt7b
|
Wnt family member 7B
|
affects expression
|
EXP
|
Diazinon affects the expression of WNT7B mRNA
|
CTD |
PMID:19130878 |
|
NCBI chr 7:118,514,684...118,559,316
Ensembl chr 7:118,514,684...118,559,316
|
|
| G
|
Wnt8a
|
Wnt family member 8A
|
decreases expression
|
EXP
|
Diazinon results in decreased expression of WNT8A mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr18:26,411,833...26,417,426
Ensembl chr18:26,411,833...26,417,426
|
|
| G
|
Wnt9a
|
Wnt family member 9A
|
affects expression decreases expression
|
EXP
|
Diazinon affects the expression of WNT9A mRNA Diazinon results in decreased expression of WNT9A mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr10:44,593,691...44,620,682
Ensembl chr10:44,593,691...44,620,682
|
|
| G
|
Wnt9b
|
Wnt family member 9B
|
decreases expression affects expression
|
EXP
|
Diazinon results in decreased expression of WNT9B mRNA Diazinon affects the expression of WNT9B mRNA
|
CTD |
PMID:18502319 PMID:19130878 |
|
NCBI chr10:89,135,362...89,157,065
Ensembl chr10:89,135,363...89,157,065
|
|
| G
|
Wrap53
|
WD repeat containing, antisense to TP53
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of WRAP53 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:54,780,873...54,797,919
Ensembl chr10:54,773,282...54,797,651
|
|
| G
|
Wsb2
|
WD repeat and SOCS box-containing 2
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of WSB2 gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:44,878,483...44,899,474
Ensembl chr12:44,878,509...44,899,474
|
|
| G
|
Wt1
|
WT1 transcription factor
|
affects expression
|
EXP
|
Diazinon affects the expression of WT1 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444
|
|
| G
|
Wwox
|
WW domain-containing oxidoreductase
|
affects expression
|
EXP
|
Diazinon affects the expression of WWOX mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:59,338,402...60,269,323
Ensembl chr19:59,341,233...60,269,441
|
|
| G
|
Wwp2
|
WW domain containing E3 ubiquitin protein ligase 2
|
affects expression
|
EXP
|
Diazinon affects the expression of WWP2 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr19:52,256,563...52,380,967
Ensembl chr19:52,256,551...52,382,415
|
|
| G
|
Xk
|
X-linked Kx blood group antigen, Kell and VPS13A binding protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of XK gene
|
CTD |
PMID:22964155 |
|
NCBI chr X:16,108,913...16,145,322
Ensembl chr X:16,108,915...16,145,409
|
|
| G
|
Xkr8
|
XK related 8
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of XKR8 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:150,222,058...150,229,184
Ensembl chr 5:150,222,061...150,228,564
|
|
| G
|
Yif1a
|
Yip1 interacting factor homolog A, membrane trafficking protein
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of YIF1A gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:211,823,921...211,828,437
Ensembl chr 1:211,824,273...211,828,802
|
|
| G
|
Yju2b
|
YJU2 splicing factor homolog B
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of YJU2B gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:40,799,392...40,810,885
Ensembl chr19:40,799,526...40,811,579
|
|
| G
|
Ywhae
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of YWHAE gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:61,082,934...61,120,618
Ensembl chr10:61,106,716...61,114,291
|
|
| G
|
Zbtb17
|
zinc finger and BTB domain containing 17
|
affects expression
|
EXP
|
Diazinon affects the expression of ZBTB17 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 5:159,036,482...159,057,580
Ensembl chr 5:159,036,515...159,057,581
|
|
| G
|
Zc3h10
|
zinc finger CCCH type containing 10
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZC3H10 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:1,557,948...1,562,129
Ensembl chr 7:1,550,764...1,564,332
|
|
| G
|
Zcchc17
|
zinc finger CCHC-type containing 17
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZCCHC17 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 5:147,942,789...147,984,596
Ensembl chr 5:147,942,789...147,984,584
|
|
| G
|
Zcchc7
|
zinc finger CCHC-type containing 7
|
increases expression
|
EXP
|
Diazinon results in increased expression of ZCCHC7 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 5:63,787,292...63,968,960
Ensembl chr 5:63,788,217...63,968,549
|
|
| G
|
Zdhhc24
|
zinc finger, DHHC-type containing 24
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZDHHC24 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:211,605,163...211,612,267
Ensembl chr 1:211,605,185...211,612,277
|
|
| G
|
Zeb2
|
zinc finger E-box binding homeobox 2
|
increases expression
|
EXP
|
Diazinon results in increased expression of ZEB2 mRNA
|
CTD |
PMID:29108742 |
|
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
|
|
| G
|
Zfand2a
|
zinc finger AN1-type containing 2A
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZFAND2A gene
|
CTD |
PMID:22964155 |
|
NCBI chr12:20,275,435...20,286,513
Ensembl chr12:20,275,450...20,286,513
|
|
| G
|
Zfand6
|
zinc finger AN1-type containing 6
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZFAND6 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:147,990,099...148,061,221
Ensembl chr 1:147,990,108...148,061,134
|
|
| G
|
Zfp180
|
zinc finger protein 180
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF180 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:88,780,342...88,800,637
Ensembl chr 1:88,780,342...88,800,627
|
|
| G
|
Zfp263
|
zinc finger protein 263
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF263 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:12,270,785...12,280,982
Ensembl chr10:12,234,057...12,277,587
|
|
| G
|
Zfp367
|
zinc finger protein 367
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF367 gene
|
CTD |
PMID:22964155 |
|
NCBI chr17:970,896...990,025
Ensembl chr17:970,741...990,029
|
|
| G
|
Zfp526
|
zinc finger protein 526
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF526 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:89,935,604...89,945,669
Ensembl chr 1:89,933,478...89,956,958
|
|
| G
|
Zfp579
|
zinc finger protein 579
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF579 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:77,876,367...77,879,591
Ensembl chr 1:77,875,814...77,879,783
|
|
| G
|
Zfp628
|
zinc finger protein 628
|
decreases expression
|
ISO
|
Diazinon results in decreased expression of ZNF628 mRNA
|
CTD |
PMID:24356939 |
|
NCBI chr 1:77,942,431...77,950,013
Ensembl chr 1:77,941,082...77,951,838
|
|
| G
|
Zfp646
|
zinc finger protein 646
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF646 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:191,915,486...191,925,440
Ensembl chr 1:191,911,332...191,937,147
|
|
| G
|
Zfp652
|
zinc finger protein 652
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF652 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:81,123,326...81,203,153
Ensembl chr10:81,146,507...81,198,827
|
|
| G
|
Zfp687
|
zinc finger protein 687
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF687 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 2:185,261,903...185,270,651
Ensembl chr 2:185,261,903...185,270,641
|
|
| G
|
Zfp688
|
zinc finger protein 688
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF688 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 1:191,469,858...191,473,527
Ensembl chr 1:191,469,858...191,478,262
|
|
| G
|
Zfp7
|
zinc finger protein 7
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF7 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:110,479,387...110,499,552
Ensembl chr 7:110,488,156...110,501,660
|
|
| G
|
Zfp703
|
zinc finger protein 703
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZNF703 gene
|
CTD |
PMID:22964155 |
|
NCBI chr16:71,779,340...71,783,510
Ensembl chr16:71,779,340...71,783,510
|
|
| G
|
Zfpm1
|
zinc finger protein, multitype 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZFPM1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr19:67,242,922...67,299,149
Ensembl chr19:67,179,751...67,299,149
|
|
| G
|
Zgpat
|
zinc finger CCCH-type and G-patch domain containing
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZGPAT gene
|
CTD |
PMID:22964155 |
|
NCBI chr 3:188,851,376...188,867,914
Ensembl chr 3:188,851,566...188,868,495
|
|
| G
|
Zhx1
|
zinc fingers and homeoboxes 1
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZHX1 gene
|
CTD |
PMID:22964155 |
|
NCBI chr 7:91,472,193...91,501,984
Ensembl chr 7:91,473,836...91,501,115
|
|
| G
|
Zmat3
|
zinc finger, matrin type 3
|
affects expression
|
EXP
|
Diazinon affects the expression of ZMAT3 mRNA
|
CTD |
PMID:22546817 |
|
NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294
|
|
| G
|
Zmym5
|
zinc finger MYM-type containing 5
|
increases methylation
|
ISO
|
Diazinon results in increased methylation of ZMYM5 gene
|
CTD |
PMID:22964155 |
|
NCBI chr15:35,036,226...35,056,842
Ensembl chr15:35,038,015...35,056,707
|
|
| G
|
Znf454
|
zinc finger protein 454
|
decreases methylation
|
ISO
|
Diazinon results in decreased methylation of ZNF454 gene
|
CTD |
PMID:22964155 |
|
NCBI chr10:35,684,741...35,701,281
Ensembl chr10:35,685,841...35,697,415
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases activity
|
ISO
|
eprinomectin results in decreased activity of ABCB1A protein
|
CTD |
PMID:17134887 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Ano1
|
anoctamin 1
|
decreases activity
|
ISO
|
eprinomectin results in decreased activity of ANO1 protein
|
CTD |
PMID:32201246 |
|
NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550
|
|
| G
|
Ncoa2
|
nuclear receptor coactivator 2
|
multiple interactions
|
ISO
|
eprinomectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]]
|
CTD |
PMID:27773686 |
|
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
ISO
|
eprinomectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]]
|
CTD |
PMID:27773686 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO EXP
|
ethoprop metabolite results in decreased activity of ACHE protein; ethoprop results in decreased activity of ACHE protein
|
CTD |
PMID:30625376 PMID:33720374 PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Anxa10
|
annexin A10
|
increases expression
|
ISO
|
ethoprop results in increased expression of ANXA10 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
|
|
| G
|
Arg1
|
arginase 1
|
decreases expression
|
ISO
|
ethoprop results in decreased expression of ARG1 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases expression
|
ISO
|
ethoprop results in decreased expression of CYP2C19 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
decreases expression
|
ISO
|
ethoprop results in decreased expression of CYP7A1 mRNA; ethoprop results in decreased expression of CYP7A1 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
G6pc1
|
glucose-6-phosphatase catalytic subunit 1
|
decreases expression
|
ISO
|
ethoprop results in decreased expression of G6PC1 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions
|
ISO
|
ethoprop binds to and results in increased activity of NR1I2 protein
|
CTD |
PMID:21115097 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity multiple interactions
|
ISO EXP
|
fenamiphos results in decreased activity of ACHE protein fenamiphos binds to and results in increased phosphorylation of and results in decreased activity of ACHE protein
|
CTD |
PMID:17382909 PMID:17402711 PMID:33720374 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions
|
ISO
|
fenamiphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
|
CTD |
PMID:33049310 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
fenamiphos binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
fenamiphos binds to and results in increased activity of ESR2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions affects activity
|
ISO
|
fenamiphos binds to and results in increased activity of NR1I2 protein fenamiphos affects the activity of NR1I2 protein
|
CTD |
PMID:21115097 PMID:23611293 PMID:33049310 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO
|
fenamiphos binds to and results in increased activity of PPARG protein
|
CTD |
PMID:33049310 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
fenamiphos metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Araf
|
A-Raf proto-oncogene, serine/threonine kinase
|
decreases expression
|
ISO
|
Fenbendazole analog results in decreased expression of ARAF protein
|
CTD |
PMID:35569513 |
|
NCBI chr X:3,780,932...3,845,919
Ensembl chr X:3,780,932...3,792,611
|
|
| G
|
Aurkb
|
aurora kinase B
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of AURKB protein
|
CTD |
PMID:23411599 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO
|
Fenbendazole analog results in increased expression of BAX protein; Fenbendazole results in increased expression of BAX protein Acetylcysteine inhibits the reaction [Fenbendazole analog results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Fenbendazole results in increased expression of BAX protein]; SB 203580 inhibits the reaction [Fenbendazole analog results in increased expression of BAX protein]; SB 203580 inhibits the reaction [Fenbendazole results in increased expression of BAX protein]
|
CTD |
PMID:35569513 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
ISO
|
Fenbendazole analog results in decreased expression of BCL2 protein; Fenbendazole results in decreased expression of BCL2 protein
|
CTD |
PMID:35569513 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
increases expression increases cleavage
|
ISO
|
Fenbendazole analog results in increased expression of CASP3 mRNA Fenbendazole analog results in increased cleavage of CASP3 protein; Fenbendazole results in increased cleavage of CASP3 protein
|
CTD |
PMID:35569513 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp8
|
caspase 8
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of CASP8 mRNA; Fenbendazole results in increased expression of CASP8 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
increases cleavage increases expression
|
ISO
|
Fenbendazole analog results in increased cleavage of CASP9 protein; Fenbendazole results in increased cleavage of CASP9 protein Fenbendazole analog results in increased expression of CASP9 mRNA; Fenbendazole results in increased expression of CASP9 mRNA
|
CTD |
PMID:35569513 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cbx5
|
chromobox 5
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CBX5 protein
|
CTD |
PMID:23411599 |
|
NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
increases expression
|
ISO
|
Fenbendazole results in increased expression of CCL2 protein
|
CTD |
PMID:20116850 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccnd1
|
cyclin D1
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CCND1 mRNA
|
CTD |
PMID:23411599 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne2
|
cyclin E2
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CCNE2 mRNA
|
CTD |
PMID:23411599 |
|
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882
|
|
| G
|
Cdh1
|
cadherin 1
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of CDH1 protein; Fenbendazole results in increased expression of CDH1 protein
|
CTD |
PMID:35569513 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh2
|
cadherin 2
|
affects expression
|
ISO
|
Fenbendazole affects the expression of CDH2 protein; Fenbendazole analog affects the expression of CDH2 protein
|
CTD |
PMID:35569513 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cdk1
|
cyclin-dependent kinase 1
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CDK1 mRNA; Fenbendazole results in increased expression of CDK1 protein
|
CTD |
PMID:23411599 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CDKN1A mRNA; Fenbendazole results in increased expression of CDKN1A protein
|
CTD |
PMID:23411599 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
increases methylation increases expression decreases expression
|
EXP
|
Fenbendazole results in increased methylation of CDKN2A gene Fenbendazole results in increased expression of CDKN2A protein Fenbendazole results in decreased expression of CDKN2A protein
|
CTD |
PMID:22659510 PMID:23411599 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
| G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CDKN2B mRNA
|
CTD |
PMID:23411599 |
|
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
|
|
| G
|
Cdr2
|
cerebellar degeneration-related protein 2
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of CDR2 mRNA
|
CTD |
PMID:23411599 |
|
NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
decreases activity
|
ISO
|
Fenbendazole results in decreased activity of CYP1A2 protein
|
CTD |
PMID:22048645 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of DNM1L mRNA; Fenbendazole results in increased expression of DNM1L mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
multiple interactions
|
ISO
|
Fenbendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
|
CTD |
PMID:23769903 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
H2ax
|
H2A.X variant histone
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of H2AX protein; Fenbendazole results in increased expression of H2AX protein
|
CTD |
PMID:35569513 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
increases activity
|
ISO
|
Fenbendazole results in increased activity of HSF1 protein
|
CTD |
PMID:34170685 |
|
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Ifng
|
interferon gamma
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of IFNG mRNA; Fenbendazole results in increased expression of IFNG mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Il6
|
interleukin 6
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of IL6 mRNA; Fenbendazole results in increased expression of IL6 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6r
|
interleukin 6 receptor
|
increases expression
|
ISO
|
Fenbendazole results in increased expression of IL6R protein modified form
|
CTD |
PMID:20116850 |
|
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
| G
|
Incenp
|
inner centromere protein
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of INCENP protein
|
CTD |
PMID:23411599 |
|
NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
decreases expression
|
ISO
|
Fenbendazole results in decreased expression of MAPT protein
|
CTD |
PMID:16930453 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Mdh2
|
malate dehydrogenase 2
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of MDH2 mRNA; Fenbendazole results in increased expression of MDH2 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of MDM2 mRNA
|
CTD |
PMID:23411599 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Mfn2
|
mitofusin 2
|
increases expression
|
ISO
|
Fenbendazole results in increased expression of MFN2 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
increases expression
|
EXP
|
Fenbendazole results in increased expression of MKI67 protein
|
CTD |
PMID:23411599 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
decreases expression
|
ISO
|
Fenbendazole analog results in decreased expression of MMP2 mRNA; Fenbendazole analog results in decreased expression of MMP2 protein
|
CTD |
PMID:35569513 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
affects expression decreases expression
|
ISO
|
Fenbendazole affects the expression of MMP9 protein; Fenbendazole analog affects the expression of MMP9 protein Fenbendazole analog results in decreased expression of MMP9 mRNA; Fenbendazole results in decreased expression of MMP9 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
multiple interactions
|
ISO
|
Fenbendazole inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
|
CTD |
PMID:25257666 |
|
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
increases expression
|
ISO
|
Fenbendazole results in increased expression of OPA1 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
decreases expression
|
ISO
|
Fenbendazole results in decreased expression of PTGS2 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases phosphorylation multiple interactions
|
ISO
|
Fenbendazole analog results in increased phosphorylation of RELA protein; Fenbendazole results in increased phosphorylation of RELA protein Acetylcysteine inhibits the reaction [Fenbendazole analog results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [Fenbendazole results in increased phosphorylation of RELA protein]
|
CTD |
PMID:35569513 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Sirt1
|
sirtuin 1
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of SIRT1 mRNA; Fenbendazole results in increased expression of SIRT1 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc2a1
|
solute carrier family 2 member 1
|
decreases expression
|
ISO
|
Fenbendazole analog results in decreased expression of SLC2A1 mRNA; Fenbendazole results in decreased expression of SLC2A1 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
decreases expression
|
ISO
|
Fenbendazole analog results in decreased expression of SLC2A4 mRNA; Fenbendazole results in decreased expression of SLC2A4 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Suclg1
|
succinate-CoA ligase GDP/ADP-forming subunit alpha
|
increases expression
|
ISO
|
Fenbendazole analog results in increased expression of SUCLG1 mRNA; Fenbendazole results in increased expression of SUCLG1 mRNA
|
CTD |
PMID:35569513 |
|
NCBI chr 4:106,866,329...106,895,686
Ensembl chr 4:106,866,114...106,895,689
|
|
| G
|
Tmem70
|
transmembrane protein 70
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with Fenbendazole] results in decreased expression of TMEM70 protein
|
CTD |
PMID:27914986 |
|
NCBI chr 5:7,420,396...7,438,023
Ensembl chr 5:7,420,396...7,438,023
|
|
| G
|
Tnf
|
tumor necrosis factor
|
increases secretion increases expression multiple interactions
|
ISO
|
Fenbendazole results in increased secretion of TNF protein Fenbendazole analog results in increased expression of TNF mRNA U 0126 inhibits the reaction [Fenbendazole results in increased secretion of TNF protein]
|
CTD |
PMID:20848085 PMID:35569513 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53
|
tumor protein p53
|
increases expression
|
EXP ISO
|
Fenbendazole results in increased expression of TP53 protein Fenbendazole analog results in increased expression of TP53 protein; Fenbendazole results in increased expression of TP53 protein
|
CTD |
PMID:23411599 PMID:35569513 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Ube2e2
|
ubiquitin-conjugating enzyme E2E 2
|
multiple interactions
|
EXP
|
[Diethylnitrosamine co-treated with Fenbendazole] results in decreased expression of UBE2E2 protein
|
CTD |
PMID:27914986 |
|
NCBI chr15:9,411,067...9,688,731
Ensembl chr15:9,411,539...9,712,661
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
increases expression
|
ISO
|
Fenbendazole results in increased expression of VEGFA protein
|
CTD |
PMID:20116850 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Wee1
|
WEE1 G2 checkpoint kinase
|
decreases expression
|
EXP
|
Fenbendazole results in decreased expression of WEE1 protein modified form
|
CTD |
PMID:23411599 |
|
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
|
|
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
fensulfothion metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases expression multiple interactions increases activity
|
ISO
|
flavone results in decreased expression of ABCB1 protein flavone inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; flavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; flavone promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]] flavone results in increased activity of ABCB1 protein
|
CTD |
PMID:34217736 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
multiple interactions decreases activity
|
ISO
|
flavone inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] flavone results in decreased activity of ABCC1 protein
|
CTD |
PMID:15041478 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
increases expression
|
ISO
|
flavone results in increased expression of ABCG2 mRNA; flavone results in increased expression of ABCG2 protein
|
CTD |
PMID:17077187 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
increases expression
|
ISO
|
flavone results in increased expression of ACAA2 protein
|
CTD |
PMID:14750173 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions affects binding
|
ISO
|
flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of AHR protein] flavone binds to AHR protein
|
CTD |
PMID:17090139 PMID:20436506 PMID:20450880 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
ISO
|
flavone results in increased expression of APAF1 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Ar
|
androgen receptor
|
affects binding
|
EXP
|
flavone binds to AR protein
|
CTD |
PMID:14565775 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases activity
|
ISO
|
Melatonin promotes the reaction [flavone results in increased activity of CASP3 protein]
|
CTD |
PMID:15289867 PMID:15800915 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
decreases expression
|
ISO
|
flavone results in decreased expression of CCL2 mRNA
|
CTD |
PMID:23782265 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
multiple interactions
|
EXP
|
flavone results in increased localization of and results in increased activity of CEBPB protein
|
CTD |
PMID:12663507 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Cep83
|
centrosomal protein 83
|
increases expression
|
ISO
|
flavone results in increased expression of CEP83 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 7:31,167,198...31,276,513
Ensembl chr 7:31,167,216...31,276,716
|
|
| G
|
Cpap
|
centrosome assembly and centriole elongation protein
|
decreases expression
|
ISO
|
flavone results in decreased expression of CPAP protein
|
CTD |
PMID:14750173 |
|
NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
increases activity
|
ISO
|
flavone results in increased activity of CYP19A1 protein
|
CTD |
PMID:15319488 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions increases expression decreases activity
|
ISO
|
flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] flavone results in increased expression of CYP1A1 mRNA flavone results in decreased activity of CYP1A1 protein flavone results in increased expression of CYP1A1 mRNA; flavone results in increased expression of CYP1A1 protein
|
CTD |
PMID:15890477 PMID:17090139 PMID:20930378 PMID:21053930 PMID:31655123 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions decreases activity
|
ISO
|
flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] flavone results in decreased activity of CYP1A2 protein
|
CTD |
PMID:17090139 PMID:21053930 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
increases expression multiple interactions
|
ISO
|
flavone results in increased expression of CYP1B1 mRNA flavone binds to and results in decreased activity of CYP1B1 protein
|
CTD |
PMID:15890477 PMID:19563207 PMID:21053930 |
|
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases activity multiple interactions
|
ISO
|
flavone results in increased activity of CYP3A4 protein [[flavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [flavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; flavone binds to and results in decreased activity of CYP3A4 protein; flavone inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]; flavone promotes the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam]
|
CTD |
PMID:21053930 PMID:31756459 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Ep300
|
E1A binding protein p300
|
multiple interactions
|
ISO
|
flavone inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]
|
CTD |
PMID:20153296 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Esr2
|
estrogen receptor 2
|
affects binding
|
ISO
|
flavone binds to ESR2 protein
|
CTD |
PMID:12224631 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Esrra
|
estrogen related receptor, alpha
|
multiple interactions affects binding
|
ISO
|
flavone binds to and results in increased activity of ESRRA protein flavone binds to ESRRA protein mutant form
|
CTD |
PMID:14638870 |
|
NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811
|
|
| G
|
Esrrb
|
estrogen-related receptor beta
|
multiple interactions
|
ISO
|
flavone binds to and results in increased activity of ESRRB protein
|
CTD |
PMID:14638870 |
|
NCBI chr 6:111,738,662...111,894,087
Ensembl chr 6:111,738,662...111,894,087
|
|
| G
|
Gsta2
|
glutathione S-transferase alpha 2
|
increases expression
|
EXP
|
flavone results in increased expression of GSTA2
|
CTD |
PMID:12663507 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
flavone inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]
|
CTD |
PMID:20153296 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
decreases expression
|
ISO
|
flavone results in decreased expression of HSPA1A protein
|
CTD |
PMID:14750173 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
decreases expression
|
ISO
|
flavone results in decreased expression of HSPD1 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
flavone analog inhibits the reaction [Adenosine Triphosphate results in increased cleavage of and results in increased secretion of IL1B protein]; flavone analog inhibits the reaction [Uric Acid results in increased cleavage of and results in increased secretion of IL1B protein]
|
CTD |
PMID:29960001 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Krt18
|
keratin 18
|
decreases expression
|
ISO
|
flavone results in decreased expression of KRT18 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848 Ensembl chr10:135,035,982...135,039,848
|
|
| G
|
Krt8
|
keratin 8
|
increases expression
|
ISO
|
flavone results in increased expression of KRT8 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
|
|
| G
|
Lmnb2
|
lamin B2
|
decreases expression
|
ISO
|
flavone results in decreased expression of LMNB2 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 7:9,443,308...9,459,468
Ensembl chr 7:9,440,128...9,459,342
|
|
| G
|
Maoa
|
monoamine oxidase A
|
decreases activity
|
ISO
|
flavone results in decreased activity of MAOA protein
|
CTD |
PMID:23009399 |
|
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
|
|
| G
|
Myo5a
|
myosin VA
|
increases expression
|
ISO
|
flavone results in increased expression of MYO5A protein
|
CTD |
PMID:14750173 |
|
NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:84,692,910...84,856,265
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
flavone promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of NFKBIA mRNA]
|
CTD |
PMID:17643414 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; flavone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
|
CTD |
PMID:18274639 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases activity
|
ISO
|
flavone results in increased activity of NR1I3 protein
|
CTD |
PMID:28927721 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage decreases activity
|
ISO
|
flavone results in increased cleavage of PARP1 protein flavone results in decreased activity of PARP1 protein
|
CTD |
PMID:15289867 PMID:17643414 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Phb1
|
prohibitin 1
|
decreases expression
|
ISO
|
flavone results in decreased expression of PHB1 protein
|
CTD |
PMID:14750173 |
|
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233
|
|
| G
|
Pkm
|
pyruvate kinase M1/2
|
multiple interactions
|
ISO
|
flavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]
|
CTD |
PMID:25388478 |
|
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396
|
|
| G
|
Pon1
|
paraoxonase 1
|
increases expression
|
ISO
|
flavone results in increased expression of PON1 mRNA
|
CTD |
PMID:15169886 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Psmc1
|
proteasome 26S subunit, ATPase 1
|
increases expression
|
ISO
|
flavone results in increased expression of PSMC1 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 6:125,122,497...125,134,859
Ensembl chr 6:125,122,490...125,134,858
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
flavone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; flavone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
|
CTD |
PMID:21341175 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rad50
|
RAD50 double strand break repair protein
|
increases expression
|
ISO
|
flavone results in increased expression of RAD50 protein
|
CTD |
PMID:14750173 |
|
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
flavone inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased activity of RELA protein]
|
CTD |
PMID:18274639 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Serpinb1a
|
serpin family B member 1A
|
increases expression
|
ISO
|
flavone results in increased expression of SERPINB1 protein
|
CTD |
PMID:14750173 |
|
NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166
|
|
| G
|
Socs3
|
suppressor of cytokine signaling 3
|
multiple interactions increases expression
|
ISO
|
dorsomorphin inhibits the reaction [flavone results in increased expression of SOCS3 protein] flavone results in increased expression of SOCS3 mRNA 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [flavone results in increased expression of SOCS3 mRNA]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [flavone results in increased expression of SOCS3 protein]; AZD 6244 inhibits the reaction [flavone results in increased expression of SOCS3 mRNA]; AZD 6244 inhibits the reaction [flavone results in increased expression of SOCS3 protein] flavone results in increased expression of SOCS3 mRNA; flavone results in increased expression of SOCS3 protein
|
CTD |
PMID:23782265 |
|
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
|
|
| G
|
Sycp1
|
synaptonemal complex protein 1
|
increases expression
|
ISO
|
flavone results in increased expression of SYCP1 protein
|
CTD |
PMID:14750173 |
|
NCBI chr 2:192,985,164...193,145,234
Ensembl chr 2:192,984,621...193,145,421
|
|
|
|
| G
|
Arhgef2
|
Rho/Rac guanine nucleotide exchange factor 2
|
decreases expression
|
ISO
|
flubendazole results in decreased expression of ARHGEF2 protein
|
CTD |
PMID:30075109 |
|
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
increases phosphorylation
|
ISO
|
flubendazole results in increased phosphorylation of BCL2 protein
|
CTD |
PMID:32652169 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
increases phosphorylation
|
ISO
|
flubendazole results in increased phosphorylation of BCL2L1 protein
|
CTD |
PMID:32652169 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Casp3
|
caspase 3
|
increases cleavage multiple interactions
|
ISO
|
flubendazole results in increased cleavage of CASP3 protein BAY 11-7085 affects the reaction [flubendazole results in increased cleavage of CASP3 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [flubendazole results in increased cleavage of CASP3 protein]; benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [flubendazole results in increased cleavage of CASP3 protein]; Cyclosporine inhibits the reaction [flubendazole results in increased cleavage of CASP3 protein]; pyrazolanthrone inhibits the reaction [flubendazole results in increased cleavage of CASP3 protein]
|
CTD |
PMID:32652169 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
flubendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]
|
CTD |
PMID:30075109 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cdh2
|
cadherin 2
|
multiple interactions
|
ISO
|
flubendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH2 protein]
|
CTD |
PMID:30075109 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
increases activity
|
ISO
|
flubendazole results in increased activity of MAPK8 protein
|
CTD |
PMID:32652169 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mcl1
|
MCL1 apoptosis regulator, BCL2 family member
|
increases phosphorylation
|
ISO
|
flubendazole results in increased phosphorylation of MCL1 protein
|
CTD |
PMID:32652169 |
|
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
|
|
| G
|
Pmaip1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
increases expression
|
ISO
|
flubendazole results in increased expression of PMAIP1 protein
|
CTD |
PMID:32652169 |
|
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
|
|
| G
|
Ptk2
|
protein tyrosine kinase 2
|
decreases expression
|
ISO
|
flubendazole results in decreased expression of PTK2 protein
|
CTD |
PMID:30075109 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
| G
|
Rac1
|
Rac family small GTPase 1
|
decreases expression
|
ISO
|
flubendazole results in decreased expression of RAC1 protein
|
CTD |
PMID:30075109 |
|
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
increases activity multiple interactions
|
ISO
|
flubendazole results in increased activity of RELA protein 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine affects the reaction [flubendazole results in increased activity of RELA protein]; BAY 11-7085 affects the reaction [flubendazole results in increased activity of RELA protein]
|
CTD |
PMID:32652169 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rhoa
|
ras homolog family member A
|
decreases expression
|
ISO
|
flubendazole results in decreased expression of RHOA protein
|
CTD |
PMID:30075109 |
|
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
ISO
|
flubendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]; flubendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH2 protein]
|
CTD |
PMID:30075109 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tp53
|
tumor protein p53
|
increases activity
|
ISO
|
flubendazole results in increased activity of TP53 protein
|
CTD |
PMID:32652169 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Cyp2f4
|
cytochrome P450, family 2, subfamily f, polypeptide 4
|
increases response to substance increases metabolic processing
|
ISO
|
CYP2F2 protein results in increased susceptibility to fluensulfone CYP2F2 protein results in increased metabolism of fluensulfone
|
CTD |
PMID:27605420 |
|
NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553
|
|
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
fosthiazate metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO EXP
|
iprodione binds to and results in increased activity of AHR protein
|
CTD |
PMID:14636698 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
multiple interactions
|
ISO
|
[Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in decreased expression of ALDH2 mRNA; [Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in decreased expression of and results in decreased activity of ALDH2 protein
|
CTD |
PMID:34830855 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Anxa10
|
annexin A10
|
increases expression
|
ISO
|
iprodione results in increased expression of ANXA10 mRNA
|
CTD |
PMID:32194361 |
|
NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
|
|
| G
|
Ar
|
androgen receptor
|
multiple interactions affects binding
|
ISO
|
[iprodione binds to and results in decreased activity of AR protein] inhibits the reaction [Metribolone binds to AR protein]; iprodione inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; iprodione inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] iprodione binds to AR protein
|
CTD |
PMID:19564212 PMID:33049310 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
EXP
|
iprodione results in decreased expression of BCL2 protein Chlorpyrifos promotes the reaction [iprodione results in decreased expression of BCL2 protein]; iprodione promotes the reaction [Chlorpyrifos results in decreased expression of BCL2 protein]
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
increases expression multiple interactions
|
EXP
|
iprodione results in increased expression of CASP3 protein Chlorpyrifos promotes the reaction [iprodione results in increased expression of CASP3 protein]; iprodione promotes the reaction [Chlorpyrifos results in increased expression of CASP3 protein]
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cdh1
|
cadherin 1
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in decreased expression of CDH1 protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in decreased expression of CDH1 protein
|
CTD |
PMID:34503147 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
| G
|
Cldn11
|
claudin 11
|
increases expression multiple interactions
|
EXP
|
iprodione results in increased expression of CLDN11 protein [carbendazim co-treated with iprodione] results in decreased expression of CLDN11 protein
|
CTD |
PMID:28576679 |
|
NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
increases activity
|
ISO
|
iprodione results in increased activity of CYP19A1 protein
|
CTD |
PMID:11884232 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases expression
|
ISO
|
iprodione results in increased expression of CYP1A1 mRNA; iprodione results in increased expression of CYP1A1 protein
|
CTD |
PMID:16696176 PMID:32194361 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases expression
|
ISO
|
iprodione results in decreased expression of CYP2C19 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:25028461 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
decreases expression
|
ISO
|
iprodione results in decreased expression of CYP7A1 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
iprodione results in increased expression of DDIT3 mRNA
|
CTD |
PMID:16696176 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
iprodione binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions
|
ISO
|
iprodione binds to and results in increased activity of ESR2 protein
|
CTD |
PMID:33049310 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
iprodione results in increased expression of FOS mRNA
|
CTD |
PMID:16696176 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions decreases expression
|
EXP
|
Chlorpyrifos inhibits the reaction [iprodione results in decreased expression of FSHB protein]; iprodione inhibits the reaction [Chlorpyrifos results in decreased expression of FSHB protein]; iprodione promotes the reaction [Chlorpyrifos results in decreased expression of FSHB protein]
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
increases expression
|
ISO
|
iprodione results in increased expression of GADD45A mRNA
|
CTD |
PMID:16696176 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
multiple interactions
|
EXP
|
[carbendazim co-treated with iprodione] results in decreased expression of GJA1 protein
|
CTD |
PMID:28576679 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gsta2
|
glutathione S-transferase alpha 2
|
increases expression
|
ISO
|
iprodione results in increased expression of GSTA2 mRNA
|
CTD |
PMID:16696176 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
[fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AX protein; [Maneb co-treated with mancozeb co-treated with iprodione co-treated with enilconazole co-treated with Chlorpyrifos co-treated with Diazinon co-treated with Dimethoate] results in increased expression of H2AX protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in increased expression of H2AX protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of H2AX protein
|
CTD |
PMID:22389207 PMID:34503147 PMID:34830855 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hsd17b3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
multiple interactions decreases expression
|
EXP
|
[Chlorpyrifos co-treated with iprodione] results in decreased expression of HSD17B3 mRNA; [iprodione co-treated with Chlorpyrifos] results in decreased expression of HSD17B3 mRNA iprodione results in decreased expression of HSD17B3 mRNA
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
iprodione results in increased expression of HSPA5 mRNA
|
CTD |
PMID:16696176 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions decreases expression
|
EXP
|
Chlorpyrifos inhibits the reaction [iprodione results in decreased expression of LHB protein]; iprodione inhibits the reaction [Chlorpyrifos results in decreased expression of LHB protein]
|
CTD |
PMID:34060014 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased activity of NR1I2 protein; iprodione binds to and results in increased activity of NR1I2 protein
|
CTD |
PMID:25028461 PMID:33049310 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr5a1
|
nuclear receptor subfamily 5, group A, member 1
|
decreases expression multiple interactions
|
EXP
|
iprodione results in decreased expression of NR5A1 mRNA [iprodione co-treated with Chlorpyrifos] results in decreased expression of NR5A1 mRNA; iprodione promotes the reaction [Chlorpyrifos results in decreased expression of NR5A1 mRNA]
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr 3:42,874,505...42,896,109
Ensembl chr 3:42,875,221...42,896,046
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
increases activity multiple interactions
|
ISO
|
iprodione results in increased activity of PPARG protein iprodione binds to and results in increased activity of PPARG protein
|
CTD |
PMID:20143881 PMID:33049310 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
decreases expression multiple interactions
|
EXP
|
iprodione results in decreased expression of PPARGC1A mRNA Chlorpyrifos promotes the reaction [iprodione results in decreased expression of PPARGC1A mRNA]; iprodione promotes the reaction [Chlorpyrifos results in decreased expression of PPARGC1A mRNA]
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Sirt1
|
sirtuin 1
|
multiple interactions decreases expression
|
EXP
|
[iprodione co-treated with Chlorpyrifos] results in decreased expression of SIRT1 mRNA; iprodione promotes the reaction [Chlorpyrifos results in decreased expression of SIRT1 mRNA] iprodione results in decreased expression of SIRT1 mRNA
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Stmn1
|
stathmin 1
|
increases expression
|
EXP
|
iprodione results in increased expression of STMN1 mRNA
|
CTD |
PMID:28576679 |
|
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
multiple interactions decreases expression
|
EXP
|
[Chlorpyrifos co-treated with iprodione] results in decreased expression of TERT mRNA; [iprodione co-treated with Chlorpyrifos] results in decreased expression of TERT mRNA iprodione results in decreased expression of TERT mRNA
|
CTD |
PMID:33586219 PMID:34060014 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Thra
|
thyroid hormone receptor alpha
|
multiple interactions
|
ISO
|
iprodione binds to and results in increased activity of THRA protein
|
CTD |
PMID:33049310 |
|
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions
|
ISO
|
iprodione binds to and results in increased activity of THRB protein
|
CTD |
PMID:33049310 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
Acetylcysteine inhibits the reaction [iprodione inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; iprodione inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
|
CTD |
PMID:33226166 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] affects the expression of TP53BP1 protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] affects the expression of TP53BP1 protein
|
CTD |
PMID:34503147 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
|
|
| G
|
Aaas
|
aladin WD repeat nucleoporin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AAAS protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545
|
|
| G
|
Aacs
|
acetoacetyl-CoA synthetase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AACS protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543
|
|
| G
|
Aagab
|
alpha- and gamma-adaptin binding protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AAGAB protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:72,978,719...73,017,275
Ensembl chr 8:72,978,741...73,017,278
|
|
| G
|
Aak1
|
AP2 associated kinase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AAK1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:120,845,012...121,009,170
Ensembl chr 4:120,858,557...121,004,236
|
|
| G
|
Aamdc
|
adipogenesis associated, Mth938 domain containing
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AAMDC protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:161,273,205...161,303,253
Ensembl chr 1:161,262,347...161,299,340
|
|
| G
|
Aar2
|
AAR2 splicing factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AAR2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:165,517,467...165,540,260
Ensembl chr 3:165,517,556...165,548,519
|
|
| G
|
Aars1
|
alanyl-tRNA synthetase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AARS1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497
|
|
| G
|
Aars2
|
alanyl-tRNA synthetase 2, mitochondrial
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AARS2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:22,981,880...22,993,536
Ensembl chr 9:22,794,978...22,993,536
|
|
| G
|
Aasdhppt
|
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AASDHPPT protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:9,731,592...9,748,934
Ensembl chr 8:9,738,172...9,748,953
|
|
| G
|
Aass
|
aminoadipate-semialdehyde synthase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AASS protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:52,572,147...52,657,600
|
|
| G
|
Aatf
|
apoptosis antagonizing transcription factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AATF protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:69,796,502...69,889,671
Ensembl chr10:69,794,007...69,889,634
|
|
| G
|
Abat
|
4-aminobutyrate aminotransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABAT protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
affects abundance increases transport increases expression decreases activity increases export decreases response to substance multiple interactions increases response to substance affects binding affects response to substance
|
ISO
|
ABCB1 gene polymorphism affects the abundance of Ivermectin ABCB1 protein results in increased transport of Ivermectin Ivermectin results in increased expression of ABCB1A mRNA Ivermectin results in decreased activity of ABCB1A protein ABCB1A protein results in increased export of Ivermectin ABCB1A protein results in decreased susceptibility to Ivermectin [ABCB1A protein co-treated with ABCB1B protein] affects the susceptibility to Ivermectin; Ivermectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride]; Ivermectin results in increased expression of and results in increased stability of ABCB1A mRNA; Ivermectin results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes] ABCB1A gene mutant form results in increased susceptibility to Ivermectin; ABCB1A protein mutant form results in increased susceptibility to Ivermectin Ivermectin results in decreased activity of ABCB1 protein ABCB1 protein affects the abundance of Ivermectin Ivermectin inhibits the reaction [ABCB1 protein results in increased export of Doxorubicin]; Ivermectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride]; spinosad inhibits the reaction [ABCB1 protein results in increased transport of Ivermectin] Ivermectin binds to ABCB1 protein ABCB1 gene polymorphism affects the susceptibility to Ivermectin
|
CTD |
PMID:8917702 PMID:8949985 PMID:9144452 PMID:17134887 PMID:18633165 PMID:19161460 PMID:20513441 PMID:20595473 PMID:20630055 PMID:21321059 PMID:22024132 PMID:22834856 PMID:24998875 PMID:25865432 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
multiple interactions increases expression
|
ISO
|
[ABCB1A protein co-treated with ABCB1B protein] affects the susceptibility to Ivermectin; Ivermectin results in increased expression of and results in increased stability of ABCB1B mRNA Ivermectin results in increased expression of ABCB1B mRNA
|
CTD |
PMID:19161460 PMID:22024132 PMID:24998875 |
|
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Abcb6
|
ATP binding cassette subfamily B member 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCB6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526
|
|
| G
|
Abcb7
|
ATP binding cassette subfamily B member 7
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCB7 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:73,361,296...73,502,464
Ensembl chr X:73,361,310...73,502,547
|
|
| G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
multiple interactions decreases activity
|
ISO
|
Ivermectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] Ivermectin results in decreased activity of ABCC1 protein
|
CTD |
PMID:25865432 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
| G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ABCC2 mRNA
|
CTD |
PMID:24998875 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
|
|
| G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCC4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
| G
|
Abcc9
|
ATP binding cassette subfamily C member 9
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCC9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348
|
|
| G
|
Abcd3
|
ATP binding cassette subfamily D member 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCD3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504
|
|
| G
|
Abce1
|
ATP binding cassette subfamily E member 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCE1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:45,109,880...45,134,819
Ensembl chr19:45,109,906...45,134,819
|
|
| G
|
Abcf1
|
ATP binding cassette subfamily F member 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240
|
|
| G
|
Abcf2
|
ATP binding cassette subfamily F member 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCF2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:11,485,865...11,500,067
Ensembl chr 4:11,487,395...11,500,053
|
|
| G
|
Abcf3
|
ATP binding cassette subfamily F member 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABCF3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:93,844,863...93,856,595
Ensembl chr11:93,844,363...93,856,595
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ABCG2 mRNA
|
CTD |
PMID:24998875 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Abhd10
|
abhydrolase domain containing 10, depalmitoylase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABHD10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:68,543,860...68,556,059
Ensembl chr11:68,543,606...68,557,640
|
|
| G
|
Abhd11
|
abhydrolase domain containing 11
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABHD11 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:27,318,739...27,322,016
Ensembl chr12:27,318,749...27,321,970
|
|
| G
|
Abhd12
|
abhydrolase domain containing 12, lysophospholipase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABHD12 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:160,119,724...160,179,959
Ensembl chr 3:160,119,724...160,179,969
|
|
| G
|
Abhd14b
|
abhydrolase domain containing 14b
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABHD14B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:115,966,792...115,970,829
Ensembl chr 8:115,965,932...115,970,833
|
|
| G
|
Abhd16a
|
abhydrolase domain containing 16A, phospholipase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABHD16A protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:3,723,756...3,738,617
Ensembl chr20:3,723,757...3,738,736
|
|
| G
|
Abi1
|
abl-interactor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABI1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:90,006,917...90,088,002
Ensembl chr17:90,006,925...90,087,827
|
|
| G
|
Abi2
|
abl-interactor 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABI2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597
|
|
| G
|
Abr
|
ABR activator of RhoGEF and GTPase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABR protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,760,743...61,959,467
|
|
| G
|
Abracl
|
ABRA C-terminal like
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABRACL protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:14,474,802...14,484,992
Ensembl chr 1:14,474,803...14,485,055
|
|
| G
|
Abraxas2
|
abraxas 2, BRISC complex subunit
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ABRAXAS2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:197,077,177...197,102,753
Ensembl chr 1:197,077,158...197,102,757
|
|
| G
|
Acaa1a
|
acetyl-CoA acyltransferase 1A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAA1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:127,956,129...127,966,241
|
|
| G
|
Acaa2
|
acetyl-CoA acyltransferase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAA2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
|
|
| G
|
Acaca
|
acetyl-CoA carboxylase alpha
|
affects expression decreases expression multiple interactions
|
ISO
|
Ivermectin affects the expression of ACACA mRNA Ivermectin results in decreased expression of ACACA mRNA; Ivermectin results in decreased expression of ACACA protein Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACACA protein] Ivermectin inhibits the reaction [Palmitic Acid results in decreased phosphorylation of ACACA protein]
|
CTD |
PMID:30738135 PMID:31199990 PMID:32959892 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888
|
|
| G
|
Acad11
|
acyl-CoA dehydrogenase family, member 11
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAD11 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:113,560,142...113,625,346
Ensembl chr 8:113,560,196...113,625,352
|
|
| G
|
Acad8
|
acyl-CoA dehydrogenase family, member 8
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAD8 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:33,641,420...33,665,542
Ensembl chr 8:33,641,420...33,665,542
|
|
| G
|
Acad9
|
acyl-CoA dehydrogenase family, member 9
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAD9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709
|
|
| G
|
Acadl
|
acyl-CoA dehydrogenase, long chain
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACADL protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164
|
|
| G
|
Acadm
|
acyl-CoA dehydrogenase medium chain
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACADM protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
|
|
| G
|
Acadsb
|
acyl-CoA dehydrogenase, short/branched chain
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACADSB protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:195,619,088...195,660,564
Ensembl chr 1:195,619,038...195,660,561
|
|
| G
|
Acadvl
|
acyl-CoA dehydrogenase, very long chain
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACADVL protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750
|
|
| G
|
Acap2
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAP2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:83,043,442...83,159,105
Ensembl chr11:83,043,511...83,159,107
|
|
| G
|
Acat1
|
acetyl-CoA acetyltransferase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAT1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042
|
|
| G
|
Acat2
|
acetyl-CoA acetyltransferase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACAT2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
|
|
| G
|
Acbd3
|
acyl-CoA binding domain containing 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACBD3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355
|
|
| G
|
Acbd5
|
acyl-CoA binding domain containing 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACBD5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:90,114,250...90,156,286
Ensembl chr17:90,114,375...90,156,286
|
|
| G
|
Acin1
|
apoptotic chromatin condensation inducer 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACIN1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
|
|
| G
|
Ackr1
|
atypical chemokine receptor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACKR1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:88,314,735...88,316,354
Ensembl chr13:88,293,188...88,317,807
|
|
| G
|
Acly
|
ATP citrate lyase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACLY protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
|
|
| G
|
Aco1
|
aconitase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACO1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
|
|
| G
|
Aco2
|
aconitase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACO2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892
|
|
| G
|
Acot1
|
acyl-CoA thioesterase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACOT1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749
|
|
| G
|
Acot13
|
acyl-CoA thioesterase 13
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACOT13 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876
|
|
| G
|
Acot7
|
acyl-CoA thioesterase 7
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACOT7 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033
|
|
| G
|
Acot9
|
acyl-CoA thioesterase 9
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACOT9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:43,922,943...43,973,311
Ensembl chr X:43,914,923...43,973,205
|
|
| G
|
Acox1
|
acyl-CoA oxidase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACOX1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
|
|
| G
|
Acp1
|
acid phosphatase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959
|
|
| G
|
Acp2
|
acid phosphatase 2, lysosomal
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACP2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:97,630,654...97,642,601
Ensembl chr 3:97,631,326...97,642,565
|
|
| G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACP5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:28,939,985...28,943,929
|
|
| G
|
Acsf2
|
acyl-CoA synthetase family member 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACSF2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050
|
|
| G
|
Acsf3
|
acyl-CoA synthetase family member 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACSF3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:67,743,660...67,784,109
Ensembl chr19:67,743,490...67,784,084
|
|
| G
|
Acsl1
|
acyl-CoA synthetase long-chain family member 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACSL1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
|
|
| G
|
Acsl3
|
acyl-CoA synthetase long-chain family member 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACSL3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
|
|
| G
|
Acsl4
|
acyl-CoA synthetase long-chain family member 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACSL4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
|
|
| G
|
Acss2
|
acyl-CoA synthetase short-chain family member 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACSS2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTA1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
decreases expression multiple interactions
|
ISO EXP
|
Ivermectin results in decreased expression of ACTA2 mRNA; Ivermectin results in decreased expression of ACTA2 protein Ivermectin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA]; Ivermectin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] Ivermectin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
|
CTD |
PMID:32959892 PMID:33955514 PMID:36555680 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Actb
|
actin, beta
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTB protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Actbl2
|
actin, beta-like 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTBL2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:44,591,391...44,594,138
Ensembl chr 2:44,591,391...44,594,138
|
|
| G
|
Actg1
|
actin, gamma 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTG1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
|
|
| G
|
Actl6a
|
actin-like 6A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTL6A protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:117,413,206...117,436,758
Ensembl chr 2:117,418,601...117,436,754
|
|
| G
|
Actn1
|
actinin, alpha 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTN1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
|
|
| G
|
Actn4
|
actinin alpha 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTN4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320
|
|
| G
|
Actr10
|
actin related protein 10
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTR10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:95,182,082...95,208,325
Ensembl chr 6:95,182,111...95,209,021
|
|
| G
|
Actr1a
|
actin related protein 1A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTR1A protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:255,179,241...255,199,009
Ensembl chr 1:255,179,242...255,199,459
|
|
| G
|
Actr1b
|
actin related protein 1B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTR1B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341
|
|
| G
|
Actr2
|
actin related protein 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTR2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998
|
|
| G
|
Actr3
|
actin related protein 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTR3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711
|
|
| G
|
Actr6
|
actin related protein 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACTR6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:26,037,574...26,058,362
Ensembl chr 7:26,037,574...26,060,604
|
|
| G
|
Acy1
|
aminoacylase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACY1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405
|
|
| G
|
Acyp1
|
acylphosphatase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ACYP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:110,650,213...110,663,404
Ensembl chr 6:110,650,213...110,663,612
|
|
| G
|
Adad2
|
adenosine deaminase domain containing 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADAD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:64,573,915...64,578,194
Ensembl chr19:64,573,883...64,578,192
|
|
| G
|
Adam10
|
ADAM metallopeptidase domain 10
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADAM10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600
|
|
| G
|
Adam9
|
ADAM metallopeptidase domain 9
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADAM9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646
|
|
| G
|
Adar
|
adenosine deaminase, RNA-specific
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADAR protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:177,436,094...177,475,971
|
|
| G
|
Adcy7
|
adenylate cyclase 7
|
multiple interactions
|
ISO
|
[Ivermectin co-treated with Albendazole] results in increased expression of ADCY7 mRNA
|
CTD |
PMID:16861626 |
|
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:34,914,322...34,936,743
|
|
| G
|
Add1
|
adducin 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADD1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:80,333,244...80,391,732
|
|
| G
|
Add2
|
adducin 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:120,001,977...120,101,090
Ensembl chr 4:120,002,054...120,101,091
|
|
| G
|
Add3
|
adducin 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADD3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504
|
|
| G
|
Adh5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADH5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:229,648,501...229,665,232
|
|
| G
|
Adi1
|
acireductone dioxygenase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADI1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:51,035,267...51,042,229
Ensembl chr 6:51,034,931...51,042,855
|
|
| G
|
Adissp
|
adipose secreted signaling protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADISSP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:138,817,752...138,832,208
Ensembl chr 3:138,813,179...138,831,847
|
|
| G
|
Adk
|
adenosine kinase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADK protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745
|
|
| G
|
Adm
|
adrenomedullin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADM mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adnp
|
activity-dependent neuroprotector homeobox
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADNP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188
|
|
| G
|
Adpgk
|
ADP-dependent glucokinase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADPGK protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:68,595,194...68,623,179
Ensembl chr 8:68,595,248...68,623,178
|
|
| G
|
Adrm1
|
ADRM1 26S proteasome ubiquitin receptor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADRM1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483
|
|
| G
|
Adsl
|
adenylosuccinate lyase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADSL protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872
|
|
| G
|
Adss2
|
adenylosuccinate synthase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ADSS2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:92,301,302...92,331,638
Ensembl chr13:92,301,302...92,331,638
|
|
| G
|
Afap1
|
actin filament associated protein 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AFAP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:78,967,961...79,081,032
Ensembl chr14:78,967,961...79,080,939
|
|
| G
|
Afdn
|
afadin, adherens junction formation factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AFDN protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:58,041,065...58,170,505
Ensembl chr 1:58,041,641...58,170,505
|
|
| G
|
Afg2a
|
AFG2 AAA ATPase homolog A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AFG2A protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:122,234,619...122,425,808
Ensembl chr 2:122,234,738...122,425,808
|
|
| G
|
Afg2b
|
AFG2 AAA ATPase homolog B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AFG2B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:130,148,061...130,162,458
Ensembl chr 3:130,148,301...130,162,112
|
|
| G
|
Afg3l2
|
AFG3 like matrix AAA peptidase subunit 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AFG3L2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:63,224,163...63,269,000
Ensembl chr18:63,224,163...63,269,000
|
|
| G
|
Agfg1
|
ArfGAP with FG repeats 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGFG1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910
|
|
| G
|
Agk
|
acylglycerol kinase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGK protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:70,081,550...70,160,642
Ensembl chr 4:70,081,035...70,160,709
|
|
| G
|
Agl
|
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGL protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724
|
|
| G
|
Ago1
|
argonaute RISC component 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGO1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624
|
|
| G
|
Ago2
|
argonaute RISC catalytic component 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGO2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
|
|
| G
|
Agpat5
|
1-acylglycerol-3-phosphate O-acyltransferase 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGPAT5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:77,641,887...77,688,148
Ensembl chr16:77,641,887...77,688,148
|
|
| G
|
Agps
|
alkylglycerone phosphate synthase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGPS protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:81,154,599...81,253,099
Ensembl chr 3:81,154,604...81,258,277
|
|
| G
|
Agr2
|
anterior gradient 2, protein disulphide isomerase family member
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGR2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677
|
|
| G
|
Agrn
|
agrin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGRN protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539
|
|
| G
|
Agtrap
|
angiotensin II receptor-associated protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AGTRAP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:163,790,565...163,802,174
Ensembl chr 5:163,791,887...163,802,174
|
|
| G
|
Ahctf1
|
AT hook containing transcription factor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHCTF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:94,013,894...94,068,348
Ensembl chr13:94,014,469...94,068,058
|
|
| G
|
Ahcy
|
adenosylhomocysteinase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHCY protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587
|
|
| G
|
Ahcyl1
|
adenosylhomocysteinase-like 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHCYL1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930
|
|
| G
|
Ahcyl2
|
adenosylhomocysteinase-like 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHCYL2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502
|
|
| G
|
Ahnak
|
AHNAK nucleoprotein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHNAK protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675
|
|
| G
|
Ahnak2
|
AHNAK nucleoprotein 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHNAK2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:137,648,867...137,697,580
Ensembl chr 6:137,652,537...137,675,546
|
|
| G
|
Ahsa1
|
activator of Hsp90 ATPase activity 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AHSA1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:112,644,479...112,655,595
|
|
| G
|
Aida
|
axin interactor, dorsalization associated
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AIDA protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:97,471,931...97,499,531
Ensembl chr13:97,471,604...97,499,535
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AIFM1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Aimp1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AIMP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994
|
|
| G
|
Aimp2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AIMP2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:15,814,854...15,824,432
Ensembl chr12:15,814,878...15,824,431
|
|
| G
|
Aip
|
aryl-hydrocarbon receptor-interacting protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AIP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634
|
|
| G
|
Ak1
|
adenylate kinase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AK1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Ak2
|
adenylate kinase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AK2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610
|
|
| G
|
Ak3
|
adenylate kinase 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AK3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
|
|
| G
|
Ak4
|
adenylate kinase 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AK4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
|
|
| G
|
Ak5
|
adenylate kinase 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AK5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366
|
|
| G
|
Ak6
|
adenylate kinase 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AK6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:33,528,388...33,540,445
Ensembl chr 2:33,528,035...33,540,441 Ensembl chr20:33,528,035...33,540,441
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKAP12 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akr1a1
|
aldo-keto reductase family 1 member A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR1A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035
|
|
| G
|
Akr1b1
|
aldo-keto reductase family 1 member B1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR1B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315
|
|
| G
|
Akr1c1
|
aldo-keto reductase family 1, member C1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR1C1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247
|
|
| G
|
Akr1c2
|
aldo-keto reductase family 1, member C2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR1C2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686
|
|
| G
|
Akr1c3
|
aldo-keto reductase family 1, member C3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR1C3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438
|
|
| G
|
Akr1d1
|
aldo-keto reductase family 1, member D1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR1D1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540
|
|
| G
|
Akr7a2
|
aldo-keto reductase family 7, member A2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKR7A2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKT1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt1s1
|
AKT1 substrate 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AKT1S1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:104,469,803...104,476,167
|
|
| G
|
Alb
|
albumin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALB protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alcam
|
activated leukocyte cell adhesion molecule
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALCAM protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
|
|
| G
|
Aldh16a1
|
aldehyde dehydrogenase 16 family, member A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH16A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:104,763,200...104,776,270
Ensembl chr 1:104,763,055...104,776,270
|
|
| G
|
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH18A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383
|
|
| G
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH1B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365
|
|
| G
|
Aldh1l2
|
aldehyde dehydrogenase 1 family, member L2
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ALDH1L2 mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr 7:22,141,872...22,193,403
Ensembl chr 7:22,141,842...22,193,398
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Aldh3a2
|
aldehyde dehydrogenase 3 family, member A2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH3A2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648
|
|
| G
|
Aldh4a1
|
aldehyde dehydrogenase 4 family, member A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH4A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673
|
|
| G
|
Aldh6a1
|
aldehyde dehydrogenase 6 family, member A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH6A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743
|
|
| G
|
Aldh9a1
|
aldehyde dehydrogenase 9 family, member A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDH9A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:82,038,679...82,055,478
Ensembl chr13:82,038,533...82,055,481
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDOA protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Aldoc
|
aldolase, fructose-bisphosphate C
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALDOC protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133
|
|
| G
|
Alg1
|
ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:10,853,014...10,863,250
Ensembl chr10:10,853,014...10,863,239
|
|
| G
|
Alg11
|
ALG11, alpha-1,2-mannosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG11 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:76,642,979...76,654,052
Ensembl chr16:76,646,795...76,654,040
|
|
| G
|
Alg2
|
ALG2, alpha-1,3/1,6-mannosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:66,564,328...66,568,887
Ensembl chr 5:66,564,330...66,568,887
|
|
| G
|
Alg3
|
ALG3, alpha-1,3- mannosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:93,804,859...93,810,403
Ensembl chr11:93,804,891...93,812,060
|
|
| G
|
Alg5
|
ALG5, dolichyl-phosphate beta-glucosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:141,087,126...141,101,397
Ensembl chr 2:141,087,147...141,102,951
|
|
| G
|
Alg6
|
ALG6, alpha-1,3-glucosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:119,520,415...119,606,365
Ensembl chr 5:119,520,430...119,606,659
|
|
| G
|
Alg8
|
ALG8, alpha-1,3-glucosyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALG8 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:161,095,570...161,115,533
Ensembl chr 1:161,095,412...161,115,527
|
|
| G
|
Alkbh7
|
alkB homolog 7
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALKBH7 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048
|
|
| G
|
Alyref
|
Aly/REF export factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ALYREF protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395
|
|
| G
|
Ampd2
|
adenosine monophosphate deaminase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AMPD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:198,395,767...198,408,514
Ensembl chr 2:198,395,768...198,408,796
|
|
| G
|
Amph
|
amphiphysin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AMPH protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:50,435,018...50,678,583
Ensembl chr17:50,435,018...50,678,501
|
|
| G
|
Anapc1
|
anaphase promoting complex subunit 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANAPC1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:136,303,350...136,383,464
Ensembl chr 3:136,303,413...136,383,464
|
|
| G
|
Anapc15
|
anaphase promoting complex subunit 15
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANAPC15 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:165,650,478...165,678,004
Ensembl chr 1:165,675,754...165,679,501
|
|
| G
|
Anapc2
|
anaphase promoting complex subunit 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANAPC2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:28,484,590...28,496,338
Ensembl chr 3:28,484,614...28,496,337
|
|
| G
|
Angptl6
|
angiopoietin-like 6
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ANGPTL6 mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr 8:27,689,804...27,696,172
Ensembl chr 8:27,689,806...27,696,111
|
|
| G
|
Ank2
|
ankyrin 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANK2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259
|
|
| G
|
Ankef1
|
ankyrin repeat and EF-hand domain containing 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKEF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:144,300,500...144,335,759
Ensembl chr 3:144,300,529...144,335,753
|
|
| G
|
Ankfy1
|
ankyrin repeat and FYVE domain containing 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKFY1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:57,810,781...57,882,495
Ensembl chr10:57,810,781...57,882,495
|
|
| G
|
Ankhd1
|
ankyrin repeat and KH domain containing 1
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ANKHD1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:28,436,296...28,534,954
Ensembl chr18:28,436,394...28,534,954
|
|
| G
|
Ankle2
|
ankyrin repeat and LEM domain containing 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKLE2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:52,077,863...52,110,775
Ensembl chr12:52,077,480...52,108,708
|
|
| G
|
Ankmy2
|
ankyrin repeat and MYND domain containing 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKMY2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:58,616,251...58,657,634
Ensembl chr 6:58,615,243...58,657,685
|
|
| G
|
Ankrd17
|
ankyrin repeat domain 17
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKRD17 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:18,007,342...18,145,980
Ensembl chr14:18,008,859...18,145,980
|
|
| G
|
Ankrd2
|
ankyrin repeat domain 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKRD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:250,796,419...250,805,867
Ensembl chr 1:250,796,409...250,805,870
|
|
| G
|
Ankrd26
|
ankyrin repeat domain containing 26
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKRD26 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:153,342,901...153,412,321
Ensembl chr 4:153,343,578...153,412,256
|
|
| G
|
Ankrd28
|
ankyrin repeat domain 28
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKRD28 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593
|
|
| G
|
Ankrd52
|
ankyrin repeat domain 52
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKRD52 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:1,390,730...1,410,139
Ensembl chr 7:1,391,325...1,407,410
|
|
| G
|
Ankrd54
|
ankyrin repeat domain 54
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKRD54 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:112,495,396...112,508,186
Ensembl chr 7:112,495,462...112,508,128
|
|
| G
|
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ANKS1B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:26,200,649...27,366,552
Ensembl chr 7:26,201,240...27,364,943
|
|
| G
|
Ankub1
|
ankyrin repeat and ubiquitin domain containing 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKUB1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:144,005,876...144,044,635
Ensembl chr 2:144,002,872...144,044,295
|
|
| G
|
Ankzf1
|
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANKZF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:84,136,862...84,143,830
Ensembl chr 9:84,136,862...84,145,091
|
|
| G
|
Anln
|
anillin, actin binding protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANLN protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513
|
|
| G
|
Ano1
|
anoctamin 1
|
decreases activity
|
ISO
|
Ivermectin results in decreased activity of ANO1 protein
|
CTD |
PMID:32201246 |
|
NCBI chr 1:209,180,755...209,329,413
Ensembl chr 1:209,180,755...209,329,550
|
|
| G
|
Anp32a
|
acidic nuclear phosphoprotein 32 family member A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANP32A protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922
|
|
| G
|
Anp32b
|
acidic nuclear phosphoprotein 32 family member B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANP32B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437
|
|
| G
|
Anp32e
|
acidic nuclear phosphoprotein 32 family member E
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANP32E protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986
|
|
| G
|
Anpep
|
alanyl aminopeptidase, membrane
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANPEP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101
|
|
| G
|
Anxa1
|
annexin A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa11
|
annexin A11
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA11 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839
|
|
| G
|
Anxa2
|
annexin A2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
|
|
| G
|
Anxa3
|
annexin A3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
|
|
| G
|
Anxa4
|
annexin A4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:120,741,750...120,798,513
|
|
| G
|
Anxa5
|
annexin A5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Anxa6
|
annexin A6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,602,106...39,657,359
|
|
| G
|
Anxa7
|
annexin A7
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ANXA7 protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891
|
|
| G
|
Ap1b1
|
adaptor related protein complex 1 subunit beta 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP1B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:84,093,529...84,144,835
Ensembl chr14:84,093,559...84,144,892
|
|
| G
|
Ap1g1
|
adaptor related protein complex 1 subunit gamma 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP1G1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:54,654,101...54,740,586
Ensembl chr19:54,620,807...54,740,586
|
|
| G
|
Ap1g2
|
adaptor related protein complex 1 subunit gamma 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP1G2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:32,541,528...32,549,392
Ensembl chr15:32,541,528...32,549,280
|
|
| G
|
Ap1m1
|
adaptor related protein complex 1 subunit mu 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP1M1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:17,620,910...17,636,431
Ensembl chr16:17,616,187...17,636,462
|
|
| G
|
Ap1s1
|
adaptor related protein complex 1 subunit sigma 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP1S1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:25,261,958...25,272,483
Ensembl chr12:25,262,036...25,272,483
|
|
| G
|
Ap2a1
|
adaptor related protein complex 2 subunit alpha 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP2A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655
|
|
| G
|
Ap2a2
|
adaptor related protein complex 2 subunit alpha 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP2A2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:206,081,856...206,155,146
Ensembl chr 1:206,081,878...206,155,150
|
|
| G
|
Ap2b1
|
adaptor related protein complex 2 subunit beta 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP2B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539
|
|
| G
|
Ap2m1
|
adaptor related protein complex 2 subunit mu 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP2M1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480
|
|
| G
|
Ap2s1
|
adaptor related protein complex 2 subunit sigma 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP2S1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:86,545,350...86,557,009
|
|
| G
|
Ap3b1
|
adaptor related protein complex 3 subunit beta 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP3B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:27,331,241...27,535,683
Ensembl chr 2:27,334,900...27,537,702
|
|
| G
|
Ap3d1
|
adaptor related protein complex 3 subunit delta 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP3D1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342
|
|
| G
|
Ap3m1
|
adaptor related protein complex 3 subunit mu 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP3M1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:3,285,591...3,314,139
Ensembl chr15:3,295,444...3,313,104
|
|
| G
|
Ap3s1
|
adaptor related protein complex 3 subunit sigma 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP3S1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:41,649,321...41,718,221
Ensembl chr18:41,648,796...41,767,641
|
|
| G
|
Ap4s1
|
adaptor related protein complex 4 subunit sigma 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP4S1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:74,863,742...74,916,907
Ensembl chr 6:74,868,558...74,912,406
|
|
| G
|
Ap5z1
|
adaptor related protein complex 5 subunit zeta 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AP5Z1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:17,207,315...17,222,975
Ensembl chr12:17,207,315...17,222,467
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APAF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apbb1ip
|
amyloid beta precursor protein binding family B member 1 interacting protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APBB1IP protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:89,849,474...89,941,099
Ensembl chr17:89,671,716...89,941,089
|
|
| G
|
Apeh
|
acylaminoacyl-peptide hydrolase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APEH protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APEX1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Apip
|
APAF1 interacting protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APIP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:109,886,919...109,913,295
Ensembl chr 3:109,886,953...109,915,862
|
|
| G
|
Aplp2
|
amyloid beta precursor like protein 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APLP2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
|
|
| G
|
Apmap
|
adipocyte plasma membrane associated protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APMAP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:159,869,451...159,897,727
Ensembl chr 3:159,869,451...159,897,726
|
|
| G
|
Apob
|
apolipoprotein B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APOB protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoe
|
apolipoprotein E
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APOE protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Apol2
|
apolipoprotein L2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APOL2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:111,211,893...111,217,223
|
|
| G
|
Apoo
|
apolipoprotein O
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APOO protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:63,151,736...63,256,696
Ensembl chr X:63,151,814...63,256,690
|
|
| G
|
App
|
amyloid beta precursor protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APP protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Appl1
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APPL1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,125,234...2,173,421
|
|
| G
|
Appl2
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APPL2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:22,022,963...22,072,385
|
|
| G
|
Aprt
|
adenine phosphoribosyl transferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of APRT protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:67,534,737...67,537,027
|
|
| G
|
Aqr
|
aquarius intron-binding spliceosomal factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AQR protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:121,329,287...121,399,375
Ensembl chr 3:121,329,289...121,399,321
|
|
| G
|
Arap1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARAP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:165,160,701...165,226,219
Ensembl chr 1:165,160,678...165,226,218
|
|
| G
|
Arcn1
|
archain 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARCN1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:53,954,401...53,979,005
Ensembl chr 8:53,954,404...53,979,005
|
|
| G
|
Arf1
|
ARF GTPase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:44,497,543...44,513,994
|
|
| G
|
Arf4
|
ARF GTPase 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARF4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011
|
|
| G
|
Arf5
|
ARF GTPase 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARF5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835
|
|
| G
|
Arf6
|
ARF GTPase 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARF6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:93,569,234...93,610,536
|
|
| G
|
Arfgap1
|
ARF GTPase activating protein 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARFGAP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:188,462,125...188,477,515
Ensembl chr 3:188,465,648...188,511,078
|
|
| G
|
Arfgap2
|
ARF GTPase activating protein 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARFGAP2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:97,692,105...97,704,246
Ensembl chr 3:97,692,110...97,704,247
|
|
| G
|
Arfgap3
|
ARF GTPase activating protein 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARFGAP3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:116,312,996...116,359,300
Ensembl chr 7:116,313,001...116,359,592
|
|
| G
|
Arfgef1
|
ARF guanine nucleotide exchange factor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARFGEF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:13,764,507...13,859,237
Ensembl chr 5:13,764,975...13,859,237
|
|
| G
|
Arfgef2
|
ARF guanine nucleotide exchange factor 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARFGEF2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:175,966,575...176,052,715
Ensembl chr 3:175,966,579...176,052,713
|
|
| G
|
Arfip1
|
ARF interacting protein 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARFIP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:172,141,862...172,224,464
Ensembl chr 2:172,141,859...172,221,280
|
|
| G
|
Arhgap1
|
Rho GTPase activating protein 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:98,077,064...98,099,163
Ensembl chr 3:98,077,150...98,099,154
|
|
| G
|
Arhgap12
|
Rho GTPase activating protein 12
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP12 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:56,284,282...56,397,630
Ensembl chr17:56,284,286...56,397,563
|
|
| G
|
Arhgap17
|
Rho GTPase activating protein 17
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP17 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:187,238,380...187,327,936
|
|
| G
|
Arhgap18
|
Rho GTPase activating protein 18
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP18 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670
|
|
| G
|
Arhgap29
|
Rho GTPase activating protein 29
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP29 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729
|
|
| G
|
Arhgap35
|
Rho GTPase activating protein 35
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP35 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:86,330,566...86,447,414
Ensembl chr 1:86,330,566...86,447,414
|
|
| G
|
Arhgap4
|
Rho GTPase activating protein 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGAP4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:156,787,566...156,802,841
Ensembl chr X:156,783,776...156,802,450
|
|
| G
|
Arhgdia
|
Rho GDP dissociation inhibitor alpha
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGDIA protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347
|
|
| G
|
Arhgef1
|
Rho guanine nucleotide exchange factor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:89,626,884...89,648,823
Ensembl chr 1:89,628,266...89,649,067
|
|
| G
|
Arhgef10
|
Rho guanine nucleotide exchange factor 10
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:81,349,429...81,440,439
Ensembl chr16:81,349,429...81,440,054
|
|
| G
|
Arhgef12
|
Rho guanine nucleotide exchange factor 12
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF12 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:52,247,047...52,373,158
Ensembl chr 8:52,247,047...52,372,376
|
|
| G
|
Arhgef16
|
Rho guanine nucleotide exchange factor 16
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF16 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:170,126,573...170,148,624
Ensembl chr 5:170,126,575...170,148,624
|
|
| G
|
Arhgef2
|
Rho/Rac guanine nucleotide exchange factor 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
|
|
| G
|
Arhgef26
|
Rho guanine nucleotide exchange factor 26
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF26 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:148,889,405...149,000,538
Ensembl chr 2:148,889,423...149,000,538
|
|
| G
|
Arhgef28
|
Rho guanine nucleotide exchange factor 28
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARHGEF28 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:30,998,292...31,294,757
Ensembl chr 2:30,998,295...31,294,853
|
|
| G
|
Arih1
|
ariadne RBR E3 ubiquitin protein ligase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARIH1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:68,673,199...68,775,648
Ensembl chr 8:68,673,200...68,775,572
|
|
| G
|
Ark2n
|
arkadia (RNF111) N-terminal like PKA signaling regulator 2N
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARK2N protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:73,431,104...73,520,759
Ensembl chr18:73,431,104...73,518,144
|
|
| G
|
Arl1
|
ARF like GTPase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:25,007,401...25,018,572
Ensembl chr 7:25,006,981...25,019,319
|
|
| G
|
Arl2
|
ARF like GTPase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:212,863,422...212,875,425
Ensembl chr 1:212,863,423...212,875,373
|
|
| G
|
Arl2bp
|
ARF like GTPase 2 binding protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL2BP protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514
|
|
| G
|
Arl3
|
ARF like GTPase 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279
|
|
| G
|
Arl4c
|
ARF like GTPase 4C
|
multiple interactions
|
ISO
|
[Ivermectin co-treated with Albendazole] results in decreased expression of ARL4C mRNA
|
CTD |
PMID:16861626 |
|
NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772
|
|
| G
|
Arl6ip4
|
ARF like GTPase 6 interacting protein 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL6IP4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:38,140,566...38,142,711
Ensembl chr12:38,140,550...38,142,724
|
|
| G
|
Arl6ip5
|
ARF like GTPase 6 interacting protein 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL6IP5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130
|
|
| G
|
Arl8a
|
ARF like GTPase 8A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL8A protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:49,137,632...49,146,633
Ensembl chr13:49,137,632...49,146,633
|
|
| G
|
Arl8b
|
ARF like GTPase 8B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARL8B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:143,304,597...143,348,580
Ensembl chr 4:143,304,621...143,349,068
|
|
| G
|
Armc1
|
armadillo repeat containing 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARMC1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:103,524,333...103,568,355
Ensembl chr 2:103,524,333...103,568,355
|
|
| G
|
Armc10
|
armadillo repeat containing 10
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARMC10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:14,291,211...14,306,799
Ensembl chr 4:14,291,211...14,306,817
|
|
| G
|
Armc8
|
armadillo repeat containing 8
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARMC8 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717
|
|
| G
|
Armc9
|
armadillo repeat containing 9
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARMC9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:94,250,492...94,376,589
Ensembl chr 9:94,250,859...94,376,589
|
|
| G
|
Armcx3
|
armadillo repeat containing, X-linked 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARMCX3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:102,230,464...102,234,017
Ensembl chr X:102,219,848...102,263,297
|
|
| G
|
Armt1
|
acidic residue methyltransferase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of DCPH1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:43,299,916...43,323,675
Ensembl chr 1:43,299,826...43,323,670
|
|
| G
|
Arpc1a
|
actin related protein 2/3 complex, subunit 1A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPC1A protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:14,616,245...14,639,052
Ensembl chr12:14,616,248...14,639,052
|
|
| G
|
Arpc1b
|
actin related protein 2/3 complex, subunit 1B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPC1B protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504
|
|
| G
|
Arpc2
|
actin related protein 2/3 complex, subunit 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPC2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:83,269,932...83,305,409
|
|
| G
|
Arpc3
|
actin related protein 2/3 complex, subunit 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPC3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:39,833,569...39,847,436
Ensembl chr12:39,833,569...39,847,436
|
|
| G
|
Arpc5
|
actin related protein 2/3 complex, subunit 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPC5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283
|
|
| G
|
Arpc5l
|
actin related protein 2/3 complex, subunit 5-like
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPC5L protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240 Ensembl chr 9:43,169,462...43,177,240
|
|
| G
|
Arpp19
|
cAMP-regulated phosphoprotein 19
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARPP19 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385 Ensembl chr 8:119,691,942...119,692,385
|
|
| G
|
Arrb2
|
arrestin, beta 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARRB2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487
|
|
| G
|
Arsl
|
arylsulfatase L
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ARSL protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:120,966,992...120,975,015
Ensembl chr 2:120,966,950...120,975,011
|
|
| G
|
As3mt
|
arsenite methyltransferase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AS3MT protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249
|
|
| G
|
Asah1
|
N-acylsphingosine amidohydrolase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASAH1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305
|
|
| G
|
Asb9
|
ankyrin repeat and SOCS box-containing 9
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASB9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:33,588,484...33,633,285
Ensembl chr X:33,588,484...33,624,397
|
|
| G
|
Ascc1
|
activating signal cointegrator 1 complex subunit 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASCC1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:28,484,044...28,574,195
Ensembl chr20:28,483,956...28,574,200
|
|
| G
|
Ascc2
|
activating signal cointegrator 1 complex subunit 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASCC2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:83,726,975...83,771,312
Ensembl chr14:83,727,049...83,771,316
|
|
| G
|
Ascc3
|
activating signal cointegrator 1 complex subunit 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASCC3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:55,089,430...55,372,374
Ensembl chr20:55,255,503...55,372,374
|
|
| G
|
Asf1a
|
anti-silencing function 1A histone chaperone
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASF1A protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:33,436,632...33,451,478
Ensembl chr20:33,436,707...33,449,639
|
|
| G
|
Asf1b
|
anti-silencing function 1B histone chaperone
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASF1B protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352
|
|
| G
|
Asl
|
argininosuccinate lyase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASL protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261
|
|
| G
|
Asmtl
|
acetylserotonin O-methyltransferase-like
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASMTL protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:21,429,119...21,431,847
Ensembl chr12:21,429,171...21,431,847
|
|
| G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASNS protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
|
|
| G
|
Aspdh
|
aspartate dehydrogenase domain containing
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASPDH protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:104,094,983...104,097,244
Ensembl chr 1:104,094,954...104,097,244
|
|
| G
|
Asph
|
aspartate-beta-hydroxylase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ASPH protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:27,398,949...27,611,215
|
|
| G
|
Atad1
|
ATPase family, AAA domain containing 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATAD1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:239,957,329...240,023,792
Ensembl chr 1:239,957,882...240,009,822
|
|
| G
|
Atad2
|
ATPase family, AAA domain containing 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATAD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238
|
|
| G
|
Atad3a
|
ATPase family, AAA domain containing 3A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATAD3A protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:171,632,545...171,652,725
Ensembl chr 5:171,632,547...171,652,725
|
|
| G
|
Ate1
|
arginyltransferase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATE1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:194,391,843...194,514,284
Ensembl chr 1:194,391,843...194,511,348
|
|
| G
|
Atf4
|
activating transcription factor 4
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ATF4 mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
|
|
| G
|
Atf5
|
activating transcription factor 5
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ATF5 mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183
|
|
| G
|
Atf6
|
activating transcription factor 6
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ATF6 mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atg3
|
autophagy related 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATG3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280
|
|
| G
|
Atg4b
|
autophagy related 4B, cysteine peptidase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATG4B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:101,729,772...101,761,456
Ensembl chr 9:101,726,782...101,761,622
|
|
| G
|
Atg5
|
autophagy related 5
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATG5 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Atg7
|
autophagy related 7
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATG7 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319
|
|
| G
|
Atg9a
|
autophagy related 9A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATG9A protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:84,126,071...84,136,723
Ensembl chr 9:84,126,071...84,136,666
|
|
| G
|
Atic
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATIC protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756
|
|
| G
|
Atl1
|
atlastin GTPase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATL1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:94,113,149...94,210,955
Ensembl chr 6:94,112,877...94,211,219
|
|
| G
|
Atl2
|
atlastin GTPase 2
|
increases expression
|
ISO
|
Ivermectin results in increased expression of ATL2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320
|
|
| G
|
Atl3
|
atlastin GTPase 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATL3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:214,110,127...214,151,098
Ensembl chr 1:214,109,702...214,152,510
|
|
| G
|
Atox1
|
antioxidant 1 copper chaperone
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATOX1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585
|
|
| G
|
Atp11a
|
ATPase phospholipid transporting 11A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP11A protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:83,359,884...83,469,807
Ensembl chr16:83,359,884...83,469,767
|
|
| G
|
Atp12a
|
ATPase H+/K+ transporting non-gastric alpha2 subunit
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP12A protein
|
CTD |
PMID:32959892 |
|
NCBI chr15:34,559,209...34,583,866
Ensembl chr15:34,559,209...34,583,866
|
|
| G
|
Atp13a1
|
ATPase 13A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP13A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:19,649,065...19,665,126
Ensembl chr16:19,649,066...19,665,120
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP1A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP1A2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
|
|
| G
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP1A3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825
|
|
| G
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP1B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
|
|
| G
|
Atp1b3
|
ATPase Na+/K+ transporting subunit beta 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP1B3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304 Ensembl chr 8:65,253,361...65,254,304
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP2A2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp2b1
|
ATPase plasma membrane Ca2+ transporting 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP2B1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904
|
|
| G
|
Atp2c1
|
ATPase secretory pathway Ca2+ transporting 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP2C1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:114,913,551...115,034,706
Ensembl chr 8:114,913,415...115,038,826
|
|
| G
|
Atp5f1a
|
ATP synthase F1 subunit alpha
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5F1A protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5F1B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Atp5f1c
|
ATP synthase F1 subunit gamma
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5F1C protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073
|
|
| G
|
Atp5f1d
|
ATP synthase F1 subunit delta
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5F1D protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583
|
|
| G
|
Atp5if1
|
ATP synthase inhibitory factor subunit 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5IF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677
|
|
| G
|
Atp5me
|
ATP synthase membrane subunit e
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5ME protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988
|
|
| G
|
Atp5mf
|
ATP synthase membrane subunit f
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5MF protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709
|
|
| G
|
Atp5mg
|
ATP synthase membrane subunit G
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5MG protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831
|
|
| G
|
Atp5mk
|
ATP synthase membrane subunit K
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5MK protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:255,915,255...255,922,185
Ensembl chr 1:255,915,259...255,922,106 Ensembl chr10:255,915,259...255,922,106
|
|
| G
|
Atp5pb
|
ATP synthase peripheral stalk-membrane subunit b
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5PB protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387
|
|
| G
|
Atp5pd
|
ATP synthase peripheral stalk subunit d
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5PD protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:101,156,673...101,161,926
Ensembl chr10:101,156,673...101,162,954
|
|
| G
|
Atp5pf
|
ATP synthase peripheral stalk subunit F6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5PF protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:37,368,045...37,375,721
Ensembl chr11:37,368,042...37,375,466
|
|
| G
|
Atp5po
|
ATP synthase peripheral stalk subunit OSCP
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP5PO protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520
|
|
| G
|
Atp6v0a1
|
ATPase H+ transporting V0 subunit a1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V0A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:86,436,089...86,490,185
Ensembl chr10:86,436,141...86,490,181
|
|
| G
|
Atp6v0c
|
ATPase H+ transporting V0 subunit C
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V0C protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:13,700,764...13,707,147
Ensembl chr10:13,700,764...13,706,245
|
|
| G
|
Atp6v0d1
|
ATPase H+ transporting V0 subunit D1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V0D1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395
|
|
| G
|
Atp6v1a
|
ATPase H+ transporting V1 subunit A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1A protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603
|
|
| G
|
Atp6v1b2
|
ATPase H+ transporting V1 subunit B2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1B2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:25,384,254...25,408,388
Ensembl chr16:25,384,257...25,408,839
|
|
| G
|
Atp6v1c1
|
ATPase H+ transporting V1 subunit C1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1C1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:71,719,404...71,757,184
|
|
| G
|
Atp6v1d
|
ATPase H+ transporting V1 subunit D
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1D protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346
|
|
| G
|
Atp6v1e1
|
ATPase H+ transporting V1 subunit E1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1E1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:155,694,534...155,716,660
Ensembl chr 4:155,694,534...155,716,678
|
|
| G
|
Atp6v1f
|
ATPase H+ transporting V1 subunit F
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1F protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:59,033,020...59,035,980
|
|
| G
|
Atp6v1g1
|
ATPase H+ transporting V1 subunit G1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1G1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930
|
|
| G
|
Atp6v1h
|
ATPase H+ transporting V1 subunit H
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP6V1H protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516
|
|
| G
|
Atp8a1
|
ATPase phospholipid transporting 8A1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATP8A1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463
|
|
| G
|
Atrx
|
ATRX, chromatin remodeler
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATRX protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:74,916,548...75,062,880
|
|
| G
|
Atxn10
|
ataxin 10
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATXN10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:118,321,516...118,444,967
Ensembl chr 7:118,319,490...118,445,636
|
|
| G
|
Atxn2
|
ataxin 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATXN2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:40,413,657...40,509,895
Ensembl chr12:40,414,904...40,510,473
|
|
| G
|
Atxn2l
|
ataxin 2-like
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATXN2L protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:190,508,878...190,526,263
Ensembl chr 1:190,508,878...190,520,579
|
|
| G
|
Atxn7l3b
|
ataxin 7-like 3B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of ATXN7L3B protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:50,208,666...50,212,190
Ensembl chr 7:50,208,676...50,212,190
|
|
| G
|
Aurkb
|
aurora kinase B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AURKB protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
|
|
| G
|
Avl9
|
AVL9 cell migration associated
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of AVL9 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:87,291,062...87,338,537
Ensembl chr 4:87,291,798...87,331,916
|
|
| G
|
B2m
|
beta-2 microglobulin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of B2M protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356
|
|
| G
|
B3galt6
|
Beta-1,3-galactosyltransferase 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of B3GALT6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:171,866,428...171,868,564
Ensembl chr 5:171,864,094...171,874,789
|
|
| G
|
B3gat3
|
beta-1,3-glucuronyltransferase 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of B3GAT3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:215,246,453...215,253,033
Ensembl chr 1:215,246,482...215,266,876
|
|
| G
|
B4galt1
|
beta-1,4-galactosyltransferase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of B4GALT1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445
|
|
| G
|
B4galt4
|
beta-1,4-galactosyltransferase 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of B4GALT4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:75,501,358...75,527,291
Ensembl chr11:75,501,366...75,527,177
|
|
| G
|
Babam1
|
BRISC and BRCA1 A complex member 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BABAM1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr16:18,102,885...18,108,916
Ensembl chr16:18,102,815...18,108,932
|
|
| G
|
Babam2
|
BRISC and BRCA1 A complex member 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BABAM2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:30,089,065...30,467,508
Ensembl chr 6:30,071,611...30,467,341
|
|
| G
|
Bacc1
|
BPTF associated chromatin complex component 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BACC1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:55,450,648...55,453,409
Ensembl chr10:55,450,250...55,453,311
|
|
| G
|
Bag2
|
BAG cochaperone 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BAG2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
multiple interactions decreases expression
|
ISO
|
[Ivermectin co-treated with Albendazole] results in increased expression of BAG3 mRNA Ivermectin results in decreased expression of BAG3 protein
|
CTD |
PMID:16861626 PMID:32959892 |
|
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bag6
|
BAG cochaperone 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BAG6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,680,607...3,693,329
|
|
| G
|
Baiap2
|
BAR/IMD domain containing adaptor protein 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BAIAP2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549
|
|
| G
|
Baiap2l1
|
BAR/IMD domain containing adaptor protein 2 like 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BAIAP2L1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605
|
|
| G
|
Bak1
|
BCL2-antagonist/killer 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BAK1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
| G
|
Banf1
|
barrier to autointegration nuclear assembly factor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BANF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:212,101,523...212,103,552
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
decreases expression multiple interactions increases expression
|
ISO
|
Ivermectin results in decreased expression of BAX protein Glutathione inhibits the reaction [Ivermectin results in increased expression of BAX protein]
|
CTD |
PMID:28811376 PMID:32959892 PMID:34904774 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Baz1b
|
bromodomain adjacent to zinc finger domain, 1B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BAZ1B protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:27,068,541...27,126,511
Ensembl chr12:27,068,541...27,126,511
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
multiple interactions
|
ISO
|
Ivermectin inhibits the reaction [geranylgeranic acid results in increased expression of BBC3 mRNA]
|
CTD |
PMID:24658405 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bcam
|
basal cell adhesion molecule (Lutheran blood group)
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCAM protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:88,542,971...88,557,358
Ensembl chr 1:88,542,972...88,557,888
|
|
| G
|
Bcap31
|
B-cell receptor-associated protein 31
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCAP31 protein
|
CTD |
PMID:32959892 |
|
NCBI chr X:156,548,911...156,581,002
Ensembl chr X:156,548,911...156,579,371
|
|
| G
|
Bcas2
|
BCAS2, pre-mRNA processing factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCAS2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:193,381,000...193,388,881
Ensembl chr 2:193,380,982...193,388,878
|
|
| G
|
Bcat2
|
branched chain amino acid transaminase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCAT2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463
|
|
| G
|
Bccip
|
BRCA2 and CDKN1A interacting protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCCIP protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:197,942,535...197,954,948
Ensembl chr 1:197,942,190...197,956,378
|
|
| G
|
Bckdha
|
branched chain keto acid dehydrogenase E1 subunit alpha
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCKDHA protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:90,266,731...90,295,521
Ensembl chr 1:90,261,629...90,295,749
|
|
| G
|
Bckdhb
|
branched chain keto acid dehydrogenase E1 subunit beta
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCKDHB protein
|
CTD |
PMID:32959892 |
|
NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798
|
|
| G
|
Bckdk
|
branched chain ketoacid dehydrogenase kinase
|
increases expression
|
ISO
|
Ivermectin results in increased expression of BCKDK protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453
|
|
| G
|
Bcl10
|
BCL10, immune signaling adaptor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCL10 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO
|
Ivermectin results in decreased expression of BCL2 protein Glutathione inhibits the reaction [Ivermectin results in decreased expression of BCL2 protein]
|
CTD |
PMID:34904774 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l13
|
Bcl2-like 13
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCL2L13 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:155,728,284...155,785,058
Ensembl chr 4:155,728,284...155,781,158
|
|
| G
|
Bcl7b
|
BAF chromatin remodeling complex subunit BCL7B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCL7B protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:27,133,412...27,146,631
Ensembl chr12:27,133,412...27,146,636
|
|
| G
|
Bclaf1
|
BCL2-associated transcription factor 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BCLAF1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801
|
|
| G
|
Bdh1
|
3-hydroxybutyrate dehydrogenase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BDH1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636
|
|
| G
|
Bdh2
|
3-hydroxybutyrate dehydrogenase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BDH2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006
|
|
| G
|
Bet1
|
Bet1 golgi vesicular membrane trafficking protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BET1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:33,070,892...33,081,162
Ensembl chr 4:33,070,891...33,081,164
|
|
| G
|
Bet1l
|
Bet1 golgi vesicular membrane trafficking protein-like
|
increases expression
|
ISO
|
Ivermectin results in increased expression of BET1L protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:205,361,041...205,365,036
Ensembl chr 1:205,361,041...205,364,706
|
|
| G
|
Bicd2
|
BICD cargo adaptor 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BICD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,435,894...15,511,305
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BID protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Bin1
|
bridging integrator 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BIN1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458
|
|
| G
|
Birc6
|
baculoviral IAP repeat-containing 6
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BIRC6 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 6:26,474,843...26,668,275
Ensembl chr 6:26,474,843...26,668,507
|
|
| G
|
Blmh
|
bleomycin hydrolase
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BLMH protein
|
CTD |
PMID:32959892 |
|
NCBI chr10:62,270,170...62,313,349
Ensembl chr10:62,270,033...62,313,345
|
|
| G
|
Bloc1s2
|
biogenesis of lysosomal organelles complex-1, subunit 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BLOC1S2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:252,973,202...252,980,873
|
|
| G
|
Blvra
|
biliverdin reductase A
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BLVRA protein
|
CTD |
PMID:32959892 |
|
NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785
|
|
| G
|
Blvrb
|
biliverdin reductase B
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BLVRB protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225
|
|
| G
|
Bmp2k
|
BMP-2 inducible kinase
|
increases expression
|
ISO
|
Ivermectin results in increased expression of BMP2K protein
|
CTD |
PMID:32959892 |
|
NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657
|
|
| G
|
Bms1
|
BMS1 ribosome biogenesis factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BMS1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:153,230,471...153,267,437
Ensembl chr 4:153,230,471...153,267,429
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BNIP3 mRNA
|
CTD |
PMID:28942281 |
|
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bola2
|
bolA family member 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BOLA2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:190,722,535...190,723,401
Ensembl chr 8:64,800,454...64,800,714 Ensembl chr 1:64,800,454...64,800,714
|
|
| G
|
Bop1
|
BOP1 ribosomal biogenesis factor
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BOP1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529
|
|
| G
|
Bpnt1
|
3'(2'), 5'-bisphosphate nucleotidase 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BPNT1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:99,397,127...99,425,056
Ensembl chr13:99,400,115...99,425,053
|
|
| G
|
Bpnt2
|
3'(2'), 5'-bisphosphate nucleotidase 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BPNT2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126
|
|
| G
|
Brat1
|
BRCA1-associated ATM activator 1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRAT1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:19,043,004...19,065,686
Ensembl chr12:19,042,591...19,055,369
|
|
| G
|
Brcc3
|
BRCA1/BRCA2-containing complex subunit 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRCC3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:2,073,184...2,084,185
|
|
| G
|
Brd2
|
bromodomain containing 2
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRD2 protein
|
CTD |
PMID:32959892 |
|
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
|
|
| G
|
Brd4
|
bromodomain containing 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRD4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923
|
|
| G
|
Brd8
|
bromodomain containing 8
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRD8 protein
|
CTD |
PMID:32959892 |
|
NCBI chr18:26,455,824...26,504,106
Ensembl chr18:26,455,512...26,504,006
|
|
| G
|
Bri3bp
|
Bri3 binding protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRI3BP protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:36,838,098...36,849,919
Ensembl chr12:36,838,098...36,849,919
|
|
| G
|
Brix1
|
biogenesis of ribosomes BRX1
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRIX1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:61,177,769...61,188,647
Ensembl chr 2:61,177,771...61,188,647
|
|
| G
|
Brk1
|
BRICK1 subunit of SCAR/WAVE actin nucleating complex
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BRK1 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 4:148,306,436...148,321,668
Ensembl chr 4:148,306,398...148,321,984
|
|
| G
|
Brox
|
BRO1 domain and CAAX motif containing
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BROX protein
|
CTD |
PMID:32959892 |
|
NCBI chr13:97,451,736...97,471,598
Ensembl chr13:97,451,737...97,471,519
|
|
| G
|
Bsg
|
basigin
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BSG protein
|
CTD |
PMID:32959892 |
|
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|
| G
|
Btf3
|
basic transcription factor 3
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BTF3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125 Ensembl chr13:31,394,011...31,401,125
|
|
| G
|
Btf3l4
|
basic transcription factor 3-like 4
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BTF3L4 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 5:128,796,594...128,816,219
Ensembl chr 5:128,796,594...128,816,602
|
|
| G
|
Bub3
|
BUB3 mitotic checkpoint protein
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BUB3 protein
|
CTD |
PMID:32959892 |
|
NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028
|
|
| G
|
Bud31
|
BUD31 homolog
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BUD31 protein
|
CTD |
PMID:32959892 |
|
NCBI chr12:14,576,602...14,584,132
Ensembl chr12:14,576,605...14,584,039
|
|
| G
|
Bysl
|
bystin-like
|
decreases expression
|
ISO
|
Ivermectin results in decreased expression of BYSL protein
|
CTD |
PMID:32959892 |
|
NCBI chr 9:20,880,341...20,890,092
Ensembl chr 9:20,880,026...20,890,900
|
|